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A Introduction 
1 Photoredox chemistry 
Photoredox catalysis using visible light is one of the few reaction processes, which can be 
performed directly using a renewable energy source, namely sunlight. The potential of 
photochemistry was realized from one of the early pioneers of this field of research, Giacomo 
Ciamician. In a talk at the Société Française de Chimie (French Chemical Society) in 1908, he 
established the idea of “green chemistry”, highlighting the importance of sustainability. 
Further Giacomo Ciamician predicted that the study and exploration of solar energy would be 
necessary for the global society once the fossil fuels were depleted.1 
Since that time photochemistry has become a powerful methodology that generates reactive 
radical species without the use of toxic or explosive reagents, such as tin reagents or 
peroxides.2 Only a few molecules absorb light in the visible range, therefore short wavelength 
and high energy ultra-violet (UV) irradiation is required to excite these molecules directly. 
Irradiation with UV light is problematic due to the stability of molecular bonds and 
occupational safety of researcher and employees. Instead of irradiation with short wavelength, 
various photosensitizers, which absorb photons from visible light and transfer the energy to 
the reagents, has been applied for the excitation of these non-absorbing molecules. Besides 
organic dyes and inorganic semiconductors, most commonly used photocatalysts in organic 
synthesis are transition-metal-pyridyl complexes, such as [Ru(bpy)3]Cl2 (bpy = 2,2´-
bipyridine).3 Under visible light irradiation, transition-metal based photocatalysts are able to 
undergo single-electron transfer (SET) processes. This grants access to reactive radical 
intermediates and new chemical transformations under ambient temperatures and mild 
reaction conditions.4 Following, the mechanisms of different catalytic processes of the 
photocatalysts were described. 
Visible light-induced transformations begin with the absorption of the emitted photons by the 
photocatalyst (PC). Subsequently the excited catalyst [PC*] can interact with suitable 
substrates in single electron transfer reactions or energy transfer. Distinction is made between 
the oxidative and reductive quenching cycle (Scheme 1).  
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Scheme 1. Photoredox catalysis of a photocatalyst (PC) by reductive, oxidative, or energy transfer 
pathways. EA = electron acceptor, ED = electron donor, EQ = energy quencher. 
 
A closer look in the molecular orbital diagram illustrates the excitation of photocatalysts 
(Scheme 2). For octahedral complexes, such as [Ru(bpy)3]2+ or Ir[(ppy)2(dtb-bpy)]+ 
(ppy = phenylpyridine, dtb-bpy = 4,4´-di-tert-butyl-2,2´-bipyridine), the metal-centered t2g 
orbital is fully occupied. Through absorption of visible light an electron is excited into the 
ligand-centered πL* (S1) via metal to ligand charge transfer (MLCT). The singlet πL* (S1) state 
rapidly undergoes intersystem crossing (ISC) and internal conversion to generate the first 
triplet excited state πL* (T1). The energy in the excited photocatalyst [PC]* can lead to 
phosphorescence, alternate intersystem crossing, or intermolecular quenching. The latter 
enables electron transfer mechanisms and productive chemistry.5,6 
 
piL*(T1)
t2g
eg
piL*
(S1)
t2g
eg
piL*
(S1) hν
MLCT
ISC
t2g
eg
[PC]*PC
 
Scheme 2. Jablonski diagram of a visible light-promoted excitation of a transition metal based 
photocatalyst (PC). 
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If a suitable electron donor (ED) is present in the reaction, the catalytic active photocatalyst 
[PC]* undergoes reductive quenching (Scheme 3). An electron of the highest occupied 
molecular orbital (HOMO) of the substrate donates into orbital t2g, whereby the catalyst gets 
reduced (PC-). In presence of an electron acceptor (EA), the catalyst [PC]* acts as a reductant 
and reduces the substrate via electron transfer from πL* state to the lowest unoccupied 
molecular orbital (LUMO) of the EA molecule. This oxidative quenching cycle leads to the 
cationic catalyst species PC+.7  
In order to regenerate the neutral photocatalyst a second redox reaction step is necessary. The 
reduced species PC- has to react with an electron acceptor (EA), equally the oxidized catalyst 
PC+ needs an electron from a suitable electron donor molecule (ED). 
 
Scheme 3. Jablonski diagram of the oxidative and reductive quenching of [PC]*. EA = electron 
acceptor, ED = electron donor, LUMO = lowest unoccupied molecular orbital, 
HOMO = highest occupied molecular orbital. 
 
Besides the photoredox pathways – reduction and oxidation – the photocatalyst can serve as 
photosensitizer and transfer energy, which was received by visible light irradiation, onto the 
substrate (EQ). The energy transfer is equal to an excited state transfer and allows the 
excitation of molecules that do not have favorable redox potentials. Two most common 
energy transfer mechanisms are the Förster and the Dexter transfer (Scheme 4).  
If an acceptor substrate (energy quencher, EQ) is closer than 10 nm to the catalyst the 
relaxation energy of the πL* (T1) state funnels into a vibrational mode of the substrate. An 
electron of the energy quencher (EQ) is transferred from the highest occupied to the lowest 
unoccupied molecular orbital. For this Förster transfer mechanism the emission spectrum of 
the photocatalyst has to overlap with the ground state absorption spectrum of substrate EQ. 
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The Dexter energy transfer is a simultaneous double electron transfer mechanism. The excited 
catalyst [PC]* and the substrate (EQ) exchange their electron from HOMO to t2g and πL* (T1) 
to LUMO. This exchange occurs through physical contact of the molecules (< 0.01 nm) and 
overlapping wavefunctions.8 
 
 
Scheme 4. Jablonski diagram of the Förster and Dexter energy transfer of [PC]*. 
 
Iridium and ruthenium based polypyridyl complexes were the most common photocatalysts in 
organic synthesis, due to their easy synthesis and the photoredox properties. As example for 
the photophysical behavior the catalysts Ir[(ppy)2(dtb-bpy)]+ (1), Ir(ppy)3 (2), and 
[Ru(bpy)3]2+ (3) are mentioned (Table 1). With the absorption maxima in the visible range the 
catalysts can be excited into their long-lived triplet states via commercial light bulbs or light 
emitting diodes (LEDs). With relatively high oxidation [see E1/2 (PC+/PC) and E1/2 (PC*/PC-)] 
and reduction [see E1/2 (PC+/PC*) and E1/2 (PC/PC-)] potentials numerous substrates can be 
transformed via electron transfer.9 
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Table 1. Transition metal based photocatalysts [Ir(ppy)2(dtb-bpy)]+ (1), Ir(ppy)3 (2), and 
[Ru(bpy)3]2+ (3) with corresponding photoredox potentials and photophysical properties.  
 
  1 2 3 
Oxidative 
quenching 
E1/2 (PC+/PC*) -0.96 V -1.73 V -0.81 V 
E1/2 (PC+/PC) +1.21 V +0.77 V +1.29 V 
Reductive 
quenching 
E1/2 (PC*/PC-) +0.66 V +0.31 V +0.77 V 
E1/2 (PC/PC-) -1.51 V -2.19 V -1.33 V 
 
excited state lifetime: Ĳ 0.56 µs 1.9 µs 1.1 µs 
 
absorption wavelength: λabs 410 nm 375 nm 452 nm 
 
emission wavelength: λem 581 nm 518 nm 652 nm 
 
During the last decade a multitude of different chemical transformations were investigated, 
using the visible light-promoted photoredox catalysis. This elegant and mild radical reaction 
tool was applied to dehalogenations,10 deoxygenations,11 cycloadditions,12 and atom transfer 
radical additions (ATRA),13 to name but a few. Following the photoinduced decarboxylation 
reactions were discussed in more detail.  
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2 Decarboxylation of N-acyloxyphthalimides 
Carboxylic acids are very common in nature and represent a substance class that can be 
extracted from renewable resources. The possibility to isolate or synthesize a multitude of 
acids from biomass makes them a group of abundant and inexpensive basic chemicals. For 
that reason carboxylic acids are widely used in the synthesis of high-value chemical 
products.14 Especially the radical decarboxylation is an important tool to generate active 
intermediates for biological and chemical synthesis. Decarboxylation methods have been 
under investigation for a fairly long time and many different reactions were established, such 
as the Hunsdiecker reaction15 or the Kolbe electrolysis.16  
With regards to sustainable and “green” chemistry in recent years, more and more visible and 
UV light-mediated decarboxylation reactions were investigated.17 One powerful photoinduced 
method is the Barton decarboxylation.18 This classical radical reaction was discovered by 
Prof. D. Barton in 1983. Acids were transferred to the corresponding thiohydroxamate esters, 
which could be cleaved homolytically by photochemical or thermal conditions. The Barton 
protocol facilitates the generation of new bonds, such as carbon-carbon, carbon-sulfur, 
carbon-halogen, or carbon-nitrogen formations, and is still under investigation.19  
In 1988 Okada et al. demonstrated an alternative synthetic tool for decarboxylation. 
Depending on the thiohydroxamate esters of the Barton decarboxylation, the group of Okada 
activated the acids with N-hydroxyphthalimide (Scheme 5).20 
 
Scheme 5. First photosensitized decarboxylation of N-acyloxyphthalimides l1.  
 
Reducing the phthalimide moiety of compound 4 via the photoexcited state of 1,6-
bis(dimethyl-amino)pyrene (BDMAP) in presence of an aqueous solvent mixture and tert-
butylthiol the decarboxylated products 5 and phthalimide (6) were obtained.  
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Extending the scope of this project the group investigated a photochemical 
chlorodecarboxylation of carboxylic acids.21 N-Acyloxyphthalimide was transferred into its 
excited state via UV-light irradiation of a 100 W high pressure mercury lamp. 
Triethylendiamine (DABCO) was used as reducing agent for the phthalimide moiety and the 
obtained radical was trapped by carbon tetrachloride leading to the corresponding chlorides in 
56-96% yield.  
The application of this new visible light decarboxylation method was once more extended to 
include a photoredox catalyzed Michael addition (Scheme 6).22 The excited photocatalyst 
[Ru(bpy)3]Cl2 was oxidized by 1-benzyl-1,4-dihydronicotinamide (BNAH) to serve as a 
reducing agent for phthalimide ester 4. After phthalimide cleavage and decarboxylation alkyl 
radical 10 undergoes a Michael addition with methyl vinyl ketone (12).  
 
Scheme 6. Visible light decarboxylative Michael addition developed by Okada et al.  
 
Taking the prior contributions of Okada and coworkers into account, Overman et al. 
established a slightly modified version of the visible light-mediated decarboxylation as key 
step for the total synthesis of (-)-aplyviolene (17, Scheme 7).23 
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Scheme 7. Visible light-mediated decarboxylation of 13 as a key step in the total synthesis of  
(-)-aplyviolene (17). 
 
With this successful application the group extended the scope of the fragmentation under mild 
reaction conditions. Using [Ru(bpy)3](PF6)2 as photocatalyst and Hantzsch ester (15) as well 
as N,N´-diisopropylethylamine (DIPEA) for sacrificial electron and hydrogen donors, tertiary 
radicals were generated from N-acyloxyphthalimide derivatives 18 (Scheme 8).24 With this 
reaction system and the protonation of the reduced phthalimide moiety 21 by Hantzsch ester 
intermediate 23 the reaction could be performed in absence of water. Obtained radicals 22 are 
coupled with a variety of alkenes and undergo substitution reactions with allylic and vinylic 
halides forming new C-C bonds and quaternary carbons. In presence of highly reactive 
coupling partners the reaction proceeds also in absence of the photocatalyst. In these special 
cases the reduction of the phthalimide moiety by the photoexcited Hantzsch ester was 
assumed.  
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Scheme 8. Photoinduced decarboxylation of tertiary acids based N-acyloxyphthalimides 18. 
This modified reaction protocol was the source for several photoinduced decarboxylative 
coupling reactions. In the latest publication of Overman et al., photodecarboxylation was 
performed in presence of methyl N-phthalimidoyl oxalate, leading to methoxycarbonyl 
radicals, which subsequently underwent conjugative additions to electron deficient olefins.25 
Fu and coworkers improved the visible light-mediated selenation reaction of Okada and 
synthesized with N-acyloxyphthalimides numerous chiral α-selenoamino acids.26  
In 2015 Chen et al. performed a photoinduced decarboxylative alkynylation reaction using 
similar reaction conditions to the work of Overman and coworkers (Scheme 9).27 After visible 
light-mediated fragmentation of 25, induced by the photoredox system [Ru(bpy)3](PF6)2, 
DIPEA, and Hantzsch ester, the corresponding primary, secondary, or tertiary alkyl radicals 
underwent addition to alkynyl sulfone 26. The sulfone moiety served as leaving group 
yielding alkyne products 27. 
 
Scheme 9. Photoinduced decarboxylative alkynylation of N-acyloxyphthalimides 25. 
 
Continuing this project Chen and coworkers extended the reaction scope to a decarboxylative 
allylation using allyl sulfones as coupling reagents.28  
Recently König et al. demonstrated the visible light initiated decarboxylative alkylation of 
phthalimide ester derivatives using the metal free eosin Y catalyst instead of common metal 
based photocatalysts, such as [Ru(bpy)3]Cl2 or [Ir(ppy)2(dtb-bpy)]PF6.29 
Fu et al. developed an efficient method installing N-protected amino acids and peptide 
residues on N-heterocycles (Scheme 10).30 Phthalimide activated α-amino acids 28 were 
decarboxylated via photoredox chemistry. Diisopropylethylamine (DIPEA) reduces the 
excited photocatalyst, which gives an electron to N-acyloxyphthalimide 28. After N-O bond 
cleavage and decarboxylation, intermediate 32 undergoes a radical addition to substituted 2-
isocyanobiphenyl 29. Intramolecular cyclization of generated imidoyl radical 33 affords 
intermediate 34, which regenerates DIPEA via reduction. Rearomatization yields to the 
desired product 30. Because of the regeneration of diisopropylethylamine (DIPEA) the 
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reductive quencher can be added in catalytic amounts (0.4 equiv.). A multitude of α-amino 
acids were coupled on N-heterocycles and phenanthridine as well as oxindole derivatives with 
biological and pharmaceutical activity were prepared. 
 
Scheme 10. Photodecarboxylative conjugation of amino acid based N-acyloxyphthalimides 28 and 
phenanthridine derivatives 29. 
 
Cheng et al. demonstrated in a similar mechanism to the reaction of Fu and coworkers 
(Scheme 10), a tandem radical cyclization of N-arylacrylamides to 3,3-dialkyl substituted 
oxindoles using N-acyloxyphthalimides of tertiary acids.31  
One non-photochemical decarboxylation method with phthalimide ester derivatives was 
reported by Baran et al. (Scheme 11).32 In contrast to the photoredox reactions, an aryl-Ni(I) 
complex, which was formed in situ from NiCl2∙6 H2O, 2,2´-bipyridine (bpy), and Ar-
ZnCl∙LiCl, delivers an electron to the phthalimide ester 36. After fragmentation and 
decarboxylation the radical species and phthalimide combine to a Ni(III)-complex, which 
upon reductive elimination afford the desired coupling product 38. The Ni-catalyzed 
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decarboxylative cross-coupling reaction can be performed on gram scale in moderate to very 
good yields. 
 
Scheme 11. Nickel-catalyzed decarboxylative cross-coupling of N-acyloxyphthalimides 36. 
 
Phthalimide activation was not only used for decarboxylation, but also for deoxygenation 
reactions. Overman et al. established a photoredox-catalyzed fragmentation of tert-alkyl-N-
phthalimidoyl oxalates 39 (Scheme 12).33 The deoxygenation proceeds the same way as 
described for the decarboxylation reactions (see Scheme 8). The phthalimide moiety is 
reduced by the photocatalyst, followed by N-O bond cleavage and decarboxylation. Obtained 
alkoxycarbonyl radical 44 undergoes a second, slower decarboxylation, which leads to tertiary 
radical 45. Addition to electron deficient alkenes 40 provides the products 41. The 
decarboxylation of the alkoxycarbonyl radical is only efficient when performed on tertiary 
alcohols. Methoxycarbonyl radicals for example react almost completely with olefins 
generating corresponding Ȗ-ketoesters.25  
Chen et al. applied this photoinduced deoxygenation method for alkynylation reactions of 
tertiary alcohols with 1-(2-(arylsulfonyl)ethynyl)benzenes.34 
 
Scheme 12. Visible light-mediated deoxygenation of N-phthalimidoyl oxalates 39. 
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N-Phthalimidoyl oxalates 39 are very sensitive because of their instability to aqueous workup 
or flash chromatography.33 For that reason Overman and MacMillan et al. improved the 
visible light-mediated deoxygenation by using simple oxalates. In presence of the 
photocatalyst [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (1 mol%), a solvent mixture of DME/DMF 
(3/1), water (10 equiv.) and the base CsF, alkyl radicals from secondary and tertiary alcohols 
were generated via simple oxalates. With these photoredox conditions no phthalimide 
activation was necessary and coupling products with Michael acceptors were obtained in 51-
93% yield.35 This concept was based on the prior contributions of MacMillan et al. in 2014 to 
the visible light-mediated decarboxylation. 
For this photoinduced decarboxylation method no additional sacrificial electron donor was 
necessary to decarboxylate simple carboxylic acids (Scheme 13).36 The excited photocatalyst 
oxidizes acid 46 in presence of K2HPO4 salt. After decarboxylation and conjugate addition to 
enolate 47, radical 50 gets reduced to product 48, while simultaneously regenerating the 
photocatalyst. 
 
Scheme 13. Visible light-mediated decarboxylative Michael addition of carboxylic acids 46. 
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Secondary, tertiary, and stabilized α-amino acids could be decarboxylated and cross coupled 
with Michael systems. This protocol was applied to various other useful transformations, 
although reactions with non stabilized primary acids were not successful. The group described 
a visible light-mediated decarboxylative arylation of α-amino acids with cyanoarenes, 
yielding benzylic amine structures in good yields.37 By merging photoredox decarboxylation 
with nickel catalysis a decarboxylative cross-coupling of carboxylic acids with vinyl and aryl 
halides was established by MacMillan et al.38 
During the last few years photoredox decarboxylation became a powerful tool for the 
synthesis of biological attractive molecules and fine chemicals.39 With energy saving light 
emitting diodes (LEDs) and compact fluorescent lamps (CFLs) this sustainable and “green” 
method is under big interest in current research. 
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3 Photoreaction setup  
Photochemistry is classified as a green chemical method. The photons, which initiate 
photochemical reactions, are regarded as a clean and traceless reagent.40 With the invention of 
light-emitting diodes (LEDs) photochemistry became even more energy efficient. Because of 
narrow emission peaks, LEDs allow the irradiation with a defined wavelength. Depending on 
the absorption maximum of the catalysts the application of different LEDs, typically blue 
(λmax = 455 nm) or green light (λmax = 530 nm) leads to optimized excitation. In contrast to 
fluorescent light bulbs, less energy is wasted. 
The widespread used photoreaction setup is build up by an external irradiation system, e.g. a 
light bulb or LED and the reaction vessel containing the reaction solution.  
Dr. Peter Kreitmeier developed an alternative reaction setup in the working group of Prof. 
O. Reiser. The light of an external LED is guided via an optical fiber directly into the reaction 
mixture (Figure 1). Regarding external irradiation systems, this setup minimizes light 
scattering at the reaction vessel and guarantee optimal irradiation. In addition the light source 
is on top of the solution, whereby the solvent is not heated by the LED. Therefore temperature 
control, with heating and cooling, is easy to handle, without special precautions for the light 
source by using an oil- or ice bath.  
All upcoming visible light-mediated photoreactions in this thesis were performed with this 
reaction setup unless noted in a different way. 
  
Figure 1. Irradiation system developed by Dr. Peter Kreitmeier. Blue light (λmax = 455 nm) is 
channeled through a glass rod into the reaction mixture. 
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B Photoinduced Decarboxylation 
1 Decarboxylation of ω-aryl-N-acyloxyphthalimides 
1.1 Preliminary studiesa 
As previously shown in my master thesis, visible light mediated decarboxylation of 
phthalimide activated acids was used to develop an intramolecular spirocyclization prozess. 
Based on renewable resources, using furans and amino acids in the starting material synthesis, 
decarboxylation enables the formation of numerous spirolactames 52.41 The reaction tolerates 
a broad range of different substituents (Scheme 14). The driving force of this work was to 
develop a “green” approach to intermediates of relevance for fine chemicals or natural 
products.41,42  
 
Scheme 14. Visible light mediated synthesis of spirolactame derivatives 52.41 
 
In contrast to preceding phthalimide assisted decarboxylations, where the phthalimide moiety 
was reduced directly by the photocatalyst, a sensitization mechanism was proposed for this 
reaction. The reducing power of the excited iridium based catalyst ([Ir3+]* → Ir4+ = -0.96 V vs. 
SCE)43 is out of range of substrate 51 (-1.25 V vs. SCE). Therefore the oxidative quenching 
cycle is not possible. [Ir(ppy)2(dtb-bpy)]PF6 serves as a sensitizer, transferring energy to the 
N-acyloxyphthalimide 51. The excited molecule 54 undergoes an intramolecular electron 
transfer, which leads to the reduction of the phthalimide. Releasing phthalimide and carbon 
                                                 
a
 This Chapter is mainly based on the results of my master thesis and Kachkovskyi, G.; Faderl, C.; Reiser, O. 
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dioxide, the alkyl radical 56 cyclizes in a 5-exo-trig manner, forming the spirocation 57 
(Scheme 15).  
 
Scheme 15. Proposed sensitization mechanism.41 
 
The field of application for spirolactame product 52a was extended, using a vinylogous 
semipinacol rearrangement to get the more stable compounds 58 or 59.44 Treating lactame 
52a with TFA initiates a cleavage of the hydroxyl group. Subsequently the acyl moiety 
undergoes a 1,2-shift with a concurrent rearomatization of the furan group.45 Depending on 
the solvent, the N-tert-butyl group was cleaved using neat TFA leading to product 59 or 
product 58 was obtained using a 0.2 M TFA in dichloromethane solvent (Scheme 16). 
 
Scheme 16. Vinylogous semipinacol rearrangement of 52a. a) 0.2 M TFA in DCM, rt, 48 h → 58 
(85%). b) TFA (neat), room temp., 16 h → 59 (97%). 
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Replacing furan with thiophene the formation of an inseparable mixture of 61 and 62 was 
observed, after irradiation under standard photosensitization reaction conditions (Scheme 17). 
The thiophene moiety of compound 60 has a slightly different electron density than furan 
based N-acyloxyphthalimide 53, whereby thienopyridinone 62 was formed simultaneously to 
61. Treating the crude product mixture with neat TFA the inseparable products were 
converted into compound 63 in overall yield of 45% 
 
Scheme 17. Photoreaction of thiophene based N-acyloxyphthalimide 60. a) [Ir(ppy)2(dtb-bpy)]PF6 
(1 mol%), MeCN/H2O (40/1, c = 0.1 mol/l), hν (455 nm LED), room temp., 16 h. b) TFA, 
room temp., 12 h. Overall yield: 45%. 
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1.2 Initial synthetic aim 
After establishing the photodecarboxylation of N-acyloxyphthalimides with furan moieties, 
the work was continued employing phenyl rings as core structures. The aim of this 
continuative project was to yield spirodienonamides 66 by a similar cyclization reaction.  
Recently Miranda et al. reported the synthesis of spirodienonamides 66 via a radical based 
dearomatizing spiroacylation process (Scheme 18, B).46 The carbamoyl radical 64 was 
obtained using the corresponding carbamoylxanthate and triethylborane to initiate the radical 
formation. After spirocyclization and oxidation the desired spirointermediate 65 was formed, 
leading to product 66. The starting material synthesis requires expensive and, because of their 
biological activity, strictly controlled phenylethylamines47 and the very toxic triphosgene. 
Another disadvantage is the starting carbamoylxanthate itself, which is very temperature 
sensitive and unstable.46 Regarding the established photoinduced decarboxylation method, 
changing the furan moiety to phenyl rings, intermediate 67 should form after the 
decarboxylation step (Scheme 18, C). The spirocyclization could lead to the same 
intermediate 65, which was described by Miranda et al. and the product formation could be 
possible. 
 
Scheme 18. Abstract of proposed radical mechanisms. A: Photodecarboxylation of furan based N-
acyloxyphthalimides. a) MeCN/H2O (9/1), [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), hν (455 nm), 
room temp., 8 h.41 B: Radical based spiroacylation by Miranda et al. b) DCM, 0.5 equiv. 
Et3B, -5 °C, 2.6 h.46 C: Proposed mechanism of a photodecarboxylation of phenyl based 
N-acyloxyphthalimides. 
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1.3 Starting material synthesis and first reaction attempts 
N-acyloxyphthalimide 74 was synthesized as a model compound in four steps from cheap and 
easy available chemicals. The nucleophilic addition of tert-butylamine (68) and ethyl acrylate 
(69) and the following amide synthesis with benzoyl chloride 71, as well as the hydrolysis 
were performed in nearly quantitative yields. The last coupling step with N-
hydroxyphthalimide results in ω-aryl-N-acyloxyphthalimide 74. Relating to the 
carbamoylxanthate starting materials described above, the big advantage of the phthalimide 
activated acid 74 is its stability. It can be stored at room temperature, on air and light for more 
than four years (Scheme 19).  
 
Scheme 19. Starting material synthesis. a) EtOH, 0°C, overnight (97%). b) NEt3 (1.1 equiv.), 0 °C-
22 °C, DCM, 15 h (90%). c) EtOH, H2O, KOH (1.1 equiv.), room temp., overnight 
(98%). d) THF, N-hydroxyphthalimide (1 equiv.), DCC (1 equiv.), room temp., 15 h 
(43%). 
 
The model substrate 74 was applied to the earlier established reaction conditions. By 
irradiation of an aqueous acetonitrile solution containing N-acyloxyphthalimide 74, via a blue 
light-emitting diode (LED, λmax = 455 nm), in the presence of catalytic amounts of 
[Ir(ppy)2(dtb-bpy)]PF6 (1 mol%) phenylethylamine derivative 75 was obtained (Scheme 20).  
 
Scheme 20. Photoinduced decarboxylation of ω-aryl-N-acyloxypthalimide 74. a Yield was determined 
by NMR analysis with 4-nitrobenzaldehyde as internal standard. 
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The synthesis of spirodienamides was not successful via this photochemical route. Instead, a 
new photochemical access to ȕ-phenylethylamines via a smiles-type rearrangement was 
discovered. In this “green” photochemical reaction cheap and easy available substrates were 
transferred into phenylethylamine derivatives, which represent a comprehensive class of 
biological active compounds. Concerning atom efficiency of this reaction, 95% of the 
released phthalimide could be recovered, whereas only two carbon dioxides were lost in this 
reaction. 
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1.4 ȕ-Phenylethylamine synthesis 
1.4.1 Optimization and control experiments 
Former studies and publications claim the necessity of water for this type of 
decarboxylation.41,48 The phthalimide moiety is dependent on protonation, which allows the 
release of phthalimide followed by the decarboxylation. After a control experiment with pure 
acetonitrile as solvent, only traces of products were observable which consequently 
demonstrates the dependence on water (entry 1). During the reaction a substantial amount of 
acid (76) is formed as a side product. An explanation for the acid formation is simple 
hydrolysis and a redox fragmentation first described by Sammis et al. by irradiation of N-
alkoxyphthalimides.49  
Table 2. Solvent and catalyst dependence of the decarboxylation reaction. 
 
Entry Catalyst (1 mol%) Solventa Solvent/water ratio Yield 2ab 
1 [Ir(ppy)2(dtb-bpy)]PF6 MeCN - Traces 
2 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O 10/1 41% 
3 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O 20/1 42% 
4 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O 30/1 51% 
5 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O 40/1 58% 
6 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O 50/1 48% 
     
     
7 [Ir(ppy)2(dtb-bpy)]PF6 THF/H2O 40/1 50% 
8 [Ir(ppy)2(dtb-bpy)]PF6 Acetone/H2O 40/1 49% 
9 [Ir(ppy)2(dtb-bpy)]PF6 DMF/H2O 40/1 41% 
     
     
10 [Ru(bpy)3]Cl2 MeCN/H2O 40/1 0% 
11 [Cu(dap)2]Cl MeCN/H2O 40/1 50% 
12 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 MeCN/H2O 40/1 0% 
13 Perylenec MeCN/H2O 40/1 0% 
a
 reaction concentration 0.1 mol/l. b yields were determined by NMR analysis with 4-nitrobenz-
aldehyde as internal standard. c 0.5 equiv. 
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The acid formation is correlated to the ratio of water. Therefore the amount of water was 
lowered in order to reduce the hydrolysis side reaction (Table 2; entry 2-6). The best results 
were achieved in an acetonitrile/water mixture of 40/1 in a 0.1 M concentrated solution, 
adding up to 13.5 equiv. of water (entry 5). 
To optimize the reaction conditions, different solvent mixtures were screened. Changing 
acetonitrile to THF, acetone or DMF shows slight decreasing in the yield of ȕ-
phenylethylamine (entry 7-9). Afterwards different photocatalysts were screened. Instead of 
[Cu(dap)2]Cl, which 50% of the ȕ-phenylethylamine 75 was detected, the metal based 
photocatalysts [Ru(bpy)3]Cl2 and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 show no product formation. 
Also the reaction with the organic dye perylene showed no conversion after 16 h of irradiation 
(entry 10-13). 
Table 3. Control experiments of the decarboxylation reaction. 
 
Entry Catalyst (1 mol%) Solventa Modifications Yield 
1 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O (40/1) 40 °C 40%b 
2 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O (40/1) 80 °C 17%b 
3 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O (40/1) no degassing 0% 
4 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O (40/1) no light 0% 
5 -
 
MeCN/H2O (40/1) no catalyst 0% 
a
 reaction concentration 0.1 mol/l. b yields were determined by NMR analysis with 4-nitrobenz-
aldehyde as internal standard. 
 
Increasing the reaction temperature to 40 °C and 80 °C leads to decreasing yields and only 
40% and 17% of ȕ-phenylethylamine 75 were obtained (Table 3, entry 1 and 2). 
Further control experiments proofed, that this decarboxylation is a photoinduced process. 
Without removing the oxygen from the reaction, which also quenches the excited state of 
[Ir(ppy)2(dtb-bpy)]PF6, no ȕ-phenylethylamine 75 could be detected (entry 3). The same 
result was found in the absence of light or photocatalyst (entry 4 and 5). 
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1.4.2 Substrate scope  
With the optimized conditions in hand, the scope of the decarboxylation/rearrangement 
reaction was evaluated (Table 4). The introduction of electron donating substituents, like 
methoxy- (entry 1-3) or halogenated-groups (entry 4-6), into the phenyl moiety was well 
tolerated and an array of different ȕ-phenylethylamines 77 in good to moderate yields was 
obtained. Para-substituated compounds were most effective (entry 1,4,6,7), but meta- and 
ortho-substituents were tolerated as well (entry 2,3,5). However, decreasing the electron 
density of the phenyl ring led to a drastic drop in yield. Unsubstituted product 78h was 
obtained in 29%, whereas the formation of 78l, bearing electron deficient pyridine ring, was 
not possible. In the latter case only the corresponding acid was formed (entry 12).  
Table 4. Scope of the ȕ-phenylethylamine synthesis. 
 
Entry Substrate 
 
Product 
 
Yield 
1 
 
77a 
 
78a 61% 
2 
 
77b 
 
78b 33% 
3 
 
77c 
 
78c 43% 
4 
 
77d 
 
78d 45% 
5 
 
77e 
 
78e 21% 
6 
 
77f 
 
78f 49% 
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Entry Substrate  Product  Yield 
7 
 
77g 
 
78g 45% 
8 
 
77h 
 
78h 29% 
9 
 
77i 
 
78i 53% 
10 
 
77j 
 
78j 38% 
11 
 
77k 
 
78k 53% 
12 
 
77l 
 
78l 0% 
 
Interestingly, a further increase of the electron density via the introduction of two (77m) or 
even three (77n) methoxy groups led to the exclusive formation of dihydroisoquinolinones 79 
and 80 in very good yields (Scheme 21). These products derive from the 1,2-acyl shift of the 
spiroradical intermediate. This 1,2-acyl shift was observed already in the further 
transformations of spirolactame product 52a (Scheme 16, Section 1.1). Surprisingly the 
disubstituted N-acyloxyphthalimide 77i does not form its dihydroisoquinolinone derivative 
(Table 4, entry 9). The chlorine substituent, which replaces one methoxy group, has a 
different influence on the phenyl ring, leading to ȕ-phenylethylamine 78i. Introducing two 
methoxy-groups in ortho-position, the rearrangement forming dihydroisoquinolinone is 
blocked (entry 10). In this case the transformation continuous towards the phenylethylamine 
product 78j.  
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Scheme 21. Decarboxylation and rearrangement reaction of N-acyloxyphthalimide 77m and 77n with 
the crystal structure of the product 80. 
 
Until now the scope of the reaction was limited to the N-tert-butyl group, because of the 
starting material synthesis. Replacing this functional group with a methyl group would lead to 
an easy access to N-methylphenylethylamine derivatives. To test the group tolerance, N-
hydrogen and N-methyl substituted N-acyloxyphthalimides were synthesized from ȕ-alanine 
and ethyl 3-(methylamino)propanoate, following starting material synthesis protocol (Scheme 
19, Section 1.3). Performing the reaction, employing the optimized conditions using 1 mol% 
[Ir(ppy)2(dtb-bpy)]PF6, a MeCN/H2O solvent mixture and a blue light emitting diode 
(λmax = 455 nm), no product formation for the hydrogen- and methyl-substituted compounds 
was observed within 14-16 h (Table 5, entry 2,3). Although the product formation decreases 
at higher temperatures (Table 3, Section 1.4.1) this could lead to faster rotations and 
movements of the molecules. Unfortunately increasing the reaction temperature to 40 °C and 
80 °C, there was still no N-methyl-ȕ-phenylethylamine (84) formation (entry 4 and 5).  
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Table 5. Effect of N-protecting groups on the photoinduced decarboxylation. 
 
Entry R Temperature Yield 
1 tert-Butyl 25 °C 61% 
2 H 25 °C 0% 
3 Me 25 °C 0% 
4 Me 40 °C 0% 
5 Me 80 °C 0% 
 
The substitution pattern on the nitrogen plays a crucial role in the decarboxylation process. 
The sterical demanding tert-butyl group and the whole conformation of the ω-aryl-N-
acyloxyphthalimide subjected to the Thorpe-Ingold effect.50 Without the bulky N-substituent 
the molecule engages an unfavorable conformation for the reaction. Therefore an 
intramolecular decarboxylation process is obvious (see mechanistic discussion: Section 1.4.5).  
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1.4.3 Carbamate synthesis 
A slight change in the reaction conditions leads to the formation of different products. By 
substitution water with alcohols corresponding carbamates were isolated (Figure 2). In the 
same way as water did before, the alcohols promote the protonation of the phthalimide 
moiety, which initiates the reaction. Subsequently the reaction intermediate is trapped by the 
alcohols forming carbamates 85. The carbamates were efficiently synthesized using primary 
(methanol, ethanol, benzyl aclcohol), secondary (2-propanol) and tertiary (tert-butanol) 
alcohols. With the exception of the sterical demanding tert-butanol (85c, 85g), the carbamates 
were isolated in good to fair yields. 
 
Figure 2. Photoinduced carbamate 85 synthesis.  
 
Following the carbamate protocol, other additives were investigated in this reaction. Primary 
and secondary amines, as well as thiols can serve as hydrogen donors and nucleophiles 
simultaneously. Unfortunately applying benzylamine or 2-aminopropane, in order to 
synthesize carbamides, only hydrolysis occurs and the simple amide products 86a were 
isolated (Scheme 22).51 Using thiols in this reaction, only complex reaction mixtures were 
observed and no desired carbothioate product could be isolated. 
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Scheme 22. Transformation of N-acyloxyphthalimide 74 in presence of different amines. 86a: R1 = H, 
R2 = iPr (91%). 86b: R1 = R2 = CH3 (92%). 86c: R1 = H, R2 = benzyl (90%) 
 
As described previously, the N-tert-butyl group is responsible for the product formation 
(Table 5). Due to the carbamate synthesis this group can be seen as a typical protecting group. 
The tert-butyl moiety was easily cleaved from carbamate 85a under mild conditions receiving 
the non-substituted carbamate 87 in quantitative yields (Scheme 23). In a further 
transformation it is possible to cleave of the carboxylate yielding the primary amine 88.52 
Despite the required tert-butyl group the carbamate synthesis enables the generation of “free” 
ȕ-phenylethylamines. Based on cheap and easy available starting materials and using a 
“green” photodecarboxylation process it is possible to extend the reaction scope from already 
shown N-tert-butyl ȕ-phenylethylamines 78 and the corresponding carbamates 85 to N-
substitution free ȕ-phenylethylamines.  
 
Scheme 23. Deprotaction of carbamate 85a and further transformation, yielding ȕ-phenylethyl- 
amine 88. a) TFA, room temp., 15 h (97%). b) 2 M LiOH, THF, MeOH, Microwave, 
120 °C, 10 min (88%). 
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1.4.4 Reaction improvements 
To stabilize of the phthalimide during the decarboxylation reaction, water or alcohols were 
used yet. Sammis et al. avoided these proton sources in their study about photoinduced redox 
fragmentation of N-alkoxyphthalimides.49 Instead they added LiBF4 to the reactions, without 
going into detail about the effect of the lewis acid.  
Using more water in the decarboxylation reaction leads to an increased formation of acid 76 
side product. In order to decrease the side reaction and increasing the yield, lewis acids have 
been investigated to replace water. The photoreaction of the phthalimide ester 77m needs 
water solely for the protonation of the phthalimide species and not as a nucleophile, like in the 
reactions yielding ȕ-phenylethylamines. Therefore ω-aryl-N-acyloxyphthalimide 77m was 
used in a test reaction. The irradiation, in presence of the photocatalyst [Ir(ppy)2(dtb-
bpy)]PF6, water free acetonitrile and 1.5 equivalents of LiBF4, took about 48 h until full 
conversion and 54% dihydroisoquinolinone 79 was isolated. The lewis acid LiBF4 can 
therefore be used to stabilize the phthalimide moiety in this reaction, but compared to water 
(16 h, 82% yield) the reaction time is more than doubled and the yield is lower (Scheme 24). 
 
Scheme 24. Photoinduced decarboxylation using LiBF4. 
 
Common photoredox systems are based on electron transfer mechanisms of the excited 
photocatalysts. Also the former discussed visible light mediated decarboxylations of N-
acyloxyphthalimides are based on the reduction of the phthalimide moiety by photocatalysts. 
The catalysts were regenerated by sacrificial electron donors or by further reacted substrates, 
mostly in consequence of Michael-additions. Using UV-light irradiation to decarboxylate N-
acyloxyphthalimides, catalysts, which absorb the UV-light and reduce the phthalimide, were 
applied. For such UV supported decarboxylation reactions only two reports were published 
yet,48a,b although UV-photoreactions of phthalimide groups in general are well-known.53  
In the developed decarboxylation reaction of ω–aryl-N-acyloxyphthalimides no additional 
compound, than the photocatalyst and the solvent, was used. In order to investigate the 
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function of the [Ir(ppy)2(dtb-bpy)]PF6 and clarify the mechanism, one UV reaction was 
performed (Scheme 25).  
 
Scheme 25. UV-mediated decarboxylation of ω-aryl-N-acyloxyphthalimide 75. 
 
The model compound 74 was diluted in acetone/water solvent mixture, degassed and 
irradiated at room temperature via high pressure mercury lamp. Acetone is known to be a 
good sensitizer in UV reactions.54 After 6 h full conversion of the starting material was 
determined and 58% ȕ-phenylethylamine derivative could be isolated. Either the UV light 
excites the acetone, which gives the energy to the N-acyloxyphthalimide 74, or the 
phthalimide ester 74 is excited directly. Therefore the reaction is not dependent on the redox 
cycle of the photocatalyst.  
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1.4.5 Mechanistic considerations 
Based on these results, a plausible mechanism for this decarboxylation and rearrangement 
reaction was proposed. The key step of this reaction is the reduction of the phthalimide 
moiety. The reduction potential of N-acyloxyphthalimide 74 was determined as -1.32 V 
versus SCE by CV in acetonitrile and is thermodynamically incompatible for photoredox 
reactions with the used [Ir(ppy)2(dtb-bpy)]PF6 catalyst ([Ir3+]* → Ir4+ = -0.96 V vs SCE).43 
Because of the absence of a sacrificial electron donor, which could act as a reductant for the 
catalyst, the reductive quenching cycle of the photocatalyst was excluded. Additionally, direct 
UV-light irradiation of the phthalimide moiety, in absence of any catalyst, leads to product 
formation, therefore an alternative function for the iridium based catalyst as a sensitizer was 
assumed. Accordingly, the excited photocatalyst [Ir(ppy)2(dtb-bpy)]PF6 transfers energy (ET) 
to the N-acyloxyphthalimide 90. Calculations from the Schütz group of the analytic energy 
gradients for the ground and excited states in this system suggest the assumption that the 
excited phthalimide species 91 is protonated.55 An intramolecular electron transfer (IET) of 
the S1 and T1 states of the protonated molecule 89 from the phenyl to the phthalimide moiety 
could be calculated (Figure 3). As already mentioned the tert-butyl group is decisive for the 
reaction. Although the energy barriers are suitable for a charge transfer, the crucial 
mechanistic step is only possible, if the phthalimide and phenyl group are sterical close to 
each other. The bulky tert-butyl group provides a suitable conformation, within which the 
intramolecular transfer can occur. 
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Figure 3. Orbital-relaxed electron density difference of the lowest triplet state T1 of the protonated N-
acyloxyphthalimide 89; provided by Dr. Thomas Merz. Yellow = electron rich areas 
(phthalimide moiety), black = electron poor areas (phenyl group). 
 
The biradical intermediate 92 undergoes N-O bond cleavage, facilitated by leaving of the 
neutral phthalimide molecule, and subsequent decarboxylation of the carboxyl radical. The 
calculated potential energy surface show that these two separations proceeds spontaneous 
under the reaction conditions (Figure 4). 
 
Figure 4. Potential energy surface of the phthalimide radical cleavage and decarboxylation of the 
carboxyl radical; provided by Dr. Thomas Merz. 
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An intramolecular radical recombination of the alkyl radical 93 affords the spiro-cation 
intermediate 94. Depending on the phenyl substituents the already discussed 1,2-acyl shift 
(Scheme 16) leads to dihydroisoquinolinone products 95 or acyl cation 96.41,56 In aqueous 
reaction condition ȕ-phenylethylamine derivatives 78 were isolated. Changing the solvent to 
acetonitrile/alcohol the corresponding carbamates 85 were obtained (Scheme 26).  
 
Scheme 26. Proposed reaction mechanism. a) R1 = p,m-OMe; p,m,m´-OMe. b) R1 = mono-substituted. 
c) MeCN/H2O, R2 = H; MeCN/alcohol, R2 = COOAlk (Alk = alkyl group).  
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1.5 Further substrate investigations 
1.5.1 Decarboxylation of hippuric acid derivatives 
To extend the substrate scope, N-acyloxyphthalimide 97 was synthesized. In contrast to the 
starting phthalimide esters described earlier in the ȕ-phenylethylamine synthesis (see 
Section 1.3) this starting material is based on the α-amino acid glycin. Interestingly the 
photodecarboxylation of 98, using the common reaction conditions, leads to benzamide 101 in 
very good yields (85%). If the mechanism of this reaction includes a radical recombination 
step, some amounts of the rearranged product should be formed, but no benzylamine was 
detected. Due to this and because of the unfavored ring size the spirocyclization, which is 
necessary for the rearrangement process, is not assumed. Instead, a second intramolecular 
electron transfer (IET) is envisoned, which results in rearomatization and alkyl cation 99. The 
water in the solvent mixture forms the amidomethanol 100 intermediate, which hydrolyses 
under the release of formaldehyde to isolated benzamide 101 (Scheme 27).57  
 
Scheme 27. Photodecarboxylation and proposed reaction mechanism of N-acyloxyphthalimide 97. 
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1.5.2 Decarboxylative tetrahydro-1H-benzazepinone synthesis 
Applying molecules, based on α-amino acids did not show the desired reaction. Consequently 
the alkyl carbon chain was elongated by one CH2-group, with respect to 74, in order to obtain 
Ȗ-phenylpropylamines. The reactions of the elongated ω-aryl-N-acyloxyphthalimides showed 
full conversion after 16 h of irradiation and phthalimide was identified as a side product. 
Surprisingly instead of the expected Ȗ-phenylpropylamine a different product was obtained – 
tetrahydrobenzazepinone 105. The photoinduced decarboxylation was successful, but no 
rearrangement took place. Regarding the product, two radical cyclizations are possible. A 6-
exo-trig cyclization forms the six membered spirocyclized intermediate 104, which was 
observed in previous studies. In contrast to the ȕ-phenylethylamine reactions, no products 
which arise from an 1,2-acyl shift of the carbonyl group were detected at all. Either only the 
alkyl chain shifts after the formation of the spiro-intermediate 104, or, more likely, the hydro-
azepinone ring is formed directly via 7-exo/endo-trig cyclization (Scheme 28).  
 
Scheme 28. Abstract of the proposed reaction mechanism. 
 
This reaction represents a new method for the synthesis of benzazepinones.58 Therefore a set 
of tetrahydrobenzazepinones with different substituents was synthesized in fair to good yields 
(Table 6). In contrast to the synthesis of ȕ-phenylethylamines 78, the electron density of the 
phenyl group had less influence on the reaction and the product yields. Remarkably after 
irradiation of the electron deficient N-acyloxyphthalimide 102b the corresponding 
hydrobenzazepinone was isolated with a yield of 35%. However, the ȕ-phenylethylamine 78l 
of the pyridine based phthalimide ester was not observed at all (Table 4, entry 12). Also the 
yield of the unsubstituted tetrahydrobenzazepinone 102a is significantly higher with 43% 
(compared to 29% for 78h). As expected, the reaction is an unsymmetrical substitution of the 
phenyl ring at the N-acyloxyphthalimides 102d and 102e. The reaction leads to two respective 
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isomers (105d´,105d´´ and 105e´, 105e´´), which were isolated separately. The yield of 
benzazepinone 105e´ (48%) is five times higher than 105e´´ (10%), due to sterical bulkiness of 
the methoxy group in meta position. Surprisingly, changing the substituent to chloride, we 
observe the reverse effect and product 105d´ was isolated in 18% and 105d´´ in 44% (1:2). 
Blocking both ortho-positions (102f, 102g) led to the isolation of the formal reductive 
decarboxylation products 105f and 105g, together with significant amount of the 
corresponding acid, formed apparently via competitive electron abstraction by the carboxylic 
group. This result is a hint for the mechanism. The ortho-substituents (-Me, -OMe) have no 
big sterical demand and the reaction towards the ortho-substituted ȕ-phenylethylamine 78j is 
able to undergo a 5-exo-trig cyclization (Table 4, entry 10, Section 1.4.2). Therefore the 
spirocyclization leading to Ȗ-phenylpropylamine products could occur, but these products 
were not detected.  
In case of the trisubstituted N-acyloxyphthalimide 102h, whose analog 77m gave the 
dihydroisoquinolinone 80 in very good yields (75%, Scheme 21), only 43% of the tetrahydro-
1H-benzazepinone 105h was isolated. Simple decarboxylation and reduction, according to the 
products of entry 7 and 8, formed the N-propylbenzamide in substantial amount (38%).  
To clarify the molecule structure of this cyclization reaction the tert-butyl group of 
benzazepinone 105c was removed, using neat TFA and reflux conditions (Scheme 29).  
 
Scheme 29. Removing of the tert-butyl group of 105c. 
 
Pure N-deprotected benzazepinone 106 was isolated in 86% and the NMR signals of the 
product were in accordance to the literature.59 This shows that under photodecarboxylative 
conditions ω-aryl-N-acyloxyphthalimides based on Ȗ-amino acid preferably undergo the 
already discussed 7-exo/endo-trig cyclization instead of the 6-exo spirocyclization. 
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Table 6. Scope of the tetrahydro-1H-benzoazepinone 105 synthesis. 
 
Entry Substrate Product Yield 
1 
 
102a 
 
105a 43% 
2 
 
102b 
 
105b 35% 
4 
 
102c 
 
105c 60% 
5 
 
102d 
 
105d´, 18% 
 
105d´´, 44% 
 
6 
 
102e 
 
105e´, 48% 
 
105e´´, 10% 
 
7 
 
102f 
 
105f 24% 
8 
 
102g 
 
105g 45%a 
9 
 
102h 
 
105h 43% 
a incomplete conversion after 24 h. 
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1.6 Decarboxylation of naphthalene diimide esters 
The crucial step of this decarboxylation method is the excitation of the N-acyloxyphthalimide, 
which enables the intramolecular charge transfer and consequently decarboxylation. So far the 
substrates were excited either indirectly by a visible light excited photocatalyst or directly via 
UV-light irradiation without a catalyst. Each process has its disadvantages. Using UV 
irradiation, you have to follow special safety regulations, special glassware and high energy is 
needed. On the other hand, visible light conditions with light emitting diodes, less power 
leads to a greener chemistry, but expensive photocatalysts were used in the reactions. If the N-
acyloxyphthalimides would absorb light in the visible range, no catalyst would be needed to 
initiate the decarboxylation process. Therefore particular attention is drawn to naphthalene 
diimides, which are known as organic dyes and triplet photosensitizers.60 
 
 
Figure 5. Absorption maxima of substituted naphthalenediimides (R = alkyl chain, n > 5). 
 
Most naphthalene diimides absorb in the visible range. Depending on the substituents of the 
naphthalene core structure and the N-substituents the absorption maxima changes (Figure 5). 
Replacing so far used phthalimides with naphthalene diimides would allow direct 
sensitization, which avoids the detour via the photocatalyst. The naphthalene diimide core 107 
is excited by visible light. This excited species 108 undergoes the intramolecular energy 
transfer. After naphthalene diimide separation, two decarboxylations take place and the 
product is formed (Scheme 30). This direct excitation could lead to shorter reaction times and 
higher yields at the same time.  
 
      λmax < 380 nm          λmax = 400 nm          λmax = 450 nm                   λmax = 600 nm 
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Scheme 30. Mechanism of the direct sensitization of colored naphthalene diimide compounds 107. 
 
To investigate if naphthalene diimides could activate acids and lead to decarboxylation like 
phthalimides, compounds 109 and 110 were synthesized. The naphthalene diimides 109 and 
110 were yellow solids and the UV-Vis absorption spectra of 109 shows absorption in the 
visible range, therefore the compounds are accessible for 455 nm LEDs (Figure 6). 
 
Figure 6. Absorption spectra of compound 109. 
 
Due to solubility problems the photoreactions were performed in DMF/water and 
DMSO/water solvent mixtures (Table 7). The reaction mixture of 109 turned dark brown 
during irradiation, so the reaction time was elongated to 36 h until full conversion was 
obtained (entry 1). Performing the reaction in DMSO, full conversion was obtained after 6 h 
(entry 2). In contrast to the reaction in DMF the mixture turned red within 2 h of irradiation, 
whereby the light still could reach the naphthalene diimide derivative 110. The isolated yields 
of 105c (40%) and 80 (52%) were around 20% less than the former reactions with 
phthalimide activation (105c – 60% and 80 – 75%). In conclusion, using strongly colored 
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starting materials, which absorb light in the visible range, direct irradiation enables the 
decarboxylation reaction and no additional sensitizer is necessary.  
 
Table 7. Decarboxylation reaction of naphthalene diimide based compounds 109 and 110. 
 
Entry R1 Solvent Time Product Yield 
1 
 
109 DMF/H2O (40/1) 32 h 
 
105c 40% 
2 
 
110 DMSO/H2O (40/1) 6 h 
 
80 52% 
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1.7 Capsazepinoid synthesis 
The products – ȕ-phenylethylamines 78, dihydroisoquinolinones 79, 80 and benzazepinones 
105 – of the developed visible light mediated transformation of ω-aryl-N-acyloxyphthalimides 
can serve as precursors for numerous biological active compounds.61 One application is the 
preparation of key intermediates 106 and 111, used in the convergent synthesis of 
bronchodilator capsazepinoid 112.62 The starting materials 102c and 77d could be synthesized 
each in 4 steps from readily and commercial available benzoyl chlorides, ethyl 4-
bromobutyrate, ethyl acrylate and N-hydroxyphthalimide in overall yields of 41% (102c) and 
55% (77d). After the visible light-mediated decarboxylation products 105c and 85e were 
isolated in 60% and 68% yield. The tert-butyl groups were removed using TFA and the 
methyl carbamate was cleaved under microwave conditions, described by Scobie et al.63 The 
obtained benzoazepinone 106 and unprotected ȕ-phenylethylamine 111 can be transformed to 
capsazepinoid 112 as reported by Sterner et al. (Scheme 31). With this strategy it is possible 
to synthesize numerous other active capsazepinoids, which acts as inhibitors of constriction of 
human airways.64 
 
Scheme 31. Formal synthesis of capsazepinoid 112. a) [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), MeCN/H2O 
(40/1), 455 nm LED, room temp., 16 h (60%). b) [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), 
MeCN/MeOH (3 equiv.), 455 nm LED, room temp., 16 h (68%). c) TFA, reflux, 6 h 
(86%). d) TFA, room temp., overnight. e) 2 M LiOH/THF/MeOH (1/1/1), MW, 120 °C, 
10 min (89%). 
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1.8 Decarboxylative phenylalanine synthesis 
Until now the used substrates were synthesized from benzoyl chlorides, giving benzamides. 
Therefore the limitation of the reaction scope is liable to suitable amines with the sterical 
demanding tert-butyl group. In order to gain access to a broader substrate range, ω-aryl-N-
acyloxyphthalimide 118 was synthesized from 4-anisaldehyde (113) and ȕ-amino acid 114 
(Scheme 32). Due to the convenient amine Boc-protection, which replaces the so far used 
bulky tert-butyl group, all ȕ-amino acids can be utilized in the starting material synthesis.  
 
Scheme 32. Synthesis of ω-aryl-N-acyloxyphthalimide 118. a) MeOH, NEt3 (1 equiv.), NaBH4 
(1 equiv.), room temp., overnight (90%). b) DCM, NEt3 (1 equiv.), Boc2O (1 equiv.), 
room temp., overnight (56%). c) EtOH, H2O, KOH (1.9 equiv.) (98%). d) THF, N-
hydroxyphthalimide (1 equiv.), DCC (1 equiv.), room temp., overnight (67%). 
 
The decarboxylation of 118, using the established photoreaction conditions, yields the Boc-
protected ȕ-phenylethylamine 122 in 52% (Scheme 33). Similar to the previous results, the 
formation of spiro-intermediate 119 is assumed, in course of the reaction. Rearomatization 
leads to cation intermediate 120, which is trapped by the solvent, releasing formaldehyde, 
similar to the reaction of N-acyloxyphthalimide 97 (Scheme 27).  
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Scheme 33. Photodecarboxylation and proposed reaction mechanism of N-acyloxyphthalimide 118. 
  
Using commercially available L-aspartic acid and substituted benzaldehydes in the starting 
material synthesis, numerous of unnatural phenylalanine derivatives 124 can be synthesized 
via this visible light-mediated decarboxylation (Scheme 34). In contrast to the N-tert-butyl 
substituted ȕ-phenylethylamines 78, the received amino acids 124 have commonly used tert-
butyloxycarbonyl and methyl ester protecting groups. As an example the para-methoxy 
substituted phenylalanine 126 was synthesized from 125 in 54% yield.b Ongoing experiments 
in the Reiser group by M.Sc. Simon Budde are extending the scope of the reaction, giving rise 
to a library of unnatural phenylalanine derivatives 124. 
 
Scheme 34. Synthesis of phenylalanine derivatives from N-acyloxyphthalimides 123. 
 
 
 
 
 
                                                 
b
 The photoreaction of 125 was performed by M.Sc. Simon Budde in course of his PhD thesis. 
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1.9 Decarboxylative tetralin synthesis 
In the previous chapters the visible light-mediated decarboxylation was limited to ω-aryl 
amino acids. After decarboxylation and spirocyclization an 1,2-acyl shift lead to ȕ-
phenylethylamines 78 and tetrahydroisoquinolinones 105. This rearrangement was observed 
using benzamide- or benzylamine based starting materials.  
In the next step the function of the amine in the spirocyclization process was investigated. For 
this ω-aryl-N-acyloxyphthalimide 127 was synthesized. Starting from 4-methoxy 
benzaldehyde and propionaldehyde the key step of the synthesis was a Horner-Wadsworth-
Emmons reaction. After hydrogenation and ester hydrolysis the desired product 127 was 
obtained after the coupling with N-hydroxyphthalimide.  
Using previous investigated photoreaction conditions, the intramolecular reduction of the 
phthalimide moiety and following decarboxylation should lead to the biradical 128. This 
intermediate 128 was assumed to undergo several transformations (Scheme 35). One possible 
mechanism continuous with an intramolecular electron back transfer to the phenyl moiety 
forms the primary alkyl cation, which was observed in the reaction with N-acyloxy-
phthalimide 97 (Scheme 27, Section 1.4.5). A reaction with water leads to the alcohol 129. 
Another possible product based on intermediate 128 is the tetralin derivative 130, which 
concludes from a 6-exo-trig cyclization and rearomatization. Spirocyclization of biradical 128 
forms the intermediate 131, which could undergo ring opening, obtaining again compound 
129 or a smiles-type rearrangement leading to compound 132. By observing the positions of 
the methyl group in the alkyl chain the assumed mechanisms and products can be 
differentiated.  
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Scheme 35. Photodecarboxylation of 127 and the possible reaction products 129, 130 and 132. 
a) reaction conditions: [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), MeCN/H2O (40/1), hν (455 nm 
LED), room temp., 16 h. b) Intramolecular electron transfer and hydroxyl addition. 
c) Cyclization and rearomatization. d) 5-Exo-trig spirocyclization. e) Ring opening and 
hydroxyl addition. 
 
N-acyloxyphthalimide 127 was irradiated with a 455 nm LED in presence of [Ir(ppy)2(dtb-
bpy)]PF6 (1 mol%) and an acetonitrile/water solvent mixture (40/1, c = 1 mol/l). After the 
photoreaction the cyclized tetralin derivative 130 was isolated in 49% yield (Scheme 36, A) 
together with the corresponding hydrolyzed acid side product. 
 
Scheme 36. Reaction comparison of compound 127 with N-methyl benzamide derivative 83 and N-
Boc protected benzylamine derivative 118. a) [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), 
MeCN/H2O (40/1, c = 1 mol/l), 455 nm LED, room temp., 16 h. 
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Incorporating an amide group into the molecule 127 the already investigated benzamide 
derivative 83 is received (Scheme 36). Regarding the photoredox mechanism of 
photocatalytic reactions, the carbonyl group in this molecule is necessary to prevent the 
nitrogen from oxidation by the photocatalyst. Former reaction studies show no product 
formation for the benzamide derivative 83 (Table 5, Section 1.4.2). The N-methyl group is not 
bulky enough to engage a favorable conformation for the reaction (Scheme 36, B). A sterical 
demanding N-protecting group enables the decarboxylation and rearrangement forming 
phenylethylamine derivatives (Scheme 36, C).  
In contrast to amide containing analogs of these N-acyloxyphthalimides, compound 127 is 
able to undergo the intramolecular electron transfer from the phenyl to the phthalimide 
moiety, without any bulky substituents. Although decarboxylation occurs, no spirocyclization 
was assumed. Instead of that, direct 6-exo-trig cyclization is forming tetralin 130. 
Table 8. Decarboxylative tetralin synthesis. 
 
Entry ω-Aryl-N-acyloxyphthalimide Time Product Yield 
1 
 
127 16 h 
 
130 49% 
2 
 
133 36 h 
 
134 33%a 
3 
 
135 65 h 
 
136 0% 
a
 incomplete conversion after 36 h of irradiation. 
 
Electron density of the phenyl group plays still a crucial role in product formation. The 
intramolecular reduction of the phthalimide is favored by increased presence of electron 
donating substituents (Table 4, Section 1.4.2). Performing the photoreaction with N-
acyloxyphthalimide 133, which has an electron withdrawing carbonyl group, after 36 h of 
irradiation the reaction was still incomplete and only 33% of the corresponding tetralin 134 
was isolated (Table 8, entry 2). The synthesis of hydro-indene 136 failed in spite of the 
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absence of the carbonyl group. In all likelihood sterical effects disable the intramolecular 
phthalimide reduction.  
In contrast to the photoreaction of N-acyloxyphthalimides 77 and 118 phenylpentanoic 
phthalimide ester derivatives reacted in a 6-exo-trig cyclization, without any additional 
rearrangement. On the basis of these simple examples the synthesis of tetralin derivatives via 
visible light-mediated decarboxylation was shown. Further investigations regarding reaction 
conditions would allow for improving yields, but were not performed as part of this thesis. 
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1.10 Conclusion 
In summary, a visible light-promoted decarboxylative Smiles-type rearrangement was 
developed. ω-Aryl-N-acyloxyphthalimides were easily synthesized from commercially 
inexpensive compounds and decarboxylated via energy transfer mechanism from a visible 
light excited photocatalyst. Depending on the aryl substituents and different solvent mixtures 
a multitude of ȕ-phenylethylamines, ȕ-phenylethylcarbamates and dihydroisoquinolinones 
were synthesized under mild and environmentally friendly reactions.  
A further substrate scope extension via the elongation of the alkyl carbon chain of the starting 
materials afforded tetrahydrobenzazepinones in good yields. After the decarboxylation of 
these substrates no additional rearrangement reaction was observed.  
As an application for the developed visible light mediated transformation of ω-aryl-N-
acyloxyphthalimides both key intermediates for the convergent synthesis of the 
bronchodilator capsazepinoid were prepared. This photoinduced process was also used in the 
synthesis of unnatural phenylalanine derivatives based on L-aspartic acid and substituted 
benzaldehydes and the synthesis of tetralin derivatives from the decarboxylation of 
phenylpentanoic acids.  
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2 UV light-mediated reactions of phthalimidesc 
2.1 Scientific bases  
The photophysical65 as well as the electrochemical66 properties of phthalimides are well 
investigated. The absorption spectra of non substituted phthalimide, N-acetyl- or N-
benzoylphthalimide show the absorption maxima at around λmax = 235 nm, λmax = 340 nm, 
and λmax = 350 nm, respectively.67 Light absorption in the UV range enables the access to the 
excited triplet state of N-substituted phthalimides with an average lifetime between 2 µs and 
10 µs at room temperature in absence of oxygen. This excited state of the phthalimide has a 
remarkably high oxidizing power, which can lead to electron transfer reactions in presence of 
suitable electron donor groups.68 
In the 1970s Kanaoka et al. utilized this behavior and demonstrated a number of phthalimide 
based photochemical reactions.69 The group focused especially on intramolecular cyclizations, 
using phthalimides with N-substituted ω-benzyl (A),70 ω-alkene,71 ω-dialkylamines (B),72 ω-
thionyl (C)73 or ether (C)74 moieties (Scheme 37).  
 
Scheme 37. Photoinduced intramolecular cyclization of N-substituted phthalimides. A: tert-Butanol, 
1 kW high pressure mercury lamp, 3 h (65%). B: 0.2 M solution acetone/petroleum ether 
(3/1), 500 W high pressure mercury lamp, 0.5 h, n = 2 (29%). C: Acetone, 400 W high 
pressure mercury lamp, 3 h; a) X = S, n = 3, R = H (86%); b) X = O, n = 1, R = Ph (60%). 
                                                 
c
 The results of this chapter were prepared during a four month research intership at James Cook University of 
Townsville/Australia. College of Science, Technology & Engineering. Supervisor: A/Prof. Michael Oelgemöller. 
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Using usually acetone as a triplet sensitizer, the phthalimide derivatives were excited via UV 
irradiation. In the excited state, the molecules undergo charge transfer from the particular 
reactive end of the molecule to the phthalimide moiety. The oxidized part of the molecule 
cleaves off hydrogen atom and a radical ion combination yields the cyclization products 139, 
142 and 145.  
Apart from the intramolecular cyclizations, intermolecular additions were also investigated. 
Based on the same process, benzylic donors,75 alkenes,76 or ethers (e.g. tetrahydrofuran)77 
were used as reducing agent in a photoaddition reaction, resulting in the alkylated phthalimide 
derivatives. 
Mariano et al. and Yoon et al. continued the work of Kanaoka et al. and introduced 
trimethylsilyl (TMS) as a leaving group. In this study, TMS is placed in ȕ-position to the 
active donor group, like ethers78 or amides.79 After the reduction of the phthalimide moiety, 
trimethylsilane is cleaved off, generating the alkyl radical 148, which undergoes 
intramolecular cyclization and to form compound 145 (Scheme 38).80 In contrast to the 
hydrogen atom cleavage, the alkyl radical is generated faster, which lowers the reaction time 
and increases the yield. Also intermolecular conditions with phthalimides and alkoxymethyl-
trimethoxysilanes, which react in a competitive single electron transfer manner, were 
investigated.81 
 
Scheme 38. Photocyclization reaction of ω-trimethylsilyl-phthalimide 146. a) MeOH, 450 W Hanovia 
medium pressure mercury vapor lamp, 2 h (98%). 
 
Griesbeck et al. and Oelgemöller et al. expanded the scope of this intramolecular phthalimide 
addition. They used UV irradiation to oxidize free carboxylic acids with the excited 
phthalimide moiety. After decarboxylation the cyclized phthalimide derivatives 150 were 
isolated. Depending on the amount of water in the reaction solvent, the simple decarboxylated 
side products 151 were obtained. By increasing the water ratio, less side product was 
observed, which could form after the decarboxylation in a second back electron transfer 
(Scheme 39).82 Via the application of aqueous nontoxic solvents and omitting further 
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additives, this process offered a new possibility for mild decarboxylation and in the spirit of 
green chemistry.83 
 
Scheme 39. Photoinduced decarboxylation of phthalimide 149 and the influence of the water amount 
on the product ratios.  
 
Intermolecular additions were investigated mainly with phenylacetic acids. The phthalimide 
reduction was performed either by the acid group or, in case of a high electron density of the 
phenyl ring (R3 = 3,4,5-OMe; 3,4-OMe), by the phenyl moiety. The oxidized phenylacetic 
acid 155 loses carbon dioxide, generating the benzyl radical 157. Radical recombination leads 
to the desired benzylated phthalimides 158 in excellent to very good yields (Scheme 40).84 
 
Scheme 40. Proposed mechanism of the decarboxylative benzylation of phthalimides.  
R1 = H, Alk, Ar; R2 = H, Alk; R3 = OMe, OAc, Hal, Alk. 
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Many target molecules of these reactions, specifically the benzylation products 158, which 
can easily be transformed into 159 or 160 via acid treatment, lead to useful and 
pharmaceutical active compounds.85,86 E.g. the 4-methoxyphenylmethylene derivative 160 
(AL-12), known for its local anesthetic activity, is superior to tetracaine and the E-
phenylethylidene derivative 161 (AKS-186), which inhibits tromboxane A2 analogue (U-
46619) induced vasoconstriction.87,88 In a simple aryl-aryl-coupling arylmethylene-isoindolin-
1-ones (159) can be transformed into aristolactams (162), which are components of many 
plants such as Aristolochia and Asarum (Figure 7).89  
 
Figure 7. The core structure of arylmethylene-isoindolin-1-ones (159), 4-methoxyphenylmethylene 
derivative 160 (Al-12), E-phenylethylidene derivative 161 (AKS-186) and the core 
structure of aristolactams (162).  
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2.2 Investigation of the light-promoted dual decarboxylation 
2.2.1 Visible light-mediated dual decarboxylation 
Thanks to the work of Okada et al. and the recently published papers the mechanism of the 
light induced decarboxylation of activated phthalimide esters is widely explained the 
phthalimide moiety is reduced before CO2 is cleaved off.48,90 As already mentioned Griesbeck 
et al. and Oelgemöller et al. explored a UV-light induced decarboxylation of free carboxylic 
acids, which is also initiated by the reduction of the phthalimide group (see 
Section 2.1).82,83,84,85 
Based on these findings a special method for decarboxylation reactions, combining both 
systems in one reaction, was investigated. Phthalimide esters should get reduced by external 
carboxylic acids, which undergo decarboxylation. Subsequently phthalimide is cleaved and 
the second decarboxylation occurs.  
Therefore N-acyloxyphthalimid 163 was synthesized as a model substrate for the test 
reactions. The electron-rich phenyl group could reduce the phthalimide moiety in an 
intramolecular way, as seen in the decarboxylation/rearrangement reactions of compound 77 
(Scheme 26, Section 1.4), without requiring the addition of phenylacetic acid. For that reason 
first experiments were carried out under visible light conditions using [Ir(ppy)2(dtb-bpy)]PF6 
for the energy transfer to the molecule (Table 9). Under the commonly used reaction 
conditions for photosensitized decarboxylation reactions of N-acyloxyphthalimides, 1 mol% 
of the catalyst [Ir(ppy)2(dtb-bpy)]PF6 and an acetonitrile/water (40/1) solvent mixture, there 
was still incomplete conversion of compound 163. Only traces of the dihydrostilbene product 
165 were determined (entry 1).  
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Table 9. Dihydrostilbene 165 synthesis under visible light conditions. 
 
Entry 163 164 Solvent Yield 165a  
1 1 equiv. - MeCN/H2O (40/1) tracesb 
2 1 equiv. - acetone/H2O (20/1) 34% 
3 1 equiv. 1 equiv. acetone/H2O (20/1) 37% 
4 1 equiv. 3 equiv. acetone/H2O (20/1) 36% 
a Yields are based on 163. b Incomplete conversion after 16 h. 
By increasing the amount of water and changing the solvent to acetone, full conversion was 
observed and 34% of product, based on N-acyloxyphthalimide E1, was isolated (entry 2). 
Oelgemöller et al. used phenylacetic acid to reduce the phthalimide.84 The presence of 
additional 4-methoxyphenylacetic acid (E2) had no notable impact on the yields (entry 3 
and 4). In all reactions, 4-methoxybenzyl alcohol and 4-methoxybenzaldehyde were detected 
as side products. 
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2.2.2 Experimental set up of UV-reactions 
The following UV reactions were performed in a Rayonet chamber reactor, equipped with 
16 x 8 W RPR-3000 Å lamps (λ = 300 ± 25 nm; Figure 8). The reaction mixture was 
irradiated in a Pyrex Schlenk flask (λ ≥ 290 nm) with cooling finger to keep a constant 
reaction temperature of approximately 15-20 °C. With a Teflon tube a slight stream of 
nitrogen was inserted, to generate a continuous movement of the solvent. 
  
Figure 8.  Rayonet photoreactor (1) and the experimental setup with 16 x 8 W RPR-3000 Å lamps 
(2), pyrex tube (3), cooling finger (4) and in/outlet for N2 (5). 
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2.2.3 UV light-mediated dihydrostilbene synthesis 
Using visible light in combination with the sensitizer [Ir(ppy)2(dtb-bpy)]PF6 only resulted in 
moderate yields (see Section 2.2.1). Therefore, UV-light was applied to excite the phthalimide 
moiety directly to harness the reducing power of phenylacetic acid, which was not observed 
under visible light conditions. Performing the dihydrostilbene synthesis under UV-light 
irradiation the product yield was increased slightly. After 3 h of irradiation in an 
acetone / water solvent mixture, in absence of additional acid, 40% of dihydrostilbene 165 
was isolated (Table 10, entry 1). For these types of UV reactions, acetone is known to be the 
best solvent as it is serving as a triplet sensitizer. The carboxylic acid functionality of 
phenylacetic acid reduces the phthalimide. Electron rich phenyl rings have the property that 
also the phenyl moiety can act as a reductant, which leads to decarboxylation of the 
phenylacetic acid derivatives. Therefore, the N-acyloxyphthalimide with para-methyl 
substituent and thereby with a lower electron density in comparison to the para-methoxy 
group, only 18% of the corresponding dihydrostilbene was obtained (entry 2). In presence of 
1 equiv. phenylacetic acid the yield increased only to 48%, whereas with 3 equiv. acid 72% 
yield was isolated (entry 3 and 4). Based on the experiences of Oelgemöller et al. 1.5 equiv. 
potassium carbonate was added in the reactions in order to deprotonate the acid and enable a 
better and faster reduction of the phthalimide moiety.84 
Table 10. Dihydrostilbene synthesis under UV-light conditions. 
 
Entry 166 167 R Solvent Yielda 
1 1 equiv. - p-OMe acetone/H2O (1/1) 40% 
2b 1 equiv. - p-Me acetone/H2O (1/1) 18% 
3c 1 equiv. 1 equiv. p-OMe acetone/H2O (1/1) 48% 
4c 1 equiv. 3 equiv. p-OMe acetone/H2O (1/1) 72% 
5d 1 equiv. 1 equiv. p-OMe acetone/buffer (1/1) 20% 
6 - 1 equiv. p-OMe acetone/H2O (10/1) - 
7e 1 equiv. 1 equiv. p-OMe acetone/H2O (1/1) - 
a Yields are based on N-acyloxyphthalimide. b 4 h reaction time. c additional 1.5 equiv. K2CO3. d pH 7 
buffer solution (Fixanal®), without K2CO3. e no light irradiation for 20 h.  
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During the photoreaction, free phthalimide (169) was formed. Due to the UV light, the well-
precedented alkylation of phthalimides takes place, forming compound 170. This competing 
reaction decreased the amount of acid available for the dihydrostilbene synthesis, thereby 
reducing its efficiency (Scheme 41). The best results (72% yield; Table 10; entry 4) were 
obtained using 3 equiv. of the phenylacetic acid additive. Using a pH 7 buffer solution 
(Fixanal®) for the reactions,85b which was generally used for the alkylation reactions to “free” 
phthalimides only 20% dihydrostilbene was isolated (entry 5). Without the phthalimide 
activation and without light irradiation, no reaction was determined (entry 6 and 7). 
 
Scheme 41. Phthalimide alkylation as a side reaction of the dihydrostilbene synthesis. 
 
In order to find out, whether the last step of the mechanism is a radical dimerization, the 
photoreaction of the non-substituted phthalimide activated acid 171 with 4-
methoxyphenylacetic acid (164) was performed. After the reaction, three dihydrostilbenes, 
originating from the combination of both benzyl radicals, were obtained in a total yield of 
approximately 78%, based on 166, and a product ratio of 1:2.4:2.1 (172:173:165; determined 
by NMR analysis (Scheme 42). In addition to this reaction, the alkylated phthalimide side 
product 170 (R = para-OMe), which only reacted with the acid 164 was isolated in 87% yield, 
based on maximum released amount of phthalimide.  
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Scheme 42. Simultaneous decarboxylation of different phenylacetic acid derivatives. 
 
The amount of mixed heterocoupling product 173 was 2.4 times higher than homocoupled 
dihydrostilbene 172 formed by the phthalimide ester 171. During the reduction of the 
phthalimide moiety by phenylacetic acid 164, the molecules are sterically close to each other. 
This proximity could be increased by the possibility of π-stacking.91 Nevertheless the amount 
of 172 and 165 product is still too high, to use this reaction for a selective, preparative useful 
C-C coupling between different acids.  
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2.2.4 Mechanistic aspects of the UV decarboxylation reaction 
With these results in hand the following sensitization reaction mechanism was proposed. The 
UV irradiation of the acetone/water reaction mixture leads to the triplet sensitization of N-
acyloxyphthalimide 166. The excited species 174 is reduced by the phenylacetic acid (167). 
Depending on the substituents and therefore the electron density of the phenyl group, a 
different phenylacetic acid moiety reduces the phthalimide group. In case of a high electron 
density in the phenyl ring, the moiety itself reduces the excited phthalimide species. If no 
electron donor substituents were present, the acid group is performing the reduction. The 
reduced phthalimide 175 gets protonated by the solvent and undergoes a phthalimide cleavage 
followed by the decarboxylation. The oxidized phenylacetic acid derivative 176 
decarboxylates spontaneously, whereby two benzyl radicals 177 are obtained. After 
dimerization of the radicals the desired dihydrostilbene 168 is formed (Scheme 43). 
 
Scheme 43. Proposed reaction mechanism for the UV light mediated decarboxylation of 166 and 167 
(PET = photoinduced electron transfer). 
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2.2.5 Scope of the dihydrostilbene synthesis 
Different dihydrostilbenes were prepared starting from phenylacetic acid derivatives and their 
N-acyloxyphthalimides via UV-light irradiation. The phthalimide activated acids could be 
synthesized in fair to very good (52-87%) yields from the corresponding phenylacetic acid 
and N-hydroxyphthalimide. The yield of unsubstituted and para-methylated phenylacetic 
acids were in the same range of 59-62%. Therefore it was surprising that 1,2-di-meta-
tolylethane (168c) was isolated in 82% yield (entry 3). Also halogenated derivatives, such as 
fluoro- or bromo-dihydrostilbenes could be synthesized (entry 4 and 5). The phthalimide 
coupled para-methoxyphenylacetic acid gave 72% yield (entry 6). For the decarboxylation of 
the trimethoxy-substituted phenylacetic acid (168g) only 1 equivalent of the corresponding 
acid was used, wherefore only 28% yield was isolated (entry 7). The phthalimide activated 4-
(dimethylamino)phenylacetic acid 168h is very light sensitive, for this reason the yield drops 
to only 17% (entry 8). Finally the secondary acid derivative 166i was decarboxylated isolating 
dihydrostilbene 168i in 43% yield (entry 9). 
Table 11. Dihydrostilbene synthesis via light induced decarboxylation. 
 
Entry Substrate 
 
Product 
 
Yield 
1 
 
166a 
 
168a 59% 
2 
 
166b 
 
168b 62% 
3 
 
166c 
 
168c 82% 
4 
 
166d 
 
168d 50% 
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Entry Substrate 
 
Product 
 
Yield 
5 
 
166e 
 
168e 61% 
6 
 
166f 
 
168f 72% 
7a 
 
166g 
 
168g 28% 
8 
 
166h 
 
168h 17%a 
9b 
 
166i 
 
168i 43% 
a
 
1 equiv. of 2-(3,4,5-trimethoxyphenyl)acetic acid. b irradiated with an high pressure mercury lamp. 
 
2.2.6 Conclusion 
A feasible “dual” decarboxylation method via UV-light irradiation, using phthalimide 
activated acids and phenylacetic acids, was investigated. In a light sensitized mechanism the 
phthalimide moiety was reduced by the phenylacetic acid. After simultaneous decarboxylation 
of both substrates the stabilized radicals combine in a crosscoupling reaction. A library of 
different dihydrostilbenes with fair to very good yields was established.  
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2.3 Photodecarboxylative benzylation of N-methoxy-
phthalimidesd 
2.3.1 Benzylation of N-substituted phthalimides 
The photochemical behavior of phthalimides is well investigated and many papers were 
published in this research area.68,92 The photo excited species of the phthalimide moieties can 
be reduced by a multiplicity of compounds, like arenes, alkenes, ethers, amines and 
thioethers.69 Griesbeck et al. and Oelgemöller et al. investigated an impressive alkylation 
method for phthalimides using carboxylic acids. Regardless if the reaction is inter- or 
intramolecular, this protocol was extended to N-substitution free phthalimide derivatives and 
a multitude of N-alkylphthalimides.93,94 At this juncture, the well-known benzylation reaction 
was observed as a side reaction in the decarboxylation project forming dihydrostilbenes, as 
described before (Scheme 41).  
Considering former studies, the established protocol for the photodecarboxylative addition of 
carboxylates to phthalimides were extended to N-hydroxy and N-methoxy substituents. The 
expected N-substituted phthalimide products are attractive precursors in the synthesis of novel 
isoindolinone derivatives and aristolactames.95  
  
Scheme 44. Photodecarboxylative benzylation of phthalimide 178 and 180. 179, 23h (0%);  
181, 26 h (73%). 
 
First decarboxylation experiments were performed in a 1/1 solvent mixture of acetone and 
pH 7 buffer (Fixanal®), because of salt effects of the phenylacetic acid. Former publications in 
this field of research showed that the reaction efficiency is correlated to the pH level of the 
solvent.85b Using 3 equiv. of acid 167a and N-hydroxypthalimide (178), no conversion was 
                                                 
d
 This Chapter is based on Pordanjani, H. M.; Faderl, C.; Wang, J.; Motti, C. A.; Junk, P. C.; Oelgemöller, M. 
Aust. J. Chem. 2015, 68, 1662-1667. Appropriate copyrights have been obtained where necessary. 
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observed after 23 h of irradiation. The reaction with N-methoxyphthalimide (180) was 
successful, forming 2-methoxyisoindolinone 181 after 26 h in 73% yield (Scheme 44).  
The mechanistic discussion starts with the triplet sensitization of N-methoxyphthalimide (180) 
by UV irradiated acetone. The intermolecular electron transfer from the phenylacetic acid to 
the excited phthalimide leads to the reduced phthalimide 183 and the decarboxylation of the 
oxidiezed acid to the alkyl radical 184. Sammis et al. reported a photoredox catalyzed 
fragmentation of N-alkoxyphthalimides.96 In their mechanism they claim a homolysis and a 
simultaneous acting intramolecular elimination of the reduced N-alkoxyphthalimide 183. This 
phthalimide cleavage (path B) couldn´t be observed, whereby protonation and C-C bond 
formation yielded the benzylated N-methoxyphthalimide 181 (path A, Scheme 45). 
 
Scheme 45. Proposed reaction mechanism of the photodecarboxylative benzylation of N-methoxy-
phthalimide 180. 
 
Hossein Mohammadkhani Pordanjani, a grad student in the Oelgemöller group, optimized the 
conditions for that reaction and benzylated N-methoxyphthalimides with a couple of different 
phenylacetic acid derivatives.97  
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2.3.2 Benzylation of N-methoxyphthalimide under flow conditionse 
An important step to commercialize a reaction and make it attractive for industry, is to 
develop a continuous flow setup for this reaction.98 The advantages over batch techniques are 
numerous, such as a better control of reaction parameter, like temperature or reaction time. 
Also in many reactions the yields increase, because products were removed from the 
irradiated zone and there is less chance of photodecomposition.99 Furthermore faster operation 
times and quick optimizations of the reactions are possible, to name but a few.100 
Accordingly the benzylated N-methoxyphthalimide 181 was prepared by continuous-flow 
photochemistry. For the flow studies the commercially available Vapourtec easy-Photochem 
reactor (Figure 9) was used. The UV-150 reactor chamber was equipped with a 150 W 
medium pressure pure mercury lamp, which operated during the reaction with 82 W at around 
30 °C. A so called “gold filter” in the reactor guarantees wavelengths of λ = 290 nm. 
 
Figure 9. Vapourtec easy-Photochem module: digital display (1), cooling system (2), in- and outlet (3) 
and UV-150 chamber (4).  
 
After the optimization reactions of Hossain M. Pordanjani the reaction time could be 
shortened to 1 h, which comes along with a decreasing yield from 73% to 52% (Table 12).97 
With these reaction conditions in hand, the concentration studies were performed with a 
constant flow rate of 5 ml/min (= 120 s irradiation / residence time; entry 1-4). Full 
conversion was achieved with 0.01 mmol/l concentration of the substrate, and 67% 2-
methoxyisoindolinone 181 was isolated. Despite the application of a relatively small reaction 
coil (internal diameter: 1.30 mm) and a strong UV irradiation the conversion dropped with 
                                                 
e
 Hossein M. Pordanjani and I myself performed the following concentration and flow rate studies under my 
supervision. 
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increasing substrate concentration. In a second step, the flow rate was changed to lower the 
reaction time (entry 5-9), which resulted in a reduction of conversion rates. The best result, 
with full conversion and 74% isolated yield, was achieved with 0.01 mmol/l concentration 
and a flow rate of 6 ml/min (100 s irradiation / residence time; entry 6). 
Table 12. Experimental details for the photoinduced benzylation of 180 with 166a in the flow reactor. 
 
Entry Conc. of 180 [mmol/l] Flow rate [ml/min] irradiation time [s] Conversion [%]a 
1 0.01 5 120 100 (67b) 
2 0.015 5 120 88 
3 0.025 5 120 39 
4 0.1 5 120 trace 
5 0.01 6 100 100 (74b) 
6 0.01 7 86 92 
7 0.01 8 75 81 
8 0.01 9 67 71 
9 0.01 10 60 61 
a Conversion was determined by 1H NMR spectroscopy (± 3%). b Isolated yields. 
 
2.3.3 Conclusion 
In conclusion, the photoinduced decarboxylation protocol was applied for the benzylation of 
N-methoxyphthalimide. A cleavage of the methoxy group, as previously described in 
literature, was not observed.96 The reaction protocol was successfully transferred and 
optimized from batch condition to a meso-scale continuous flow photoreactor. 
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3 Decarboxylative hydroxylation/alkoxylationf 
3.1 Preliminary studies and state of the art 
In preliminary studies using visible light and a photocatalyst for the synthesis of 
dihydrostilbene 165, decarboxylation of N-acyloxyphthalimide 163 generated aldehyde 185 
and a significant amount of benzyl alcohol 186 as side products (Scheme 46 and 
Section 2.2.1). Slightly changing of the reaction conditions, e.g. using acetonitrile instead of 
acetone as solvent, led to a dramatically change of the product formation. UV-light irradiation 
turned out to be the most efficient way synthesizing dihydrostilbenes (50-82%), following this 
decarboxylation procedure (Table 11, Section 2.2.5). Vice versa visible light photochemistry 
seemed to be the method of choice transforming phenylacetic acid derivatives into benzyl 
alcohols. 
 
Scheme 46. Visible light-mediated decarboxylation of 163. a) [Ir(dtb-bpy)(ppy)2]PF6 (1 mol%), 
acetone/H2O (20/1, c = 0.1 mol/l), hν (455 nm), room temp., 16 h. 
 
Analysis of the literature showed that only few examples of decarboxylation/hydroxylation 
protocols are known.101 These reactions include complex reaction mixtures with excess of 
harmful and expensive chemicals. First Barton et al. reported the 
decarboxylation/hydroxylation reaction using a Barton decarboxylation with 2 equiv. 
(PhS)3Sb and oxygen.101a,102 A few years later, this reaction was improved by the same 
working group replacing the antimony compound with 4 equiv. tert-dodecanethiol and 
1.5 equiv. triphenylphosphine in toluene using visible light (Scheme 47, A.). Another very 
special method, because it was only done for N-aryl-Ȗ-lactame carboxylic acids 189, was 
investigated by Ray et al. Performing the reaction in presence of 2.2 equiv. ceric ammonium 
nitrate (CAN) not only hydroxylations, but also alkoxylations were possible, while the sterical 
                                                 
f
 This Chapter is based on a cooperation with M.Sc. Simon Budde, who conducted investigations for this project 
in his master thesis “Decarboxylation of N-Hydroxyphthalimide esters: Attempted synthesis of annulated indoles 
and investigations of a new reaction pathway”. Appropriate copyrights have been obtained where necessary. 
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information is retained. (Scheme 47, B).101c This is also the only example where free acids 
were applied.  
 
Scheme 47. Literature examples of decarboxylation/hydroxylation reactions (A101b, B101c).  
 
The decarboxylative hydroxylation/alkoxylation is a useful tool in organic synthesis. Acids, 
which are very common in nature and the synthesis of fine chemicals, can be transferred into 
further important hydroxyl/alkoxy derivatives. For example the Barton decarboxylation and 
hydroxylation employing (PhS)3Sb was used in natural compound synthesis of 
debromoflustramide B,103 (-)-Paeoniflorin),104 or (-)-Verrucarol.105 
Below the visible light-mediated decarboxylative hydroxylation of N-acyloxyphthalimides 
was investigated, which represents an easy and chemical saving alternative to the literature 
known methods. 
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3.2 Optimization experiments and mechanistic considerationsg 
To optimize the reaction conditions phenylacetic acid based phthalimide ester 171 was used 
(Scheme 48). M.Sc. Simon Budde performed the optimization reactions regarding solvents, 
catalysts and catalyst amount. Water plays a crucial role in this reaction. Besides the 
protonation of the phthalimide moiety, water is also necessary for the hydroxyl addition. 
Therefore only water miscible solvents were screened. 
 
Scheme 48. Model reaction for the decarboxylative hydroxylation.  
Compound 171 was irradiated in presence of 2 mol% [Ir(dtb-bpy)(ppy)2]PF6 in 0.1 molar 
reaction mixtures in 4/1 ratios of acetone/water, MeCN/water, DMF/water and THF/water. 
The biggest amount of benzyl alcohol was obtained using MeCN/water, which is in 
agreement to the results of the dihydrostilbene synthesis (see Section 2.2.1). Subsequently the 
amount of water was changed in the reaction. Performing the reaction in a 0.1 molar solution 
with different MeCN/water ratios from 8/1 to 1/4 the highest yield of 85% was achieved with 
a 2/1 reaction mixture. The photocatalyst screening suggests a photosensitization mechanism. 
Application of [Ru(bpy)3]Cl2 showed no reaction and the photoreactions with [Cu(dap)2]Cl 
and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 only low conversions were observed. The best yields 
were obtained using [Ir(dtb-bpy)(ppy)2]PF6, whose redox potential of the excited state  
([Ir3+]* → Ir4+ = -0.96 V vs SCE)43 is too low for direct reduction of the phthalimide moiety of 
compound 171 (E1/2 = -1.22 V vs SCE). Therefore the catalyst serves as a sensitizer in the 
reaction, transferring energy to N-acyloxyphthalimide 166 (Scheme 49).  
                                                 
g
 The optimization reactions of this chapter were performed by M.Sc. Simon Budde. 
B  Photoinduced Decarboxylation 3  Decarboxylative hydroxylation/alkoxylation 
 
72 
 
 
Scheme 49. Proposed visible light-mediated decarboxylation/hydroxylation mechanism. 
 
The excited molecule 174 undergoes an intramolecular electron transfer, reducing the 
phthalimide moiety by the phenyl group. After protonation of intermediate 191 phthalimide 
cleavage occurs, followed by decarboxylation. Nucleophilic addition of the mesomeric 
stabilized benzyl radical 192, via the water containing solvent, leads to appropriate benzyl 
alcohol 194 (Scheme 49). In a side reaction, which is caused by photosensitization of the 
catalyst, dihydrostilbene was synthesized (Section 2.2.1). 
The photoinduced decarboxylation/hydroxylation reaction of phenylacetic acid derivatives 
leads to corresponding benzyl alcohols in good yields (Table 13). Besides the non-substituted 
compound 171, which gave 85% of benzyl alcohol (186a, entry 1), 4-methoxy and 4-chloro 
substituted phenylacetic acid derivatives were applied in this reaction leading to the alcohols 
186b and 186c in 92% and 71% yield (entry 3 and 4). Also secondary alcohol 186d could be 
isolated in a good yield (entry 5). Changing the solvent to acetonitrile/alcohol reaction 
mixture, alkoxylation of the cation intermediate 192c is the consequence. According to this 
the ethers 194 and 195 were synthesized (entry 2 and 5). Side reactions with the solvent 
acetonitrile were not detected. 
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Table 13. Decarboxylative hydroxylation and alkoxylation of phenylacetic acid derivatives.  
 
Entry N-Acyloxyphthalimide Solventa Product Yield 
1b 
 
171 MeCN/H2O 
 
186a 85% 
2b 
 
171 MeCN/MeOH 
 
194 76% 
3 
 
163 MeCN/H2O 
 
186b 92% 
4 
 
166j MeCN/H2O 
 
186c 71% 
5 
 
166i MeCN/H2O 
 
186d 73% 
6 
 
166i MeCN/EtOH 
 
195 68% 
a
 c = 0.1 M solution. b Performed by M.Sc. Simon Budde.  
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3.3 Further decarboxylative hydrogenation investigations 
Regarding the mechanism, decarboxylation of phenylacetic acid derivative 166 leads to the ω-
alkyl cation intermediate 192c via mesomeric effects. Other phthalimide esters need another 
mechanism to generate the cation intermediate. Photodecarboxylation of compound 196, 
which was performed by M.Sc. Simon Budde, yields 60% of hydroxyl product 197 (Scheme 
50). Instead of mesomeric effects, a second intramolecular electron transfer from the alkyl 
radical to the phenyl moiety forming the ω-alkyl cation intermediate was assumed. This 
second charge transfer was already observed in the photoreaction of N-acyloxyphthalimide 97 
(Scheme 27, Section 1.5.1). 
 
Scheme 50. Photodecarboxylation of 196.h 
 
Unfortunately using simple ω-aryl-phthalimide esters, such as compound 198 or the 
phthalimide ester of cinnamic acid, no reaction was observed (Scheme 51). These molecules 
were not able to undergo the intramolecular electron transfer, accompanied by phthalimide 
cleavage and decarboxylation.  
 
Scheme 51. Photoreaction of 198. 
 
This sensitization mechanism limits the reaction scope not only to ω-aryl compounds, but also 
linear molecules with a disfavored conformation show no reaction. In order to use alkyl acid 
derivatives in general for this decarboxylation/hydroxylation reaction, another reaction with a 
different mechanism was proposed (Scheme 52).  
                                                 
h
 Reaction was performed by M.Sc. Simon Budde. 
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Scheme 52. Proposed decarboxylation/hydroxylation mechanism for alkyl acid derivatives 200. 
 
This reaction is based on photocatalysts, whose excited states have redox potentials which are 
high enough to reduce the phthalimide moiety directly. After phthalimide cleavage and 
decarboxylation, the alkyl radicals should get oxidized via the oxidized species of the 
photocatalyst, such as in ATRA (atom transfer radical addition) reactions.106 The cation 
intermediate 204 can be trapped by the water containing solvent.  
In order to find suitable photocatalysts the redox potentials of several N-acyloxyphthalimides 
were measured (Figure 10). The potentials of the phthalimide esters of phenylacetic acid 
(171), octanoic acid (206) and cyclohexane carboxylic acid (207) were all in the same range 
of -1.22 V to -1.25 V (vs. SCE).  
 
Figure 10. Redox potentials of 171, 206, and 207. Measured in acetonitrile and calculated vs. SCE. 
 
The metal based photocatalysts fac-Ir(ppy)3 (E1/2 Ir4+/[Ir3+]* = -1.73 V vs. SCE) and 
[Cu(dap)2]Cl (E1/2 Cu2+/[Cu+]* = -1.43 V vs. SCE) come into consideration for the reduction 
of these phthalimide ester derivatives.  
Irradiation of primary carboxylic acid derivative 206 in presence of fac-Ir(ppy)3 or 
[Cu(dap)2]Cl and acetonitrile/water solvent mixture no conversion was observed (Table 14, 
entry 1 and 2). The addition of formic acid to the reaction in order to support the phthalimide 
protonation did not lead to any conversion of the starting material (entry 3).  
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Applying compound 207, which should form stabilized secondary radicals after 
decarboxylation, no product formation was observed. This applies analogously to the reaction 
with [Ir(dtb-bpy)(ppy)2]PF6 (entry 6). The formation of 1-adamantanol was also not 
successful using fac-Ir(ppy)3 and [Cu(dap)2]Cl as catalysts (entry 7 and 8). Switching the 
solvent to DMF/water no influence on the reaction was observable (entry 9). Also the 
increasing of the temperature to 60 °C leads only to small amount of hydrolyzation, but has 
no effect on decarboxylation (entry 10). 
Table 14. Decarboxylation/hydroxylation reactions of primary, secondary, and tertiary acid 
derivatives. 
 
Entry R Catalyst Solvent Modification Yield 
1 n-heptyl fac-Ir(ppy)3 MeCN/H2O  0% 
2 n-heptyl [Cu(dap)2]Cl MeCN/H2O  0% 
3 n-heptyl fac-Ir(ppy)3 MeCN/H2O formic acida 0% 
4 ω-phenylpropanyl fac-Ir(ppy)3 MeCN/H2O  0% 
5 cyclohexyl fac-Ir(ppy)3 MeCN/H2O  0% 
6 cyclohexyl [Ir(dtb-bpy)(ppy)2]PF6 MeCN/H2O  0% 
7 1-adamantyl fac-Ir(ppy)3 MeCN/H2O  0% 
8 1-adamantyl [Cu(dap)2]Cl MeCN/H2O  0% 
9 1-adamantyl fac-Ir(ppy)3 DMF/H2O  0% 
10 1-adamantyl fac-Ir(ppy)3 DMF/H2O 60°C 0% 
a
 1 equiv. of formic acid. 
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3.4 Conclusion 
In summary, a protocol for the visible light mediated decarboxylative 
hydroxylation/alkoxylation was developed. Irradiation of N-acyloxyphthalimides based on 
phenylacetic acid derivatives in presence of [Ir(ppy)2(dtb-bpy)]PF6 and aqueous acetonitrile 
the corresponding benzyl alcohols were isolated in good yields. Using alcohol instead of 
water in the solvent mixture allowed the isolation of benzyl ethers. Applying this reaction to 
other phthalimide coupled aliphatic acids was not successful. Changing the reaction 
conditions utilizing direct phthalimide reduction via photoredox chemistry, instead of a 
sensitization mechanism, showed no product formation. Consequently the reaction scope of 
this decarboxylative hydroxylation was limited to phenylacetic acid derivatives. 
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4 Photoredox catalyzed decarboxylative α-amination 
4.1 Introduction 
Photoredox chemistry is a mild and elegant tool for the reduction of certain compounds. The 
underlying mechanism has been studied thoroughly in the last decades.107 Regarding common 
photocatalysts, the reduction potential of the PC--species (Scheme 53, red) is much higher 
than the potential of its excited states (blue).108 Therefore usually the reductive quenching 
cycle is applied for these reactions. After excitation of the photocatalyst (PC) via visible light, 
a reductive quencher (RQ) accepts an electron, forming the reduced species PC-.  
 
Scheme 53. Oxidative and reductive quenching cycle and redox potentials of selected photocatalysts. 
PC = photocatalyst, RQ = reductive quencher, OQ = oxidative quencher, EA = electron 
acceptor, ED = electron donor.108 
 
To get access to the high reductive power of photocatalysts, sacrificial electron donors, like 
NEt3, DIPEA, BNAH or Hantzsch ester were added.108 These consumables usually 
accumulate as waste and are only rarely used in subsequently occurring reactions. Using 
triethylamine (NEt3), for example, after its oxidation by the excited photocatalyst, the α-C-H 
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bond of the cation radical is weakened to approximately 42 kcal/mol, which could lead to 
proton abstraction.109  
One possible application for using photoredox chemistry is the field of α-amino 
functionalizations. Stephenson et al. applied this functionalization using tetrahydro-
isoquinoline 208 in an oxidative aza-Henry reaction. In the presence of a photocatalyst and 
nitromethane, tetrahydroisoquinoline 208 undergoes an oxidative C-H functionalization, 
concluding in the formation of nitro compound 210 in 92% yield (Scheme 54).110  
 
Scheme 54. Photocatalytic aza-Henry reaction of tetrahydroisoquinoline 208. 
 
The best results were obtained using [Ir(ppy)2(dtb-bpy)]PF6 as photocatalyst. The excited 
iridium based catalyst oxidizes tetrahydroisoquinoline 208. Afterwards oxygen oxidizes the 
catalyst, regenerating the initial state. The generated superoxide radical subsequently abstracts 
a hydrogen from the cationic species 211. The iminium ion 212 is the key intermediate in this 
reaction mechanism and is attacked by a deprotonated nitromethane (209), forming the 
product 210 (Scheme 55). 
 
Scheme 55. Reaction mechanism of the photocatalytic aza-Henry reaction.110 
 
Applying oxygen in the reaction limits the scope and increases the reaction time for this 
oxidative aza-Henry reaction since the species can interact with the catalyst or other reactive 
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substrates.111 To prevent these side reactions Stephenson et al. introduced 
bromotrichloromethane (BrCCl3) for the synthesis of the iminium salt 214 instead. The 
photocatalyst is regenerated by the reduction of BrCCl3, which splits into bromine anion and 
trichloromethane radical. Under the formation of chloroform, iminium salt 214 was 
obtained.111 This iminium salt synthesis was the basis for several nucleophilic addition 
reactions (Scheme 56).  
 
Scheme 56. Synthesis and transformation of the iminium salt 214. a) NEt3 (5 equiv.), CuBr 
(15 mol%), alkyne (5 equiv.), DMF, R = Ph, CH2CH2Ph (53-82%).111  
b) trimethylsiloxyfuran (5 equiv.), DMF, 55%.111 c) RMgBr (2 equiv.), MeCN, 0 °C, 
N2, < 5 min, R = alkyl, vinyl, phenyl (66-90%).112 
 
In 2015 Zeitler et al. proved, that this iminium salt formation does not require any 
photocatalyst.113  Under the same reaction conditions, but in absence of the photocatalyst, the 
desired products, in even higher yields, were isolated. By blue light irradiation of a BrCCl3 
solution, the formation of oxidative reagents was detected. Therefore the light promotes 
homolytic bond fission and the direct formation of bromine and CCl3 radicals. Additionally a 
tetrahydroisoquinoline 208 solution containing BrCCl3 seems to build an amine 
polyhalomethane electron donor acceptor (EDA) complex. Irradiating this complex leads to 
cation radical 211 and the decomposition of CBrCl3 into CCl3 radical. Both pathways promote 
the synthesis of iminium salt 214, which can be used in subsequent nucleophilic addition 
reactions.113  
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Scheme 57. Possible reaction pathways of the amino radical cation 211. 
 
So far oxidized tetrahydroisoquinoline species 211 was transformed into its iminium salt via 
photoredox chemistry followed by an irradiation independent nucleophilic addition reaction 
(Scheme 57, Pathway A). Recently Reiser et al. developed a photoreaction to generate α-
amino radicals from tetrahydroisoquinoline 211 (Pathway B).114 These radicals were coupled 
with a variety of Michael acceptors 219 in moderate to good yields (Scheme 58).  
 
Scheme 58. Photocatalyzed α-functionalization of N-aryl-isoquinoline (213). R1,2 = alkyl, phenyl. 
 
No electron donor or acceptor is needed in this reaction. In the proposed mechanism the 
oxidation of tetrahydroisoquinoline 208 via the visible light excited ruthenium based 
photocatalyst, leads to the radical cation 211. In contrast to the iminium synthesis, the cation 
211 abstracts a proton forming the radical intermediate 218 followed by a coupling reaction 
with enones, such as methyl vinyl ketone (221). The cation 222 accepts an electron from the 
photocatalyst and resulting in the desired product 223 (Scheme 59).114 Yoon et al. improved 
this reaction by adding TFA. Yields were increased and the reaction time was shortened from 
24 h to 5 h. The lewis acid (TFA) subsequently protonates enone 219, leading to an increased 
reactivity of the species, allowing for an easier attack by radical 218.115  
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Scheme 59. Proposed mechanism of the α-amino radical conjugate addition to methyl vinyl 
ketone (221). 
 
Besides the commonly used N-aryl-tetrahydroisoqinolines 213,110-115 photocatalyzed α-C-H-
activations were also performed with N-methyl-9,10-dihydroacridine,116 DMF117 or 1-
phenylpyrrolidine,118 to name but a few.  
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4.2 Decarboxylative α-amination via visible light 
4.2.1 Optimization and control experiments 
Earlier in the thesis the photoredox catalyzed decarboxylation of N-acyloxyphthalimides of 
Okada et al.48 and Overman et al.90 were described. To reduce the phthalimide moiety the 
working groups utilize the reductive quenching cycle of the photocatalysts (Scheme 53). A 
sacrificial electron donor reduces the excited catalyst, which donates an electron to the 
phthalimide moiety, leading to decarboxylation.  
In the following project it was envisioned to combine this phthalimide assisted 
decarboxylation reaction with the photocatalyzed α-amino activation of tetrahydro-
isoquinolines, generating a new C-C bond.  
As a test reaction N-phenyl-tetrahydroisoquinoline (208) and N-acyloxyphthalimide 171 were 
irradiated under previously established photoreaction conditions (Section 1.4.1), using 
1 mol% [Ir(ppy)2(dtb-bpy)]PF6 in an acetonitrile water solvent mixture (ratio 40/1, 
c = 0.1 M). After 16 h the benzylated tetrahydroisoquinoline 224 was isolated in 45% yield 
(Scheme 60).  
 
Scheme 60. Photoredox reaction of N-phenyl-tetrahydroisoquinoline (208) and N-acyloxy-
phthalimide 171. 
 
Solvent screening showed that no additional proton source for the phthalimide protonation is 
necessary and the reaction can be performed in water free solvents (Table 15). Apart from 
DCM, where only 8% product was isolable (entry 8), moderate to good yields were obtained 
with common solvents. Using [Ru(bpy)3]Cl2 as catalyst no full conversion of the starting 
material and lower yields were observed, within 20 h of irradiation.  
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Table 15. Catalyst and solvent screening of the α-amino benzylation. 
 
Entry Catalyst (1 mol%) Solvent Yieldb 
1 [Ir(ppy)2(dtb-bpy)]PF6 MeCN/H2O (40/1)a 45% 
2 [Ir(ppy)2(dtb-bpy)]PF6 
MeCN 
65% 
3 [Ru(bpy)3]Cl2 32%c 
4 [Ir(ppy)2(dtb-bpy)]PF6 
DMF 
36% 
5 [Ru(bpy)3]Cl2 41% 
6 [Ir(ppy)2(dtb-bpy)]PF6 
THF 
36% 
7 [Ru(bpy)3]Cl2 15%c 
8 [Ir(ppy)2(dtb-bpy)]PF6 
DCM 
8% 
9 [Ru(bpy)3]Cl2 9%c 
10 [Ir(ppy)2(dtb-bpy)]PF6 acetone 46% 
a
 reaction concentration 0.1 mol/l. b Yields were determined by NMR analysis with 4-nitrobenz-
aldehyde as internal standard. c no full conversion after 20 h. 
 
Further optimizations proved, that neither using an additional base (Table 16, entry 2), for 
improving proton abstraction of tetrahydroisoquinoline 208, nor formic acid (entry 3), 
protonating the phthalimide moiety of 171, improved the product formation. Employing 
Hantzsch ester in this reaction, which is able to act as an additional sacrificial electron and 
hydrogen donor,119 product 224 was not isolated (entry 2). In the absence of light or 
photocatalyst no reaction takes place (entries 4 and 5). Oxygen reduces the reaction rate, 
although 22% yield was still observed in a non-degassed system (entry 6). 
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Table 16. Control and optimization experiments of the α-amino benzylation. 
 
Entry Catalyst (1 mol%) Modifications Yielda 
1 [Ir(ppy)2(dtb-bpy)]PF6 pyridine (1 equiv.) 46% 
2 [Ir(ppy)2(dtb-bpy)]PF6 Hantzsch ester (1 equiv.) 0%b 
3 [Ir(ppy)2(dtb-bpy)]PF6 formic acid (1 equiv.) 43% 
4 -
 
no catalyst 0% 
5 [Ir(ppy)2(dtb-bpy)]PF6 no light 0% 
6 [Ir(ppy)2(dtb-bpy)]PF6 not degassed 22%c 
a
 Yields were determined by NMR analysis with 4-nitrobenzaldehyde as internal standard. b full 
conversion but no product formation. c no full conversion of 171. 
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4.2.2 Mechanistic aspects 
With regard to the publications of the photoredox catalyzed α-amino functionalization114,115, 
the decarboxylation using N-acyloxyphthalimides41,48,90 and the previously presented 
optimization and control experiments (see Section 4.2.1), a plausible mechanism for this 
reaction was proposed (Scheme 61). Light irradiation in the visible spectrum leads to the 
excited photocatalyst (PC), which oxidizes N-phenyl-tetrahydroisoquinoline (208) to the 
radical cation 211. The reduced photocatalyst species has a higher reduction potential 
compared to its excited state (Scheme 53) and is able to reduce the phthalimide moiety of 
225.90 The oxidized tetrahydroisoquinoline species 211 abstracts a proton and forms radical 
218. Former optimization reactions show that no additional proton source is needed in the 
experiment. Therefore the reduced phthalimide moiety accepts the proton that was previously 
cleaved from 211. Afterwards phthalimide is released and decarboxylation occurs, which 
leads to alkyl radical 227. After radical recombination the desired product 228 is formed.  
 
Scheme 61. Proposed reaction mechanism. PC = photocatalyst, R = alkyl. 
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4.2.3 Substrate scope 
The decarboxylative benzylation of tetrahydroisoquinoline 208 under visible light conditions 
was successful. With the optimized reaction conditions in hand the reaction was applied in a 
1 mmol scale and different phthalimide esters were used. Performing the reaction in a 1 mmol 
scale, 79% of the benzylated N-Phenyl-tetrahydroisoquinoline 224 was isolated after 14 h of 
irradiation (Table 17, entry 1). Similar results were obtained by the reaction with the para-
methoxy derivative of the starting material (entry 2). Decarboxylation of 230 yielded 52% of 
isoquinoline 231, however 36% tetrahydroisoquinoline 208 was recovered (entry 3). During 
the reaction N-acyloxyphthalimide 230 was consumed without taking part in product 
formation. Therefore 2 equiv. of phthalimide ester 230 was set in subsequent reaction, for 
achieving full conversion and higher yields. Contrary to expectations, no increase of yields 
was observed.  
Table 17. Reactions with phenyl-/vinylacetic acid derivatives. 
 
Entry N-Acyloxyphthalimide Product Yield 
1 
 
171 
 
224 79% 
2 
 
163 
 
229 66% 
3 
 
230 
 
231 52%a 
a
 36% of the starting material N-phenyl-tetrahydroisoquinoline 208 was reisolated. 
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Photodecarboxylation of phenyl- and vinylacetic acid derivatives 171, 163 and 230 leads to 
radicals, which are stabilized and able to undergo the proposed radical recombination in good 
yields (Table 17).  
In order to enlarge the scope of the reaction primary, secondary and tertiary carboxylic acid 
derivatives were synthesized (Table 18). Compounds 232 and 233 have a redox potential of 
-1.25 V and -1.23 V, respectively. Therefore these N-acyloxyphthalimides can get reduced by 
all common metal based photocatalysts (Scheme 53, Section 4.1). Performing the reaction 
with the acid derivatives 232, 233 and 238 no product formation was observed (Table 18, 
entries 1-3). Using either the formerly established acetonitrile/water or non dried solvents, 
such as DMF, in the reaction with 232 or 236, products of oxidized isoquinoline species 234 
and simple phthalimide (169) were isolated (Scheme 62). This can be explained by initial 
coupling of radical 218 (Scheme 61) with present water. 
 
Scheme 62. Photoreaction of 232 and 233 with tetrahydroisoquinoline 208 using MeCN/H2O and non 
dried DMF as solvent. 
 
In the next step two phthalimide activated amino acids were applied in the reaction. The 
coupling with hippuric acid derivative 240 yielded in 46% of desired product 241 (Table 18, 
entry 5). In contrast to this moderate product formation, the decarboxylation of Boc-protected 
glycine 242 yielded only 18% of 243 (entry 6). Since the radical intermediates of 241 and 242 
were both stabilized by the α-amide moiety, a second reason has to play a role in product 
formation to explain these differences in yields. One notable difference is the ability of the 
hippuric acid derivative 241 to interact with N-phenyl-tetrahydroisoquinoline (208) by π-π-
stacking. This would place those reaction partners in a sterically close proximity to each 
other, which would facilitate the radical coupling step. This π-π-stacking is not possible for N-
acyloxyphthalimide 242, for which reason the product formation is more inefficient.  
For the same reason the reactions with aliphatic acids (232, 233, 238) were also unsuccessful, 
since apart from being stabilized radicals, the reactants have to be sterically close to each 
other to initiate coupling. 
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Table 18. Photoredox α-amination using primary, secondary, and tertiary phthalimide esters. 
 
Entry N-Acyloxyphthalimide Product Yield 
1 
 
232 
 
235 0% 
3 
 
236 
 
237 0% 
4 
 
238 
 
239 0% 
5 
 
240 
 
241 46% 
6 
 
242 
 
243 18% 
 
The photoredox catalyzed α-amino activation of N-phenylpyrrolidine (244) is challenging and 
it has been previously shown that these types of coupling reactions generally result in low 
yields.114 Without an activating substituent on the α-position the radical or even iminium 
cation formation is unfavorable.110 Nevertheless benzylation of N-phenylpyrrolidine (244) 
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was explored using [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%) in acetonitrile (Scheme 63). After 15 h 
of irradiation no benzylated product 245 was synthesized. Under light irradiation in the visible 
spectrum N-acyloxyphthalimide 171 undergoes decarboxylation and forms dihydrostilbene 
172 in a side reaction. This mechanism was already investigated and discussed in section 2.2.  
 
Scheme 63. Photoinduced α-amino activation of N-phenylpyrrolidine (244). 
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4.2.4 Intramolecular reaction 
Intermolecular reactions were investigated for the combined photoredox decarboxylation/α-
amino activation so far. One limitation of these intermolecular reactions was the necessity of 
the reactants being sterically close. Simultaneously this reaction is limited to N-aryl-
tetrahydroisoquinolines to activate the α-amino position. In order to circumvent these 
problems and enlarge the substrate scope the reaction protocol was applied to an 
intramolecular version. To that end N-acyloxyphthalimide 249 was synthesized from 2-
fluorobenzaldehyde (246), piperidine and malonic acid (Scheme 64).  
 
Scheme 64. Synthetic route of N-acyloxyphthalimide 249. a) piperidine (1.1 equiv.), K2CO3 
(2.2 equiv.), DMF, 155 °C, 20 h (83%). b) Malonic acid (1.5 equiv.), pyridine, 120 °C, 
2 h, 10% Pd/C, EtOH, overnight (93%). c) N-hydroxyphthalimide (1 equiv.), DCC 
(1 equiv.), THF, 2 d, room temp. (18%). 
 
The cyclization reaction of compound 249 was performed in acetonitrile under visible light 
irradiation, using [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%) as photocatalyst. After a reaction time of 
28 h an inseparable mixture of the desired cyclized product 250 and the simple 
decarboxylated side product 251 was obtained with an approximately yield of 19% (Scheme 
65).  
 
Scheme 65. Photoredox catalyzed intramolecular decarboxylative cyclization of 249. 
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An intramolecular cyclization via photoredox catalyzed decarboxylation and subsequent α-
amino activation is possible. An additional activation by a benzyl group is necessary for the α-
activation and crucial for a successful cyclization. 
 
4.3 Conclusion 
Based on two well established photochemical reactions a dual visible light-promoted system 
of decarboxylation and α-amino activation was investigated. With this strategy the 
bifunctional property of the photoredox catalyst could be efficiently utilized. 
Tetrahydroisoquinoline serves as an electron donor for the photocatalyst to enable the 
reduction and subsequent decarboxylation of a phthalimide activated acid derivative. The 
corresponding α-amino and alkyl radicals, which were derived from the same catalytic cycle, 
can then react in a cross coupling process. Although being limited to phenylacetic-, 
vinylacetic-, and amino acids so far, the examples demonstrate the feasibility of this process, 
which allows the efficient synthesis of benzylation, allylation, and α-amino derivative 
products. Preliminary results suggest that an intramolecular version of this reaction gave rise 
to the desired product. This reaction will be optimized and investigate in future. 
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C Summary/Zusammenfassung 
1 Summary 
This PhD thesis demonstrates new applications for photoinduced decarboxylation of N-
acyloxyphthalimides.  
The first chapter, “Decarboxylation of ω-aryl-N-acyloxyphthalimides”, discusses the 
decarboxylation of phthalimide activated amino acid derivatives via visible light irradiation. 
Performing the reaction of N-acyloxyphthalimides 77 in presence of photocatalyst 
[Ir(ppy)2(dtb-bpy)]PF6 and a solvent mixture MeCN/H2O give rise to ȕ-phenylethylamine 
derivatives 78 (Scheme 66). Initiated by energy transfer of the catalyst, an intramolecular 
electron transfer from the phenyl group to the phthalimide moiety enables the decarboxylation 
and a Smiles-type rearrangement occurs. Reaction conditions were optimized and a set of 
ȕ-phenylethylamine derivatives were synthesized to evaluate the scope of the reaction. A 
slight change in the reaction conditions – substitution of H2O on alcohol in the solvent 
mixture – allows the isolation of carbamate 85 of corresponding β-phenylethylamines. The 
carbamates were efficiently synthesized using primary, secondary and even tertiary alcohols.  
 
Scheme 66. Scope of the visible light promoted decarboxylation of N-acyloxyphthalimides 77. 
Reaction conditions: [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), hν (455 nm LED), room temp., 
16 h. Solvent: a) MeCN/H2O (40/1) (v/v). b) MeCN, R3OH (3 equiv.). 
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Interestingly increasing the electron density in the phenyl moiety via introduction of two or 
three methoxy groups led to the exclusive formation of dihydroisoquinolinones 252 in very 
good yields. 
A further substrate scope extension via the elongation of the alkyl carbon chain afforded 
tetrahydrobenzazepinones 105 in good yields (Scheme 67). In this reaction no rearrangement 
was observed, the primary alkyl radical rather undergoes a 7-exo/endo-trig cyclization after 
decarboxylation instead of the 6-exo spirocyclization of N-acyloxyphthalimides 77. 
 
Scheme 67. Photodecarboxylative tetrahydrobenzazepinone 105 synthesis. 
 
The developed visible light mediated transformation of ω-aryl-N-acyloxyphthalimides 77 and 
102 was applied for the preparation of both key intermediates 106 and 111, used in the 
convergent synthesis of the bronchodilator capsazepinoid 112 (Scheme 68). 
 
Scheme 68. Formal synthesis of capsazepinoid 112. a) [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), MeCN/H2O 
(40/1), 455 nm LED, room temp., 16 h (60%). b) TFA, reflux, 6 h (86%). 
c) [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), MeCN/MeOH (3 equiv.), 455 nm LED, room temp., 
16 h (68%). d) TFA, room temp., overnight. e) 2 M LiOH/THF/MeOH (1/1/1), MW, 
120 °C, 10 min (89%). 
 
Another application of this decarboxylative rearrangement reaction was demonstrated with 
the synthesis of Boc-protected unnatural phenylalanine derivatives starting from 
commercially available L-aspartic acid and substituted benzaldehydes. 
C  Summary/Zusammenfassung 1  Summary 
 
101 
 
As the mechanism of these decarboxylations is based on energy transfer, hence a feasible dual 
decarboxylation method via UV-light irradiation was investigated in the second chapter, 
“UV light-mediated reactions of phthalimides”. Excited N-acyloxyphthalimides 166 were 
reduced by phenylacetic acids 167, which leads to a simultaneous decarboxylation of both 
substrates. In a subsequent crosscoupling reaction dihydrostilbenes 168 were isolated in fair 
to very good yields (Scheme 69).  
 
Scheme 69. Dihydrostilbene 168 synthesis under UV-light irradiation. 
 
In the third chapter, a “Decarboxylative hydroxylation/alkoxylation” was investigated. 
Performing the sensitized decarboxylation reaction of N-acyloxyphthalimides 166 using 
visible light and the photocatalyst [Ir(ppy)2(dtb-bpy)]PF6, instead of UV irradiation, benzyl 
alcohols 253 (R3 = H) were obtained as major products in good yields (Scheme 70). Using 
alcohol instead of water in the solvent mixture gave rise to corresponding benzyl ethers 253 
(R3 = Alk). Applying this reaction to other phthalimide-coupled aliphatic acids, via visible 
light-induced photoredox chemistry, was not successful. Consequently the reaction scope of 
this decarboxylative hydroxylation/alkoxylation was limited to phenylacetic acid derivatives. 
 
Scheme 70. Visible light-promoted decarboxylative hydroxylation/alkoxylation. Solvent:  
a) MeCN/H2O, R3 = H. b) MeCN/Alk-OH, R3 = Alk. 
 
In Chapter four, “Photoredox catalyzed decarboxylative α-amination”, two well established 
photochemical reactions were combined into a dual visible light-promoted system of 
decarboxylation and α-amino activation (Scheme 71). With this strategy the bifunctional 
property of the photoredox catalyst could be efficiently utilized. Tetrahydroisoquinoline 208 
serves as an electron donor for the photocatalyst to enable the reduction and subsequent 
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decarboxylation of N-acyloxyphthalimide 225. The corresponding α-amino and alkyl radicals, 
which were derived from the same catalytic cycle, can then react in a cross coupling process. 
Although being limited to phenylacetic-, vinylacetic-, and amino acids so far, the examples 
demonstrate the feasibility of this meaningful process, which allows the efficient synthesis of 
benzylation, allylation, and α-amino derivative products.  
 
Scheme 71. Photoredox catalyzed decarboxylative α-amination. 
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2 Zusammenfassung 
Die vorliegende Arbeit behandelt die photochemische Decarboxylierung von N-Acyloxy-
phthalimiden.  
Im ersten Kapitel „Decarboxylation of ω-aryl-N-acyloxyphthalimides“ wurde das photo-
chemische Verhalten von Phthalimid aktivierten Benzoylaminosäurederivaten untersucht. Die 
N-Acyloxyphthalimide 77 dienten hierbei als Ausgangsmoleküle. Durch Belichtung mit 
blauen LEDs und unter Einsatz des Photokatalysators [Ir(ppy)2(dtb-bpy)]PF6 unterlief N-
Acyloxyphthalimid 77 eine Decarboxylierung und wurde zum ȕ-Phenylethylaminderivat 78 
umgelagert (Schema 1). Initiiert durch eine Energieübertragung des Katalysators auf das 
Substrat findet ein intramolekularer Elektronentransfer von der Phenylgruppe hin zum 
Phthalimidrest statt. Daraufhin spaltet sich die reduzierte Phthalimiduntereinheit ab, was eine 
Decarboxylierung mit anschließender „Smiles-Umlagerung“ ermöglicht. Die 
Reaktionsbediungungen wurden daraufhin optimiert und eine Reihe an ȕ-
Phenylethylaminderivaten hergestellt. Durch Änderung des Lösungsmittelgemisches zu 
Acetonitril/Alkohol-Mischungen konnten, mittels primärer, sekundärer sowie tertiärer 
Alkohole, die entsprechenden Carbamate 85 isoliert werden.  
 
Schema 1. Photoinduzierte Decarboxylierung der N-acyloxyphthalimide 77.  
Reaktionsbedingungen: [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), hν (455 nm LED), rt, 16 h. 
Lösungsmittel: a) MeCN/H2O (40/1) (v/v). b) MeCN, R3OH (3 equiv.). 
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Durch Einführung von zwei oder drei Methoxy-Substituenten wurde die Elektrondichte am 
Phenylring erhöht und nach der photoinduzierten Decarboxylierung ausschließlich 
Dihydroisochinoline 252 in sehr guten Ausbeuten erhalten.  
Bei der Erweiterung des Substratbereichs dieser photoinduzierten Decarboxylierungsreaktion 
wurden um eine Alkylgruppe verlängerte N-Acyloxyphthalimide 102 eingesetzt. Nach der 
Photoreaktion konnten Tetrahydrobenzoazepinone 105 in guten Ausbeuten isoliert werden 
(Schema 2). In dieser Reaktion war keine Umlagerung zu beobachten, weshalb nach der 
Decarboxylierung eine 7-exo/endo-trig Zyklisierung des N-Acyloxyphthalimids 102 
angenommen wird.  
 
Schema 2. Photoinduzierte Synthese von Tetrahydrobenzoazepinon 105. 
 
Die entwickelte photoinduzierte Decarboxylierung von ω-Aryl-N-acyloxyphthalimiden 102 
und 77 wurden anschließend zur Synthese der beiden Schlüsselsubstrate 106 und 111 genutzt, 
welche bei der Herstellung des Broncholytikums 112 zum Einsatz kommen (Schema 3). 
 
Schema 3. Synthese von Capsazepinoid 112. a) [Ir(ppy)2(dtb-bpy)]PF6 (1 mol%), MeCN/H2O (40/1), 
455 nm LED, rt, 16 h (60%). b) TFA, reflux, 6 h (86%). c) [Ir(ppy)2(dtb-bpy)]PF6 
(1 mol%), MeCN/MeOH (3 equiv.), 455 nm LED, rt, 16 h (68%). d) TFA, rt, über Nacht. 
e) 2 M LiOH/THF/MeOH (1/1/1), MW, 120 °C, 10 min (89%). 
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Eine weitere Anwendung dieser photoinduzierten Umlagerungsreaktion wurde mit der 
Herstellung von unnatürlichen Phenylalaninen ausgehend von billiger, kommerziell 
erhältlicher L-Asparaginsäure und unterschiedlich substituierter Benzaldehyde gezeigt.  
 
Im zweiten Kapitel „UV light-mediated reactions of phthalimides” wurde eine auf 
Energietransfer basierte doppelte Decarboxylierung mittels UV-Belichtung entwickelt. Das 
angeregte N-Acyloxyphthalimid 166 wurde hierbei von der Phenylessigsäure 167 reduziert, 
wodurch die Decarboxylierung beider Substrate erfolgte. In einer anschließenden 
Kopplungsreaktion wurde Dihydrostilbene 168 in ordentlichen bis sehr guten Ausbeuten 
erhalten (Schema 4).  
 
Schema 4. Synthese von Dihydrostilben 168 mittels UV-Belichtung. 
 
Im dritten Kapitel „Decarboxylative hydroxylation/alkoxylation“ werden die Forschungs-
ergebnisse einer photoinduzierten Decarboxylierung mit anschließender Hydroxylierung bzw. 
Alkoxylierung beschrieben. Wird das N-Acyloxyphthalimid 166 anstelle von UV-Licht mit 
sichtbarem Licht unter Einsatz des Photokatalysators [Ir(ppy)2(dtb-bpy)]PF6 bestrahlt, so 
wurde anstelle der Dihydrostilbene 168 der entsprechende Benzylalkohol 253 (R3 = H) als 
Hauptprodukt erhalten. Bei einem Acetonitril/Alkohol Lösungsmittelgemisch konnten die 
entsprechenden Ether 253 (R3 = Alk) in guten Ausbeuten isoliert werden (Schema 5). Diese 
neuartige Transformation konnte allerdings mittels Photoredoxkatalyse nicht auf andere 
aliphatische Säuren übertragen werden, weshalb der Substratbereich vorerst auf 
Phenylessigsäurederivate beschränkt bleibt. 
 
Schema 5. Hydroxylierung/Alkoxylierung mittels photoinduzierter Decarboxylierung von 166. 
Lösungsmittel: a) MeCN/H2O, R3 = H. b) MeCN/Alk-OH, R3 = Alk. 
C  Summary/Zusammenfassung 2  Zusammenfassung 
 
106 
 
In Kapitel vier „Photoredox catalyzed decarboxylative α-amination“ wurden zwei etablierte 
Photoreaktionen zu einem neuen gemeinsamen Photoredox-katalysierten Prozess kombiniert. 
Tetrahydroisochinolin 208 diente dabei als Elektronendonator und wurde vom 
Photokatalysator [Ir(ppy)2(dtb-bpy)]PF6 oxidiert. Anschließend konnte die reduzierte 
Katalysatorspezies das N-Acyloxyphthalimid 225 reduzieren, wodurch ein N-O-
Bindungsbruch mit anschließender Decarboxylierung induziert wurde. Die entstandenen 
Radikale der Substrate rekombinierten in einer Kreuzkopplungsreaktion und die α-
Aminierungsprodukte 228 wurden isoliert (Schema 6). Nach aktuellem Forschungsstand ist 
dieser Decarboxylierungs- und Aminierungsprozess auf stabilisierte Radikale beschränkt, 
wonach bisher benzylierte (R = Benzyl), allylierte (R = Allyl) und α-amino (R = CH2NHAlk) 
Produkte synthetisiert wurden. 
 
Schema 6. Photoredox katalysierte Decarboxylierung und N-α-Funktionalisierung. 
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D Experimental Part 
1 General information 
Solvents and chemicals 
All commercially available compounds were used as received. Absolute THF was taken from 
a MB-SPS solvent purification system. Other absolute solvents were prepared by established 
laboratory procedures. Ethyl acetate, hexanes (40/60) and DCM for chromatography were 
distilled prior to use. [Ir(ppy)2(dtb-bpy)]PF6 was prepared according to literature.120  
NMR spectroscopy 
1H-NMR spectra were recorded on BRUKER Avance 300 (300 MHz), BRUKER Avance III 
400 “σanobay” (400 MHz), and Oxford 300 MHz spectrometers. 13C-NMR spectra were 
recorded on BRUKER Avance γ00 (75 MHz) and BRUKER Avance III 400 “σanobay” (100 
MHz) spectrometers. The spectra were recorded in CDCl3. The Chemical shifts for 1H-NMR 
were reported as , parts per million, relative to the signal of CDCl3 at 7.26 ppm.  
The Chemical shifts for 13C-NMR were reported as , parts per million, relative to the center 
line signal of the CDCl3 triplet at 77.0 ppm.  
For column chromatography silica gel (Merck, Geduran 60, 0.063-0.200 mm particle size) 
and flash silica gel 60 (Merck, 0.040-0.063 mm particle size) was used. 
The thin layer chromatography (TLC) analysis was done on a silica gel 60 F254 (Merck) 
coated on aluminium sheets and visualized with UV, ninhydrin solution (300 mg ninhydrin, 
5 ml conc. acetic acid, 35 ml isopropyl alcohol) or KMnO4 solution (1.0 g KMnO4, 2 g 
Na2CO3, 100 ml water).  
ATR-IR spectroscopy was carried out on a Biorad Excalibur FTS 3000 spectrometer, 
equipped with a Specac Golden Gate Diamond Single Reflection ATR-System. Solid and 
liquid compounds were measured neatly and wave numbers are reported in cm-1. 
The melting points were measured with a Büchi SMP-20 apparatus in silicon oil bath.  
Mass spectrometry was done by the Central Analytical Laboratory of the University of 
Regensburg on a Varian MAT 311A, Finnigan MAT 95, ThermoQuest Finnigan TSQ 7000, 
Agilent Q-TOF 6540 UHD or Finnigan MAT SSQ 710 A.  
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X-Ray crystallographic analyses were recorded on a Bruker APEX-II CCD diffractometer. 
Elementary analysis was measured on a Vario EL III or Mikro-Rapid CHN (Heraeus) - 
Microanalytic section of the University of Regensburg. 
As light source in batch process CREE XLamp XP-E D5-15 LED ( = 450 - 465 nm) were 
used. The UV-batch reactions were performed in a Rayonet chamber reactor (RPR-200; 
Southern New England Ultraviolet Co., USA) equipped with 16 x 8 W RPR-3000 Å lamps at 
15-20 °C.  
Microwave reactions were performed in a CEM Discover S-Class microwave oven using 
pressure stable sealed 10 ml vials.  
Cyclic voltammetry measurements were carried out on an Autolab PGSTAT 302N set-up at 
20 °C in acetonitrile, containing tetrabutyl ammonium tetrafluoroborate as supporting 
electrolyte. A conventional undivided electrochemical cell equipped with a glassy carbon 
working electrode, platinum wire as the counter electrode and silver wire as the reference 
electrode was used. The solvent was degassed by vigorous nitrogen bubbling prior to the 
measurements Redox potentials were referenced against ferrocene as an internal standard. All 
values are reported in reference to the SCE electrode. 
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2 Synthesis of N-acyloxyphthalimides 
Amino acid based N-acyloxyphthalimides were mainly synthesized in a 5 step procedure: α-, 
-, and Ȗ-amino-carboxylate 70, as well as benzoyl chloride 71 synthesis, N-acylation to 72 
followed by ester hydrolysis. The coupling of the acids 73 and N-hydroxyphthalimide was 
mediated by DCC (Scheme 72). 
 
Scheme 72. General synthesis of amino acid based N-acyloxyphthalimides. 
 
Synthesis of α-, ȕ-, and Ȗ-aminocarboxylates 70 
Ethyl 3-(tert-butylamino)propionate (70a). 
 
To a 30 ml ethanol solution of tert-butylamine (30.0 ml, 287.1 mmol, 4 equiv.) was added 
dropwise a 30 ml ethanol solution of ethyl acrylate (7.70 ml, 72.3 mmol, 1 equiv.) at 0 °C. 
The reaction was stirred overnight at the same temperature. The solvent was removed under 
reduced pressure, and the residue was destilled under vacuum (3 mbar). One fraction of clear, 
colorless liquid was collected (12.20 g, 70.42 mmol, 97%; B.P. 60 °C (3 mbar)). 1H NMR 
(γ00 MHz, CDClγ) δ = 4.14 (q, J = 7.1 Hz, 2H), 3.34 (s, 2H), 1.23 (t, J = 7.1 Hz, 3H), 1.05 (s, 
9H). 13C σMR (75 MHz, CDClγ) δ = 17γ.0, 60.γ, 50.γ, γ8.1, γ5.7, β9.0 (γ C), 14.β. 
Analytical data match to the reported data.121 
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Ethyl 3-(tert-butylamino)-2-methylpropanoate (70b). 
 
A solution of tert-butylamine (40 ml, 377.37 mmol, 2.9 equiv.) and ethyl methacrylate 
(15.15 g, 132.73 mmol, 1 equiv.) in 80 ml EtOH was heated under reflux for four days 
(60 °C). The solvent and tert-butylamine was removed by distillation (50 °C) and product was 
purified by vacuum disillation (8.7 mbar). One fraction of clear, colorless liquid was collected 
(14.80 g, 79.03 mmol, 60%; 70 °C (8.7 mbar)). 1H NMR (400 MHz, CDCl3) δ = 4.1β (qd, J = 
7.1, 0.6 Hz, 2H), 2.87 – 2.69 (m, 1H), 2.53 (td, J = 12.6, 5.8 Hz, 2H), 1.24 (td, J = 7.1, 0.6 Hz, 
3H), 1.20 – 1.11 (m, 3H), 1.06 (d, J = 0.6 Hz, 9H). 13C NMR (101 MHz, CDCl3) δ = 176.1, 
60.2, 50.2, 45.8, 41.1, 29.0 (3 C), 15.5, 14.3. 
Analytical data match to the reported data.121 
 
Ethyl 2-(tert-butylamino)acetate (70c). 
 
Tert-butylamine (17.0 ml, 162.71 mmol, 4 equiv.) was dissolved in dry acetonitrile (30 ml) 
and ethyl 2-bromoacetate (6.07 g, 39.68 mmol, 1 equiv.) was added at 0 °C. The reaction 
mixture was stirred for overnight. After evaporation of the solvent under reduced pressure the 
maintained solution was extracted with 1 M HCl solution (2 x 20 ml) solution. The hydrous 
phase was basified with a 1 M KOH solution (50 ml) and extracted with ethylacetate (3 x 
30 ml). The solvent was dried under MgSO4 and removed under reduced pressure, yielding a 
orange to brown oil (5.04 g, 31.65 mmol, 80%). 1H NMR (300 MHz, CDCl3) δ = 4.14 (q, J = 
7.1 Hz, 2H), 3.34 (s, 2H), 1.23 (t, J = 7.1 Hz, 3H), 1.05 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 
= 173.00, 60.78, 50.18, 44.85, 28.71 (3 C), 14.16. 
Analytical data match to the reported data.122 
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Ethyl 3-(tert-butylamino)butanoate (70d). 
 
Ethyl 4-bromobutyrate (7.04 ml, 36.09 mmol, 1 equiv.), tert-butylamine (15.0 ml, 
143.57 mmol, 4 equiv.) and K2CO3 (16.70 g, 120.83 mmol, 3.5 equiv.) were dissolved in 
acetonitrile (50 ml) and stirred at room temperature for 2.5 days. Precipitate was filtered and 
the solvent was removed under reduced pressure. The obtained oil was distilled under vacuum 
(3 mbar) to get a slightly yellow oil (5.41 g, 28.88 mmol, 80%, B.P. 60 °C (3 mbar)). 
1H σMR (400 MHz, CDClγ) δ = 4.10 (q, J = 7.1 Hz, 2H), 2.55 (t, J = 7.2 Hz, 2H), 2.34 (t, J = 
7.4 Hz, 2H), 1.74 (p, J = 7.3 Hz, 2H), 1.23 (t, J = 7.1 Hz, 3H), 1.06 (s, 9H), 0.61 (s, 1H). 
13C σMR (101 MHz, CDClγ) δ = 17γ.6, 60.β, 50.β, 41.9, γβ.4, β9.1 (γ C), 26.5, 14.2. 
Analytical data match to the reported data.121 
 
(S)-Dimethyl 2-aminosuccinate hydrochloride (70e). 
 
Chlorotrimethylsilane (35 ml, 275.77 mmol, 3.5 equiv.) was added dropwise to a solution of 
L-aspartic acid (10.01 g, 75.21 mmol, 1 equiv.) in methanol (absolute, 100 ml) at 0 °C and 
stirred for overnight. The solvent was removed under reduced pressure and a clear oil was 
obtained. The residue was consecutively diluted in methanol (50 ml) and diethylether (50) and 
the particular solvent was evaporated again, yielding a white solid (14.14 g, 71.55 mmol, 
95%). 1H σMR (400 MHz, MeτD) δ = 4.γ8 (t, J = 15.7 Hz, 1H), 3.85 (s, 3H), 3.75 (s, 3H), 
3.06 (d, J = 5.7 Hz, 2H). 13C σMR (101 MHz, MeτD) δ = 171.63, 169.84, 54.20, 53.22, 
50.60, 34.97. 
Analytical data match to the reported data.123 
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Synthesis of benzoyl chlorides 71 
3-Methoxybenzoyl chloride (71a). 
 
General protocol A 
3-Methoxybenzoic acid (3.07 g, 20.18 mmol, 1 equiv.) was dissolved in thionyl chloride 
(14.00 ml, 192.99 mmol, 10 equiv.) and heated under reflux conditions for 3 h (until no more 
gas was produced). The solvent was removed by distillation of the warm reaction mixture and 
then again by vacuum distillation. A red oil was obtained (3.28 g, 19,23 mmol, 95%). 
1H NMR (300 MHz, CDCl3) δ = 7.7γ (ddd, J = 7.8, 1.7, 1.0 Hz, 1H), 7.57 (dd, J = 2.4, 1.9 
Hz, 1H), 7.41 (t, J = 8.0 Hz, 1H), 7.21 (ddd, J = 8.3, 2.6, 0.9 Hz, 1H), 3.86 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ = 168.γβ, 159.8γ, 1γ4.4β, 1β9.91, 1β4.14, 1β1.95, 115.γ4, 55.60. 
Analytical data match to the reported data.124 
 
2-Methoxybenzoyl chloride (71b). 
 
2-Methoxybenzoyl chloride (71b) was prepared from 2-methoxybenzoic acid (3.12 g, 
20.51 mmol, 1 equiv.) and thionyl chloride (15.00 ml, 206.77 mmol, 10 equiv.) following 
general protocol A. Yield: 3.34 g (19.58 mmol, 95%), orange oil. 1H NMR (300 MHz, 
CDCl3) δ = 8.09 (dd, J = 8.0, 1.7, 1H), 7.59 (ddd, J = 8.5, 7.4, 1.8, 1H), 7.09 – 6.97 (m, 
J = 11.3, 8.9, 4.7, 2H), 3.92 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 16γ.98, 159.67, 1γ6.γ1, 
134.74, 122.20, 120.37, 112.04, 56.11. 
Analytical data match to the reported data.125 
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3-Chlorobenzoyl chloride (71c). 
 
3-Chlorobenzoyl chloride (71c) was prepared from 3-chlorobenzoic acid (6.88 g, 43.94 mmol, 
1 equiv.) and thionyl chloride (15.00 ml, 206.77 mmol, 4 equiv.) following general protocol 
A. Yield: 7.60 g (43.43 mmol, 99%), yellow oil. 1H NMR (300 MHz, CDCl3) δ = 8.10 – 8.04 
(m, 1H), 8.03 – 7.96 (m, 1H), 7.65 (ddd, J = 8.0, 2.0, 1.0 Hz, 1H), 7.47 (t, J = 8.0 Hz, 1H).13C 
NMR (75 MHz, CDCl3) δ = 167.γβ, 1γ5.γ0 (β C), 1γ4.80, 1γ1.11, 1γ0.β4, 1β9.4β. 
Analytical data match to the reported data.126 
 
4-Bromobenzoyl chloride (71d). 
 
4-Bromobenzoyl chloride (71d) was prepared from 4-bromobenzoic acid (2.38 g, 
11.84 mmol, 1 equiv.) and thionyl chloride (30.00 ml, 413.55 mmol, 35 equiv.) following 
general protocol A. Yield: 2.54 g (11.16 mmol, 94%), yellow oil. 1H NMR (300 MHz, 
CDCl3) δ = 7.97 (d, J = 8.8 Hz, 1H), 7.66 (d, J = 8.8 Hz, 1H). 13C NMR (75 MHz, CDCl3) 
δ = 167.68, 132.65, 132.42 (2 C), 132.09 (2 C), 131.21. 
Analytical data match to the reported data.127 
 
3-Chloro-4-methoxybenzoyl chloride (71e). 
 
3-Chloro-4-methoxybenzoyl chloride (71e) was prepared from 3-chloro-4-methoxybenzoic 
acid (3.90 g, 43.94 mmol, 1 equiv.) and thionyl chloride (12.00 ml, 165.42 mmol, 8 equiv.) 
following general protocol A. Yield: 3.73 g (18.19 mmol, 87%), yellow oil. 1H NMR (300 
MHz, CDCl3) δ = 8.14 (d, J = 2.3 Hz, 1H), 8.05 (dd, J = 8.8, 2.3 Hz, 1H), 7.01 (d, J = 8.8 Hz, 
1H), 4.01 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 166.40, 160.65, 1γγ.γγ, 1γβ.β8, 1β6.11, 
123.38, 111.46, 56.69.  
Analytical data match to the reported data.128 
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2,6-Dimethoxybenzoyl chloride (71f). 
 
2,6-Dimethoxybenzoyl chloride (71f) was prepared from 2,6-dimethoxybenzoic acid (6.69 g, 
36.72 mmol, 1 equiv.) and thionyl chloride (16.00 ml, 220.56 mmol, 6 equiv.) following 
general protocol A. Yield: 6.98 g (34.79 mmol, 95%), red solid. 1H NMR (400 MHz, CDCl3) 
δ = 7.γ4 (t, J = 8.5 Hz, 1H), 6.57 (d, J = 8.5 Hz, 2H), 3.87 (s, 6H). 13C NMR (101 MHz, 
CDCl3) δ = 166.08, 156.19 (β C), 1γβ.6γ, 117.71, 104.00 (β C), 56.β1 (β C). 
Analytical data match to the reported data.129 
 
Isonicotinoyl chloride (71g). 
 
Isonicotinoyl chloride (71g) was prepared from Isonicotinic acid (4.04 g, 32.82 mmol, 
1 equiv.) and thionyl chloride (35.0 ml, 482.47 mmol, 15 equiv.) following general protocol 
A with a reaction time of 18 h. Yield: 3.61 g (25.50 mmol, 78%), yellow solid. 1H NMR 
(300 MHz, CDCl3) δ = 9.β1 (d, J = 6.6 Hz, 2H), 8.56 (d, J = 6.6 Hz, 2H). 13C NMR (101 
MHz, CDCl3) δ = 166.5β, 147.19 (β C), 14γ.58, 1β5.γ4 (β C). 
Analytical data match to the reported data.130 
 
3,4-Dimethoxybenzoyl chloride (71h). 
 
3,4-Dimethoxybenzoyl chloride (71h) was prepared from 3,4-dimethoxybenzoic acid (8.13 g, 
44.63 mmol, 1 equiv.) and thionyl chloride (30.00 ml, 413.55 mmol, 10 equiv.) following 
general protocol A. Yield: 8.80 g (43.86 mmol, 98%), grey solid. 1H NMR (300 MHz, 
CDCl3) δ = 7.84 (dd, J = 8.6, 2.2 Hz, 1H), 7.53 (d, J = 2.2 Hz, 1H), 6.93 (d, J = 8.6 Hz, 1H), 
3.98 (s, 3H), 3.94 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 167.γ4, 155.19, 148.65, 1β7.β8, 
124.61, 112.71, 110.40, 56.32, 56.13. 
Analytical data match to the reported data.131 
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3,4,5-Trimethoxybenzoyl chloride (71i). 
 
3,4,5-Trimethoxybenzoyl chloride (71i) was prepared from 3,4,5-trimethoxybenzoic acid 
(4.21 g, 19.84 mmol, 1 equiv.) and thionyl chloride (14.00 ml, 192.99 mmol, 10 equiv.) 
following general protocol A. Yield: 4.25 g (18.44 mmol, 93%), red solid. 1H NMR (300 
MHz, CDCl3) δ = 7.γ6 (s, βH), γ.95 (s, γH), γ.9β (s, 6H). 13C NMR (75 MHz, CDCl3) 
δ = 171.80, 152.99 (2 C), 143.01, 124.11, 107.43 (2 C), 60.98, 56.26 (2 C). 
Analytical data match to the reported data.132 
 
Thiophene-2-carbonyl chloride (71j). 
 
Thiophene-2-carbonyl chloride (71j) was prepared from thiophene-2-carboxylic acid (6.02 g, 
46.98 mmol, 1 equiv.) and thionyl chloride (10.00 ml, 141.21 mmol, 3 equiv.) following 
general protocol A. Yield: 6.7 g (45.7 mmol, 97%) red oil. 1H NMR (300 MHz, CDCl3) δ = 
7.98 (dd, J = 3.9, 1.3 Hz, 1H), 7.83 (dd, J = 5.0, 1.3 Hz, 1H), 7.20 (dd, J = 5.0, 4.0 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 159.75, 1γ8.00, 1γ7.69, 1γ7.4β, 1β8.69. 
Analytical data match to the reported data.133 
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Synthesis of compounds 72 
Ethyl 3-(N-tert-butyl-4-methoxybenzamido)propanoate (72a). 
 
General protocol B 
A solution of 4-methoxybenzoyl chloride (3.05 g, 17.88 mmol, 1 equiv.) in 30 ml DCM was 
added dropwise to an ice cooled solution of amine 70a (3.36 g, 19.39 mmol, 1.1 equiv.) and 
triethylamine (2.80 ml, 20.20 mmol, 1.1 equiv.) in 50 ml DCM. The reaction was allowed to 
warm up to room temperature (22 °C) and was stirred for 15 h. The solution was washed with 
1M HCl (20 ml), saturated NaHCO3 solution (20 ml) and brine (20 ml). The organic phase 
was dried over MgSO4, filtered and concentrated. The residue was dried in vacuo to give 
4.93 g (16.04 mmol, 90%) of the product as a pale yellow oil. IR (neat): 2978, 2840, 1730, 
1636, 1607, 1513, 1461, 1375, 1297, 1245, 1170, 1111, 1025, 947, 842, 809, 768, 664 cm-1. 
1H NMR (300 MHz, CDCl3) δ = 7.30 (d, J = 8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 4.01 (q, J 
= 7.1 Hz, 2H), 3.80 (s, 3H), 3.68 – 3.58 (m, 2H), 2.50 – 2.41 (m, 2H), 1.51 (s, 9H), 1.17 (t, J = 
7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17γ.69, 170.87, 160.18, 1γ1.68, 1β8.15 (β C), 
113.71 (2 C), 60.58, 57.02, 55.29, 42.99, 36.31, 28.96 (3C), 14.08. 
 
Ethyl 3-(N-tert-butyl-3-methoxybenzamido)propanoate (72b). 
 
Compound 72b was prepared from 3-methoxybenzoyl chloride (71a, 3.28 g, 19.23 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 3.23 g, 18,64 mmol, 1 equiv.) and 
triethylamine (2.70 ml, 19.48 mmol, 1 equiv.) following general protocol B. Yield: 5.67 g 
(18.45 mmol, 96%), yellow oil. IR (neat): 2978, 1730, 1641, 1580, 1536, 1484, 1428, 1394, 
1320, 1290, 1238, 1182, 1033, 865, 790, 753, 675 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.31 
– 7.24 (m, 1H), 6.92 – 6.81 (m, 3H), 4.01 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 3.64 – 3.54 (m, 
2H), 2.53 – 2.42 (m, 2H), 1.53 (s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
= 173.18, 170.76, 159.60, 140.55, 129.66, 118.21, 114.88, 111.41, 60.59, 57.22, 55.34, 42.74, 
36.44, 28.90 (3 C), 14.06. 
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Ethyl 3-(N-tert-butyl-2-methoxybenzamido)propanoate (72c). 
 
Compound 72c was prepared from 2-methoxybenzoyl chloride (71b, 3.34 g, 19.58 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 3.35 g, 19,34 mmol, 1 equiv.) and 
triethylamine (3.00 ml, 21.64 mmol, 1.1 equiv.) following general protocol B. Yield: 5.79 g 
(18.84 mmol, 96%), yellow oil. IR (neat): 2978, 1730, 1640, 1599, 1490, 1461, 1439, 1394, 
1364, 1290, 1245, 1185, 1156, 1099, 1021, 767 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.β7 
(ddd, J = 8.3, 7.5, 1.8 Hz, 1H), 7.12 (dd, J = 7.4, 1.7 Hz, 1H), 6.92 (ddd, J = 22.6, 11.3, 4.6 
Hz, 2H), 3.98 (q, J = 7.1 Hz, 2H), 3.80 (s, 3H), 3.64 – 3.33 (m, 2H), 2.60 – 2.30 (m, 2H), 1.53 
(s, 9H), 1.14 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 171.01, 170.48, 154.66, 
129.65, 128.93, 126.91, 120.79, 111.09, 60.44, 57.28, 55.55, 42.27, 36.22, 28.96 (3 C), 14.08. 
 
Ethyl 3-(N-tert-butyl-4-chlorobenzamido)propanoate (72d). 
 
Compound 72d was prepared from 4-chlorobenzoyl chloride (1.2 ml, 9.33 mmol, 1 equiv.), 
ethyl 3-(tert-butylamino)propanoate (70a, 1.64 g, 9.47 mmol, 1 equiv.) and triethylamine 
(1.30 ml, 9.38 mmol, 1 equiv.) following general protocol B. Yield: 2.50 g (8.02 mmol, 
86%), white solid. IR (neat): 2971, 1730, 1629, 1487, 1394, 1320, 1293, 1223, 1193, 1156, 
1088, 1040, 1010, 839, 872, 738, 701 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.γ1 (dd, J = 
27.7, 8.6 Hz, 4H), 4.02 (q, J = 7.1 Hz, 2H), 3.63 – 3.54 (m, 2H), 2.49 – 2.40 (m, 2H), 1.51 (s, 
9H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17β.46, 170.59, 1γ7.65, 1γ4.98, 
128.78 (2 C), 127.71 (2 C), 60.73, 57.36, 42.84, 36.24, 28.88 (3 C), 14.07. 
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Ethyl 3-(N-tert-butyl-3-chlorobenzamido)propanoate (72e). 
 
Compound 72e was prepared from 3-Chlorobenzoyl chloride (71c, 2.00 g, 10.89 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 2.00 g, 11.54 mmol, 1 equiv.) and 
triethylamine (2.40 ml, 17.31 mmol, 1.5 equiv.) following general protocol B. Yield: 3.30 g 
(10.58 mmol, 93%), orange oil. IR (neat): 2982, 1730, 1640, 1566, 1476, 1390, 1320, 1286, 
1252, 1185, 1149, 1096, 1044, 880, 798, 753, 716, 664 cm-1. 1H NMR (400 MHz, CDCl3) δ = 
7.36 – 7.28 (m, 3H), 7.21 (dt, J = 6.8, 1.7 Hz, 1H), 4.02 (q, J = 7.1 Hz, 2H), 3.63 – 3.50 (m, 
2H), 2.51 – 2.40 (m, 2H), 1.52 (s, 9H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
= 171.87, 170.57, 140.81, 134.48, 129.96, 129.18, 126.33, 124.26, 60.74, 57.46, 42.79, 36.26, 
28.83 (3 C), 14.06. 
 
Ethyl 3-(4-bromo-N-tert-butylbenzamido)propanoate (72f). 
 
Compound 72f was prepared from 4-bromobenzoyl chloride (71d, 1.49 g, 6.79 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 1.19 g, 6.87 mmol, 1 equiv.) and 
triethylamine (1.00 ml, 7.21 mmol, 1 equiv.) following general protocol B. Yield: 1.93 g 
(5.42 mmol, 80%), orange oil. IR (neat): 3306, 2960, 1730, 1705, 1633, 1592, 1539, 1483, 
1439, 1379, 1320, 1260, 1226, 1182, 1070, 1010, 928, 850, 798, 750, 705 cm-1. 1H NMR (300 
MHz, CDCl3) δ 7.54 – 7.47 (m, 2H), 7.24 – 7.17 (m, 2H), 4.02 (q, J = 7.1 Hz, 2H), 3.64 – 
3.50 (m, 2H), 2.52 – 2.35 (m, 2H), 1.51 (s, 9H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ = 17β.4γ, 170.56, 1γ8.1β, 1γ1.71 (β C), 1β7.9γ (β C), 1βγ.17, 60.7β, 57.γ6, 42.81, 
36.22, 28.87 (3 C), 14.08. 
 
 
 
 
 
D  Experimental Part 2  Synthesis of N-acyloxyphthalimides 
 
119 
 
Ethyl 3-(N-tert-butyl-4-methylbenzamido)propanoate (72g). 
 
Compound 72g was prepared from 4-toluoyl chloride (2.04 g, 13.20 mmol, 1 equiv.), ethyl 3-
(tert-butylamino)propanoate (70a, 2.30 g, 13.28 mmol, 1 equiv.) and triethylamine (2.00 ml, 
14.43 mmol, 1.1 equiv.) following general protocol B. Yield: 3.44 g (11.81 mmol, 89%), 
clear oil. IR (neat): 2978, 2930, 1730, 1640, 1506, 1375, 1320, 1252, 1178, 1111, 1040, 947, 
831, 757, 664 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.β5 – 7.18 (m, 2H), 7.18 – 7.11 (m, 
2H), 4.00 (q, J = 7.1 Hz, 2H), 3.66 – 3.54 (m, 2H), 2.50 – 2.39 (m, 2H), 2.33 (s, 3H), 1.51 (s, 
9H), 1.15 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17γ.79, 170.8β, 1γ8.90, 1γ6.46, 
129.06 (2 C), 126.18 (2 C), 60.54, 57.05, 42.83, 36.32, 28.94 (3 C), 21.34, 14.05. 
 
Ethyl 3-(N-tert-butylbenzamido)propanoate (72h). 
 
Compound 72h was prepared from benzoyl chloride (1.13 g, 8.04 mmol, 1.1 equiv.), ethyl 3-
(tert-butylamino)propanoate (70a, 1.27 g, 7.32 mmol, 1 equiv.) and triethylamine (1.30 ml, 
9.38 mmol, 1.2 equiv.) following general protocol B. Yield: 1.83 g (6.60 mmol, 90%), pale 
yellow oil. IR (neat): 2978, 1789, 1730, 1640, 1446, 1394, 1320, 1252, 1185, 1114, 1040, 
924, 857, 783, 734, 701 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.γ9 – 7.29 (m, 5H), 4.01 (q, J 
= 7.1 Hz, 2H), 3.65 – 3.55 (m, 2H), 2.52 – 2.40 (m, 2H), 1.53 (s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3) δ = 17γ.55, 170.75, 1γ0.60, 1β8.98 (β C), 1β8.51 (β C), 1β6.07, 
60.60, 57.19, 42.78, 36.32, 28.94 (3 C), 14.07. 
 
Ethyl 3-(N-tert-butyl-3-chloro-4-methoxybenzamido)propanoate (72i). 
 
Compound 72i was prepared from 3-chloro-4-methoxybenzoyl chloride (71e, 1.98 g, 
9.66 mmol, 1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a
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and triethylamine (2.00 ml, 14.43 mmol, 1.5 equiv.) following general protocol B. Yield: 3.11 
g (9.10 mmol, 94%), orange oil. IR (neat): 2978, 2844, 1785, 1730, 1630, 1599, 1498, 1461, 
1368, 1260, 1185, 1062, 1018, 891, 858, 820, 764, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ = 
7.36 (d, J = 2.1 Hz, 1H), 7.23 (dd, J = 8.5, 2.0 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H), 4.02 (q, J = 
7.2 Hz, 2H), 3.89 (s, 3H), 3.66 – 3.57 (m, 2H), 2.51 – 2.39 (m, 2H), 1.49 (s, 9H), 1.20 – 1.12 
(m, 3H). 13C NMR (75 MHz, CDCl3) δ = 17β.11, 170.71, 155.60, 1γβ.γ6, 1β8.64, 1β6.γ6, 
122.37, 111.71, 60.69, 57.22, 56.21, 43.00, 36.25, 28.86 (3 C), 14.07. 
 
Ethyl 3-(N-tert-butyl-2,6-dimethoxybenzamido)propanoate (72j). 
 
Compound 72j was prepared from 2,6-dimethoxybenzoyl chloride (71f, 2.97 g, 14.80 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 2.51 g, 14.49 mmol, 1 equiv.) and 
triethylamine (3.00 ml, 20.73 mmol, 1.4 equiv.) following general protocol B. Yield: 4.14 g 
(12.27 mmol, 83%), orange oil. IR (neat): 2974, 2840, 1730, 1640, 1592, 1472, 1394, 1364, 
1290, 1249, 1185, 1107, 1021, 947, 876, 731, 664 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.19 
(t, J = 8.4 Hz, 1H), 6.52 (dd, J = 8.4, 6.0 Hz, 3H), 3.97 (q, J = 7.1 Hz, 2H), 3.78 (s, 6H), 3.49 
– 3.42 (m, 2H), 2.50 – 2.42 (m, 2H), 1.54 (s, 9H), 1.14 (t, J = 7.1 Hz, 3H). 13C NMR (101 
MHz, CDCl3) δ = 171.γ6, 167.87, 155.97 (β C), 1β9.59, 117.77, 104.06 (2 C), 60.33, 57.32, 
55.81, 42.25, 36.05, 28.99 (3 C), 14.12. 
 
Ethyl 3-(N-tert-butyl-4-methoxybenzamido)-2-methylpropanoate (72k). 
 
Compound 72k was prepared from 4-methoxybenzoyl chloride (2.04 g, 11.96 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)-2-methylpropanoate (70b, 2.24 g, 11.97 mmol, 1 equiv.) 
and triethylamine (1.90 ml, 13.71 mmol, 1.1 equiv.) following general protocol B. Yield: 
2.43 g (7.55 mmol, 63%), orange oil. IR (neat): 2974, 2840, 1730, 1633, 1607, 1510, 1461, 
1387, 1334, 1301, 1245, 1170, 1141, 1085, 1055, 1029, 932, 842, 809, 768, 716 cm-1. 1H 
NMR (300 MHz, CDCl3) δ = 7.4β – 7.27 (m, 2H), 6.92 – 6.79 (m, 2H), 4.05 (dd, J = 7.1, 4.0 
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Hz, 2H), 3.85 – 3.73 (m, 4H), 3.52 (dd, J = 15.0, 7.9 Hz, 1H), 2.73 (dd, J = 14.5, 7.0 Hz, 1H), 
1.52 (s, 9H), 1.20 (t, J = 7.1 Hz, 3H), 0.95 (d, J = 7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
= 174.38, 174.10, 160.45, 131.53, 129.44 (2 C), 113.58 (2 C), 60.62, 56.88, 55.31, 50.68, 
41.07, 29.03 (3 C), 14.46, 14.13. 
 
Ethyl 3-(N-tert-butylisonicotinamido)propanoate (72l). 
 
Compound 72l was prepared from isonicotinoyl chloride (71g, 2.07 g, 14.62 mmol, 
1.5 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 1.65 g, 9,52 mmol, 1 equiv.) and 
triethylamine (2.00 ml, 14.43 mmol, 1.5 equiv.) following general protocol B. Yield: 1.60 g 
(5.75 mmol, 59%), yellow oil. 1H NMR (400 MHz, CDCl3) δ = 8.65 (d, J = 5.7 Hz, 2H), 7.22 
(d, J = 6.0 Hz, 2H), 4.02 (q, J = 7.1 Hz, 2H), 3.59 – 3.50 (m, 2H), 2.50 – 2.41 (m, 2H), 1.53 
(s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 170.63, 170.23, 150.24 (2 
C), 146.60, 120.44 (2 C), 60.80, 57.69, 42.55, 36.20, 28.78 (3 C), 14.05. 
 
Ethyl 3-(N-tert-butyl-3,4-dimethoxybenzamido)propanoate (72m). 
 
Compound 72m was prepared from 3,4-Dimethoxybenzoyl chloride (71h, 4.12 g, 
20.54 mmol, 1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 3.76 g, 21,70 mmol, 1.1 
equiv.) and triethylamine (3.00 ml, 21.64 mmol, 1.1 equiv.) following general protocol B. 
Yield: 5.83 g (17.28 mmol, 84%), orange oil. Ir (neat): 2971, 2840, 1730, 1633, 1603, 1514, 
1461, 1320, 1264, 1223, 1174, 1137, 1021, 921, 869, 816, 768 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 6.90 (m, J = 7.5 Hz, 2H), 6.82 (d, J = 8.4 Hz, 1H), 4.02 (q, J = 7.1 Hz, 2H), 3.89 
(s, 3H), 3.88 (s, 3H), 3.69 – 3.59 (m, 2H), 2.55 – 2.42 (m, 2H), 1.52 (s, 9H), 1.17 (t, J = 7.1 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17γ.55, 170.8γ, 149.7β, 148.89, 1γ1.81, 119.1γ, 
110.59, 109.94, 60.61, 57.14, 55.98, 55.93, 43.00, 36.47, 28.93 (3 C), 14.08. 
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Ethyl 3-(N-tert-butyl-3,4,5-trimethoxybenzamido)propanoate (72n). 
 
Compound 72n was prepared from 3,4,5-Trimethoxybenzoyl chloride (71i, 2.05 g, 
8.89 mmol, 1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 1.59 g, 9,18 mmol, 1.1 
equiv.) and triethylamine (1.40 ml, 10.10 mmol, 1.1 equiv.) following general protocol B. 
Yield: 2.78 g (7.75 mmol, 85%), orange oil. Ir (neat): 2941, 2837, 1730, 1640, 1584, 1506, 
1461, 1412, 1327, 1226, 1178, 1122, 1055, 1006, 865, 831, 768, 731 cm-1. 1H NMR (300 
MHz, CDCl3) δ = 6.5β (s, βH), 4.01 (q, J = 7.1 Hz, 2H), 3.85 (s, 6H), 3.82 (s, 3H), 3.69 – 3.53 
(m, 2H), 2.61 – 2.39 (m, 2H), 1.52 (s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ = 17γ.17, 170.70, 15γ.γβ (β C), 1γ4.75, 106.70 (β C), 10γ.γ6, 60.89, 60.68, 57.29, 
56.22 (2 C), 42.89, 36.68, 28.86 (3 C), 14.07. 
 
Ethyl 3-(4-methoxy-N-methylbenzamido)propanoate (72o). 
 
Compound 72o was prepared from 4-methoxybenzoyl chloride (3.61 g, 21.16 mmol, 
1 equiv.), ethyl 3-(methylamino)propanoate (2.73 g, 20.81 mmol, 1 equiv.) and triethylamine 
(4.40 ml, 31.74 mmol, 1.5 equiv.) following general protocol B. Yield: 5.52 g (20.81 mmol, 
100%) clear oil. IR (neat): 2937, 2840, 1730, 1607, 1513, 1489, 1443, 1398, 1301, 1245, 
1174, 1074, 1025, 842, 798, 764, 716 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.γ9 – 7.32 (m, 
2H), 6.93 – 6.85 (m, 2H), 4.13 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 3.73 (s, 2H), 3.03 (d, J = 1.6 
Hz, 3H), 2.64 (s, 2H), 1.24 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 171.78, 
160.68, 132.15, 128.94, 128.13 (2 C), 113.65 (2 C), 60.77, 55.33, 44.47, 38.68, 32.51, 14.18.  
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Ethyl 2-(N-tert-butyl-4-methoxybenzamido)acetate (72p). 
 
Compound 72p was prepared from 4-methoxybenzoyl chloride (3.02 g, 17.70 mmol, 
1 equiv.), ethyl 2-(tert-butylamino)acetate (70c, 3.23 g, 20.29 mmol, 1.1 equiv.) and 
triethylamine (2.70 ml, 19.48 mmol, 1.1 equiv.) following general protocol B. Yield: 5.10 g 
(17.38 mmol, 98%), yellow oil. IR (neat): 2971, 2937, 1744, 1640, 1607, 1513, 1461, 1428, 
1379, 1297, 1249, 1170, 1111, 1025, 977, 842, 768, 690 cm-1. 1H NMR (300 MHz, CDCl3) δ 
= 7.42 – 7.35 (m, 2H), 6.87 – 6.80 (m, 2H), 4.16 (q, J = 7.1 Hz, 2H), 3.99 (s, 2H), 3.79 (s, 
3H), 1.50 (s, 9H), 1.24 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17γ.57, 171.γ7, 
160.39, 131.20, 128.17 (2 C), 113.69 (2 C), 61.26, 57.64, 55.30, 49.97, 28.09 (3 C), 14.13. 
 
Ethyl 4-(N-tert-butylbenzamido)butanoate (72q). 
 
Compound 72q was prepared from benzoyl chloride (1.84 g, 13.09 mmol, 1 equiv.), ethyl 3-
(tert-butylamino)butanoate (70d, 2.51 g, 13,40 mmol, 1 equiv.) and triethylamine (2.00 ml, 
14.44 mmol, 1.1 equiv.) following general protocol B. Yield: 3.72 g (12.77 mmol, 97%), pale 
yellow oil. IR (neat): 3313, 2937, 1707, 1629, 1539, 1577, 1450, 1375, 1312, 1238, 1174, 
1095, 1025, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.γ9 – 7.27 (m, 5H), 3.99 (q, J = 7.1 
Hz, 2H), 3.29 (dd, J = 8.9, 6.9 Hz, 2H), 2.00 (t, J = 7.2 Hz, 2H), 1.77 (dq, J = 10.1, 7.5 Hz, 
2H), 1.54 (s, 9H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17γ.γ7, 1γ9.56, 
135.38, 131.44, 128.91, 128.42, 126.12, 60.47, 57.02, 46.82, 31.39, 28.92 (3 C), 27.02, 14.15. 
13C NMR (75 MHz, CDCl3) δ = 17γ.γ7, 17β.54, 1γ1.44, 1β8.91 (β C), 1β8.4β (β C), 1β6.1β, 
60.47, 57.02, 46.82, 31.39, 28.92 (3 C), 27.02, 14.15. 
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Ethyl 4-(N-tert-butylisonicotinamido)butanoate (72r). 
 
Compound 72r was prepared from Isonicotinoyl chloride (71g, 2.02 g, 14.27 mmol, 1 equiv.), 
ethyl 3-(tert-butylamino)butanoate (70d, 1.74 g, 9.56 mmol, 1 equiv.) and triethylamine 
(1.50 ml, 10.82 mmol, 1.1 equiv.) following general protocol B. Yield: 2.09 g (7.15 mmol, 
75%), orange oil. 1H NMR (400 MHz, CDCl3) δ = 8.64 (dd, J = 4.5, 1.3 Hz, 2H), 7.20 (dd, J 
= 4.4, 1.6 Hz, 2H), 3.99 (q, J = 7.1 Hz, 2H), 3.26 – 3.17 (m, 2H), 2.00 (t, J = 7.1 Hz, 2H), 
1.83 – 1.70 (m, 2H), 1.54 (s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 
172.19, 170.39, 150.17 (2 C), 146.82, 120.41 (2 C), 60.58, 57.58, 46.55, 31.23, 28.76 (3 C), 
27.02, 14.13. 
 
Ethyl 4-(N-tert-butyl-4-methoxybenzamido)butanoate (72s). 
 
Compound 72s was prepared from 4-methoxybenzoyl chloride (3.09 g, 18.11 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)butanoate (70d, 3.65 g, 19.49 mmol, 1.1 equiv.) and 
triethylamine (3.00 ml, 21.64 mmol, 1.2 equiv.) following general protocol B. Yield: 5.09 g 
(15.84 mmol, 87%), pale yellow oil. IR (neat): 2967, 1730, 1633, 1607, 1513, 1461, 1390, 
1297, 1245, 1170, 1111, 1062, 1029, 809, 768 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.γβ – 
7.24 (m, 2H), 6.89 – 6.81 (m, 2H), 4.00 (q, J = 7.1 Hz, 2H), 3.80 (s, 3H), 3.39 – 3.28 (m, 2H), 
2.02 (t, J = 7.3 Hz, 2H), 1.76 (dt, J = 18.8, 7.4 Hz, 2H), 1.52 (s, 9H), 1.17 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3) δ = 17γ.50, 17β.6β, 159.99, 1γ1.94, 1β8.16 (β C), 11γ.64 (β C), 
60.45, 56.87, 55.29, 47.01, 31.40, 28.97 (3 C), 27.01, 14.14. 
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Ethyl 4-(N-tert-butyl-3-chloro-4-methoxybenzamido)butanoate (72t). 
 
Compound 72t was prepared from 3-chloro-4-methoxybenzoyl chloride (71e, 1.75 g, 
8.54 mmol, 1 equiv.), ethyl 3-(tert-butylamino)butanoate (70d, 1.60 g, 8.54 mmol, 1 equiv.) 
and triethylamine (2.00 ml, 14.43 mmol, 1.7 equiv.) following general protocol B. Yield: 
3.03 g (8.51 mmol, 99%), pale yellow oil. IR (neat): 2974, 1730, 1633, 1603, 1502, 1461, 
1394, 1293, 1260, 1178, 1111, 1062, 1021, 887, 820, 768, 693 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.γ5 (d, J = 2.1 Hz, 1H), 7.22 (dd, J = 8.4, 2.1 Hz, 1H), 6.88 (d, J = 8.4 Hz, 1H), 
4.00 (q, J = 7.1 Hz, 2H), 3.89 (s, 3H), 3.36 – 3.27 (m, 2H), 2.03 (t, J = 7.2 Hz, 2H), 1.75 (dt, J 
= 15.1, 7.3 Hz, 2H), 1.50 (s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 
172.49, 171.90, 155.41, 132.60, 128.61, 126.33, 122.29, 111.67, 60.52, 57.12, 56.20, 47.01, 
31.30, 28.86, 26.96 (3 C), 14.13. 
 
Ethyl 4-(N-tert-butyl-3,4-dimethoxybenzamido)butanoate (72u). 
 
Compound 72u was prepared from 3,4-Dimethoxybenzoyl chloride (71h, 4.10 g, 20.44 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)butanoate (70d, 3.79 g, 20,24 mmol, 1 equiv.) and 
triethylamine (2.90 ml, 20.92 mmol, 1 equiv.) following general protocol B. Yield: 6.15 g 
(17.50 mmol, 86%), orange oil. IR (neat): 3295, 2937, 2840, 1726, 1625, 1580, 1543, 1510, 
1457, 1413, 1267, 1238, 1178, 1133, 1096, 1018, 845, 753, 701 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 6.9β – 6.86 (m, 2H), 6.81 (d, J = 8.7 Hz, 1H), 4.01 (q, J = 7.1 Hz, 2H), 3.88 (s, 
3H), 3.88 (s, 3H), 3.35 (m, J = 8.8, 6.9 Hz, 2H), 2.03 (t, J = 7.3 Hz, 2H), 1.79 (dt, J = 14.7, 
7.2 Hz, 2H), 1.53 (s, 9H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17γ.γ6, 
172.59, 149.50, 148.82, 132.08, 119.11, 110.56, 109.99, 60.49, 56.99, 55.99, 55.93, 47.06, 
31.47, 28.94 (3 C), 27.19, 14.14. 
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Ethyl 4-(N-tert-butyl-2,4,6-trimethylbenzamido)butanoate (72v). 
 
Compound 72v was prepared from 2,4,6-trimethylbenzoyl chloride (1.50 g, 8.21 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)butanoate (70d, 1.57 g, 8,38 mmol, 1 equiv.) and 
triethylamine (1.20 ml, 8.66 mmol, 1 equiv.) following general protocol B. Yield: 1.24 g 
(3.70 mmol, 45%) yellow solid. 1H NMR (300 MHz, CDCl3) δ = 6.77 (s, βH), γ.99 (q, J = 7.1 
Hz, 2H), 3.15 – 3.00 (m, 2H), 2.23 (s, 3H), 2.20 (s, 6H), 1.94 (t, J = 7.1 Hz, 2H), 1.73 – 1.61 
(m, 2H), 1.57 (s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17β.49, 
172.13, 137.21, 135.72, 132.88 (2 C), 128.34 (2 C), 60.45, 57.45, 46.19, 31.76, 28.89 (3 C), 
26.52, 21.05, 19.07 (2 C), 14.10. 
 
Ethyl 4-(N-tert-butyl-2,6-dimethoxybenzamido)butanoate (72w). 
 
Compound 72w was prepared from 2,6-Dimethoxybenzoyl chloride (71f, 2.01 g, 10.02 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)butanoate (70d, 1.89 g, 10.09 mmol, 1 equiv.) and 
triethylamine (3.00 ml, 21.64 mmol, 2.3 equiv.) following general protocol B. Yield: 3.04 g 
(8.65 mmol, 86%), yellow oil. IR (neat):  2967, 2840, 1730, 1636, 1592, 1472, 1394, 1364, 
1290, 1249, 1178, 1029, 1107, 1030, 876, 790, 738 cm-1. 1H NMR (300 MHz, CDCl3) δ = 
7.17 (t, J = 8.4 Hz, 1H), 6.50 (d, J = 8.4 Hz, 2H), 3.98 (q, J = 7.1 Hz, 2H), 3.76 (s, 6H), 3.14 – 
3.08 (m, 2H), 1.93 (t, J = 7.4 Hz, 2H), 1.73 (dq, J = 10.8, 7.7 Hz, 2H), 1.53 (s, 9H), 1.15 (t, J 
= 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17β.84, 167.69, 155.99 (β C), 1β9.4β, 117.89, 
103.91 (2 C), 60.33, 57.21, 55.77 (2 C), 46.36, 31.83, 28.97 (3 C), 26.65, 14.17. 
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Ethyl 4-(N-tert-butyl-3,4,5-trimethoxybenzamido)butanoate (72x). 
 
Compound 72x was prepared from 3,4,5-Trimethoxybenzoyl chloride (71i, 4.05 g, 
17.56 mmol, 1 equiv.), ethyl 3-(tert-butylamino)butanoate (70d, 3.31 g, 17,67 mmol, 1 
equiv.) and triethylamine (2.50 ml, 18.04 mmol, 1 equiv.) following general protocol B. 
Yield: 5.90 g (15.47 mmol, 88%), orange oil. IR (neat): 3302, 2941, 2840, 1729, 1633, 1580, 
1536, 1502, 1465, 1413, 1375, 1334, 1234, 1178, 1122, 1036, 992, 850, 701 cm-1. 1H NMR 
(300 MHz, CDCl3) δ = 6.5β (s, βH), 4.01 (q, J = 7.1 Hz, 2H), 3.85 (s, 6H), 3.82 (s, 3H), 3.39 
– 3.25 (m, 2H), 2.04 (t, J = 6.7 Hz, 2H), 1.81 (dq, J = 15.3, 7.5 Hz, 2H), 1.54 (s, 9H), 1.17 (t, 
J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17β.98, 17β.50, 15γ.β6 (β C), 1γ8.33, 
135.03, 103.33 (2 C), 60.88, 60.52, 57.13, 56.21 (2 C), 46.97, 31.52, 28.85 (3 C), 27.41, 
14.14. 
 
Ethyl 3-(4-methoxybenzylamino)propanoate (72y). 
 
ȕ-Alanine ethyl ester hydrochloride (3.19 g, 20.77 mmol, 1 equiv.) was dissolved in methanol 
(absolute, 20 ml). Anisaldehyde (2.8 g, 20.57 mmol, 1 equiv.) and NEt3 (3 ml, 21.64 mmol, 
1 equiv.) were added to the solution and stirred at room temperature for 3 h. NaBH4 
(781.6 mg, 20.66 mmol, 1 equiv.) was added slowly and the solution was stirred for 
overnight. Saturated NH4Cl solution (20 ml) was added to quench the reaction and the 
mixture was extracted with diethylether (2 x 30 ml). The organic phases were combined, dried 
over Na2SO4, filtered and evaporated, which gave 4.41 g (18.58 mmol, 90%) of white solid. 
1H NMR (400 MHz, CDCl3) δ = 7.βγ (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 4.13 (q, J 
= 7.1 Hz, 2H), 3.79 (s, 3H), 3.74 (s, 2H), 2.88 (t, J = 6.5 Hz, 2H), 2.52 (t, J = 6.5 Hz, 2H), 
1.78 (s, 1H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 17β.8γ, 158.70, 
132.16, 129.32 (2 C), 113.84 (2 C), 60.46, 55.29, 53.15, 44.38, 34.72, 14.23. 
Analytical data match to the reported data.134 
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Ethyl 3-(tert-butoxycarbonyl(4-methoxybenzyl)amino)propanoate (72z). 
 
Compound 72y (4.41 g, 18.58 mmol, 1 equiv.) and NEt3 (2.7 ml, 19.48 mmol, 1 equiv.) were 
dissolved in dichloromethane (50 ml), treated with di-tert-butyl dicarbonate (4.16 g, 
19.06 mmol, 1 equiv.) and stirred at room temperature for overnight. Solvent was evaporated 
and product was purified by column chromatography. Yield: 3.53 g (10.46 mmol, 56%). 
Rf (hexanes/EtOAc = 2/1) = 0.54. 1H NMR (400 MHz, CDCl3) δ = 7.16 (s, βH), 6.89 – 6.80 
(m, 2H), 4.38 (s, 2H), 4.10 (q, J = 7.1 Hz, 2H), 3.79 (s, 3H), 3.54 – 3.32 (m, 2H), 2.49 (d, J = 
10.2 Hz, 2H), 1.47 (s, 9H), 1.23 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 171.96, 
158.89, 155.53 (d) 130.43, 128.87 (d, 2 C), 113.94 (2 C), 79.95, 60.50, 55.28, 50.29 (d), 42.63 
(d), 33.57 (d), 28.45 (3 C), 14.19. 
 
(S)-Dimethyl 2-(tert-butoxycarbonyl(4-methoxybenzyl)amino)succinate (72aa). 
 
Amine 70e (2.40 g, 14.89 mmol, 1 equiv.) was dissolved in methanol (absolute, 20 ml). 
Anisaldehyde (1.8 ml, 14.81 mmol, 1 equiv.) and NEt3 (2.0 ml, 14.83 mmol, 1 equiv.) were 
added to the solution and stirred at room temperature for 1 h. NaBH4 (561.0 mg, 14.83 mmol, 
1 equiv.) was added slowly and the solution was stirred for 5 h. Saturated NH4Cl solution 
(20 ml) was added to quench the reaction and the mixture was extracted with diethylether (3 x 
30 ml). The organic phases were combined, washed with brine (30 ml), dried over Na2SO4, 
filtered and evaporated. The residue was used directly for the Boc-protection. The residue was 
dissolved in dichloromethane (50 ml) and treated with NEt3 (2.o ml, 14.43 mmol, 1 equiv.) 
and di-tert-butyl dicarbonate (3.26 g, 14.94 mmol, 1 equiv.) and stirred at room temperature 
for overnight. Solvent was evaporated and product was purified by column chromatography. 
Yield: 3.91 g (10.26 mmol, 69%). Rf (hexanes/EtOAc = 3/1) = 0.38. 1H NMR (400 MHz, 
CDCl3) δ = 7.β7 – 7.16 (m, 2H), 6.83 (d, J = 8.6 Hz, 2H), 4.63 – 4.21 (m, 3H), 3.78 (s, 3H), 
3.61 (d, J = 1.5 Hz, 6H), 3.12 (dd, J = 16.2, 7.5 Hz, 1H), 2.65 – 2.37 (m, 1H), 1.44 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ = 190.8β, 171.γ0, 146.76, 1γβ.00, 1β9.96, 1β9.β6 (d, β C), 
113.91, 113.79 (d, 2 C), 85.17, 56.34, 55.23, 52.24, 51.86, 51.55, 35.99, 27.85 (d, 3 C). 
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Ethyl 3-(N-tert-butylthiophene-2-carboxamido)propanoate (72ab). 
 
Compound S31-2 was prepared from thiophene-2-carbonyl chloride (71j, 2.50 g, 17.05 mmol, 
1 equiv.), ethyl 3-(tert-butylamino)propanoate (70a, 2.92 g, 16.85 mmol, 1 equiv.) and 
triethylamine (2.40 ml, 17.31 mmol, 1 equiv.) following general protocol B. Yield: 2.57 g 
(9.05 mmol, 53%), orange oil. 1H NMR (300 MHz, CDCl3) δ = 7.γβ – 7.26 (m, 1H), 7.17 (dt, 
J = 3.6, 1.1 Hz, 1H), 6.92 (ddd, J = 5.0, 3.6, 1.2 Hz, 1H), 4.00 (qd, J = 7.1, 1.1 Hz, 2H), 3.84 
– 3.70 (m, 2H), 2.55 (dd, J = 9.1, 6.6 Hz, 2H), 1.44 (d, J = 1.0 Hz, 9H), 1.13 (td, J = 7.1, 1.2 
Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 170.7β, 166.45, 140.57, 1β7.69, 1β7.γ9, 1β6.58, 
60.64, 57.88, 42.99, 36.81, 28.77 (3 C), 14.10. 
 
Synthesis of compounds 73 
3-(N-tert-butyl-4-methoxybenzamido)propanoic acid (73a). 
 
General protocol C 
Ethylester 72a (4.93 g, 16.04 mmol, 1 equiv.) was dissolved in 50 ml ethanol and a solution 
of KOH (992.40 mg, 17.69 mmol, 1.1 equiv.) in 40 ml water was added slowly. The reaction 
mixture was stirred at room temperature (22 °C) for overnight and ethanol was evaporated. 
The aqueous solution was acidified with concentrated HCl dropwise (2.10 ml, 24.47 mmol, 
1.5 equiv.) and stirred additionally for 5 min. The white precipitate was filtered and dried in 
vacuo to give 4.40 g (15.75 mmol, 98%) of the product as white solid. IR (neat): 3004, 2967, 
2930, 2557, 1714, 1588, 1517, 1489, 1420, 1364, 1305, 1264, 1204, 1111, 1029, 973, 924, 
846, 813, 727 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.β7 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.6 
Hz, 2H), 3.80 (s, 3H), 3.67 – 3.57 (m, 2H), 2.53 – 2.42 (m, 2H), 1.50 (s, 9H). 13C NMR (75 
MHz, CDCl3) δ = 175.10, 174.1γ, 160.β6, 1γ1.β5, 1β8.15 (β C), 11γ.78 (β C), 57.β9, 55.γ0, 
42.87, 35.88, 29.00 (3 C). 
 
 
D  Experimental Part 2  Synthesis of N-acyloxyphthalimides 
 
130 
 
3-(N-tert-butyl-3-methoxybenzamido)propanoic acid (73b). 
 
Compound 73b was prepared from ester 72b (5.66 g, 18.41 mmol, 1 equiv.) and potassium 
hydroxide (1.21 g, 21.57 mmol, 1.1 equiv.) following general protocol C. After the 
acidification with concentrated HCl, a yellow oil was observed, which was extracted with 
DCM (2 x 30 ml). The organic phase was dried over MgSO4, filtered and concentrated. The 
residue was dried in vacuo to give 5.79 g (18.84 mmol, 96%), of the product as white solid. IR 
(neat): 3075, 2971, 2930, 2837, 2661, 2553, 2486, 1718, 1580, 1461, 1398, 1286, 1181, 1033, 
910, 872, 787, 746, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.γ0 – 7.23 (m, 1H), 6.93 – 
6.80 (m, 3H), 3.80 (s, 3H), 3.65 – 3.55 (m, 2H), 2.57 – 2.48 (m, 2H), 1.52 (s, 9H). 13C NMR 
(101 MHz, CDCl3) δ = 175.06, 17γ.γ8, 159.6γ, 140.γ0, 1β9.69, 118.ββ, 115.06, 111.49, 
57.40, 55.35, 42.46, 35.88, 28.97 (3 C). 
 
3-(N-tert-butyl-2-methoxybenzamido)propanoic acid (73c). 
 
Compound 73c was prepared from ester 72c (5.78 g, 18.80 mmol, 1 equiv.) and potassium 
hydroxide (1.12 g, 19.96 mmol, 1.1 equiv.) following general protocol C. After the 
acidification with concentrated HCl, a yellow oil was observed, which was extracted with 
DCM (2 x 30 ml). The organic phase was dried over MgSO4, filtered and concentrated. The 
residue was dried in vacuo to give 4.90 g (17.54 mmol, 93%) of the product as orange oil. IR 
(neat): 2971, 2840, 1722, 1595, 1491, 1461, 1435, 1401, 1286, 1245, 1185 1148, 1021, 
757 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.β8 (dt, J = 8.3, 2.2 Hz, 1H), 7.11 (dd, J = 7.4, 1.7 
Hz, 1H), 6.96 – 6.89 (m, 1H), 6.87 (d, J = 8.3 Hz, 1H), 3.80 (s, 3H), 3.49 (m, 2H), 2.48 (m, 
2H), 1.52 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 175.45, 170.7β, 154.69, 1β9.84, 1β8.60, 
126.95, 120.83, 111.18, 57.52, 55.60, 42.03, 35.75, 29.00 (3 C). 
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3-(N-tert-butyl-4-chlorobenzamido)propanoic acid (73d). 
 
Compound 73d was prepared from ester 72d (3.48 g, 11.16 mmol, 1 equiv.) and potassium 
hydroxide (898.0 mg, 16.01 mmol, 1.4 equiv.) following general protocol C. Yield: 2.89 g 
(10.18 mmol, 91%), white solid. IR (neat): 3310, 2971, 2926, 2550, 2654, 1718, 1633, 1588, 
1566, 1483, 1424, 1305, 1267, 1185, 1115, 1036, 1010, 924, 820, 760, 723 cm-1. 1H NMR 
(300 MHz, CDCl3) δ = 7.γ8 – 7.31 (m, 2H), 7.28 – 7.24 (m, 2H), 4.16 (s, 1H), 3.62 – 3.53 (m, 
2H), 2.54 – 2.44 (m, 2H), 1.51 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 175.44, 17β.78, 
137.26, 135.18, 128.83 (2 C), 127.71 (2 C), 57.60, 42.58, 35.75, 28.91 (3 C). 
 
3-(N-tert-butyl-3-chlorobenzamido)propanoic acid (73e). 
 
Compound 73e was prepared from ester 72e (3.30 g, 10.58 mmol, 1 equiv.) and potassium 
hydroxide (977.1 mg, 17.42 mmol, 1.5 equiv.) following general protocol C. Yield: 2.62 g 
(9.23 mmol, 87%), white solid. IR (neat): 3075, 2978, 2922, 2661, 2557, 1715, 1592, 1483, 
1397, 1364, 1305, 1193, 1092, 1040, 917, 880, 794, 760, 708 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 7.γ6 – 7.27 (m, 3H), 7.19 (dt, J = 7.2, 1.5 Hz, 1H), 3.68 – 3.50 (m, 2H), 2.59 – 
2.38 (m, 2H), 1.52 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 175.59, 17β.09, 140.49, 1γ4.5γ, 
129.99, 129.35, 126.36, 124.26, 57.66, 42.53, 35.77, 28.87 (3 C). 
 
3-(4-bromo-N-tert-butylbenzamido)propanoic acid (73f). 
 
Compound 73f was prepared from ester 72f (1.92 g, 5.39 mmol, 1 equiv.) and potassium 
hydroxide (367.35 mg, 6.55 mmol, 1.1 equiv.) following general protocol C. Yield: 1.36 g 
(4.14 mmol, 77%), white solid. IR (neat): 2974, 2922, 2855, 2658, 2490, 1677, 1633, 1588, 
1484, 1379, 1320, 1290, 1192, 1010, 924, 835, 801, 757, 682 cm-1. 1H NMR (300 MHz, 
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CDCl3) δ = 7.54 – 7.46 (m, 2H), 7.24 – 7.16 (m, 2H), 3.58 (dd, J = 8.7, 6.7 Hz, 2H), 2.49 (dd, 
J = 8.7, 6.8 Hz, 2H), 1.51 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 175.β1, 17β.7β, 1γ7.80, 
131.77 (2 C), 127.92 (2 C), 123.39, 57.59, 42.54, 35.74, 28.93 (3 C). 
 
3-(N-tert-butyl-4-methylbenzamido)propanoic acid (73g). 
 
Compound 73g was prepared from ethyl ester 72g (3.41 g, 11.70 mmol, 1 equiv.) and 
potassium hydroxide (745.2 mg, 13.28 mmol, 1.1 equiv.) following general protocol C. 
Yield: 2.96 g (11.24 mmol, 96%), white solid. IR (neat):  2967, 2915, 1722, 1595, 1487, 
1394, 1361, 1305, 1275, 1223, 1189, 1040, 951, 828, 764, 697 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 8.β0 (s, 1H), 7.β0 (d, J = 8.2 Hz, 2H), 7.14 (d, J = 8.3 Hz, 2H), 3.64 – 3.56 (m, 
2H), 2.48 (dd, J = 8.8, 6.8 Hz, 2H), 2.34 (s, 3H), 1.51 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 
= 174.89, 174.17, 139.16, 136.10, 129.13 (2 C), 126.17 (2 C), 57.33, 42.64, 35.82, 29.00 (3 
C), 21.35.  
 
3-(N-tert-butylbenzamido)propanoic acid (73h). 
 
Compound 73h was prepared from ester 72h (4.09 g, 14.75 mmol, 1 equiv.) and potassium 
hydroxide (1.42 g, 25.31 mmol, 1.5 equiv.) following general protocol C. Yield: 3.31 g 
(13.28 mmol, 90%), white solid. IR (neat): 2967, 2822, 2661, 2564, 1715, 1592, 1577, 1446, 
1424, 1401, 1364, 1305, 1204, 1189, 1111, 1073, 1040, 943, 876, 824, 794, 731, 705, 667 cm-
1
. 
1H NMR (400 MHz, CDCl3) δ = 9.94 (s, 1H), 7.γ8 – 7.32 (m, 3H), 7.32 – 7.27 (m, 2H), 
3.62 – 3.53 (m, 2H), 2.48 (dd, J = 8.9, 6.7 Hz, 2H), 1.52 (s, 9H). 13C NMR (101 MHz, CDCl3) 
δ = 175.6γ, 17γ.9γ, 1γ8.91, 1β9.15 (β C), 1β8.54 (β C), 1β6.07, 57.47, 4β.6γ, γ5.99, β8.98 
(3 C). 
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3-(N-tert-butyl-3-chloro-4-methoxybenzamido)propanoic acid (73i). 
 
Compound 73i was prepared from ester 72i (3.11 g, 9.10 mmol, 1 equiv.) and potassium 
hydroxide (784.8 mg, 13.99 mmol, 1.5 equiv.) following general protocol C. Yield: 2.44 g 
(7.77 mmol, 85%), white solid. IR (neat): 2967, 2933, 2680, 2572, 1722, 1584, 1476, 1416, 
1368, 1320, 1267, 1185, 1062, 1025, 954, 883, 813, 768, 693 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.γ7 (d, J = 2.1 Hz, 1H), 7.26 – 7.21 (m, 1H), 6.90 (d, J = 8.5 Hz, 1H), 3.91 (s, 
3H), 3.69 – 3.59 (m, 2H), 2.57 – 2.47 (m, 2H), 1.51 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 
175.73, 172.45, 155.73, 132.00, 128.68, 126.40, 122.46, 111.75, 57.47, 56.23, 42.80, 35.84, 
28.93 (3 C). 
 
3-(N-tert-butyl-2,6-dimethoxybenzamido)propanoic acid (73j). 
 
Compound 73j was prepared from ester 72j (4.11 g, 12.18 mmol, 1 equiv.) and potassium 
hydroxide (1.15 g, 20.50 mmol, 1.5 equiv.) following general protocol C. Yield: 2.35 g 
(7.60 mmol, 62%), white solid. IR (neat): 2974, 2937, 2840, 1722, 1648, 1592, 1476, 1435, 
1420, 1365, 1290, 1252, 1185, 1111, 1025, 913, 877, 805, 746 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 7.19 (t, J = 8.4 Hz, 1H), 6.50 (d, J = 8.4 Hz, 2H), 3.77 (s, 6H), 3.48 – 3.40 (m, 
2H), 2.53 – 2.41 (m, 2H), 1.54 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 175.76, 168.07, 
155.97 (2 C), 129.75, 117.46, 104.10 (2 C), 57.51, 55.84 (2 C), 42.01, 35.47, 28.97 (3 C). 
 
3-(N-tert-butyl-4-methoxybenzamido)-2-methylpropanoic acid (73k). 
 
Compound 73k was prepared from ester 72k (2.42 g, 7.53 mmol, 1 equiv.) and potassium 
hydroxide (656.0 mg, 11.69 mmol, 1.5 equiv.) following general protocol C. Yield: 2.02 g 
(6.89 mmol, 91%), white solid. IR (neat): 2974, 2937, 2840, 1733, 1685, 1588, 1517, 1457, 
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1420, 1364, 1305, 1257, 1200, 1137, 1029, 921, 839, 771 cm-1. 1H NMR (400 MHz, CDCl3) δ 
= 7.34 – 7.28 (m, 2H), 6.84 (d, J = 8.8 Hz, 2H), 3.85 – 3.78 (m, 1H), 3.81 (s, 3H), 3.54 (dd, J 
= 15.1, 8.0 Hz, 1H), 2.77 (dd, J = 14.4, 7.0 Hz, 1H), 1.53 (s, 9H), 1.00 (d, J = 7.0 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ = 179.γγ, 174.41, 160.51, 1γ1.βγ, 1β9.46 (2 C), 113.62 (2 C), 
57.08, 55.30, 50.48, 40.76, 29.08 (3 C), 14.24. 
 
3-(N-tert-butylisonicotinamido)propanoic acid (73l). 
 
Compound 73l was prepared from ester 72l (1.36 g, 4.89 mmol, 1 equiv.) and potassium 
hydroxide (309.4 mg, 5.52 mmol, 1.1 equiv.) following general protocol C. Yield: 240.05 mg 
(0.961 mmol, 20%), ochre solid. 1H NMR (400 MHz, CDCl3) δ = 8.59 (d, J = 5.3 Hz, 1H), 
7.32 (d, J = 6.0 Hz, 1H), 3.57 – 3.47 (m, 1H), 2.55 – 2.46 (m, 1H), 1.56 (s, 4H). 13C NMR 
(101 MHz, CDCl3) δ = 17β.76, 169.98, 148.γ6 (β C), 148.β4, 1β1.06 (β C), 57.90, 4β.55, 
36.40, 28.66 (3 C).  
 
3-(N-tert-butyl-3,4-dimethoxybenzamido)propanoic acid (73m). 
 
Compound 73m was prepared from ester 72m (5.79 g, 17.16 mmol, 1 equiv.) and potassium 
hydroxide (1.21 g, 21.57 mmol, 1.1 equiv.) following general protocol C. Yield: 4.59 g 
(14.84 mmol, 86%), white solid. IR (neat): 3086, 2967, 25575, 1714, 1677, 1569, 1521, 1469, 
1424, 1398, 1305, 1264, 1230, 1178, 1148m, 1118, 1025, 902, 820, 760 cm-1. 1H NMR (300 
MHz, CDCl3) δ = 6.9β – 6.84 (m, 2H), 6.81 (d, J = 8.7 Hz, 1H), 3.87 (d, J = 2.0 Hz, 6H), 3.64 
(dd, J = 8.8, 6.7 Hz, 2H), 2.53 (dd, J = 8.7, 6.8 Hz, 2H), 1.51 (s, 9H). 13C NMR (75 MHz, 
CDCl3) δ = 175.88, 17γ.89, 149.8β, 148.9β, 1γ1.4β, 119.11, 110.54, 109.94, 57.γ5, 55.95, 
55.91, 42.80, 36.06, 28.96 (3 C). 
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3-(N-tert-butyl-3,4,5-trimethoxybenzamido)propanoic acid (73n). 
 
Compound 73n was prepared from ester 72n (2.21 g, 6.02 mmol, 1 equiv.) and potassium 
hydroxide (398.1 mg, 7.10 mmol, 1.2 equiv.) following general protocol C. Yield: 1.89 mg 
(5.13 mmol, 85%), white solid. IR (neat): 3399, 2971, 2840, 1715, 1629, 1580, 1547, 1502, 
1454, 1416, 1334, 1271, 1193, 1122, 1059, 1025, 917, 857, 760, 723, 667 cm-1. 1H NMR (400 
MHz, CDCl3) δ = 6.5γ (s, γH), γ.85 (s, 8H), γ.84 (s, 4H), γ.68 – 3.57 (m, 3H), 2.62 – 2.51 (m, 
3H), 1.53 (s, 14H). ). 13C NMR (101 MHz, CDCl3) δ = 175.β9, 17γ.γ6, 15γ.γβ (β C), 1γ8.61, 
134.56, 103.38 (2 C), 60.90, 57.44, 56.22 (2 C), 42.74, 36.35, 28.90 (3 C). 
 
3-(4-Methoxybenzamido)propanoic acid (73o). 
 
ȕ-Alanine (1.33 g, 14,93 mmol, 1 equiv.) and sodium hydroxide (1.12 g, 28 mmol, 2 equiv.) 
were dissolved in H2O (10 ml) and cooled to 0 °C. A solution of 4-methoxybenzoyl chloride 
(3.00 g, 17.59 mmol, 1.2 equiv.) in THF (20 ml) was added slowly and stirred for 20 h. The 
THF was removed under reduced pressure and the precipitated solid was filtered of. Yield: 
2.19 g (9.81 mmol, 67%) white solid. 1H NMR (300 MHz, CDCl3) δ = 7.57 – 7.47 (m, 2H), 
6.65 (m, 2H), 3.59 (s, 3H), 3.40 (q, J = 6.3 Hz, 2H), 2.36 (t, J = 6.4 Hz, 2H). 
Analytical data match to the reported data.135 
 
3-(4-Methoxy-N-methylbenzamido)propanoic acid (73p). 
 
Compound 73p was prepared from ester 72o (5.50 g, 20.73 mmol, 1 equiv.) and potassium 
hydroxide (1.81 g, 32.26 mmol, 1.5 equiv.) following general protocol C. Yield: 4.32 g 
(18.23 mmol, 88%), white solid. IR (neat): 2937, 2840, 1722, 1595, 1517, 1487, 1439, 1402, 
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1301, 1249, 1174, 1077, 1025, 951, 902, 839, 764, 719 cm-1. 1H NMR (300 MHz, CDCl3) δ = 
9.26 (s, 1H), 7.36 (d, J = 8.5 Hz, 2H), 6.92 – 6.85 (m, 2H), 3.81 (s, 3H), 3.74 (s, 2H), 3.03 (s, 
3H), 2.68 (s, 2H). 13C NMR (75 MHz, CDCl3) δ = 17β.β6, 160.8γ, 1γβ.γ0, 1β9.07 (β C), 
127.60, 113.70 (2 C), 58.36, 55.35, 53.49, 18.20.  
 
2-(N-tert-Butyl-4-methoxybenzamido)acetic acid (73q). 
 
Compound 73q was prepared from ester 72p (5.02 g, 17.11 mmol, 1 equiv.) and potassium 
hydroxide (1.12 g, 19.96 mmol, 1.1 equiv.) following general protocol C. Yield: 3.63 g 
(13.69 mmol, 80%), white solid. IR (neat): 2967, 2933, 2844, 2717, 2658, 2579, 2509, 1730, 
1644, 1588, 1513, 1480, 1431, 1390, 1305, 1252, 1193, 1025, 977, 842, 772, 712 cm-1. 1H 
NMR (300 MHz, CDCl3) δ = 7.40 – 7.37 (m, 2H), 6.88 – 6.81 (m, 2H), 3.79 (s, 3H), 3.78 (s, 
2H), 1.50 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 17γ.61, 168.4γ, 160.89, 1β8.17 (β C), 
114.19 (2 C), 58.28, 55.39, 47.84, 28.05 (3 C). 
 
4-(N-tert-butylbenzamido)butanoic acid (73r). 
 
Compound 73r was prepared from ester 72q (3.72 g, 12.77 mmol, 1 equiv.) and potassium 
hydroxide (799.1 mg, 14.24 mmol, 1.1 equiv.) following general protocol C. After 
acidification a white oil obtained, which was extracted by EtOAc. The organic layer was dried 
over MgSO4, filtered and concentrated. The residue was dried in vacuo to give 2.33 g 
(8.85 mmol, 69%), of the product as white solid. IR (neat): 3064, 2937, 2646, 2568, 1703, 
1573, 1491, 1413, 1364, 1323, 1293, 1241, 1185, 1118, 1025, 887, 850, 790, 746, 701 cm-1. 
1H NMR (300 MHz, CDCl3) δ = 10.78 (s, 1H), 7.γ7 – 7.28 (m, 5H), 3.39 – 3.23 (m, 2H), 2.03 
(t, J = 7.2 Hz, 2H), 1.77 (dt, J = 10.0, 7.3 Hz, 2H), 1.54 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 
= 177.84, 173.76, 139.08, 130.13 (2 C), 128.46 (2 C), 126.03, 57.31, 46.75, 31.08, 28.91 
(3 C), 26.74. 
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4-(N-tert-butylisonicotinamido)butanoic acid (73s). 
 
Compound 73s was prepared from ester 72r (1.79 g, 6.12 mmol, 1 equiv.) and potassium 
hydroxide (382.5 mg, 6.82 mmol, 1.1 equiv.) following general protocol C. After 
acidification a white oil obtained, which was extracted by dichloromethane (2 x 30 ml). The 
organic layer was dried over MgSO4, filtered and concentrated. The residue was dried in 
vacuo to give 937 mg (3.54 mmol, 58%), of the product as white solid. IR (neat): 2930, 2445, 
1890, 1700, 1610, 1554, 1491, 1409, 1349, 1293, 1249, 1215, 1159, 1118, 1066, 973, 842, 
801, 764 cm-1. 1H NMR (400 MHz, CDCl3) δ = 8.51 (d, J = 6.1 Hz, 2H), 7.36 (dd, J = 4.7, 1.4 
Hz, 2H), 3.43 – 3.33 (m, 2H), 2.22 – 2.14 (m, 2H), 1.83 (m, 2H), 1.57 (s, 9H). 13C NMR (101 
MHz, CDCl3) δ = 174.60, 169.85, 148.41 (β C), 147.70, 1β1.61 (β C), 57.6β, 46.γγ, γ0.91, 
28.73 (3 C), 27.21. 
 
4-(N-tert-butyl-4-methoxybenzamido)butanoic acid (73t). 
 
Compound 73t was prepared from ester 72s (4.98 g, 15.49 mmol, 1 equiv.) and potassium 
hydroxide (921.78 mg, 16.43 mmol, 1.05 equiv.) following general protocol C. Yield: 4.46 g 
(15.20 mmol, 98%), white solid. IR (neat): 2933, 2710, 2568, 1722, 1610, 1566, 1416, 1368, 
1301, 1256, 1174, 1025, 936, 835, 768, 727 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.γβ – 7.22 
(m, 2H), 6.89 – 6.80 (m, 2H), 3.79 (s, 3H), 3.42 – 3.27 (m, 2H), 2.05 (t, J = 7.2 Hz, 2H), 1.77 
(dd, J = 15.1, 7.4 Hz, 2H), 1.52 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 177.55, 17γ.79, 
160.03, 131.56, 128.14 (2 C), 113.66 (2 C), 57.08, 55.26, 46.88, 30.98, 28.97 (3 C), 26.73. 
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4-(N-tert-butyl-3-chloro-4-methoxybenzamido)butanoic acid (73u). 
 
Compound 73u was prepared from ethyl 4-(N-tert-butyl-3-chloro-4-methoxy-
benzamido)butanoate (72t, 3.03 g, 8.51 mmol, 1 equiv.) and potassium hydroxide (727.5 mg, 
12.97 mmol, 1.5 equiv.) following general protocol C. Yield: 2.43 g (7.41 mmol, 87%), white 
solid. IR (neat): 2982, 2956, 1730, 1629, 1580, 1505, 1454, 1368, 1297, 1174, 1062, 1021, 
924, 880, 846, 768, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.γ6 (d, J = 2.1 Hz, 1H), 7.24 
(dd, J = 8.4, 2.1 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H), 3.90 (s, 3H), 3.41 – 3.31 (m, 2H), 2.10 (t, J 
= 7.1 Hz, 2H), 1.83 – 1.73 (m, 2H), 1.52 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 177.78, 
172.13, 155.48, 132.30, 128.60, 126.37, 122.32, 111.69, 57.29, 56.17, 46.85, 30.87, 28.90 (3 
C), 26.66. 
 
4-(N-tert-butyl-3,4-dimethoxybenzamido)butanoic acid (73v). 
 
Compound 73v was prepared from ester 72u (6.15 g, 17.5 mmol, 1 equiv.) and potassium 
hydroxide (1.12 g, 19.96 mmol, 1.1 equiv.) following general protocol C. After the 
acidification with concentrated HCl, a yellow oil was observed, which was extracted with 
EtOAc (2 x 40 ml). The organic phase was dried over MgSO4, filtered and concentrated. The 
residue was dried in vacuo to give 5.32 g (16.45 mmol, 94%) of the product as orange oil. IR 
(neat): 3317, 2937, 2840, 1707, 1580, 1513, 1461, 1416, 1301, 1264, 1230, 1182, 1021, 924, 
869, 820, 757 cm-1. 1H NMR (300 MHz, CDCl3) δ = 6.90 – 6.84 (m, 2H), 6.79 (d, J = 8.7 Hz, 
1H), 3.86 (s, 6H), 3.44 – 3.31 (m, 2H), 2.07 (t, J = 7.2 Hz, 2H), 1.86 – 1.70 (m, 2H), 1.52 (s, 
9H). 13C NMR (75 MHz, CDCl3) δ = 177.71, 17γ.64, 149.56, 148.80, 1γ1.65, 119.11, 110.51, 
109.97, 57.16, 55.94, 55.85, 46.93, 31.00, 28.92 (3 C), 26.84. 
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4-(N-tert-Butyl-2,4,6-trimethylbenzamido)butanoic acid (73w). 
 
Compound 73w was prepared from ester 72v (1.24g, 3.72 mmol, 1 equiv.) and potassium 
hydroxide (0.211 g, 3.77 mmol, 1 equiv.) following general protocol C. Yield: 1.06 g 
(3.46 mmol, 93%), pale yellow solid. IR (neat): 2978, 2922, 2866, 1722, 1610, 1435, 1379, 
1264, 1170, 1081, 1036, 936, 850, 779, 717 cm-1. 1H NMR (300 MHz, CDCl3) δ = 6.79 (s, 
2H), 3.15 – 3.03 (m, 2H), 2.24 (s, 3H), 2.21 (s, 6H), 1.97 (t, J = 7.2 Hz, 2H), 1.69 (dt, J = 
15.2, 7.3 Hz, 2H), 1.58 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 177.1β, 17β.β0, 1γ7.γβ, 
135.63, 132.88 (2 C), 128.36 (2 C), 57.48, 46.09, 31.23, 28.91 (3 C), 26.25, 21.09, 19.11 
(2 C). 
 
4-(N-tert-butyl-2,6-dimethoxybenzamido)butanoic acid (73x). 
 
Compound 73x was prepared from ester 72w (3.04 g, 8.65 mmol, 1 equiv.) and potassium 
hydroxide (728.0 mg, 12.98 mmol, 1.5 equiv.) following general protocol C. Yield: 2.53 g 
(7.82 mmol, 90%), white solid. IR (neat): 2967, 2840, 2535, 1726, 1636, 1580, 1472, 1416, 
1290, 1249, 1200, 1174, 1107, 1033, 947, 854, 790, 738 cm-1. 1H NMR (300 MHz, CDCl3) δ 
= 7.17 (t, J = 8.4 Hz, 1H), 6.49 (d, J = 8.4 Hz, 2H), 3.75 (s, 6H), 3.12 (dd, J = 11.6, 4.4 Hz, 
2H), 1.94 (t, J = 7.3 Hz, 2H), 1.73 (dq, J = 15.4, 7.5 Hz, 2H), 1.53 (s, 9H). 13C NMR (75 
MHz, CDCl3) δ = 177.58, 168.00, 156.01 (β C), 1β9.57, 117.60, 10γ.95 (2 C), 57.38, 55.79 (2 
C), 46.35, 31.49, 28.96 (3 C), 26.41. 
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4-(N-tert-butyl-3,4,5-trimethoxybenzamido)butanoic acid (73y). 
 
Compound 73y was prepared from ester 72x (5.79 g, 15.18 mmol, 1 equiv.) and potassium 
hydroxide (1.1 g, 19.61 mmol, 1.1 equiv.) following general protocol C. After acidification 
an orange oil obtained, which was extracted by EtOAc. The organic layer was dried over 
MgSO4, filtered and concentrated. The residue was dried in vacuo to give 4.84 g (13.70 
mmol, 90%) of the product as orange oil. IR (neat): 2964, 2840, 2632, 1715, 1580, 1506, 
1461, 1416, 1326, 1237, 1174, 1022, 999, 939 857, 708 cm-1. 1H NMR (300 MHz, CDCl3) δ = 
6.52 (s, 2H), 3.83 (s, 6H), 3.81 (s, 3H), 3.39 – 3.27 (m, 2H), 2.10 (t, J = 7.2 Hz, 2H), 1.83 (dd, 
J = 15.2, 7.4 Hz, 2H), 1.53 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 177.8γ, 17γ.β7, 15γ.β4 (β 
C), 138.39, 134.65, 103.38 (2 C), 60.87, 57.30, 56.19 (2 C), 46.88, 31.08, 28.85 (3 C), 27.02. 
 
3-(tert-Butoxycarbonyl(4-methoxybenzyl)amino)propanoic acid (73z). 
 
Compound 73z was prepared from ester 72z (3.52 g, 10.43 mmol, 1 equiv.) and potassium 
hydroxide (1.11 g, 19.82 mmol, 1.9 equiv.) following general protocol C. Yield: 3.15 g 
(10.18 mmol, 98%), clear solid. 1H NMR (300 MHz, CDCl3) δ = 7.16 (d, J = 6.9 Hz, 2H), 
6.89 – 6.80 (m, 2H), 4.39 (s, 2H), 3.79 (s, 3H), 3.43 (s, 2H), 2.53 (s, 2H), 1.47 (s, 9H). 13C 
NMR (101 MHz, CDCl3) δ = 177.44, 158.95, 155.68, 1γ0.19, 1β8.9 (d, β C), 114.00 (β C), 
80.33, 55.27, 50.41 (d), 42.46, 33.30, 28.43 (3 C). 
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(S)-3-(tert-Butoxycarbonyl(4-methoxybenzyl)amino)-4-methoxy-4-oxobutanoic acid 
(73aa). 
 
Ester 72aa (3.91 g, 10.25 mmol, 1 equiv.) was dissolved in 90 ml methanol and a 1 M KOH 
solution (110.0 ml, 11.0 mmol, 1 equiv.) was added slowly. The reaction mixture was stirred 
at room temperature for overnight and methanol was evaporated. The aqueous solution was 
acidified with 1 M HCl and extracted with ethyl acetate (2 x 100 ml). The combined organic 
layers were dried over Na2SO4, filtered and evaporated to give 2.94 g (8.01 mmol, 78%) of 
the product as yellow oil. 1H NMR (300 MHz, CDCl3) δ = 7.β4 (dd, J = 6.6, 4.1 Hz, 2H), 6.84 
(dd, J = 8.8, 2.3 Hz, 2H), 4.64 – 4.20 (m, 3H), 3.78 (d, J = 1.9 Hz, 3H), 3.67 – 3.55 (m, 3H), 
3.14 (td, J = 16.6, 7.7 Hz, 1H), 2.67 – 2.38 (m, 1H), 1.44 (s, 9H). 13C NMR (101 MHz, 
CDCl3) δ = 176.96, 171.γγ, 159.10, 154.75, 1γβ.08, 1β9.98 (β C), 11γ.91 (β C), 81.γ6, 60.47, 
55.24, 52.33, 51.75 (d), 35.99, 28.30 (3 C). 
 
3-(N-tert-Butylthiophene-2-carboxamido)propanoic acid (73ab). 
 
Compound 73ab was prepared from ester 72ab (2.57 g, 9.07 mmol, 1 equiv.) and potassium 
hydroxide (1.154 g, 20.57 mmol, 1.1 equiv.) following general protocol C. Yield: 0.845 g 
(3.31 mmol, 36%), white solid. 1H NMR (300 MHz, CDCl3) δ = 7.γ8 (dd, J = 5.0, 0.9 Hz, 
1H), 7.24 (dd, J = 3.6, 1.0 Hz, 1H), 7.00 (dd, J = 5.0, 3.7 Hz, 1H), 3.92 – 3.77 (m, 2H), 2.67 
(dd, J = 8.9, 6.7 Hz, 2H), 1.52 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 175.46, 166.77, 
140.20, 127.85, 127.60, 126.66, 58.07, 42.74, 36.25, 28.85 (3 C). 
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Synthesis of compounds 77 
1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-4-methoxybenzamido)propanoate (74/77a). 
 
General protocol D 
A solution of DCC (1.65 g, 8.00 mmol, 1 equiv.) in 30 ml anhydrous THF was added to a 
solution of acid 73a (2.20 g, 7.88 mmol, 1 equiv.) and N-hydroxyphthalimide (1.29 g, 
7.91 mmol, 1 equiv.) in 40 ml of anhydrous THF. The reaction mixture was stirred at room 
temperature for 15 h, filtered and evaporated. Purification by column chromatography on 
flash silica gel (hexanes/EtOAc = 1/1, Rf = 0.31) gave 1.45 g (3.42 mmol, 43%) of white 
solid, m.p. = 135-139 °C. IR (neat): 3127, 2930, 2851, 1789, 1711, 1603, 1577, 1461, 1297, 
1245, 1178, 1137, 1081, 1014, 977, 842, 768, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.88 
– 7.82 (m, 2H), 7.78 (m, 2H), 7.37 – 7.30 (m, 2H), 6.94 – 6.87 (m, 2H), 3.82 (s, 3H), 3.81 – 
3.74 (m, 2H), 2.86 (dd, J = 8.6, 6.6 Hz, 2H), 1.54 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 
173.89, 167.10, 161.66, 160.50 (2 C), 134.85 (2 C), 131.31, 128.83 (2 C), 128.14 (2 C), 
124.02 (2 C), 114.00 (2 C), 57.35, 55.32, 42.46, 33.22, 29.07 (3 C). HRMS: (ES-MS) m/z 
calculated for C23H25N2O6 [M+H]: 425.1707, found 425.1719. The redox potential of 1a was 
determined as -1.32 V (vs. SCE, irreversible peak) by cyclic voltametry. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3-methoxybenzamido)propanoate (77b). 
 
Compound 77b was prepared from acid 73b (1.09 g, 3.90 mmol, 1 equiv.), N-
hydroxyphthalimide (639.9 mg, 3.92 mmol, 1 equiv.) and DCC (807.8 mg, 3.92 mmol, 
1 equiv.) following general protocol D. The precipitated DCC urea was removed by filtration 
and the solvent was evaporated. Rf (hexanes/EtOAc = 1/1) = 0.55. Yield: 1.15 g (2.71 mmol, 
69%) pale yellow solid, m.p. = 132-136 °C. IR (neat): 2967, 2840, 1815, 1789, 1741, 1640, 
1580, 1465, 1428, 1364, 1290, 1219, 1185, 1133, 1077, 1029, 965, 876, 839, 787, 753, 
697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.90 – 7.82 (m, 2H), 7.79 (m, 2H), 7.36 – 7.27 (m, 
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1H), 6.91 (dtd, J = 9.3, 3.6, 1.4 Hz, 3H), 3.82 (s, 3H), 3.79 – 3.70 (m, 2H), 2.94 – 2.82 (m, 
2H), 1.57 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 17γ.γ8, 166.98, 161.64 (β C), 159.79, 
140.16, 134.86, 129.90 (2 C), 128.80 (2 C), 124.02 (2 C), 118.10, 115.26, 111.47, 57.55, 
55.37, 42.27, 33.31, 28.99 (3 C). HRMS: (ES-MS) m/z calculated for C23H25N2O6 [M+H]: 
425.1707, found 425.1719. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-2-methoxybenzamido)propanoate (77c). 
 
Compound 77c was prepared from acid 73c (3.90 g, 13.96 mmol, 1 equiv.), N-
hydroxyphthalimide (2.31 g, 14.16 mmol, 1 equiv.) and DCC (2.90 g, 14.06 mmol, 1 equiv.) 
following general protocol D. Purification by column chromatography on flash silica gel 
(hexanes/EtOAc = 1/1, Rf = 0.6) gave 4.49 g (10.58 mmol, 76%) pale yellow solid, 
m.p. = 129-134 °C. IR (neat): 2967, 2840, 2482, 1815, 1789, 1741, 1640, 1599, 1491, 1465, 
1439, 1394, 1364, 1290, 1245, 1185, 1133, 1077, 1021, 962, 876, 753, 697 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 7.87 – 7.82 (m, 2H), 7.80 – 7.76 (m, 2H), 7.30 (ddd, J = 8.3, 7.5, 1.7 
Hz, 1H), 7.15 (dd, J = 7.4, 1.7 Hz, 1H), 6.97 (td, J = 7.4, 0.8 Hz, 1H), 6.92 (d, J = 8.3 Hz, 
1H), 3.87 (s, 3H), 3.76 – 3.68 (m, 1H), 3.64 – 3.56 (m, 1H), 2.97 – 2.89 (m, 1H), 2.86 – 2.78 
(m, 1H), 1.58 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 175.45, 170.7β, 154.69 (β C), 1γγ.81, 
129.84 (2 C), 128.60 (2 C), 126.95 (2 C), 122.14, 120.83, 111.68, 111.18, 57.52, 55.60, 42.03, 
35.75, 29.00 (3 C). HRMS: (ES-MS) m/z calculated for C23H25N2O6 [M+H]: 425.1707, found 
425.1719. 
 
1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-4-chlorobenzamido)propanoate (77d). 
 
Compound 77d was prepared from acid 73d (1.73 g, 6.10 mmol, 1 equiv.), N-
hydroxyphthalimide (1.01 g, 6.19 mmol, 1 equiv.) and DCC (1.30 g, 6.30 mmol, 1 equiv.) 
following general protocol D. Purification by column chromatography on flash silica gel 
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(hexanes/EtOAc = 2/1, Rf = 0.25) gave 1.92 g (4.48 mmol, 73%) white solid, m.p. = 119-
121 °C. IR (neat): 3355, 3142, 2933, 1789, 1733, 1640, 1592, 1528, 1465, 1357, 1305, 1252, 
1185, 1033, 1137, 1077, 1033, 917, 876, 839, 787, 757, 693 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.90 – 7.83 (m, 2H), 7.80 (dt, J = 5.2, 3.6 Hz, 2H), 7.40 – 7.34 (m, 2H), 7.34 – 
7.28 (m, 2H), 3.74 (dd, J = 8.5, 6.6 Hz, 2H), 2.86 (dd, J = 8.6, 6.6 Hz, 2H), 1.55 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ = 17β.6β, 166.91, 161.64 (β C), 1γ7.β8, 1γ4.9β (β C), 1β9.0β (β C), 
128.75 (2 C), 127.71 (2 C), 124.09 (2 C), 57.65, 42.34, 33.10, 29.01 (3 C). HRMS: (ES-MS) 
m/z calculated for C22H22ClN2O5 [M+H]: 429.1212, found 429.1217. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3-chlorobenzamido)propanoate (77e). 
 
Compound 77e was prepared from acid 73e (2.61 g, 9.21 mmol, 1 equiv.), N-
hydroxyphthalimide (1.52 g, 9.32 mmol, 1 equiv.) and DCC (1.92 g, 9.31 mmol, 1 equiv.) 
following general protocol D. For Purification the residue was dissolved in dichloromethane 
(20 ml) and cooled to 0 °C. The precipitated DCC urea was removed by filtration and the 
solvent was evaporated. Recrystallization from EtOH gave 3.13 g (7.30 mmol, 79%) as a 
white solid, m.p. = 114-117 °C. IR (neat): 2971, 2930, 1815, 1789, 1733, 1636, 1566, 1469, 
1394, 1372, 1293, 1256, 1185, 1161, 1090, 1025, 965, 783, 780, 693 cm-1. 1H NMR (400 
MHz, CDCl3) δ = 7.87 - 7.84 (m, 2H), 7.81 – 7.75 (m, 2H), 7.39 – 7.31 (m, 3H), 7.26 – 7.21 
(m, 1H), 3.78 – 3.70 (m, 2H), 2.89 – 2.82 (m, 2H), 1.55 (s, 9H). 13C NMR (101 MHz, CDCl3) 
δ = 171.98, 166.87, 161.61 (β C), 140.51, 1γ4.91 (β C), 1γ4.76, 130.16, 129.55, 128.77 (2 C), 
126.40, 124.18, 124.07 (2 C), 57.76, 42.31, 33.13, 28.97 (3 C). HRMS: (ES-MS) m/z 
calculated for C22H22ClN2O5 [M+H]: 429.1212, found 429.1218. 
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1,3-dioxoisoindolin-2-yl 3-(4-bromo-N-tert-butylbenzamido)propanoate (77f). 
 
Compound 77f was prepared from acid 73f (1.35 g, 4.11 mmol, 1 equiv.), N-
hydroxyphthalimide (679.9 mg, 4.17 mmol, 1 equiv.) and DCC (856.0 mg, 4.15 mmol, 
1 equiv.) following general protocol D. Purification by column chromatography on flash 
silica gel (hexanes/EtOAc = 1/1, Rf = 0.75) gave 1.23 g (2.60 mmol, 63%) white solid, 
m.p. = 111-114 °C. IR (neat): 2967, 2933, 1823, 1789, 1744, 1710, 1640, 1603, 1461, 1364, 
1264, 1185, 1137, 1073, 977, 880, 835, 805, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.90 – 
7.83 (m, 2H), 7.83 – 7.75 (m, 2H), 7.56 – 7.50 (m, 2H), 7.27 – 7.21 (m, 2H), 3.81 – 3.65 (m, 
2H), 2.91 – 2.77 (m, 2H), 1.55 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 17β.67, 166.90, 
161.63 (2 C), 137.70, 134.92 (2 C), 131.96 (2 C), 128.74 (2 C), 127.90 (2 C), 124.09 (2 C), 
123.64, 57.70, 42.33, 33.07, 29.00 (3 C). HRMS: (ES-MS) m/z calculated for C22H22BrN2O5 
[M+H]: 473.0707, found 473.0707. 
 
1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-4-methylbenzamido)propanoate (77g). 
 
Compound 77g was prepared from acid 73g (1.55 g, 5.89 mmol, 1 equiv.), N-
hydroxyphthalimide (966.2 mg, 5.92 mmol, 1 equiv.) and DCC (1.27 g, 6.16 mmol, 1 equiv.) 
following general protocol D. Purification by column chromatography on flash silica gel 
(hexanes/EtOAc = 1/1, Rf = 0.77) gave 2.01 g (4.92 mmol, 84%) white solid, m.p. = 82-
89 °C. IR (neat): 3138, 3034, 2967, 2922, 2658, 1789, 1711, 1595, 1461, 1398, 1364, 1282, 
1185, 1137, 1081, 1040, 973, 828, 753, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.89 – 7.82 
(m, 2H), 7.82 – 7.74 (m, 2H), 7.25 (m, 2H), 7.19 (d, J = 7.9 Hz, 2H), 3.80 – 3.69 (m, 2H), 
2.89 – 2.79 (m, 2H), 2.35 (s, 3H), 1.56 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 174.00, 
167.06, 161.68 (2 C), 139.40, 136.05, 134.89 (2 C), 129.33 (2 C), 128.76 (2 C), 126.12 (2 C), 
124.04 (2 C), 57.42, 42.33, 33.15, 29.04 (3 C), 21.39. HRMS: (ES-MS) m/z calculated for 
C23H25N2O5 [M+H]: 409.1758, found 409.1761. 
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1,3-dioxoisoindolin-2-yl 3-(N-tert-butylbenzamido)propanoate (77h). 
 
Compound 77h was prepared from acid 73h (4.02 g, 16.12 mmol, 1 equiv.), N-
hydroxyphthalimide (2.91 mg, 17.84 mmol, 1.1 equiv.) and DCC (3.69 g, 17.88 mmol, 
1.1 equiv.) following general protocol D. Purification by recrystallization from ethanol. 
Yield: 3.56 g (9.03 mmol, 56%) white solid, m.p. = 86-88 °. IR (neat): 2974, 2930, 1812, 
1781, 1744, 1640, 1489, 1357, 1293, 1256, 1185, 1140, 1081, 1010, 980, 921, 876, 842, 799, 
753, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.85 (dt, J = 6.8, 3.6 Hz, 2H), 7.82 – 7.75 (m, 
2H), 7.43 – 7.32 (m, 5H), 3.80 – 3.69 (m, 2H), 2.93 – 2.80 (m, 2H), 1.57 (s, 9H). 13C NMR 
(101 MHz, CDCl3) δ = 17γ.69, 166.98, 161.64 (β C), 1γ8.97 (β C), 1γ4.88 (β C), 1γ0.67, 
129.34, 128.74 (2 C), 126.03 (2 C), 124.03 (2 C), 57.50, 42.30, 33.23, 29.04 (3 C). HRMS: 
(ES-MS) m/z calculated for C22H23N2O5 [M+H]: 395.1609, found 395.1601. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3-chloro-4-methoxybenzamido)propanoate (77i). 
 
Compound 77i was prepared from acid 73i (2.44 g, 7.77 mmol, 1 equiv.), N-
hydroxyphthalimide (1.28 g, 7.85 mmol, 1 equiv.) and DCC (1.60 g, 7.76 mmol, 1 equiv.) 
following general protocol D. For Purification the residue was dissolved in dichloromethane 
(20 ml) and cooled to 0 °C. The precipitated DCC urea was removed by filtration and the 
solvent was evaporated. Purification by column chromatography on flash silica gel 
(hexanes/EtOAc = 1/1, Rf = 0.23) gave 2.10 g (4.58 mmol, 59%) white solid, m.p. = 139-
142 °C. IR (neat): 2926, 2844, 1815, 1785, 1744, 1633, 1599, 1504, 1460, 1405, 1367, 1264, 
1186, 1081, 842, 760, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.91 – 7.83 (m, 2H), 7.79 
(dt, J = 5.2, 3.6 Hz, 2H), 7.41 (d, J = 2.1 Hz, 1H), 7.28 (dd, J = 8.2, 1.8 Hz, 1H), 6.93 (d, J = 
8.5 Hz, 1H), 3.91 (s, 3H), 3.77 (dd, J = 8.4, 6.7 Hz, 2H), 2.87 (dd, J = 8.4, 6.7 Hz, 2H), 1.54 
(s, 9H). 13C NMR (75 MHz, CDCl3) δ = 17β.46, 166.99, 161.65 (β C), 155.91, 1γ4.9β (β C), 
131.82, 128.75, 128.68 (2 C), 126.25, 124.07 (2 C), 122.72, 111.91, 57.66, 56.22, 42.50, 
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33.09, 28.98 (3 C). HRMS: (ES-MS) m/z calculated for C23H24ClN2O6 [M+H]: 459.1317, 
found 459.1319. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-2,6-dimethoxybenzamido)propanoate (77j). 
 
Compound 77j was prepared from acid 73j (2.28 g, 7.37 mmol, 1 equiv.), N-
hydroxyphthalimide (1.33 g, 8.15 mmol, 1.1 equiv.) and DCC (1.69 g, 8.19 mmol, 1.1 equiv.) 
following general protocol D. For Purification the residue was dissolved in diethylether 
(20 ml) and cooled to 0 °C. The precipitated DCC urea was removed by filtration and the 
solvent was evaporated. Column chromatography and recrystallization from EtOH gave 
2.12 g (4.66 mmol, 63%) as a white solid, m.p. = 131-133 °C. 
Rf (hexanes/EtOAc = 1/1) = 0.39. IR (neat): 2982, 2823, 2839, 1807, 1744, 1643, 1592, 1472, 
1440, 1383, 1300, 1249, 1189, 1166, 1111, 1081, 989, 924, 872, 794, 740, 701 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 7.85 – 7.82 (m, 2H), 7.79 – 7.74 (m, 2H), 7.20 (t, J = 8.4 Hz, 1H), 
6.55 (d, J = 8.4 Hz, 2H), 3.83 (s, 6H), 3.66 – 3.59 (m, 2H), 2.90 – 2.83 (m, 2H), 1.59 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ = 168.1γ, 167.45, 161.71 (β C), 155.88 (β C), 1γ4.85, 1β9.97 
(2 C), 128.81 (2 C), 123.98 (2 C), 117.25, 104.21 (2 C), 57.55, 55.87 (2 C), 41.90, 33.00, 
29.03 (3 C). HRMS: (ES-MS) m/z calculated for C24H27N2O7 [M+H]: 455.1813, found 
455.1821. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-4-methoxybenzamido)-2-methylpropanoate 
(77k). 
 
Compound 77k was prepared from acid 73k (2.42 g, 8.25 mmol, 1 equiv.), N-
hydroxyphthalimide (1.36 g, 8.34 mmol, 1 equiv.) and DCC (1.76 g, 8.53 mmol, 1 equiv.) 
following general protocol D. For Purification the residue was dissolved in dichloromethane 
(20 ml) and cooled to 0 °C. The precipitated DCC urea was removed by filtration and the 
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solvent was evaporated. Recrystallization from EtOH gave 2.38 g (5.43 mmol, 66%) as a 
white solid, m.p. = 134-139 °C. IR (neat):2982, 2112, 1804, 1778, 1741, 1633, 1599, 1513, 
1450, 1398, 1361, 1305, 1252, 1182, 1111, 1021, 1062, 962, 835, 872, 693 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 7.86 (td, J = 5.3, 2.0 Hz, 2H), 7.81 – 7.75 (m, 2H), 7.41 – 7.34 (m, 
2H), 6.90 – 6.84 (m, 2H), 3.96 (dd, J = 15.0, 5.1 Hz, 1H), 3.81 (s, 3H), 3.77 (dd, J = 15.0, 9.0 
Hz, 1H), 3.18 (ddd, J = 8.9, 7.0, 5.2 Hz, 1H), 1.57 (s, 9H), 1.21 (d, J = 7.0 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 174.40, 170.69, 161.77, 160.70 (β C), 1γ4.85 (β C), 1γ1.βγ, 1β9.54 (β 
C), 128.87 (2 C), 124.01 (2 C), 113.80 (2 C), 57.20, 55.33, 50.02, 38.77, 29.22 (3 C), 14.23. 
HRMS: (ES-MS) m/z calculated for C24H27N2O6 [M+H]: 439.1864, found 439.187. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butylisonicotinamido)propanoate (77l). 
 
Compound 77l was prepared from acid 73l (240 mg, 0.959 mmol, 1 equiv.), N-
hydroxyphthalimide (174 mg, 1.07 mmol, 1.1 equiv.) and DCC (219.6 mg, 1.06 mmol, 
1.1 equiv.) following general protocol D. Purification by recrystallization from toluene. 
Yield: 313 mg (0.791 mmol, 83%) pale yellow solid, m.p. = 121-126 °C. IR (neat):  3131, 
2930, 2851, 1789, 1710, 1633, 1461, 1413, 1327, 1290, 1185, 1137, 1066, 977, 880, 835, 
697 cm-1. 1H NMR (400 MHz, CDCl3) δ = 8.70 (d, J = 4.6 Hz, 2H), 7.89 – 7.83 (m, 2H), 7.83 
– 7.77 (m, 2H), 7.31 (d, J = 5.9 Hz, 2H), 3.71 (dd, J = 8.3, 6.6 Hz, 2H), 2.88 (dd, J = 8.3, 6.6 
Hz, 2H), 1.57 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 170.46, 166.69, 161.55 (2 C), 149.63, 
134.94 (2 C), 128.74 (2 C), 124.12 (2 C), 123.18 (2 C), 120.78 (2 C), 58.06, 42.09, 33.13, 
28.93 (3 C). LRMS: (ES-MS) m/z calculated for C21H22N3O5 [M+H]: 396.0317, found 
396.0608. 
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1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-3,4-dimethoxybenzamido)propanoate (77m). 
 
Compound 77m was prepared from acid 73m (4.48 g, 14.48 mmol, 1 equiv.), N-
hydroxyphthalimide (2.38 g, 14.59 mmol, 1 equiv.) and DCC (3.03 g, 14.69 mmol, 1 equiv.) 
following general protocol D using CHCl3 as solvent. For Purification the residue was 
dissolved in diethylether (20 ml) and cooled to 0 °C. The precipitated DCC urea was removed 
by filtration and the solvent was evaporated. Recrystallization from CHCl3 gave 4.56 g 
(10.03 mmol, 69%) as a white solid, m.p. = 118-120 °C. IR (neat): 2963, 2933, 2840, 1819, 
1789, 1744, 1629, 1603, 1513, 1465, 1413, 1264, 1230, 1182, 1137, 1074, 1021, 969, 880, 
782, 757, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.85 (m, J = 5.7, 3.0 Hz, 2H), 7.81 – 
7.74 (m, 2H), 6.96 – 6.84 (m, 3H), 3.89 (s, 6H), 3.83 – 3.72 (m, 2H), 2.95 – 2.79 (m, 2H), 
1.55 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 17γ.80, 167.10, 161.68 (β C), 150.0γ, 149.10, 
134.91, 131.36 (2 C), 128.73 (2 C), 124.03 (2 C), 119.08, 110.72, 109.89, 57.43, 55.99, 55.93, 
42.51, 33.36, 28.99 (3 C). HRMS: (ES-MS) m/z calculated for C24H27N2O7 [M+H]: 455.1813, 
found 455.1813. 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3,4,5-trimethoxybenzamido)propanoate (77n). 
 
Compound 77n was prepared from acid 73n (1.89 g, 5.57 mmol, 1 equiv.), N-
hydroxyphthalimide (989.6 mg, 6.07 mmol, 1 equiv.) and DCC (1.16 g, 5.62 mmol, 1 equiv.) 
following general protocol D using CHCl3 as solvent. For Purification the residue was 
dissolved in diethylether (20 ml) and cooled to 0 °C. The precipitated DCC urea was removed 
by filtration and the solvent was evaporated. Recrystallization from CHCl3 gave 4.56 g 
(10.03 mmol, 69%) of pale yellow solid, m.p. = 134-139 °C. IR (neat): 2952, 2840, 1815, 
1789, 1744, 1633, 1584, 1461, 1364, 1331, 1238, 1185, 1126, 1066, 995, 965, 876, 794, 
701 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.89 – 7.82 (m, 2H), 7.82 – 7.74 (m, 2H), 6.56 (s, 
2H), 3.88 (s, 6H), 3.84 (s, 3H), 3.83 – 3.75 (m, 2H), 2.94 – 2.85 (m, 2H), 1.56 (s, 9H). 13C 
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NMR (75 MHz, CDCl3) δ = 17γ.γ5, 166.96, 161.66 (β C), 15γ.48 (β C), 1γ8.9β, 1γ4.9β (β C), 
134.31, 128.73 (2 C), 124.06 (2 C), 103.42 (2 C), 60.92, 57.58, 56.28, 42.47, 33.47, 28.98 (3 
C). HRMS: (ES-MS) m/z calculated for C25H29N2O8 [M+H]: 485.1918, found 485.1920. 
 
1,3-Dioxoisoindolin-2-yl 3-(4-methoxybenzamido)propanoate (81). 
 
Compound 81 was prepared from acid 73o (1.98 g, 8.87 mmol, 1 equiv.), N-
hydroxyphthalimide (1.32 g, 8.09 mmol, 0.9 equiv.) and DCC (1.67 g, 8.09 mmol, 0.9 equiv.) 
following general protocol D. Recrystallization from MeOH gave 2.43 g (6.60 mmol, 74%) 
of white solid. IR (neat): 3370, 3317, 3086, 2922, 2840, 1812, 1785, 1707, 1629, 1543, 1502, 
1461, 1323, 1252, 1182, 1081, 1033, 965, 876, 764, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ 
= 7.95 – 7.87 (m, 2H), 7.85 – 7.78 (m, 4H), 6.95 – 6.91 (m, 2H), 3.96 – 3.86 (m, 2H), 3.84 (s, 
3H), 3.04 – 2.96 (m, 2H). 13C NMR (75 MHz, CDCl3) δ = 168.78, 167.14, 16β.γβ, 161.99 (β 
C), 134.98 (2 C), 128.96 (2 C), 128.80 (2 C), 126.25, 124.18 (2 C), 113.78 (2 C), 55.42, 
35.62, 32.21. HRMS: (ES-MS) m/z calculated for C19H17N2O6 [M+H]: 369.1081, found 
369.1089. 
 
1,3-Dioxoisoindolin-2-yl 3-(4-methoxy-N-methylbenzamido)propanoate (83). 
 
Compound 83 was prepared from acid 73p (4.32 g, 18.23 mmol, 1 equiv.), N-
hydroxyphthalimide (2.99 g, 18.33  mmol, 1 equiv.) and DCC (3.77 g, 18.27 mmol, 1 equiv.) 
following general protocol D. For Purification the residue was dissolved in diethylether 
(20 ml) and cooled to 0 °C. The precipitated DCC urea was removed by filtration and the 
solvent was evaporated. Yield: 4.10 g (10.72 mmol, 59%) pale yellow solid. IR (neat): 2933, 
2844, 1722, 1595, 1517, 1487, 1443, 1402, 1301, 1249, 1174, 1077, 1025, 969, 842, 794, 764, 
701 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H), 7.78 (dd, J = 5.5, 
3.1 Hz, 2H), 7.43 (d, J = 8.3 Hz, 2H), 6.89 (dd, J = 6.7, 4.8 Hz, 2H), 3.87 (d, J = 3.8 Hz, 2H), 
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3.80 (s, 3H), 3.15 – 3.02 (m, 5H). 13C NMR (101 MHz, CDCl3) δ = 171.9β, 161.81 (β C), 
160.85, 134.90 (2 C), 133.82, 129.17, 128.84 (2 C), 127.93 (2 C), 124.06 (2 C), 113.72 (2 C), 
55.35, 33.76, 29.77, 24.90. HRMS: (ES-MS) m/z calculated for C20H19N2O6 [M+H]: 
383.1238, found 383.1244. 
 
1,3-Dioxoisoindolin-2-yl 2-(N-tert-butyl-4-methoxybenzamido)acetate (97). 
 
Compound 97 was prepared from acid 73q (3.60 g, 13.57 mmol, 1 equiv.), N-
hydroxyphthalimide (2.45 g, 15.02 mmol, 1.1 equiv.) and DCC (3.11 g, 15.07 mmol, 
1.1 equiv.) following general protocol D. For purification the solvent of the reaction mixture 
was removed and the product was precipitated by adding diethylether. Yield: 3.22 g 
(7.85 mmol, 58%) white solid. IR (neat): 2967, 2933, 1830, 1789, 1744, 1644, 1603, 1580, 
1510, 1469, 1416, 1357, 1308, 1249, 1138, 1174, 1077, 1029, 951, 876, 846, 790, 734, 701 
cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.91 (dd, J = 5.5, 3.1 Hz, 2H), 7.82 (dd, J = 5.6, 3.1 
Hz, 2H), 7.41 (d, J = 8.6 Hz, 2H), 6.93 (d, J = 8.7 Hz, 2H), 4.43 (s, 2H), 3.84 (s, 3H), 1.58 (s, 
9H). 13C NMR (75 MHz, CDCl3) δ = 173.73, 168.37, 161.66 (2 C), 160.88, 135.02 (2 C), 
130.08, 128.76 (2 C), 128.13 (2 C), 124.14 (2 C), 114.20 (2 C), 58.35, 55.36, 47.85, 28.06 
(3 C). 
 
1,3-dioxoisoindolin-2-yl 4-(N-tert-butylbenzamido)butanoate (102a). 
 
Compound 102a was prepared from acid 73r (2.33 g, 8.85 mmol, 1 equiv.), N-
hydroxyphthalimide (1.49 g, 9.13 mmol, 1 equiv.) and DCC (1.91 g, 9.26 mmol, 1 equiv.) 
following general protocol D. Purification by column chromatography on flash silica gel 
(hexanes/DCM = 1/2 to hexanes/EtOAc = 1/1, Rf = 0.56) gave 1.98 g (4.89 mmol, 56%) pale 
yellow solid, m.p. = 100-109 °C. IR (neat): 3064, 2933, 2605, 1789, 1707, 1589, 1484, 1446, 
1409, 1368, 1305, 1241, 1185, 1070, 973, 783, 749, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ 
= 7.90 – 7.82 (m, 2H), 7.82 – 7.75 (m, 2H), 7.37 – 7.31 (m, 10H), 3.46 – 3.35 (m, 2H), 2.36 
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(t, J = 7.2 Hz, 2H), 1.93 (dt, J = 19.7, 7.5 Hz, 2H), 1.56 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 
= 173.55, 168.71, 161.80 (2 C), 139.25 (2 C), 134.91 (2 C), 128.93, 128.76, 128.60 (2 C), 
125.98 (2 C), 124.03 (2 C), 57.34, 46.43, 28.97 (3 C), 28.34, 26.66. HRMS: (ES-MS) m/z 
calculated for C23H25N2O8 [M+H]: 409.1758, found 409.1763. 
 
1,3-dioxoisoindolin-2-yl 4-(N-tert-butylisonicotinamido)butanoate (102b). 
 
Compound 102b was prepared from acid 73s (936 mg, 3.54 mmol, 1 equiv.), N-
hydroxyphthalimide (637.4 mg, 3.91 mmol, 1.1 equiv.) and DCC (805.7 mg, 3.90 mmol, 
1.1 equiv.) following general protocol D. Recrystallization from toluene gave 1.21 g 
(2.96 mmol, 83%) white solid, m.p. = 134-151 °C. IR (neat): 3127, 2930, 1789, 1707, 1625, 
1461, 1409, 1364, 1297, 1252, 1215, 1185, 1133, 1062, 973, 880, 835, 764, 731, 697 cm-1. 1H 
NMR (400 MHz, CDCl3) δ = 8.66 (d, J = 5.6 Hz, 2H), 7.87 (td, J = 5.3, 2.0 Hz, 2H), 7.80 (td, 
J = 5.2, 1.9 Hz, 2H), 7.26 – 7.22 (m, 2H), 3.41 – 3.32 (m, 2H), 2.42 (t, J = 6.9 Hz, 2H), 1.94 
(ddd, J = 15.0, 10.9, 7.0 Hz, 2H), 1.56 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 175.ββ, 
169.84, 164.61 (2 C), 148.51, 147.78 (2 C), 134.13 (2 C), 129.25 (2 C), 123.24 (2 C), 121.59 
(2 C), 57.79, 46.38, 30.92, 28.72 (3 C), 27.08. HRMS: (ES-MS) m/z calculated for 
C22H24N3O5 [M+H]: 410.1710, found 410.1716. 
 
1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-4-methoxybenzamido)butanoate (102c). 
 
Compound 102c was prepared from acid 73t (2.49 g, 8.49 mmol, 1 equiv.), N-
hydroxyphthalimide (1.41 g, 8.64 mmol, 1 equiv.) and DCC (1.77 g, 8.58 mmol, 1 equiv.) 
following general protocol D. Purification by column chromatography on flash silica gel 
(hexanes/EtOAc = 1/1, Rf = 0.45) gave 2.25 g (5.13 mmol, 60%) white solid, m.p. = 109-
114 °C. IR (neat):2967, 2110, 1815, 1789, 1744, 1607, 1513, 1465, 1394, 1297, 1249, 1170, 
1133, 1080, 1029, 969, 880, 839, 768, 734, 697 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.88 
(dt, J = 7.1, 3.6 Hz, 2H), 7.80 (td, J = 5.2, 2.0 Hz, 2H), 7.32 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 
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8.7 Hz, 2H), 3.81 (d, J = 4.0 Hz, 3H), 3.50 – 3.42 (m, 2H), 2.40 (t, J = 7.2 Hz, 2H), 1.99 – 
1.87 (m, 2H), 1.55 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 17γ.61, 168.74, 161.79 (β C), 
160.11, 134.87 (2 C), 131.73, 128.84 (2 C), 128.09 (2 C), 124.02 (2 C), 113.83 (2 C), 57.12, 
55.28, 46.64, 29.04 (3 C), 28.40, 26.70. HRMS: (ES-MS) m/z calculated for C24H27N2O6 
[M+H]: 439.1864, found 439.1866. 
 
1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-3-chloro-4-methoxybenzamido)butanoate 
(102d). 
 
Compound 102d was prepared from acid 73u (2.43 g, 7.41 mmol, 1 equiv.), N-
hydroxyphthalimide (1.22 g, 7.48 mmol, 1 equiv.) and DCC (1.53 g, 7.43 mmol, 1 equiv.) 
following general protocol D. For Purification the residue was dissolved in dichloromethane 
(20 ml) and cooled to 0 °C. The precipitated DCC urea was removed by filtration and the 
solvent was evaporated. Recrystallization from EtOH gave 2.04 g (4.31 mmol, 58%) white 
solid, m.p. = 134-139 °C. IR (neat):2974, 2922, 1812, 1785, 1744, 1625, 1506, 1405, 1290, 
1264, 1223, 1185, 1085, 1018, 958, 876, 824, 787, 693 cm-1. 1H NMR (400 MHz, CDCl3) δ = 
7.88 (dt, J = 7.1, 3.6 Hz, 2H), 7.83 – 7.77 (m, 2H), 7.39 (d, J = 2.1 Hz, 1H), 7.29 – 7.26 (m, 
1H), 6.92 (d, J = 8.4 Hz, 1H), 3.89 (s, 3H), 3.45 (dd, J = 9.1, 7.0 Hz, 2H), 2.43 (t, J = 7.1 Hz, 
2H), 1.99 – 1.88 (m, 2H), 1.54 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 171.99, 168.65, 
161.77 (2 C), 155.52, 134.89 (2 C), 132.40, 128.79, 128.54 (2 C), 126.26, 124.05 (2 C), 
122.48, 111.82, 57.34, 56.18, 46.62, 28.94 (3 C), 28.35, 26.65. HRMS: (ES-MS) m/z 
calculated for C24H26ClN2O6 [M+H]: 473.1474, found 473.1483. 
 
1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-3,4-dimethoxybenzamido)butanoate (102e). 
 
Compound 102e was prepared from acid 73v (2.51 g, 7.76 mmol, 1 equiv.), N-
hydroxyphthalimide (1.29 g, 7.91 mmol, 1 equiv.) and DCC (1.61 g, 7.80 mmol, 1 equiv.) 
following general protocol D using CHCl3 as solvent. Purification by column 
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chromatography on flash silica gel (hexanes/EtOAc = 1/1, Rf = 0.5) gave 2.29 g (4.89 mmol, 
63%) white solid, m.p. = 113-118 °C. IR (neat): 2922, 2651, 1782, 1744, 1618, 1513, 1412, 
1327, 1293, 1260, 1182, 1144, 1092, 1047, 962, 869, 779, 693 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 7.86 (dt, J = 7.1, 3.6 Hz, 2H), 7.83 – 7.75 (m, 2H), 6.94 – 6.87 (m, 2H), 6.80 (d, J 
= 8.1 Hz, 1H), 3.89 (s, 3H), 3.83 (s, 3H), 3.46 (dd, J = 9.1, 6.9 Hz, 2H), 2.41 (t, J = 7.2 Hz, 
2H), 1.99 – 1.90 (m, 2H), 1.55 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 17γ.60, 168.67, 
161.77 (2 C), 149.64, 148.95, 134.87 (2 C), 131.72, 128.83 (2 C), 124.02 (2 C), 119.01, 
110.71, 109.84, 57.32, 56.00, 55.86, 46.70, 29.00, 28.46 (3 C), 26.83. HRMS: (ES-MS) m/z 
calculated for C25H29N2O7 [M+H]: 469.1969, found 469.1975. 
 
1,3-Dioxoisoindolin-2-yl 4-(N-tert-butyl-2,4,6-trimethylbenzamido)butanoate (102f). 
 
Compound 102f was prepared from acid 73w (0.30 g, 0.982 mmol, 1 equiv.), N-
hydroxyphthalimide (0.167 g, 1.02 mmol, 1 equiv.) and DCC (0.206 g, 0.999 mmol, 1 equiv.) 
following general protocol D. Purification by column chromatography on flash silica gel 
(hexanes/EtOAc = 1/1, Rf = 0.55) gave 0.311 g (0.69 mmol, 70%) yellow solid. IR (neat): 
3138, 3034, 2960, 1789, 1737, 1703, 1625, 1461, 1416, 1390, 1305, 1352, 1189, 1137, 1055, 
977, 939, 880, 853, 787, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.89 – 7.81 (m, 2H), 7.81 
– 7.75 (m, 2H), 6.79 (s, 2H), 3.26 – 3.16 (m, 2H), 2.31 (t, J = 7.1 Hz, 2H), 2.23 (s, 6H), 2.20 
(s, 3H), 1.82 (tt, J = 11.3, 7.2 Hz, 2H), 1.58 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 17β.10, 
168.65, 161.80 (2 C), 137.36, 135.69, 134.90 (2 C), 132.84 (2 C), 128.77 (2 C), 128.48 (2 C), 
124.01 (2 C), 57.54, 45.74, 28.94 (3 C), 28.47, 26.04, 21.06, 19.12 (2 C). HRMS: (ES-MS) 
m/z calculated for C26H31N2O5 [M+H]: 451.2227, found 451.2236. 
 
1,3-Dioxoisoindolin-2-yl 4-(N-tert-butyl-2,6-dimethoxybenzamido)butanoate (102g). 
 
Compound 102g was prepared from acid 73x (2.53 g, 7.82 mmol, 1 equiv.), N-
hydroxyphthalimide (1.28 g, 7.88 mmol, 1 equiv.) and DCC (1.62 g, 7.83 mmol, 1 equiv.) 
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following general protocol D. Purification by column chromatography on flash silica gel 
(hexanes/EtOAc = 1/1, Rf = 0.29) and recrystallization from EtOH gave 2.73 g (5.83 mmol, 
75%) as a white solid, m.p. = 173-175 °C. IR (neat): 2967, 2844, 1812, 1744, 1636, 1588, 
1472, 1440, 1394, 1361, 1252, 1219, 1152, 1107, 1073, 988, 876, 831, 794, 749, 697 cm-1. 1H 
NMR (400 MHz, CDCl3) δ = 7.86 (m, βH), 7.81 – 7.76 (m, 2H), 7.18 (t, J = 8.4 Hz, 1H), 6.53 
(d, J = 8.4 Hz, 2H), 3.81 (s, 6H), 3.25 (dd, J = 9.2, 7.0 Hz, 2H), 2.32 (t, J = 7.4 Hz, 2H), 1.91 
(dt, J = 15.4, 7.5 Hz, 2H), 1.57 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 168.86, 167.84, 
161.84 (2 C), 156.05 (2 C), 134.85 (2 C), 129.61, 128.88 (2 C), 123.99 (2 C), 117.79, 104.06 
(2 C), 57.44, 55.85 (2 C), 45.97, 29.04 (3 C), 28.62, 26.26. HRMS: (ES-MS) m/z calculated 
for C25H29N2O7 [M+H]: 469.1969, found 469.1976. 
 
1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-3,4,5-trimethoxybenzamido)butanoate (102h). 
 
Compound 102h was prepared from acid 73y (2.50 g, 7.07 mmol, 1 equiv.), N-
hydroxyphthalimide (1.21 g, 7.42 mmol, 1 equiv.) and DCC (1.49 g, 7.22 mmol, 1 equiv.) 
following general protocol D using CHCl3 as solvent. Purification by column 
chromatography on flash silica gel (hexanes/EtOAc = 1/1, Rf = 0.34) gave 1.98 g (4.89 mmol, 
56%) white solid, m.p. = 132-139 °C. IR (neat):  3125, 3015, 2930, 2848, 1812, 1750, 1737, 
1636, 1584, 1461, 1409, 1361, 1234, 1185, 1126, 1043, 880, 805, 783, 697 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 7.87 (m, βH), 7.79 (m, βH), 6.54 (s, βH), γ.86 (s, 6H), γ.78 (s, γH), 
3.43 (dd, J = 9.2, 6.9 Hz, 2H), 2.44 (t, J = 7.2 Hz, 2H), 2.02 – 1.93 (m, 2H), 1.56 (s, 9H). 13C 
NMR (101 MHz, CDCl3) δ = 17γ.09, 168.65, 161.77 (β C), 15γ.γ9 (β C), 1γ8.60, 1γ4.88 (β 
C), 134.79, 128.84 (2 C), 124.04 (2 C), 103.42 (2 C), 60.85, 57.33, 56.27 (2 C), 46.56, 28.95 
(3 C), 28.47, 27.06. HRMS: (ES-MS) m/z calculated for C26H31N2O8 [M+H]: 499.2075, 
found 499.2078. 
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1,3-Dioxoisoindolin-2-yl 3-(tert-butoxycarbonyl(4-methoxybenzyl)amino)propanoate 
(118). 
 
Compound 118 was prepared from acid 73z (3.14 g, 10.15 mmol, 1 equiv.), N-
hydroxyphthalimide (1.66 g, 10.18 mmol, 1 equiv.) and DCC (2.01 g, 9.74 mmol, 1 equiv.) 
following general protocol D. Purification by column chromatography gave 3.11 g 
(6.84 mmol, 67%) of white solid. Rf (hexanes/EtOAc = 2/1) = 0.35). 1H NMR (300 MHz, 
CDCl3) δ = 7.9γ – 7.84 (m, 2H), 7.82 – 7.75 (m, 2H), 7.17 (d, J = 7.8 Hz, 2H), 6.90 – 6.81 (m, 
2H), 4.44 (s, 2H), 3.79 (s, 3H), 3.56 (d, J = 8.5 Hz, 2H), 2.88 (d, J = 39.3 Hz, 2H), 1.49 (s, 
9H). 13C NMR (101 MHz, CDCl3) δ = 171.58, 171.09, 159.08 (β C), 154.80, 132.29 (2 C), 
130.23, 129.98 (2 C), 129.40 (2 C), 129.14 (2 C), 113.79 (2 C), 81.18, 55.26, 52.26, 51.89, 
51.57, 28.31 (3 C). 
 
(S)-4-(1,3-Dioxoisoindolin-2-yl) 1-methyl 2-(tert-butoxycarbonyl(4-methoxybenzyl)-
amino)succinate (125). 
 
Compound 125 was prepared from acid 73aa (2.93 g, 7.98 mmol, 1 equiv.), N-
hydroxyphthalimide (1.33 g, 8.18 mmol, 1 equiv.) and DCC (1.65 g, 7.97 mmol, 1 equiv.) 
following general protocol D. After evaporation of the solvent, the residue was dissolved in 
dichloromethane at 0 °C and the precipitated urea was removed by filtration. Column 
chromatography gave 2.43 g (4.74 mmol, 59%) of colorless oil. 
Rf (hexanes/EtOAc = 1/1) = 0.34). 1H NMR (300 MHz, CDCl3) δ = 7.91 – 7.85 (m, 2H), 7.82 
– 7.76 (m, 2H), 7.28 (d, J = 9.0 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 4.72 – 4.59 (m, 1H), 4.35 
(dd, J = 22.2, 10.9 Hz, 1H), 3.79 (d, J = 1.7 Hz, 3H), 3.65 (d, J = 23.3 Hz, 3H), 3.59 – 3.43 
(m, 1H), 3.32 – 2.97 (m, 1H), 2.94 – 2.55 (m, 1H), 1.52 (d, J = 23.2 Hz, 9H). 13C NMR (75 
MHz, CDCl3) δ = 170.08, 167.70, 161.67 (2 C), 161.35, 159.17, 134.84 (2 C), 130.10 (2 C), 
129.40, 128.84 (2 C), 124.02 (2 C), 113.99 (2 C), 81.63, 55.91, 55.27, 52.61, 51.75, 33.36, 
28.32 (3 C). 
D  Experimental Part 2  Synthesis of N-acyloxyphthalimides 
 
157 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butylthiophene-2-carboxamido)propanoate (60). 
 
Compound 60 was prepared from acid 73ab (0.823 g, 3.22 mmol, 1 equiv.), N-
hydroxyphthalimide (527.8 mg, 3.24 mmol, 1 equiv.) and DCC (664.4 mg, 3.22 mmol, 
1 equiv.) following general protocol D. Purification by column chromatography on flash 
silica gel (hexanes/EtOAc = 1/1, Rf = 0.65) Yield: 812 mg (2.03 mmol, 63%) yellow solid. IR 
(neat): 3101, 2978, 1789, 1707, 1625, 1521, 1461, 1424, 1379, 1282, 1249, 1185, 1137, 1077, 
958, 902, 880, 805, 746, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.84 (dt, J = 6.8, 3.6 Hz, 
2H), 7.77 (dt, J = 5.3, 3.6 Hz, 2H), 7.38 (dd, J = 5.0, 1.0 Hz, 1H), 7.29 – 7.26 (m, 1H), 7.01 
(dd, J = 5.0, 3.7 Hz, 1H), 4.03 – 3.86 (m, 2H), 3.08 – 2.92 (m, 2H), 1.53 (s, 9H). 13C NMR 
(75 MHz, CDCl3) δ = 167.1γ, 166.85, 161.68 (2 C), 139.84, 134.94 (2 C), 128.73, 128.12 (2 
C), 127.83, 126.91 (2 C), 124.06, 58.24, 42.51, 33.80, 28.81 (3 C). HRMS: (ES-MS) m/z 
calculated for C20H21N2O5S [M+H]: 401.1166, found 401.1167. 
 
1,3-Dioxoisoindolin-2-yl 2-benzamidoacetate (240). 
 
Compound 240 was prepared from hippuric acid (2.02 g, 11.25 mmol, 1 equiv.), N-
hydroxyphthalimide (1.85 g, 11.34 mmol, 1 equiv.) and DCC (2.33 g, 11.29 mmol, 1 equiv.) 
following general protocol D. Recrystallization in DCM gave a white solid. Yield: 2.86 g 
(8.82 mmol, 78%). 1H NMR (400 MHz, CDCl3) δ = 7.90 (dd, J = 5.5, 3.1 Hz, 2H), 7.86 – 
7.77 (m, 4H), 7.56 – 7.40 (m, 3H), 7.26 (s, 1H), 6.64 (s, 1H), 5.30 (s, 1H), 4.70 (d, J = 5.4 Hz, 
2H). 13C NMR (101 MHz, CDCl3) δ = 167.45, 167.01, 161.45 (2 C), 134.98 (2 C), 133.23, 
132.15 (2 C), 128.79 (2 C), 128.75 (2 C), 127.20 (2 C), 124.19 (2 C), 39.58. HRMS: (ES-MS) 
m/z calculated for C17H13N2O5 [M+H]: 325.0819, found 325.0825. 
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1,3-Dioxoisoindolin-2-yl 2-(tert-butoxycarbonylamino)acetate (242). 
 
Compound 242 was prepared from 2-(tert-butoxycarbonylamino)acetic (1.50 g, 8.59 mmol, 
1 equiv.), N-hydroxyphthalimide (1.42 g, 8.70 mmol, 1 equiv.) and DCC (1.83 g, 8.87 mmol, 
1 equiv.) following general protocol D. Recrystallization in DCM gave a white solid. Yield: 
2.21 g (6.90 mmol, 80%). 1H NMR (400 MHz, CDCl3) δ = 7.89 (dd, J = 5.5, 3.1 Hz, 2H), 
7.80 (dd, J = 5.5, 3.1 Hz, 2H), 5.04 (s, 1H), 4.35 (m, 2H), 1.46 (s, 9H). 13C NMR (75 MHz, 
CDCl3) δ = 167.β1, 161.50 (β C), 1γ4.9γ (β C), 1β8.77 (β C), 1β4.1γ (β C), 80.76, 40.γ6, 
33.62, 28.27 (3 C).  
Analytical data match to the reported data.136 
 
N-acyloxyphthalimides for tetralin synthesis 
(E)-3-(4-Methoxyphenyl)-2-methylacrylaldehyde (254). 
 
Propanal (13 ml, 179.07 mmol, 1.2 equiv.) in benzene (20 ml) was added dropwise to a 
solution of 4-methoxybenzaldehyde (18 ml, 148.7 mmol, 1 equiv.) in benzene (30 ml). 
Potassium hydroxide (1.24 g, 22 mmol, 0.15 equiv.) and tetrabutylammonium 
hexafluorophosphate (5.7 g, 14.7 mmol, 0.1 equiv.) was powdered into the solution and 
stirred at room temperature for 36 h. The solvent was evaporated and the residue was distilled 
under vacuum (1.9 mbar). One fraction of yellow oil was collected (B.P. 70-75 °C). After 
column chromatography a yellow oil was obtained (2.82 g, 16 mmol, 11%). 
Rf (hexanes/EtOAc = 4/1) = 0.4. IR (neat): 2960, 2840, 2714, 1670, 1599, 1510, 1443, 1405, 
1305, 1252, 1174, 1115,1014, 891, 820, 768 cm-1. 1H NMR (300 MHz, CDCl3) δ = 9.5β (s, 
1H), 7.51 (d, J = 8.8 Hz, 2H), 7.17 (s, 1H), 6.99 (d, J = 8.6 Hz, 2H), 3.84 (s, 3H), 2.06 (d, J = 
1.3 Hz, 3H). 
Analytical data match to the reported data.137 
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(2E,4E)-Ethyl 5-(4-methoxyphenyl)-4-methylpenta-2,4-dienoate (255). 
 
Triethyl phosphonoacetate (4.03 g, 17.98 mmol, 1.1 equiv.) was added to a solution of NaH 
(60% dispersion in mineral oil, 667.3 mg, 16.88 mmol, 1.05 equiv.) in THF (20 ml) and 
stirred for 30 min at 0 °C. Aldehyde 254 was added dropwise at 0 °C and stirred for additional 
15 h at room temperature. The reaction was quenched with brine (30 ml) and the THF was 
removed under reduced pressure. The aqueous layer was extracted with DCM (2 x 30 ml). 
The combined organic phases were dried over MgSO4, filtered and the solvent was 
evaporated. Purification via column chromatography gave a yellow oil (2.54 g, 10.31 mmol, 
65%). Rf (hexanes/EtOAc = 10/1) = 0.33. IR (neat): 3474, 2982, 2840, 1707, 1633, 1603, 
1513, 1461, 1368, 1305, 1249, 1163, 1029, 984, 828, 768 cm-1. 1H NMR (300 MHz, CDCl3) δ 
= 7.64 (d, J = 16.0 Hz, 1H), 7.31 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 5.7 Hz, 2H), 6.78 (s, 1H), 
5.93 (dd, J = 15.6, 0.5 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 3.82 (s, 3H), 2.04 (d, J = 1.2 Hz, 
3H), 1.32 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 167.45, 161.33, 144.32, 131.04, 
129.72 (2 C), 127.19, 115.71, 114.32, 113.83 (2 C), 60.39, 55.39, 14.37, 14.24. LRMS: 
(APCI-MS) m/z calculated for C15H19O3 [M+H]: 247.13, found 247.1332. 
 
Ethyl 5-(4-methoxyphenyl)-4-methylpentanoate (256). 
 
Compound 255 (2.54 g, 10.31 mmol, 1 equiv.) and 10% palladium on activated charcoal 
(100 mg, 0.1 mmol, 0.01 equiv.) was dissolved in EtOH (absolute, 30 ml). The mixture was 
stirred under hydrogen atmosphere overnight. The mixture was filtered through Celite and the 
solvent was removed under reduced pressure to give a pale yellow oil (2.37 g, 9.47 mmol, 
92%). IR (neat): 2930, 1733, 1614, 1584, 1513, 1461, 1372, 1342, 1301, 1245, 1178, 1107, 
1036, 939, 824, 708 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.15 – 7.09 (m, 2H), 6.86 – 6.78 
(m, 2H), 4.12 (q, J = 7.1 Hz, 2H), 3.78 (s, 3H), 2.89 (t, J = 7.8 Hz, 1H), 2.62 – 2.55 (m, 2H), 
2.39 – 2.28 (m, 2H), 1.76 – 1.65 (m, 1H), 1.52 – 1.42 (m, 1H), 1.25 (t, J = 7.1 Hz, 3H), 0.87 
(dd, J = 8.9, 5.3 Hz, 3H). LRMS: (ES-MS) m/z calculated for C15H23O3 [M+H]: 251.16, 
found 251.1655. 
D  Experimental Part 2  Synthesis of N-acyloxyphthalimides 
 
160 
 
5-(4-Methoxyphenyl)-4-methylpentanoic acid (257). 
 
Compound 257 was prepared from ester 256 (1.37 g, 5.47 mmol, 1 equiv.) and potassium 
hydroxide (0.307 g, 5.47 mmol, 1 equiv.) following general protocol C. Yield: 0.915 g 
(4.12 mmol, 75%), white solid. 1H NMR (300 MHz, CDCl3) δ = 7.17 – 7.10 (m, 2H), 6.86 – 
6.83 (m, 2H), 3.79 (s, 4H), 2.91 (t, J = 7.7 Hz, 2H), 2.58 (dd, J = 13.6, 5.9 Hz, 1H), 2.44 – 
2.28 (m, 2H), 1.81 – 1.62 (m, 2H), 1.56 – 1.40 (m, 1H), 0.87 (d, J = 6.5 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 180.04, 158.17, 132.84, 130.02 (2 C), 113.66 (2 C), 55.27, 42.42, 
35.88, 34.65, 31.24, 18.96. LRMS: (ES-MS) m/z calculated for C13H17O3 [M-H]: 221.13, 
found 221.1189. 
 
1,3-Dioxoisoindolin-2-yl 5-(4-methoxyphenyl)-4-methylpentanoate (127). 
 
Compound 127 was prepared from acid 257 (0.915 g, 4.12 mmol, 1 equiv.), N-
hydroxyphthalimide (0.739 g, 4.53 mmol, 1.1 equiv.) and DCC (0.936 g, 4.54 mmol, 
1.1 equiv.) following general protocol D. Purification by column chromatography on flash 
silica gel (hexanes/EtOAc = 1/1, Rf = 0.61) gave 0.431 g (1.17 mmol, 29%) white solid. IR 
(neat): 3097, 2960, 2933, 1785, 1703, 1607, 1510, 1461, 1413, 1297, 1245, 1174, 1133, 1074, 
1033, 973, 932, 880, 846, 783, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.9γ – 7.84 (m, 
2H), 7.82 – 7.75 (m, 2H), 7.12 – 7.05 (m, 2H), 6.87 – 6.80 (m, 2H), 3.79 (s, 3H), 2.78 – 2.56 
(m, 3H), 2.40 (dd, J = 13.6, 7.7 Hz, 1H), 1.93 – 1.78 (m, 2H), 1.64 (ddd, J = 11.8, 8.4, 5.3 Hz, 
1H), 0.92 (d, J = 6.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 168.70, 160.96 (2 C), 156.81, 
133.72 (2 C), 131.52, 128.99 (2 C), 127.88 (2 C), 122.92 (2 C), 112.64 (2 C), 54.19, 41.31, 
33.41, 30.10, 27.87, 17.87. HRMS: (ES-MS) m/z calculated for C21H22NO5 [M+H]: 
368.1492, found 368.1498. 
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5-Oxo-5-phenylpentanoic acid (258). 
 
A suspension of AlCl3 (3.4 g, 25.5 mmol, 1 equiv.) and benzene (6 ml, 67.6 mmol, 3 equiv.) 
was treated with DCM (10 ml). Glutaric anhydride (2.9 g, 25.42 mmol, 1 equiv.) in DCM 
(10 ml) was added to the suspension and stirred for overnight. The black solution was 
quenched with ice cooled water and the phases were separated. The aqeous layer was 
extracted with ethyl acetate (2 x 10 ml) and the solvent of the combined organic phases was 
removed. The obtained solid was diluted again with ethyl acetate and washed with water (2 x 
10 ml). The organic layer was extracted with a saturated NaHCO3 solution, which was 
acidified by concentrated HCl. The product was extracted with ethyl acetate, dried over 
MgSO4, filtered and evaporated off. Yield: 1.24 g (6.45 mmol, 29%) white solid. 1H NMR 
(300 MHz, CDCl3) δ = 11.0γ (s, 1H), 7.95 (dd, J = 5.3, 3.3 Hz, 2H), 7.61 – 7.52 (m, 1H), 7.51 
– 7.41 (m, 2H), 3.08 (t, J = 7.1 Hz, 2H), 2.53 – 2.41 (m, 2H), 2.11 – 2.04 (m, 2H). 13C NMR 
(75 MHz, CDCl3) δ = 199.40, 179.65, 1γ6.71, 133.17, 128.62 (2 C), 128.03 (2 C), 37.29, 
33.09, 18.96. 
Analytical data match to the reported data.138 
 
1,3-Dioxoisoindolin-2-yl 5-oxo-5-phenylpentanoate (133). 
 
Compound 133 was prepared from acid 258 (0.500 g, 2.6 mmol, 1 equiv.), N-
hydroxyphthalimide (0.469 g, 2.87 mmol, 1.1 equiv.) and DCC (0.594 g, 2.88 mmol, 
1.1 equiv.) following general protocol D. Purification by column chromatography on flash 
silica gel (hexanes/EtOAc = 2/1, Rf = 0.51) gave 0.439 g (1.30 mmol, 50%) white solid. IR 
(neat): 3056, 2922, 1815, 1789, 1737, 1689, 1595, 1446, 1413, 1379, 1320, 1267, 1185, 1044, 
965, 880, 790, 734, 690 cm-1. 1H NMR (300 MHz, CDCl3) δ = 8.04 – 7.97 (m, 2H), 7.93 – 
7.86 (m, 2H), 7.83 – 7.76 (m, 2H), 7.61 – 7.53 (m, 1H), 7.52 – 7.44 (m, 2H), 3.20 (t, J = 7.1 
Hz, 2H), 2.84 (t, J = 7.0 Hz, 2H), 2.25 (p, J = 7.1 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ = 
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198.88, 169.39, 161.95 (2 C), 136.73, 134.79 (2 C), 133.22, 128.95 (2 C), 128.68 (2 C), 
128.10 (2 C), 124.02 (2 C), 36.75, 30.27, 19.17. 
 
1,3-Dioxoisoindolin-2-yl 4-phenylbutanoate (135). 
 
Compound 135 was prepared from 4-phenylbutanoic acid (1.50 g, 9.14 mmol, 1 equiv.), N-
hydroxyphthalimide (1.66 g, 10.18 mmol, 1.1 equiv.) and DCC (2.12 g, 10.27 mmol, 
1.1 equiv.) following general protocol D. Purification by column chromatography on flash 
silica gel (hexanes/EtOAc = 2/1, Rf = 0.60) gave 2.62 g (8.47 mmol, 93%) white solid. IR 
(neat): 3027, 2945, 2874, 1785, 1737, 1603, 1491, 1461, 1375, 1290, 1252, 1185, 1141, 1077, 
965, 917, 876, 787, 693 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.95 – 7.85 (m, 2H), 7.84 – 
7.74 (m, 2H), 7.32 (ddd, J = 7.2, 4.5, 2.0 Hz, 2H), 7.27 – 7.18 (m, 3H), 2.78 (t, J = 7.5 Hz, 
2H), 2.68 (t, J = 7.4 Hz, 2H), 2.12 (p, J = 7.4 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ = 
169.46, 162.00 (2 C), 140.68, 134.79 (2 C), 128.95 (2 C), 128.60 (2 C), 128.56 (2 C), 126.25, 
124.00 (2 C), 34.63, 30.23, 26.32. HRMS: (ES-MS) m/z calculated for C18H16NO4 [M+H]: 
310.1074, found 310.1076. 
Analytical data match to the reported data.139 
 
Phenylacetic acid based N-acyloxyphthalimides 
1,3-Dioxoisoindolin-2-yl 2-phenylacetate (171/166a). 
 
General protocol E 
N-(3-dimethylaminopropyl)-N´-ethylcarbodiimide hydrochloride (EDAC, 430 mg, 2.2 mmol, 
1.1 equiv.) was dissolved in dichloromethane (20 ml) and added slowly to a solution of 
phenylacetic acid (270 mg, 2.0 mmol, 1 equiv.) and N-hydroxyphthalimide (326 mg, 
2.0 mmol, 1 equiv.) in THF (30 ml). The reaction was stirred at room temperature for 
overnight and washed with water (2x 30 ml) and brine (1x 30 ml). The pure compound was 
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obtained after an additional washing step with a saturated NaHCO3 solution. The organic 
phase was dried over NaSO4, filtered and evaporated. Compound 171 was isolated as white 
solid (0.433 g, 1.54 mmol, 77%), m.p. = 102-109 °C. Ir (neat): 3131, 2922, 1812, 1789, 1733, 
1705, 1607, 1461, 1409, 1364, 1185, 1133, 1058, 973, 880, 824, 783, 723, 697 cm-1.  1H 
NMR (300 MHz, CDCl3) δ = 7.86 (ddd, J = 4.9, 3.7, 2.0 Hz, 2H), 7.81 – 7.75 (m, 2H), 7.45 – 
7.27 (m, 5H), 4.00 (s, 2H). 13C NMR (75 MHz, CDCl3) δ = 167.69, 161.84 (2 C), 141.78, 
134.80 (2 C), 131.54, 129.31 (2 C), 128.89 (2 C), 127.82 (2 C), 124.01 (2 C), 37.73. HRMS: 
(APCI-MS) m/z calculated for C16H15N2O4 [M+NH4]: 299.1026, found 299.1031. 
Analytical data match to the reported data.140 
 
1,3-Dioxoisoindolin-2-yl 2-p-tolylacetate (166b).  
 
Compound 166b was prepared from p-tolylacetic acic (0.700 g, 4.66 mmol, 1.2 equiv.), N-
hydroxyphthalimide (0.633 g, 3.88 mmol, 1 equiv.) and EDAC (0.894 g, 4.66 mmol, 
1.2 equiv.) following general protocol E. Purification by column chromatography 
(hexanes/EtOAc = 1/1, Rf = 0.72) gave a yellow solid (0.673 g, 2.28 mmol, 59%), m.p. = 97-
100 °C. IR (neat): 3131, 2922, 1823, 1789, 1737, 1610, 1517, 1469, 1422, 1357, 1185, 1141, 
1055, 969, 880, 839, 775, 690 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.88 (ddd, J = 9.2, 4.3, 
2.8 Hz, 2H), 7.83 – 7.74 (m, 2H), 7.31 – 7.24 (m, 2H), 7.19 (d, J = 7.4 Hz, 2H), 3.95 (s, 2H), 
2.35 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 167.95, 161.96 (β C), 141.87, 1γ7.6β, 1γ4.89 (β 
C), 129.67 (2 C), 129.03 (2 C), 128.57 (2 C), 124.09 (2 C), 37.45, 21.25. 
Analytical data match to the reported data.141 
 
1,3-Dioxoisoindolin-2-yl 2-m-tolylacetate (166c). 
 
Compound 166c was prepared from 2-m-tolylacetic acic (0.800 g, 5.33 mmol, 1.1 equiv.), N-
hydroxyphthalimide (0.790 g, 4.84 mmol, 1 equiv.) and EDAC (1.0 g, 5.21 mmol, 1.1 equiv.) 
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following general protocol E. After extraction work up a yellow solid (1.01 g, 3.42 mmol, 
71%) was obtained; m.p. = 105-113 °C. 1H NMR (300 MHz, CDCl3) δ = 7.91 – 7.84 (m, 2H), 
7.81 – 7.74 (m, 2H), 7.27 (dd, J = 8.7, 6.3 Hz, 1H), 7.24 – 7.07 (m, 3H), 3.96 (s, 2H), 2.37 (s, 
3H). 13C NMR (75 MHz, CDCl3) δ = 167.74, 161.98 (β C), 1γ7.ββ, 1γ4.90 (β C), 1γ0.68, 
130.47, 130.38, 129.00 (2 C), 128.28, 126.52, 124.08 (2 C), 35.99, 19.64. HRMS: (ES-MS) 
m/z calculated for C17H14NO4 [M+H]: 269.0917, found 296.0919. 
 
1,3-Dioxoisoindolin-2-yl 2-(4-fluorophenyl)acetate (166d). 
 
Compound 166d was prepared from 4-fluorophenylacetic acic (0.700 g, 4.54 mmol, 
1.2 equiv.), N-hydroxyphthalimide (0.617 g, 3.78 mmol, 1 equiv.) and EDAC (0.870 g, 
4.54 mmol, 1.2 equiv.) following general protocol E. After extraction work up a yellow solid 
(0.988 g, 3.3 mmol, 87%) was obtained; m.p. = 103-105 °C. Ir (neat): 3116, 2926, 2658, 
1789, 1696, 1607, 1510, 1467, 1410, 1342, 1290, 1223, 1185, 1137, 1062, 973, 932, 880, 828, 
783, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.91 – 7.83 (m, 2H), 7.82 – 7.74 (m, 2H), 
7.41 – 7.30 (m, 2H), 7.12 – 7.01 (m, 2H), 3.96 (s, 2H). 13C NMR (75 MHz, CDCl3) δ = 
167.62, 161.83 (2 C), 134.88 (2 C), 131.05 (2 C), 130.94, 128.84 (2 C), 124.04 (2 C), 115.97, 
115.69 (2 C), 36.91. HRMS: (ES-MS) m/z calculated for C16H11FNO4 [M+H]: 300.0667, 
found 300.0670. 
 
1,3-Dioxoisoindolin-2-yl 2-(4-bromophenyl)acetate (166e). 
 
Compound 166e was prepared from 4-bromophenylacetic acic (1.0 g, 4.65 mmol, 1.2 equiv.), 
N-hydroxyphthalimide (0.632 g, 3.88 mmol, 1 equiv.) and EDAC (0.891 g, 4.65 mmol, 
1.2 equiv.) following general protocol E. Recrystallization by EtOH gave a yellow solid 
(1.02 g, 2.83 mmol, 73%), m.p. = 11-114 °C. 1H NMR (300 MHz, CDCl3) δ = 7.9β – 7.84 (m, 
2H), 7.82 – 7.76 (m, 2H), 7.55 – 7.46 (m, 2H), 7.32 – 7.21 (m, 2H), 3.95 (s, 2H). 13C NMR 
(75 MHz, CDCl3) δ = 167.γ7, 161.90 (β C), 1γ4.99 (β C), 1γβ.14 (2 C), 131.13 (2 C), 130.60, 
128.94 (2 C), 124.17 (2 C), 122.11, 37.25. 
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Analytical data match to the reported data.139 
1,3-Dioxoisoindolin-2-yl 2-(4-methoxyphenyl)acetate (163/166f). 
 
2-p-Methoxyphenylacetic acid (2.02 g, 12.16 mmol, 1 equiv.) and N-hydroxyphthalimide 
(2.01 g, 12.32 mmol, 1 equiv.) was dissolved in anhydrous THF (40 ml). N,N′-
Dicyclohexylcarbodiimid (DCC, 2.57 g, 12.46 mmol, 1 equiv.) in THF (15 ml) was added 
dropwise at 0 °C and the reaction mixture was stirred for overnight. The solvent was 
evaporated under reduced pressure and after purification by column chromatography 
(hexanes/EtOAc = 2/1, Rf = 0.26) pure product 163 (3.16 g, 10.15 mmol, 84%) was obtained 
as a pale yellow solid, m.p. = 94-96 °C. Ir (neat): 2977, 1823, 1785, 1737, 1610, 1513, 1469, 
1420, 1357, 1249, 1186, 1118, 1081, 1029, 969, 872, 816, 768, 693 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.90 – 7.84 (m, 2H), 7.82 – 7.75 (m, 2H), 7.33 – 7.27 (m, 2H), 6.94 – 6.87 (m, 
2H), 3.93 (s, 2H), 3.80 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 168.09, 16β.00 (β C), 159.β7, 
134.92 (2 C), 130.52 (2 C), 128.99 (2 C), 124.11 (2 C), 123.61, 114.39 (2 C), 55.40, 36.98. 
HRMS: (ES-MS) m/z calculated for C17H17N2O5 [M+NH4]: 329.1132, found 329.1136. 
Analytical data match to the reported data.139  
 
1,3-Dioxoisoindolin-2-yl 2-(3,4,5-trimethoxyphenyl)acetate (166g). 
 
Compound 166g was prepared from 2-(3,4,5-trimethoxyphenyl)acetic acid (1.37 g, 
6.07 mmol, 1.1 equiv.), N-hydroxyphthalimide (0.900 g, 5.52 mmol, 1 equiv.) and EDAC 
(1.16 g, 6.05 mmol, 1.1 equiv.) following general protocol E. Recrystallization by EtOH gave 
a beige solid (1.71 g, 4.60 mmol, 83%), m.p. = 130-131 °C. 1H NMR (300 MHz, CDCl3) δ = 
7.88 (dt, J = 7.3, 3.6 Hz, 2H), 7.84 – 7.75 (m, 2H), 6.61 (s, 2H), 3.93 (s, 2H), 3.89 (s, 6H), 
3.84 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 167.72, 161.97 (2 C), 153.56 (2 C), 137.56, 
134.98 (2 C), 128.96 (2 C), 127.20, 124.15 (2 C), 106.28 (2 C), 60.98, 56.30 (2 C), 38.08. 
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1,3-Dioxoisoindolin-2-yl 2-(4-(dimethylamino)phenyl)acetate (166h). 
 
Compound 166h was prepared from 4-dimethylaminophenylacetic acic (1.0 g, 5.58 mmol, 
1.1 equiv.), N-hydroxyphthalimide (0.830 g, 5.09 mmol, 1 equiv.) and EDAC (1.0 g, 
5.21 mmol, 1 equiv.) following general protocol E. After extraction work up a yellow solid 
(0.972 g, 3.0 mmol, 59%) was obtained; m.p. = 108-115 °C. IR (neat): 3131, 2956, 2922, 
1789, 1707, 1606, 1513, 1461, 1379, 1282, 1230, 1185, 1133, 1081, 973, 880, 816, 783, 738, 
697 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.91 – 7.83 (m, 2H), 7.80 – 7.74 (m, 2H), 7.24 (dd, 
J = 6.7, 4.5 Hz, 2H), 6.76 – 6.71 (m, 2H), 3.90 (s, 2H), 2.94 (s, 6H). 13C NMR (75 MHz, 
CDCl3) δ = 168.36, 162.04 (2 C), 141.88, 134.85 (2 C), 130.09 (2 C), 129.07, 124.06 (2 C), 
112.99 (2 C), 40.72 (2 C), 36.92. HRMS: (ES-MS) m/z calculated for C18H17N2O4 [M+H]: 
325.1183, found 325.1189. 
 
1,3-Dioxoisoindolin-2-yl 2,2-diphenylacetate (166i). 
 
Compound 166i was prepared from 2,2-diphenylacetic acid (2.00 g, 9.42 mmol, 1 equiv.), N-
hydroxyphthalimide (1.54 g, 9.42 mmol, 1 equiv.) and DCC (1.94 g, 9.42 mmol, 1 equiv.) 
following general protocol D. For purification the solvent filtered and removed under reduced 
pressure. Ethanol (80 ml) was added and heated to 100 °C for 1 h. The white undiluted solid 
was filtered and dried in vacuum. Yield: 2.71 g (7.58 mmol, 80%) white solid. 1H NMR (400 
MHz, CDCl3) δ = 7.88 (dd, J = 5.5, 3.1 Hz, 2H), 7.78 (dd, J = 5.5, 3.1 Hz, 2H), 7.46 – 7.35 
(m, 8H), 7.35 – 7.28 (m, 2H), 5.42 (s, 1H). 13C NMR (75 MHz, CDCl3) δ = 169.08, 161.86 (2 
C), 136.78 (2 C), 134.83 (2 C), 128.91 (4 C), 128.73 (4 C), 127.93 (2 C), 124.01 (2 C), 54.04. 
HRMS: (APCI-MS) m/z calculated for C22H19N2O4 [M+NH4]: 375.1339, found 375.1346. 
Analytical data match to the reported data.140 
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1,3-Dioxoisoindolin-2-yl 2-(4-chlorophenyl)acetate (166j). 
 
Compound 166j was prepared from 4-chlorophenylacetic acic (1.0 g, 5.86 mmol, 1.2 equiv.), 
N-hydroxyphthalimide (0.797 g, 4.88 mmol, 1 equiv.) and EDAC (1.2 g, 5.86 mmol, 
1.2 equiv.) following general protocol E. Purification by column chromatography 
(hexanes/EtOAc, 1/1, Rf = 0.62) gave a yellow solid (0.673 g, 2.28 mmol, 59%), m.p. = 93-
96 °C. IR (neat): 3101, 2971, 2903, 2654, 1819, 1789, 1737, 1700, 1602, 1491, 1413, 1351, 
1290, 1252, 1178, 1115, 1059, 969, 928, 880, 805, 738, 693 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.9γ – 7.85 (m, 2H), 7.83 – 7.74 (m, 2H), 7.38 – 7.28 (m, 4H), 3.96 (s, 2H). 13C 
NMR (75 MHz, CDCl3) δ = 13C NMR (75 MHz, CDCl3) δ = 167.39, 161.83 (2 C), 134.90 (2 
C), 130.78, 130.70 (2 C), 129.97, 129.08 (2 C), 128.82 (2 C), 124.08 (2 C), 37.06. 
Analytical data match to the reported data.141 
 
Aliphatic acid based N-acyloxyphthalimides 
1,3-Dioxoisoindolin-2-yl octanoate (206/232). 
 
Octanoyl chloride (1.50 mL, 13.28 mmol, 1.0 equiv.) in THF (20 ml) was added dropwise to a 
solution of N-hydroxyphthalimide (2.11 g, 12.93 mmol, 1 equiv.) and NEt3 (2.00 ml, 
14.43 mmol, 1.1 equiv.) in THF (30 ml) and stirred at room temperature for overnight. The 
reaction mixture was washed with water (50 ml), a half-saturated NaHCO3 solution (50 ml) 
and a saturated NaCl solution (50 ml). The organic phase was dried over MgSO4, filtrated and 
the solvent was removed under reduced pressure, which gave a white solid (1.99 g, 
6.88 mmol, 52%). 1H NMR (300 MHz, CDCl3) δ = 7.95 – 7.84 (m, 2H), 7.83 – 7.72 (m, 2H), 
2.66 (t, J = 7.5 Hz, 2H), 1.95 – 1.63 (m, 2H), 1.55 – 1.17 (m, 8H), 1.03 – 0.70 (t, 3H). 13C 
NMR (75 MHz, CDCl3) δ = 169.70, 16β.06, 1γ4.76, 1β8.95, 1βγ.98, γγ.96, γ1.58, γ1.00, 
28.80, 24.68, 22.59, 14.08. HRMS: (APCI-MS) m/z calculated for C16H23N2O4 [M+NH4]: 
307.1652, found 307.1657.  
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Analytical data match to the reported data.142  
The redox potential of P8 was determined as -1.25 V (vs. SCE, irreversible peak) by cyclic 
voltametry. 
 
1,3-Dioxoisoindolin-2-yl cyclohexanecarboxylate (207/236). 
 
Cyclohexanecarboxylic acid (2.0 g, 15.6 mmol, 1 equiv.) was diluted in THF (30 ml). Thionyl 
chloride (2.3 ml, 31.71 mmol, 2 equiv.) was added and stirred at room temperature for 
20 min. A solution of N-hydroxyphthalimide (2.56 g, 15.69 mmol, 1 equiv.) and NEt3 (4.3 ml, 
31.02 mmol, 2 equiv.) in THF (50 ml), was added to the reaction mixture and stirred at room 
temperature for overnight. The solvent was removed under reduced pressure and the residue 
dissolved in ethyl acetate (50 ml). The organic phase was washed with water (50 ml), 1 M 
HCl (50 ml) and a half-saturated NaHCO3 solution (50 ml). The organic layer was dried over 
MgSO4, filtrated and the solvent was removed. Purification by column chromatography 
(hexanes/EtOAc = 3/1, Rf  = 0.56) and recrystallization with ethanol gave a white solid 
(3.10 g, 11.34 mmol, 73%). 1H NMR (400 MHz, CDCl3) δ = 7.88 (dd, J = 5.4, 3.1 Hz, 2H), 
7.78 (dd, J = 5.5, 3.1 Hz, 2H), 2.74 (tt, J = 10.9, 3.7 Hz, 1H), 2.16 – 2.05 (m, 2H), 1.89 – 1.78 
(m, 2H), 1.66 (td, J = 14.0, 3.2 Hz, 3H), 1.36 (qdd, J = 11.1, 8.4, 2.9 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ = 171.86, 16β.1γ (β C), 1γ4.71 (β C), 1β9.0β (β C), 1βγ.9γ (β C), 40.48, 
28.80 (2 C), 25.47, 25.04 (2 C). The redox potential of P7 was determined as -1.23 V (vs. 
SCE, irreversible peak) by cyclic voltametry. 
Analytical data match to the reported data.142 
 
1,3-Dioxoisoindolin-2-yl adamantanate (238). 
 
Adamantanecarboxylic acid (1.83 g, 9.21 mmol, 1 equiv.) in DCM (20 ml) was added to a 
solution of N-hydroxyphthalimide (1.53 g, 9.38 mmol, 1 equiv.) and NEt3 (1.30 ml, 
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9.38 mmol, 1 equiv.) in DCM (80 ml) and stirred at room temperature for 2 h. The reaction 
mixture was washed with water (100 ml), a half-saturated NaHCO3 solution (100 ml) and a 
saturated NaCl solution (100 ml). The organic phase was dried over MgSO4, filtrated and the 
solvent was removed under reduced pressure, which gave a white solid (2.42 g, 7.44 mmol, 
81%). 1H NMR (300 MHz, CDCl3) δ=7.9γ – 7.83 (m, 2H), 7.82 – 7.73 (m, 2H), 2.13 (m, J = 
6.0 Hz, 9H), 1.78 (d, J = 2.8 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ = 17γ.γ0, 16β.19, 
134.65, 129.09, 123.87, 40.53, 38.46, 36.20, 27.64. 
Analytical data match to the reported data.143 
 
1,3-Dioxoisoindolin-2-yl but-3-enoate (230). 
 
N-hydroxyphthalimide (1.92 g, 11.77 mmol, 1 equiv.) was added to a solution of 3-butanoic 
acid (1.0 ml, 11.77 mmol, 1 equiv.) in THF (80 ml). The solution was treated with DCC 
(2.45 g, 11.87 mmol, 1 equiv.) and stirred at room temperature for overnight. The solvent was 
removed under reduced pressure and the product was purified by column chromatography 
(hexanes/EtOAc = 3/1). Yield: 2.10 g (9.08 mmol, 77%) yellow solid. 1H NMR (400 MHz, 
CDCl3) δ = 7.9β – 7.86 (m, 2H), 7.83 – 7.76 (m, 2H), 5.97 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 
5.41 – 5.29 (m, 2H), 3.46 (dt, J = 6.7, 1.4 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ = 167.5γ, 
161.86 (2 C), 134.84 (2 C), 128.86 (2 C), 127.57, 124.03 (2 C), 120.63, 35.53. HRMS: 
(APCI-MS) m/z calculated for C12H10NO4 [M+H]: 232.0607, found 232.0604. 
 
2-(piperidin-1-yl)benzaldehyde (247). 
 
A solution of 2-Fluorobenzaldehyde (246, 1.06 ml, 10.06 mmol, 1 equiv.), piperidine (1.1 ml, 
11.14 mmol, 1.1 equiv.) and potassium carbonate (2.2 g, 15.92 mmol, 2.2 equiv.) in DMF 
(25 ml) was heated at 155 °C for 20 h. Water was added to the cooled reaction mixture and 
the solution was extracted with ethyl acetate (3x 50 ml). The combined organic phases were 
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washed with water (3x 50 ml) and brine (1x 50 ml), dried over Na2SO4 and filtered. The 
solvent was removed under reduced pressure, yielding 1.58 g (8.35 mmol, 83%) of dark 
orange oil. 1H NMR (300 MHz, CDCl3) δ = 10.β9 (d, J = 0.7 Hz, 1H), 7.78 (dd, J = 7.7, 1.7 
Hz, 1H), 7.49 (ddd, J = 8.2, 7.2, 1.8 Hz, 1H), 7.12 – 7.00 (m, 2H), 3.09 – 2.98 (m, 4H), 1.75 
(dt, J = 10.9, 5.6 Hz, 4H), 1.59 (ddd, J = 7.7, 5.6, 3.8 Hz, 2H). 13C NMR (75 MHz, CDCl3) 
δ = 191.78, 157.02, 134.85, 129.18, 128.59, 121.97, 118.99, 55.64 (2 C), 26.20 (2 C), 24.06. 
Analytical data match to the reported data.144 
 
3-(2-(piperidin-1-yl)phenyl)propanoic acid (248). 
 
To a solution of benzaldehyde 247 (1.58 g, 8.35 mmol, 1 equiv.) in pyridine (20 ml) were 
added dropwise a solution of malonic acid (1.30 g, 12.52 mmol, 1.5 equiv.) in pyridine 
(10 ml). The reaction mixture was stirred under reflux conditions (120 °C) for 2 h. The 
mixture was acidified with 1 M HCl and extracted with ethyl acetate (3x 50 ml). The 
combined organic phases were dried over Na2SO4, filtered and the solvent was removed under 
reduced pressure. The residue was dissolved in EtOH and a catalytic amount of 10% 
palladium on activated carbon (300 mg) was added. The reaction was stirred under hydrogen 
atmosphere and room temperature for overnight. The mixture was filtered through Celite pat 
and the solvent was removed under reduced pressure yielding 1.82 g (7.79 mmol, 93%) of 
brown oil. 1H NMR (300 MHz, CDCl3) δ = 7.ββ – 7.12 (m, 2H), 7.11 – 7.06 (m, 1H), 7.02 
(td, J = 7.3, 1.4 Hz, 1H), 3.03 – 2.90 (m, 3H), 2.87 – 2.82 (m, 3H), 2.66 (t, J = 7.6 Hz, 2H), 
1.71 (dd, J = 10.5, 5.4 Hz, 4H), 1.55 (d, J = 5.3 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ = 
176.84, 150.77, 136.49, 130.38, 127.51, 125.15, 120.30, 54.81, 44.18, 37.09, 26.41, 25.90, 
23.92, 22.69. HRMS: (ES-MS) m/z calculated for C14H20NO2 [M+H]: 234.1489, found 
234.1493. 
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1,3-dioxoisoindolin-2-yl 3-(2-(piperidin-1-yl)phenyl)propanoate (249). 
 
Compound 249 was prepared from acid 248 (1.81 g, 7.76 mmol, 1 equiv.), N-
hydroxyphthalimide (1.28 g, 7.85 mmol, 1 equiv.) and DCC (1.61 g, 7.80 mmol, 1 equiv.) 
following general protocol D. Column chromatography (hexanes/EtOAc = 4:1 → 2:1) and 
recrystallization in EtOH gave a yellow solid. Yield: 0.53 g (1.40 mmol, 18%). 
Rf (hexanes/EtOAc = 5/1) = 0.3. 1H NMR (300 MHz, CDCl3) δ = 7.94 – 7.85 (m, 2H), 7.83 – 
7.76 (m, 2H), 7.25 – 7.18 (m, 2H), 7.17 – 7.11 (m, 1H), 7.06 (t, J = 7.3 Hz, 1H), 3.18 – 3.03 
(m, 4H), 2.89 – 2.79 (m, 4H), 1.79 – 1.68 (m, 4H), 1.58 (d, J = 5.1 Hz, 2H). 13C NMR (75 
MHz, CDCl3) δ = 169.57, 16β.04, 1γ4.88, 1γ4.76 (β C), 1β9.80 (β C), 1β8.98 (β C), 1β7.71 (β 
C), 124.06, 123.98 (2 C), 120.89, 54.43 (2 C), 31.59, 26.95, 26.70 (2 C), 24.34. HRMS: (ES-
MS) m/z calculated for C22H23N2O4 [M+H]: 379.1652, found 379.1658. 
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3 Naphthalindiimide ester derivatives 
2,7-dihydroxybenzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone (259). 
 
Naphthalene[1,8:4,5]tetracarboxylic acid dianhydride (1.54 g, 5.74 mmol, 1 equiv.) and 
hydroxylamine hydrochloride (0.834 mg, 12 mmol, 2 equiv.) were dissolved in DMF (25 ml). 
Tributylamine (3 ml, 12 mmol, 2 equiv.) were added and the stirred at 140 °C for 1 h. The 
reaction was cooled to room temperature and diluted with acetonitrile (25 ml). The brown 
precipitate was filtrated and washed with acetonitrile and diethylether. Yield: 1.46 g 
(4.89 mmol, 85%). IR (neat): 3474, 3422, 3261, 3086, 2654, 1659, 1580, 1446, 1413, 1346, 
1238, 1208, 1126, 1003, 895, 839, 738, 671 cm-1. 1H σMR (γ00 MHz, DMSτ) δ = 11.0β (s, 
2H), 8.67 (s, 4H). 13C σMR (75 MHz, DMSτ) δ = 159.97 (4 C), 1γ0.48 (4 C), 1β6.80 (6 C). 
LRMS: (ES-MS) m/z calculated for C14H7N2O6 [M+H]: 299.21, found 299.0297. 
Analytical data match to the reported data.145 
 
1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl bis(4-(N-tert-
butyl-4-methoxybenzamido)butanoate) (109). 
 
Compound 109 was prepared from acid 73t (1.0 g, 3.41 mmol, 2 equiv.), naphthalindiimid 
259 (0.506 g, 1.70 mmol, 1 equiv.) and DCC (0.778 g, 3.77 mmol, 2.2 equiv.) following 
general protocol D. The solvent was evaporated and ice cooled dichloromethane was added. 
The precipitated urea was removed by filtration and the solvent was removed under reduced 
pressure. Purification by column chromatography on flash silica gel (hexanes/EtOAc = 1/2, 
Rf = 0.53) 0.25 g (0.295 mmol, 17%) yellow solid. IR (neat): 3325, 2930, 2848, 1800, 1730, 
1633, 1510, 1446, 1394, 1334, 1293, 1245, 1200, 1096, 1059, 980, 876, 839, 697, 749 cm-1. 
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1H NMR (400 MHz, CDCl3) δ = 8.80 (s, 4H), 7.γ6 – 7.31 (m, 4H), 6.89 – 6.86 (m, 4H), 3.78 
(s, 6H), 3.57 – 3.49 (m, 4H), 2.50 (t, J = 7.2 Hz, 4H), 2.05 – 1.96 (m, 4H), 1.56 (s, 18H). 13C 
NMR (101 MHz, CDCl3) δ = 17γ.66, 168.47, 160.10, 157.8β, 1γ1.8γ, 1γ1.75, 1β8.14, 1β7.04, 
126.51, 113.81, 57.15, 55.27, 46.74, 29.06, 28.59, 26.80. HRMS: (ES-MS) m/z calculated for 
C46H49N4O12 [M+H]: 849.3341, found 849.3352. 
 
1,3,6,8-Tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl bis(3-(N-tert-
butyl-3,4,5-trimethoxybenzamido)propanoate) (110). 
 
Compound 110 was prepared from acid 73n (0.521 g, 1.54 mmol, 2 equiv.), naphthalindiimid 
259 (0.23 g, 0.772 mmol, 1 equiv.) and DCC (0.318 g, 1.54 mmol, 2 equiv.) following 
general protocol D. Purification by column chromatography (hexanes/EtOAc = 1/4, 
R = 0.40). Desired product was insoluble in methanol. Yield: 117.3 mg (0.125 mmol, 16%) 
yellow solid. 1H NMR (300 MHz, CDCl3) δ = 8.76 (s, 4H), 6.58 (s, 4H), γ.88 (s, 1βH), γ.87 – 
3.83 (m, 4H), 3.83 (s, 6H), 2.99 (dd, J = 8.9, 6.4 Hz, 4H), 1.59 (s, 18H). 13C NMR (75 MHz, 
CDCl3) δ = 17γ.γ9 (2 C), 166.58 (2 C), 157.69 (4 C), 153.47 (4 C), 138.84 (2 C), 134.34 (2 
C), 131.87 (4 C), 126.95 (4 C), 126.48 (2 C), 103.36 (4 C), 60.90 (2 C), 57.64 (2 C), 56.28 (4 
C), 42.61 (2 C), 33.76 (2 C), 28.99 (6 C). LRMS: (ES-MS) m/z calculated for C48H53N4O16 
[M+H]: 941.3394, found 941.3458. 
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4 Photochemical decarboxylations 
4.1 Photoinduced ȕ-phenylethylamine synthesis 
General protocol F 
General procedure for visible light-promoted decarboxylations:  
A Schlenk tube with a magnetic stir bar was charged with N-acyloxyphthalimide (1 mmol, 
1 equiv.) and the photocatalyst [Ir(ppy)2(dtb-bpy)]PF6 (10 µmol, 1 mol%) in 10 ml 
acetonitrile/water (40/1, v/v) mixture (0.1 M concentration). The solution was degassed using 
three freeze-pump-thaw cycles and closed with a Teflon-sealed inlet for a glass rod, through 
which irradiation with a 455 nm high power LED took place. The photochemical reaction was 
stirred at room temperature and monitored by TLC analysis. After completion the solvent was 
removed under reduced pressure. The residue was purified by flash silica gel column 
chromatography or by extraction. For this the solvent was evaporated, the residue dissolved in 
EtOAc and extracted with 1 M HCl (3 x). The water phase was basified with KOH and 
extracted with dichloromethane (3 x). The side product phthalimide (hexanes/EtOAc = 2/1; 
Rf = 0.51) could be isolated in > 95% yield. 
 
N-(4-methoxyphenethyl)-2-methylpropan-2-amine (75/78a). 
 
Compound 75 was prepared from 74 (205.2 mg, 0.483 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(4.5 mg, 4.9 µmol, 1 mol%) following general protocol F. Yield: 77.8 mg (0.293 mmol, 61%) 
orange oil. Rf (dichloromethane/EtOAc = 5/1) = 0.23. 1H NMR (300 MHz, CDCl3) δ = 7.17 – 
7.09 (m, 2H), 6.87 – 6.80 (m, 2H), 3.78 (s, 3H), 2.84 – 2.72 (m, 4H), 1.10 (s, 9H). 13C NMR 
(75 MHz, CDCl3) δ = 158.β5, 1γ0.77, 1β9.7β (β C), 11γ.99 (β C), 55.β7, 5γ.β1, 4γ.75, γγ.91, 
27.38 (3 C). HRMS: (CI-MS) m/z calculated for C13H22NO [M+H]: 208.1696, found 
208.1699. 
Analytical data match to the reported data.146,147 
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N-(3-methoxyphenethyl)-2-methylpropan-2-amine (78b). 
 
Compound 78b was prepared from 77b (430.4 mg, 1.01 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(10.0 mg, 10.9 µmol, 1 mol%) following general protocol F. Yield: 70.0 mg (0.338 mmol, 
33%) yellow oil. 1H NMR (300 MHz, CDCl3) δ = 7.β5 – 7.16 (m, 1H), 6.82 (d, J = 7.6 Hz, 
1H), 6.75 (dt, J = 2.6, 1.9 Hz, 2H), 3.79 (s, 3H), 2.90 – 2.72 (m, 4H), 1.10 (s, 9H). 13C NMR 
(75 MHz, CDCl3) δ = 159.67, 141.68, 1β9.44, 1β1.06, 114.γ8, 111.5β, 55.17, 50.71, 4γ.9β, 
36.95, 28.81 (3 C). HRMS: (CI-MS) m/z calculated for C13H22NO [M+H]: 208.1696, found 
208.1698. 
 
N-(2-methoxyphenethyl)-2-methylpropan-2-amine (78c). 
 
Compound 78c was prepared from 77c (524.0 mg, 1.23 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(11.5 mg, 12.5 µmol, 1 mol%) following general protocol F. Yield: 110.0 mg (0.53 mmol, 
43%) yellow oil. 1H NMR (300 MHz, CDCl3) δ = 7.βγ – 7.14 (m, 2H), 6.92 – 6.81 (m, 2H), 
3.81 (s, 3H), 2.79 (s, 4H), 1.08 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 157.66, 1γ0.γ0, 
128.69, 127.39, 120.42, 110.38, 55.27, 50.42, 42.74, 31.86, 29.00 (3 C). HRMS: (ES-MS) 
m/z calculated for C13H22NO [M+H]: 208.1696, found 208.1696. 
Analytical data match to the reported data.146 
 
N-(4-chlorophenethyl)-2-methylpropan-2-amine (78d). 
 
Compound 78d was prepared from 77d (456.7 mg, 1.07 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(10.0 mg, 10.9 µmol, 1 mol%) following general protocol F. Yield: 102.3 mg (0.483 mmol, 
45%) yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.41 (d, J = 8.3 Hz, 2H), 7.09 (d, J = 8.3 
Hz, 2H), 2.80 (m, 2H), 2.75 (m, 2H), 1.08 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 1γ6.β4, 
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132.65, 130.13 (2 C), 128.83 (2 C), 55.21, 43.03, 32.66, 26.35 (3 C). HRMS: (CI-MS) m/z 
calculated for C12H19ClN [M+H]: 212.1201, found 212.1205. 
Analytical data match to the reported data.146,148 
 
N-(3-chlorophenethyl)-2-methylpropan-2-amine (78e). 
 
Compound 78e was prepared from 77e (425.0 mg, 0.991 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.2 mg, 10.1 µmol, 1 mol%) following general protocol F. Yield: 44.8 mg (0.212 mmol, 
21%) yellow oil. 1H NMR (300 MHz, CDCl3) δ = 1H NMR (400 MHz, CDCl3) δ = 7.β5 – 
7.15 (m, 3H), 7.10 (d, J = 7.1 Hz, 1H), 2.84 – 2.78 (m, 2H), 2.77 – 2.71 (m, 2H), 1.08 (s, 9H). 
13C NMR (75 MHz, CDCl3) δ = 141.β5, 1γγ.1β, 1β8.6β, 1β7.7γ, 1β5.86, 1β5.γ1, 49.γ8, 4β.78, 
35.86, 27.92 (3 C). HRMS: (ES-MS) m/z calculated for C12H19ClN [M+H]: 212.1201, found 
212.1202. 
Analytical data match to the reported data.148 
 
N-(4-bromophenethyl)-2-methylpropan-2-amine (78f). 
 
Compound 78f was prepared from 77f (330.2 mg, 0.698 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(7.0 mg, 7.7 µmol, 1 mol%) following general protocol F. Yield: 87.5 mg (0.342 mmol, 49%) 
orange oil. 1H NMR (400 MHz, CDCl3) δ = 7.41 (d, J = 8.3 Hz, 2H), 7.09 (d, J = 8.3 Hz, 2H), 
2.80 (m, 2H), 2.75 (m, 2H), 1.08 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 1γ6.16, 1γ1.91 (β 
C), 130.49 (2 C), 120.95, 56.66, 43.09, 32.36, 26.12 (3 C). HRMS: (ES-MS) m/z calculated 
for C13H22N [M+H]: 256.0695, found 256.0700. 
Analytical data match to the reported data.146 
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2-Methyl-N-(4-methylphenethyl)propan-2-amine (78g). 
 
Compound 78g was prepared from 77g (409 mg, 1.0 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.4 mg, 10.3 µmol, 1 mol%) following general protocol F. Yield: 86.3 mg (0.451 mmol, 
45%) orange oil. 1H NMR (300 MHz, CDCl3) δ = 7.15 – 7.05 (m, 4H), 2.91 – 2.73 (m, 4H), 
2.32 (s, 3H), 1.13 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 1γ6.γ0, 1γ5.84, 1β9.β1 (β C), 
128.60 (2 C), 52.00, 43.91, 35.35, 28.04 (3 C), 21.04. HRMS: (ES-MS) m/z calculated for 
C13H22N [M+H]: 192.1747, found 192.1747. 
 
2-Methyl-N-phenethylpropan-2-amine (77h). 
 
Compound 77h was prepared from 78h (312.9 mg, 0.793 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.5 mg, 10.4 µmol, 1.3 mol%) following general protocol F. Yield: 40.2 mg (0.227 mmol, 
29%) pale yellow oil. 1H NMR (300 MHz, CDCl3) δ = 7.β6 – 7.12 (m, 5H), 2.92 (qd, J = 7.7, 
4.4 Hz, 4H), 1.99 (s, 1H), 1.22 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 1γ7.79, 1γ4.18, 
128.79, 128.71, 126.80, 123.47, 55.23, 43.20, 33.26, 26.32 (3 C). HRMS: (CI-MS) m/z 
calculated for C13H22NO [M+H]: 178.1589, found 178.1590. 
Analytical data match to the reported data.146, 147 
 
N-(3-chloro-4-methoxyphenethyl)-2-methylpropan-2-amine (78i). 
 
Compound 78i was prepared from 77i (298.1 mg, 0.650 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(7.2 mg, 7.87 µmol, 1.2 mol%) following general protocol F. Yield: 93.5 mg (0.387 mmol, 
60%) colorless oil. 1H NMR (300 MHz, CDCl3) δ = 7.ββ (d, J = 2.1 Hz, 1H), 7.06 (dd, J = 
8.4, 2.2 Hz, 1H), 6.84 (d, J = 8.4 Hz, 1H), 3.87 (s, 3H), 2.83 – 2.74 (m, 2H), 2.74 – 2.66 (m, 
2H), 1.08 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 15γ.γ8, 1γγ.γ4, 1γ0.γ0, 1β7.86, 1ββ.19, 
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112.05, 56.17, 50.48, 44.01, 35.96, 28.94 (3 C). HRMS: (ES-MS) m/z calculated for 
C13H21ClNO [M+H]: 242.1306, found 242.1308. 
 
N-(2,6-dimethoxyphenethyl)-2-methylpropan-2-amine (78j). 
 
Compound 78j was prepared from 77j (463.8 mg, 1.02 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(10.2 mg, 11.1 µmol, 1.1 mol%) following general protocol F. Yield: 92.3 mg (0.398 mmol, 
38%) yellow oil. 1H NMR (400 MHz, CDCl3) δ = 7.1β (t, J = 8.3 Hz, 1H), 6.53 (d, J = 8.3 
Hz, 2H), 3.80 (s, 6H), 2.84 – 2.79 (m, 2H), 2.70 – 2.64 (m, 2H), 1.06 (s, 9H). 13C NMR (75 
MHz, CDCl3) δ = 158.51 (β C), 1β7.0β, 116.9γ, 10γ.65 (β C), 55.66 (β C), 50.β6, 4β.09, 
29.05 (3 C), 24.71. HRMS: (ES-MS) m/z calculated for C14H24NO2 [M+H]: 238.1802, found 
238.1803. 
 
N-tert-butyl-2-(4-methoxyphenyl)propan-1-amine (78k). 
 
Compound 78k was prepared from 77k (425.2 mg, 0.970 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.7 mg, 10.6 µmol, 1.1 mol%) following general protocol F. Yield: 113.2 mg (0.512 mmol, 
53%) yellow oil. Rf (hexanes/EtOAc = 1/1, with 10% NEt3) = 0.32. 1H NMR (300 MHz, 
CDCl3) δ = 7.14 – 7.10 (m, 2H), 6.85 – 6.81 (m, 2H), 3.76 (s, 3H), 2.87 – 2.75 (m, 1H), 2.74 
– 2.67 (m, 2H), 1.21 (d, J = 6.7 Hz, 3H), 1.02 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 158.06, 
137.49, 128.07 (2 C), 113.91 (2 C), 55.22, 50.10, 49.83, 39.77, 28.89 (2 C), 20.87. HRMS: 
(APCI-MS) m/z calculated for C14H24NO [M+H]: 222.1852, found 222.1857. 
Analytical data match to the reported data.146 
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2-tert-butyl-6,7-dimethoxy-3,4-dihydroisoquinolin-1(2H)-one (79). 
 
Compound 79 was prepared from 77m (456 mg, 1.0 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.5 mg, 10.3 µmol, 1 mol%) following general protocol F. Yield: 214.7 mg (0.815 mmol, 
82%) pale yellow solid, m.p. = 138-140 °C. Rf (hexanes/EtOAc = 1/1) = 0.45. IR (neat): 
2997, 2960, 2930, 1726, 1633, 1599, 1510, 1465, 1429, 1357, 1334, 1219, 1148, 1070, 992, 
880, 808, 746 cm-1. 1H NMR (300 MHz, CDCl3) δ = 7.60 (s, 1H), 6.60 (s, 1H), γ.90 (d, J = 
2.2 Hz, 6H), 3.62 – 3.52 (m, 2H), 2.91 – 2.78 (m, 2H), 1.53 (s, 9H). 13C NMR (101 MHz, 
CDCl3) δ = 165.76, 151.49, 147.90, 1γ1.79, 1β4.14, 110.57, 108.60, 57.β9, 56.0γ, 56.00, 
42.62, 29.01 (3 C). HRMS: (ES-MS) m/z calculated for C15H21NO3 [M+]: 263.1521, found 
263.1525.  
Analytical data match to the reported data.146 
 
2-tert-butyl-6,7,8-trimethoxy-3,4-dihydroisoquinolin-1(2H)-one (80). 
 
Compound 80 was prepared from 77n (490.0 mg, 1.01 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.5 mg, 10.3 µmol, 1 mol%) following general protocol F. Yield: 222.7 mg (0.759 mmol, 
75%) pale yellow solid, m.p. = 98-101 °C. Rf (hexanes/EtOAc = 2/1) = 0.18. IR (neat): 2963, 
2926, 1633, 1595, 1487, 1457, 1402, 1357, 1308, 1260, 1215, 1190, 1148, 1118, 1025, 969, 
928, 850, 824, 734, 667 cm-1. 1H NMR (300 MHz, CDCl3) δ = 6.41 (s, 1H), γ.94 (s, γH), γ.86 
(s, 3H), 3.84 (s, 3H), 3.51 – 3.44 (m, 2H), 2.79 – 2.71 (m, 2H), 1.54 (s, 9H). 13C NMR (75 
MHz, CDCl3) δ = 16γ.67, 155.00, 154.9γ, 141.81, 1γ6.07, 119.00, 104.66, 61.75, 61.09, 
57.25, 55.95, 42.27, 31.08, 29.24 (3 C). HRMS: (ES-MS) m/z calculated for C15H22NO2 
[M+H]: 294.17, found 294.1706. 
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6,7-Dihydrothieno[3,2-c]pyridin-4(5H)-one (63). 
 
Compound 63 was prepared from 60 (408.2 mg, 0.986 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(10.1 mg, 11.0 µmol, 1.1 mol%) following general protocol F. The crude product was treated 
with TFA and stirred at room temperature for 12 h. TFA was removed under reduced pressure 
and product was purified by column chromatography (eluted with pure MeOH).Yield: 
68.0 mg (0.444 mmol, 45%) yellow solid. 1H NMR (300 MHz, CDCl3) δ = 7.4γ (d, J = 5.2 
Hz, 1H), 7.12 (d, J = 5.2 Hz, 1H), 6.35 (s, 1H), 3.66 (td, J = 6.9, 2.7 Hz, 2H), 3.07 (t, J = 6.9 
Hz, 2H). HRMS: (ES-MS) m/z calculated for C7H8NOS [M+H]: 154.0321, found 154.0322. 
 
N-tert-butyl-4-methoxybenzamide (101). 
 
Compound 101 was prepared from 97 (412.0 mg, 1.0 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.0 mg, 9.9 µmol, 1 mol%) following general protocol F. Yield: 175.3 mg (0.846 mmol, 
85%) white solid. Rf (hexanes/EtOAc = 1/1) = 0.70. 1H NMR (300 MHz, CDCl3) δ = 7.74 – 
7.62 (m, 2H), 6.93 – 6.85 (m, 2H), 5.88 (s, 1H), 3.83 (s, 3H), 1.45 (s, 9H). 13C NMR (75 
MHz, CDCl3) δ = 166.45, 161.84, 1β8.46 (β C), 1β8.18, 11γ.61 (β C), 55.40, 51.47, β8.95 (γ 
C). 13C NMR (75 MHz, CDCl3) δ = 166.45, 161.84, 1β8.46 (β C), 1β8.18 (2 C), 113.61, 
55.40, 51.47, 28.95 (3 C). 
Analytical data match to the reported data.149  
 
tert-Butyl 4-methoxyphenethylcarbamate (122). 
 
Compound 122 was prepared from 118 (234 mg, 0.515 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(5.1 mg, 5.6 µmol, 1.1 mol%) following general protocol F. Yield: 67.3 mg (268 mmol, 52%) 
colorless oil. 1H NMR (300 MHz, CDCl3) δ 7.10 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 
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4.53 (s, 1H), 3.79 (s, 3H), 3.33 (d, J = 6.6 Hz, 2H), 2.73 (t, J = 7.0 Hz, 2H), 1.43 (s, 9H). 13C 
NMR (101 MHz, CDCl3) δ = 158.β4, 155.9β, 1γ1.0γ, 1β9.75 (β C), 114.0β (β C), 79.19, 
55.28, 41.99, 35.30, 28.43 (3 C). LRMS: (ES-MS) m/z calculated for C10H14NO3 [M-C4H8]: 
296.22, found 296.0903. 
Analytical data match to the reported data.150 
 
4.2 Photoinduced carbamate synthesis 
Methyl tert-butyl(4-methoxyphenethyl)carbamate (85a). 
 
Compound 85a was prepared from 77a (224.4 mg, 0.528 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(3.2 mg, 3.5 µmol, 0.7 mol%) following general protocol F. As solvent 4 ml MeCN and 70 µl 
methanol (3 equiv.) was used. Yield: 89.0 mg (0.335 mmol, 64%) pale yellow oil. 
Rf (DCM/EtOAc = 19/1) = 0.84. 1H NMR (300 MHz, CDCl3) δ = 7.11 (d, J = 8.6 Hz, 2H), 
6.84 (d, J = 8.6 Hz, 2H), 3.78 (d, J = 4.1 Hz, 3H), 3.68 (s, 3H), 3.49 – 3.40 (m, 2H), 2.74 (dd, 
J = 9.4, 7.0 Hz, 2H), 1.42 (d, J = 4.8 Hz, 9H). 13C NMR (101 MHz, CDCl3) δ = 158.1β, 
156.58, 131.59, 129.64 (2 C), 113.90 (2 C), 55.84, 55.28, 51.88, 46.94, 36.63, 29.39 (3 C). 
HRMS: (ES-MS) m/z calculated for C15H24NO3 [M+H]: 266.1751, found 266.1745. 
 
Isopropyl tert-butyl(4-methoxyphenethyl)carbamate (85b). 
 
Compound 85b was prepared from 77a (206.8 mg, 0.487 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(2.9 mg, 3.2 µmol, 0.7 mol%) following general protocol F. As solvent 4 ml MeCN and 
120 µl 2-propanol (3 equiv.) was used. Yield: 83.2 mg (0.284 mmol, 58%) yellow oil. 
Rf (DCM/EtOAc = 19/1) = 0.87. 1H NMR (400 MHz, CDCl3) δ = 7.11 (d, J = 8.6 Hz, 2H), 
6.84 (d, J = 8.6 Hz, 2H), 4.96 (dt, J = 12.5, 6.2 Hz, 1H), 3.79 (s, 3H), 3.48 – 3.39 (m, 2H), 
2.74 (dd, J = 9.4, 7.0 Hz, 2H), 1.43 (s, 9H), 1.29 (d, J = 6.2 Hz, 6H). 13C NMR (101 MHz, 
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CDCl3) δ = 158.1γ, 155.7β, 1γ1.75, 1β9.62 (2 C), 113.94 (2 C), 67.74, 55.66, 55.28, 47.00, 
36.73, 29.54 (3 C), 22.36 (2 C). HRMS: (ES-MS) m/z calculated for C17H28NO3 [M+H]: 
294.2064, found 294.2068. 
 
tert-butyl tert-butyl(4-methoxyphenethyl)carbamate (85c). 
 
Compound 85c was prepared from 77a (200.1 mg, 0.471 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(3.1 mg, 3.4 µmol, 0.7 mol%) following general protocol F. As solvent 4 ml MeCN and 
140 µl tert-butyl alcohol (3 equiv.) was used. Yield: 53.3 mg (0.173 mmol, 37%) yellow oil. 
Rf (DCM/EtOAc = 19/1) = 0.88. 1H NMR (400 MHz, CDCl3) δ = 7.11 (d, J = 8.6 Hz, 2H), 
6.83 (d, J = 8.6 Hz, 2H), 3.79 (s, 3H), 3.44 – 3.35 (m, 2H), 2.74 (dd, J = 9.5, 7.0 Hz, 2H), 
1.50 (s, 9H), 1.42 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 158.09, 1γ1.85, 1β9.87, 1β9.64 (β 
C), 113.92 (2 C), 79.08, 55.39, 55.28, 47.20, 36.68, 29.67 (3 C), 28.67 (3 C). HRMS: (ES-
MS) m/z calculated for C18H30NO3 [M+H]: 308.222, found 308.222. 
 
Methyl tert-butyl(2-methoxyphenethyl)carbamate (85d). 
 
Compound 85d was prepared from 77c (520.0 mg, 1.23 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(11.0 mg, 12.0 µmol, 1 mol%) following general protocol F. As solvent 10 ml MeCN and 
140 µl methanol (3 equiv.) was used. Yield: 122.5 mg (0.462 mmol, 38%) yellow oil. 
Rf (DCM/EtOAc = 19/1) = 0.77. IR (neat): 2960, 2840, 1700, 1588, 1491, 1465, 1361, 1290, 
1241, 1178, 1081, 1029, 775, 753 cm -1. 1H NMR (400 MHz, CDCl3) δ = 7.19 (td, J = 7.9, 1.7 
Hz, 1H), 7.14 (dd, J = 7.4, 1.6 Hz, 1H), 6.89 (td, J = 7.4, 1.0 Hz, 1H), 6.85 (d, J = 8.2 Hz, 
1H), 3.82 (s, 3H), 3.68 (s, 3H), 3.49 – 3.43 (m, 2H), 2.82 (dd, J = 9.1, 7.0 Hz, 2H), 1.44 (s, 
9H). 13C NMR (101 MHz, CDCl3) δ = 157.64, 156.66, 1γ0.56, 1β7.9γ, 1β7.56, 1β0.5γ, 
110.18, 55.89, 55.16, 51.76, 45.05, 32.13, 29.31 (3 C). LRMS: (ES-MS) m/z calculated for 
C15H24NO3 [M+H]: 266.1751, found 266.1754. 
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Methyl tert-butyl(4-chlorophenethyl)carbamate (85e). 
 
Compound 85e was prepared from 77d (206.8 mg, 0.483 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(4.2 mg, 4.6 µmol, 1 mol%) following general protocol F. As solvent 5 ml MeCN and 60 µl 
methanol (3 equiv.) was used. Yield: 88.6 mg (0.328 mmol, 68%) colorless oil. 
Rf (hexanes/EtOAc = 2/1) = 0.82. IR (neat): 2960, 1703, 1491, 1439, 1364, 1288, 1256, 1178, 
1149, 1085, 1014, 850, 775, 701, 682 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.β5 (d, J = 8.3 
Hz, 2H), 7.11 (d, J = 8.3 Hz, 2H), 3.67 (s, 3H), 3.48 – 3.42 (m, 2H), 2.80 – 2.72 (m, 2H), 1.42 
(s, 9H). 13C NMR (101 MHz, CDCl3) δ = 156.54, 1γ7.9β, 1γβ.07, 1γ0.08 (β C), 1β8.60 (β C), 
55.91, 51.93, 46.58, 36.91, 29.41 (3 C). HRMS: (ES-MS) m/z calculated for C14H21ClNO2 
[M+H]: 270.1255, found 270.1262. 
 
Ethyl tert-butyl(4-chlorophenethyl)carbamate (85f). 
 
Compound 85f was prepared from 77d (429.8 mg, 1.00 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.4 mg, 10.3 µmol, 1 mol%) following general protocol F. As solvent 10 ml MeCN and 
120 µl ethanol (3 equiv.) was used. Yield: 199.7 mg (0.704 mmol, 70%) colorless oil. 
Rf (hexanes/EtOAc = 2/1) = 0.84. 1H NMR (300 MHz, CDCl3) δ = 7.β8 – 7.22 (m, 2H), 7.11 
(dd, J = 8.7, 2.1 Hz, 2H), 4.12 (q, J = 7.1 Hz, 2H), 3.49 – 3.40 (m, 2H), 2.76 (dd, J = 9.3, 7.0 
Hz, 2H), 1.42 (s, 9H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 156.11, 
137.99, 132.04, 130.06 (2 C), 128.61 (2 C), 60.65, 55.80, 46.62, 36.94, 29.47 (3 C), 14.69. 
HRMS: (ES-MS) m/z calculated for C15H23ClNO2 [M+H]: 284.1412, found 284.1418. 
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Isopropyl tert-butyl(4-chlorophenethyl)carbamate (85g). 
 
Compound 85g was prepared from 77d (241.4 mg, 0.563 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(5.2 mg, 5.7 µmol, 1 mol%) following general protocol F. As solvent 2 ml MeCN and 200 µl 
2-propanol (4 equiv.) was used. Yield: 94.4 mg (0.317 mmol, 56%) colorless oil. 
Rf (hexanes/EtOAc = 2/1) = 0.87. 1H NMR (300 MHz, CDCl3) δ = 7.β5 (d, J = 8.4 Hz, 2H), 
7.11 (d, J = 8.5 Hz, 2H), 4.95 (hept, J = 6.2 Hz, 1H), 3.49 – 3.38 (m, 2H), 2.76 (dd, J = 9.4, 
7.0 Hz, 2H), 1.42 (s, 9H), 1.28 (s, 3H), 1.26 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 155.67, 
138.05, 132.02, 130.05 (2 C), 128.61 (2 C), 67.89, 55.69, 46.64, 36.96, 29.54 (3 C), 22.33. 
HRMS: (ES-MS) m/z calculated for C16H25ClNO2 [M+H]: 298.1568, found 298.157. 
 
tert-butyl tert-butyl(4-chlorophenethyl)carbamate (85h). 
 
Compound 85h was prepared from 77d (78.7 mg, 0.184 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(1.8 mg, 2.0 µmol, 1.1 mol%) following general protocol F. As solvent 2 ml MeCN and 
100 µl tert-butyl alcohol (5 equiv.) was used. Yield: 20.2 mg (65 µmol, 35%) colorless oil. 
Rf (hexanes/EtOAc = 2/1) = 0.90. 1H NMR (300 MHz, CDCl3) δ = 7.β1 (dd, J = 6.7, 1.6 Hz, 
2H), 7.07 (d, J = 8.4 Hz, 2H), 3.40 – 3.32 (m, 2H), 2.72 (dd, J = 9.4, 6.9 Hz, 2H), 1.45 (s, 
9H), 1.37 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 155.γ6, 1γ8.14, 1γ1.96, 1γ0.07 (β C), 
128.58 (2 C), 79.28, 55.42, 46.81, 36.91, 29.69 (3 C), 28.64 (3 C). HRMS: (ES-MS) m/z 
calculated for C17H27ClNO2 [M+H]: 312.1725, found 312.1728. 
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Benzyl tert-butyl(4-chlorophenethyl)carbamate (85i). 
 
Compound 85i was prepared from 77d (232.6 mg, 0.542 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(5.4 mg, 5.9 µmol, 1 mol%) following general protocol F. As solvent 2 ml MeCN and 200 µl 
benzyl alcohol (2 equiv.) was used. Yield: 112.4 mg (0.325 µmol, 60%) colorless oil. 
Rf (hexanes/EtOAc = 2/1) = 0.85. 1H NMR (300 MHz, CDCl3) δ = 7.4β – 7.32 (m, 5H), 7.20 
(d, J = 8.5 Hz, 2H), 7.00 (d, J = 8.4 Hz, 2H), 5.13 (s, 2H), 3.53 – 3.42 (m, 2H), 2.76 (dd, J = 
9.3, 7.0 Hz, 2H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 155.7β, 1γ7.78, 1γ6.91, 
132.04, 130.05 (2 C), 128.58 (2 C), 128.53 (2 C), 128.08 (2 C), 128.00, 66.80, 56.07, 46.73, 
37.02, 29.40 (3 C). HRMS: (ES-MS) m/z calculated for C20H25ClNO2 [M+H]: 346.1568, 
found 346.1574. 
 
N-tert-Butyl-N-(3-(isopropylamino)-3-oxopropyl)-4-methoxybenzamide (86a). 
 
Compound 86a was prepared from 74 (208.4 mg, 0.491 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(3.1 mg, 3.4 µmol, 1 mol%) following general protocol F. As solvent 4 ml MeCN and 85 µl 
isopropylamine (2 equiv.) was used. Yield: 143.2 mg (0.447 µmol, 91%) yellow solid. 
Rf (hexanes/EtOAc = 1/1) = 0.15. 1H NMR (300 MHz, CDCl3) δ = 7.γ4 – 7.27 (m, 2H), 6.90 
– 6.84 (m, 2H), 5.17 (s, 1H), 3.97 – 3.83 (m, 1H), 3.81 (d, J = 8.7 Hz, 3H), 3.70 – 3.56 (m, 
2H), 2.34 – 2.20 (m, 2H), 1.49 (s, 9H), 1.00 (d, J = 6.6 Hz, 6H). 13C NMR (101 MHz, CDCl3) 
δ = 173.65, 169.15, 160.17, 131.89, 128.06 (2 C), 113.78, (2 C) 57.23, 55.30, 43.93, 41.20, 
38.88, 29.15 (3 C), 22.61 (2 C). LRMS: (ES-MS) m/z calculated for C18H29N2O3 [M+H]: 
321.43, found 321.2183. 
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N-tert-Butyl-N-(3-(dimethylamino)-3-oxopropyl)-4-methoxybenzamide (86b). 
 
Compound 86b was prepared from 74 (212.1 mg, 0.450 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(3.3 mg, 3.6 µmol, 1 mol%) following general protocol F. As solvent 4 ml MeCN and 70 µl 
dimethylamine (2 equiv.) was used. Yield: 126.4 mg (0.413 µmol, 92%) colorless oil. 
Rf (hexanes/EtOAc = 1/1) = 0.22. 1H NMR (300 MHz, CDCl3) δ = 7.β8 – 7.21 (m, 2H), 6.82 
– 6.75 (m, 2H), 3.72 (s, 3H), 3.67 – 3.54 (m, 2H), 2.74 (s, 3H), 2.70 (s, 3H), 2.40 – 2.31 (m, 
2H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 17γ.6β, 170.09, 160.10, 1γ1.71, 1β8.09 (β 
C), 113.73 (2 C), 57.16, 55.30, 43.68, 36.85, 35.09, 34.98, 29.10. 
 
N-(3-(Benzylamino)-3-oxopropyl)-N-tert-butyl-4-methoxybenzamide (86c). 
 
Compound 86c was prepared from 74 (210.6 mg, 0.496 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(3.5 mg, 3.8 µmol, 1 mol%) following general protocol F. As solvent 4 ml MeCN and 110 µl 
dimethylamine (2 equiv.) was used. Yield: 164.5 mg (0.446 µmol, 90%) white solid. 
Rf (hexanes/EtOAc = 1/1) = 0.20. 1H NMR (300 MHz, CDCl3) δ = 7.β6 (m, 5H), 7.17 – 7.09 
(m, 2H), 6.86 – 6.79 (m, 2H), 5.88 (s, 1H), 4.48 (d, J = 5.7 Hz, 1H), 4.26 (d, J = 5.5 Hz, 2H), 
3.77 (s, 3H), 3.72 – 3.60 (m, 2H), 2.41 – 2.24 (m, 2H), 1.49 (s, 9H). 13C NMR (101 MHz, 
CDCl3) δ = 17γ.67, 169.0γ, 160.β0, 1γ7.80, 134.54, 130.36, 128.78 (2 C), 128.73 (2 C), 
128.44, 128.07, 127.87 (2 C), 127.75, 127.60, 113.79 (2 C), 57.25, 55.30, 44.15, 43.50, 38.59, 
29.20 (3 C). 
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4.3 Photoinduced benzoazepinone synthesis 
2-tert-butyl-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105a). 
 
Compound 105a was prepared from 102a (300.0 mg, 0.734 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(7.9 mg, 8.6 µmol, 1.2 mol%) following general protocol F. Purification by column 
chromatography (hexanes/EtOAc = 2/1, Rf = 0.62) gave 69.0 mg (0.318 mmol, 43%) 
colorless oil. 1H NMR (300 MHz, CDCl3) δ = 7.70 – 7.64 (m, 1H), 7.32 – 7.27 (m, 2H), 7.11 
– 7.04 (m, 1H), 3.23 (t, J = 6.3 Hz, 2H), 2.78 (t, J = 7.0 Hz, 2H), 1.89 (p, J = 6.8 Hz, 2H), 
1.54 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 171.99, 1γ8.γ9, 1γ7.ββ, 1γ0.47, 1β8.67, 1β7.95, 
126.88, 57.03, 42.74, 31.49, 30.10, 28.82 (3 C). HRMS: (ES-MS) m/z calculated for 
C14H19NO [M+]: 218.1539, found 218.1544. 
 
6-tert-butyl-6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one (105b) 
 
Compound 105b was prepared from 102b (412.8 mg, 1.01 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.4 mg, 10.3 µmol, 1 mol%) following general protocol F. For column chromatography 
neutral alumina oxide (DCM/EtOAc = 1/1, Rf = 0.54) was used. Yield: 76.6 mg (0.351 µmol, 
35%) yellow oil. 1H NMR (400 MHz, CDCl3) δ = 8.60 (d, J = 5.0 Hz, 1H), 8.42 (s, 1H), 7.56 
(d, J = 5.0 Hz, 1H), 3.24 (t, J = 6.3 Hz, 2H), 2.82 (t, J = 7.1 Hz, 2H), 2.00 – 1.92 (m, 2H), 
1.56 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 169.57, 148.86, 148.74, 145.76, 1γ1.47, 
122.18, 57.57, 42.43, 30.91, 28.65 (3 C), 26.67. HRMS: (CI-MS) m/z calculated for 
C13H19N2O [M+H]: 219.1492, found 219.1496. 
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2-tert-butyl-7-methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105c). 
 
Compound 105c was prepared from 102c (440.2 mg, 1.01 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.4 mg, 10 µmol, 1 mol%) following general protocol F. For column chromatography 
neutral alumina oxide (DCM/EtOAc = 9/1, Rf = 0.59) was used. Yield: 152.3 mg (0.61 mmol, 
60%) yellow oil. IR (neat):2960, 2863, 1785, 1737, 1633, 1599, 1491, 11457, 1387, 1316, 
1249, 1197, 1167, 1092, 1036, 831, 779, 716 cm -1. 1H NMR (400 MHz, CDCl3) δ = 7.65 (d, 
J = 8.5 Hz, 1H), 6.80 (dd, J = 8.5, 2.6 Hz, 1H), 6.62 (d, J = 2.6 Hz, 1H), 3.81 (s, 3H), 3.25 (t, 
J = 6.3 Hz, 2H), 2.77 (t, J = 7.0 Hz, 2H), 1.89 (p, J = 6.8 Hz, 2H), 1.54 (s, 9H). 13C NMR 
(101 MHz, CDCl3) δ = 17β.04, 161.β8, 1γ9.49, 1γ0.95, 130.79, 113.66, 111.60, 56.89, 55.26, 
42.92, 31.46, 30.61, 28.84 (3 C). HRMS: (ES-MS) m/z calculated for C15H22NO2 [M+H]: 
248.1645, found 248.1648. 
 
2-tert-butyl-8-chloro-7-methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105d´). 
 
2-tert-butyl-6-chloro-7-methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105d´´). 
 
Compound 105d´ and 105d´´ were prepared from 102d (459.7 mg, 1.03 mmol) and 
[Ir(ppy)2(dtb-bpy)]PF6 (9.5 mg, 10.4 µmol, 1 mol%) following general protocol F. 
Purification by column chromatography (dichloromethane/EtOAc = 10/1) gave 105d´ in 
52.8 mg (0.187 mmol, 18%) as white solid and 105d´´ in 127.4 mg (0.452 mmol, 44%) as 
white solid.  
Compound 105d´: 
M.p. = 135-138 °C. Rf (DCM/EtOAc = 10/1) = 0.69. IR (neat): 3012, 2933, 2863, 1722, 1628, 
1595, 1491, 1446, 1409, 1361, 1301, 1223, 1148, 1051, 936, 898, 842, 775, 712 cm-1. 1H 
NMR (300 MHz, CDCl3) δ = 7.71 (s, 1H), 6.64 (s, 1H), γ.91 (s, γH), γ.β4 (t, J = 6.3 Hz, 2H), 
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2.77 (t, J = 7.0 Hz, 2H), 1.91 (p, J = 6.7 Hz, 2H), 1.52 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 
= 170.76, 156.32, 137.83, 131.48, 131.02, 120.70, 111.44, 57.10, 56.22, 42.79, 31.36, 30.44, 
28.75 (3 C). HRMS: (ES-MS) m/z calculated for C15H21ClNO2 [M+H]: 282.1255, found 
282.1260. 
Compound 105d´´: 
M.p. = 135-138 °C. Rf (DCM/EtOAc = 10/1) = 0.45. IR (neat): 3194, 3079, 2952, 2862, 1726, 
1633, 1592, 1562, 1476, 1439, 1387, 1301, 1260, 1189, 1141, 1062, 917, 883, 801, 716, 
671 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.58 (d, J = 8.6 Hz, 1H), 6.85 (d, J = 8.6 Hz, 1H), 
3.91 (s, 3H), 3.21 (t, J = 6.2 Hz, 2H), 3.06 (t, J = 6.8 Hz, 2H), 1.88 (p, J = 6.6 Hz, 2H), 1.55 
(s, 9H). 13C NMR (101 MHz, CDCl3) δ = 171.05, 156.55, 136.52, 134.28, 132.44, 128.07, 
123.57, 120.62, 109.62, 57.18, 56.29, 42.86, 30.26, 28.85 (3 C), 25.82. HRMS: (ES-MS) m/z 
calculated for C15H21ClNO2 [M+H]: 282.1255, found 282.1261. 
 
2-tert-butyl-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105e´). 
 
2-tert-butyl-6,7-dimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105e´´). 
 
Compound 105e´ and 105e´´ were prepared from 102e (468.5 mg, 1.0 mmol) and 
[Ir(ppy)2(dtb-bpy)]PF6 (9.3 mg, 10.2 µmol, 1 mol%) following general protocol F. For 
column chromatography neutral alumina oxide (hexanes/EtOAc = 4/1) was used. Yield 105e´: 
134.0 mg (0.483 mmol, 48%) pale yellow solid. Yield 105e´´: 28.6 mg (0.103 mmol, 10%) 
pale yellow solid.  
Compound 105e´: 
Rf (hexanes/EtOAc = 4/1) = 0.24. Ir (neat): 2963, 2930, 2863, 1625, 1599, 1536, 1446, 1415, 
1368, 1334, 1282, 1261, 1215, 1033, 1088, 1029, 957, 869, 783 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.β5 (s, 1H), 6.58 (s, 1H), γ.88 (s, 6H), γ.β5 (t, J = 6.3 Hz, 2H), 2.73 (t, J = 7.0 
Hz, 2H), 1.89 (p, J = 6.7 Hz, 2H), 1.53 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 17β.β0, 
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150.42, 147.52, 130.93, 130.19, 111.90, 110.93, 56.98, 56.00, 55.93, 43.01, 31.86, 30.08, 
28.90, 28.81 (3 C). HRMS: (ES-MS) m/z calculated for C16H24NO3 [M+H]: 278.1751, found 
278.1757. 
Compound 105e´´: 
Rf (hexanes/EtOAc = 4/1) = 0.33. Ir (neat): 2963, 2930, 2863, 1629, 1599, 1510, 1450, 1417, 
1383, 1359, 1260, 1215, 1077, 1029, 958, 869, 749 cm-1. 1H NMR (300 MHz, CDCl3) δ = 
7.44 (d, J = 8.5 Hz, 1H), 6.83 (d, J = 8.6 Hz, 1H), 3.87 (s, 3H), 3.75 (s, 3H), 3.23 (t, J = 6.3 
Hz, 2H), 2.89 (t, J = 6.9 Hz, 2H), 1.54 (s, 9H). 13C NMR (75 MHz, CDCl3) δ = 170.7γ, 
153.36, 143.99, 130.97, 130.42, 124.14, 108.84, 60.18, 55.91, 54.66, 41.90, 29.99, 27.80 (3 
C), 20.43. HRMS: (ES-MS) m/z calculated for C16H24NO3 [M+H]: 278.1751, found 
278.1753. 
 
N-tert-Butyl-2,4,6-trimethyl-N-propylbenzamide (105f). 
 
Compound 105f was prepared from 102f (225.0 mg, 0.5 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(4.7 mg, 5.1 µmol, 1 mol%) following general protocol F. Yield: 31.9 mg (0.122 mmol, 24%) 
white solid. Rf (hexanes/EtOAc = 4/1) = 0.58. IR (neat): 2960, 2922, 2874, 1625, 1454, 1387, 
1361, 1297, 1252, 1200, 1144, 1070, 1036, 887, 753, 690 cm-1. 1H NMR (300 MHz, CDCl3) δ 
= 6.79 (d, J = 0.4 Hz, 2H), 3.04 – 2.95 (m, 2H), 2.26 (s, 3H), 2.22 (s, 6H), 1.57 (s, 9H), 1.46 – 
1.33 (m, 2H), 0.58 (t, J = 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 171.80, 1γ6.97, 
136.22, 132.92 (2 C), 128.23 (2 C), 57.11, 48.61, 28.91 (3 C), 24.69, 21.10, 19.12 (2 C), 
11.29. LRMS: (ES-MS) m/z calculated for C17H28NO [M+H]: 262.21, found 262.2178. 
 
N-tert-butyl-2,6-dimethoxy-N-propylbenzamide (105g). 
 
Compound 105g was prepared from 102g (424.0 mg, 0.905 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(10.1 mg, 11.1 µmol, 1.2 mol%) following general protocol F. Purification by column 
chromatography (hexanes/EtOAc = 1/1, Rf = 0.30) gave 113.5 mg (0.406 mmol, 45%) pale 
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yellow oil. 1H NMR (300 MHz, CDCl3) δ = 7.19 (t, J = 8.4 Hz, 1H), 6.52 (d, J = 8.4 Hz, 2H), 
3.78 (s, 6H), 3.06 – 2.98 (m, 2H), 1.55 (s, 9H), 1.48 – 1.37 (m, 2H), 0.56 (t, J = 7.4 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ = 167.59, 156.1β (β C), 1β9.β1, 118.γ7, 10γ.96 (β C), 57.0γ, 
55.81 (2 C), 48.83, 29.00 (3 C), 24.69, 11.28. HRMS: (ES-MS) m/z calculated for C16H26NO3 
[M+H]: 280.1907, found 280.1915. 
 
2-tert-butyl-6,7,8-trimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105h). 
 
N-tert-butyl-3,4,5-trimethoxy-N-propylbenzamide (260). 
 
Compound 105h and 260 were prepared from 102h (50.0 mg, 0.1 mmol) and [Ir(ppy)2(dtb-
bpy)]PF6 (1.87 mg, 10.2 µmol, 2 mol%) following general protocol F. For column 
chromatography neutral alumina oxide (hexanes/EtOAc = 4/1) was used. Yield 105h: 20 mg 
(65 µmol, 43%) pale yellow solid. Yield 260: 15 mg (48 µmol, 38%) yellow oil.  
Compound 105h: 
Rf (hexanes/EtOAc = 4/1) = 0.52. IR (neat): 2960, 2937, 1752, 1722, 1636, 1592, 1484, 1457, 
1416, 1387, 1323, 1241, 1193, 1111, 1074, 1033, 954, 917, 857, 809, 690 cm-1. 1H NMR (300 
MHz, CDCl3) δ = 7.04 (s, 1H), γ.86 (s, γH), γ.84 (s, γH), γ.77 (s, γH), γ.ββ (t, J = 6.2 Hz, 
2H), 2.79 (t, J = 6.9 Hz, 2H), 1.89 – 1.76 (m, 2H), 1.52 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 
= 171.66, 151.75, 150.02, 144.07, 133.94, 123.73, 108.05, 61.57, 60.87, 57.12, 56.01, 42.93, 
31.35, 28.79 (3 C), 20.97. HRMS: (ES-MS) m/z calculated for C17H26NO4 [M+H]: 308.1856, 
found 308.1863. 
Compound 260: 
Rf (hexanes/EtOAc = 4/1) = 0.35. IR (neat):  2933, 2837, 1722, 1633, 1584, 1502, 1457, 
1394, 1327, 1293, 1230, 1126, 1006, 951, 850, 775, 697 cm-1. 1H NMR (300 MHz, CDCl3) δ 
= 6.54 (s, 2H), 3.86 (s, 6H), 3.84 (s, 3H), 3.21 (dd, J = 9.7, 6.0 Hz, 2H), 1.54 (s, 11H), 0.67 (t, 
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J = 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 17γ.05, 153.22 (2 C), 138.28, 135.45, 
103.47 (2 C), 60.96, 56.97, 56.26 (2 C), 49.43, 28.88 (3 C), 25.61, 11.19. HRMS: (ES-MS) 
m/z calculated for C17H28NO4 [M+H]: 310.2013, found 310.2017. 
 
6-methoxy-2-methyl-1,2,3,4-tetrahydronaphthalene (130). 
 
Compound 130 was prepared from 127 (214 mg, 0.58 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(5 mg, 5.5 µmol, 1 mol%) following general protocol F. Purification via column 
chromatography with pure hexanes. Yield: 50 mg (0.284 mmol, 49%) white solid. IR (neat): 
2960, 2922, 2855, 1715, 1607, 1498, 1461, 1379, 1260, 1085, 1010, 865, 787, 701 cm-1. 1H 
NMR (300 MHz, CDCl3) δ = 6.97 (d, J = 8.3 Hz, 1H), 6.68 (dd, J = 8.3, 2.7 Hz, 1H), 6.63 (d, 
J = 2.6 Hz, 1H), 3.77 (s, 3H), 2.82 – 2.72 (m, 3H), 2.37 – 2.27 (m, 1H), 1.92 – 1.78 (m, 2H), 
1.43 – 1.33 (m, 1H), 1.05 (d, J = 6.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 157.40, 1γ7.75, 
129.84, 129.12, 113.40, 111.77, 55.26, 37.32, 31.47, 29.64, 29.52, 22.03. 
Analytical data match to the reported data.151 
 
3,4-Dihydronaphthalen-1(2H)-one (134). 
 
Compound 134 was prepared from 133 (189.6 mg, 0.56 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(7.3 mg, 8.0 µmol, 1.4 mol%) following general protocol F. Yield: 15.3 mg (0.105 mmol, 
19%) white solid. Rf (hexanes/EtOAc = 3/1) = 0.71. 1H NMR (300 MHz, CDCl3) δ = 7.99 
(dd, J = 7.8, 1.3 Hz, 1H), 7.42 (td, J = 7.5, 1.5 Hz, 1H), 7.26 (ddd, J = 7.9, 1.2, 0.6 Hz, 1H), 
7.21 (t, J = 3.8 Hz, 1H), 2.93 (t, J = 6.1 Hz, 2H), 2.66 – 2.57 (m, 2H), 2.16 – 2.04 (m, 2H). 
13C NMR (101 MHz, CDCl3) δ = 198.41, 144.51, 1γγ.40, 132.65, 128.78, 127.19, 126.65, 
39.19, 29.73, 23.31. 
Analytical data match to the reported data.152 
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4.4 UV light-mediated reactions 
General protocol G 
General procedure for UV light-promoted decarboxylations:  
N-acyloxyphthalimide (1 mmol, 1 equiv.) was dissolved in acetone (60 ml) and a solution of 
corresponding phenylacetic acid (3 mmol, 3 equiv.) and potassium carbonate (1.5 mmol, 
1.5 equiv.) in water (60 ml) was added. The mixture was degassed for 10 min in a Pyrex 
Schlenk flask (internal diameter (ID): 30 mm) equipped with a cold finger (outer diameter 
(OD): 20 mm) with a slow stream of nitrogen. While the continuous stream of nitrogen the 
solution was irradiated until full conversion of the starting material (judged by TLC, typically 
3 h) in a Rayonet chamber reactor equipped with 16 x 8 W RPR-3000 Å lamps. The acetone 
was evaporated under reduced pressure and the remaining water phase was extracted with 
dichloromethane (3 x 40 ml). The organic layer was washed with a saturated NaHCO3 
solution (50 ml) and brine (50 ml), dried over Na2SO4 and evaporated. Purification by column 
chromatography. 
 
Dihydrostilbene synthesis 
1,2-Diphenylethane (172/168a). 
 
Compound 168a was prepared from 171 (168.6 mg, 0. 60 mmol, 1 equiv.), phenylacetic acic 
(248 mg, 1.82 mmol, 3 equiv.) and K2CO3 (126 mg, 1.82 mmol, 1.5 equiv.) following general 
protocol G. Yield: gave 65.1 mg (0.360 mmol, 59%) as a white solid. Rf (hexanes/EtOAc, 
1/1) = 0.94. 1H NMR (300 MHz, CDCl3) δ = 7.γγ – 7.26 (m, 2H), 7.21 (ddd, J = 6.8, 3.8, 1.2 
Hz, 3H), 2.93 (s, 2H). 13C NMR (75 MHz, CDCl3) δ = 141.9β (β C), 1β8.59 (4 C), 1β8.47 (4 
C), 126.05 (2 C), 38.09 (2 C). 
Analytical data match to the reported data.153 
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1,2-Di-p-tolylethane (168b). 
 
Compound 168b was prepared from 166b (284.5 mg, 0.96 mmol, 1 equiv.), p-tolylacetic acic 
(445.3 mg, 2.97 mmol, 3 equiv.) and K2CO3 (203 mg, 1.47 mmol, 1.5 equiv.) following 
general protocol G. Yield: 125.8 mg (0.598 mmol, 62%), white solid, m.p. = 75-76 °C. 
Rf (hexanes/EtOAc, 1/1) = 0.96. 1H NMR (300 MHz, CDCl3) δ = 7.10 (s, 4H), β.87 (s, βH), 
2.33 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 1γ9.01 (β C), 1γ5.4γ (β C), 1β9.14 (4 C), 
128.43 (4 C), 37.79 (2 C), 21.16 (2 C). 
Analytical data match to the reported data.153 
 
1,2-Di-m-tolylethane (168c). 
 
Compound 168c was prepared from 166c (284.9 mg, 0.96 mmol, 1 equiv.), 2-m-tolylacetic 
acic (449.1 mg, 2.99 mmol, 3 equiv.) and K2CO3 (207 mg, 1.5 mmol, 1.5 equiv.) following 
general protocol G. Yield: 165.9 mg (0. 79 mmol, 82%), white solid. Rf (hexanes/EtOAc, 
1/1) = 0.9. 1H NMR (300 MHz, CDCl3) δ = 7.β1 (t, J = 7.2 Hz, 2H), 7.04 (d, J = 8.8 Hz, 6H), 
2.89 (s, 4H), 2.36 (s, 6H). 13C NMR (75 MHz, CDCl3) δ = 14β.06 (2 C), 138.01 (2 C), 129.40 
(2 C), 128.40 (2 C), 126.79 (2 C), 125.56 (2 C), 38.17 (2 C), 21.56 (2 C). 
Analytical data match to the reported data.154 
 
1,2-Bis(4-fluorophenyl)ethane (168d). 
 
Compound 168d was prepared from 166d (295.2 mg, 0.986 mmol, 1 equiv.), 4-
fuorophenylacetic acic (450 mg, 2.92 mmol, 3 equiv.) and K2CO3 (205 mg, 1.48 mmol, 
1.5 equiv.) following general protocol G. Yield: 106.9 mg (0.490 mmol, 50%), yellow solid, 
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m.p. = 89-91 °C. Rf (hexanes/EtOAc, 1/1) = 0.94. 1H NMR (300 MHz, CDCl33) δ = 7.1β 
(ddd, J = 8.0, 5.4, 2.3 Hz, 4H), 7.06 – 6.92 (m, 4H), 2.90 (d, J = 2.2 Hz, 4H). 13C NMR (75 
MHz, CDCl3) δ = 161.47 (d, J = 243.5 Hz, 2 C), 137.09 (d, J = 3.2 Hz, 2 C), 129.96 (d, J = 
7.8 Hz, 4 C), 115.18 (d, J = 21.1 Hz, 4 C), 37.26 (s, 2 C). 
Analytical data match to the reported data.153 
 
1,2-Bis(4-bromophenyl)ethane (168e). 
 
Compound 168e was prepared from 166e (249.3 mg, 0.692 mmol, 1 equiv.), 4-
bromophenylacetic acic (443.9 mg, 2.06 mmol, 3 equiv.) and K2CO3 (143 mg, 1.03 mmol, 
1.5 equiv.) following general protocol G. Yield: 143.9 mg (0.423 mmol, 61%), yellow solid, 
m.p. = 101-106 °C. Rf (hexanes/EtOAc, 1/1) = 0.81. 1H NMR (300 MHz, CDCl3) δ = 7.4β – 
7.35 (m, 4H), 7.03 – 6.96 (m, 4H), 2.85 (s, 4H). 13C NMR (75 MHz, CDCl3) δ = 140.ββ (β C), 
131.55 (4 C), 130.38 (4 C), 119.95 (2 C), 37.15 (2 C). 
Analytical data match to the reported data.153 
 
1,2-Bis(4-methoxyphenyl)ethane (165/168f). 
 
Compound 168f was prepared from 163 (311.6 mg, 1.00 mmol, 1 equiv.), 2-p-
methoxyphenylacetic acid (454.6 mg, 2.74 mmol, 2.7 equiv.) and K2CO3 (230 mg, 
1.66 mmol, 1.6 equiv.) following general protocol G. Yield: 173.9 mg (0.718 mmol, 72%), 
white solid, m.p. = 127-128 °C. Rf (hexanes/EtOAc, 1/1) = 0.86. 1H NMR (300 MHz, CDCl3) 
δ = 7.15 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 3.84 (s, 3H), 2.90 (s, 2H). 13C NMR (75 
MHz, CDCl3) δ = 157.86 (β C), 1γ4.01 (β C), 1β9.44 (4 C), 11γ.77 (4 C), 55.β7 (β C), γ7.γ6 
(2 C). HRMS: (EI-MS) m/z calculated for C16H18O2 [M+]: 242.1307, found 242.1305. 
Analytical data match to the reported data.155 
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1,2-Bis(3,4,5-trimethoxyphenyl)ethane (168g). 
 
Compound 168g was prepared from 166g (369.4 mg, 1.00 mmol, 1 equiv.), 2-(3,4,5-
trimethoxyphenyl)acetic acid (235.1 mg, 1.04 mmol, 1 equiv.) and K2CO3 (204 mg, 
1.48 mmol, 1.5 equiv.) following general protocol G. Yield: 100.8 mg (0.278 mmol, 28%), 
yellow solid, m.p. = 135-137 °C. Rf (hexanes/EtOAc, 1/1) = 0.56. 1H NMR (300 MHz, 
CDCl3) δ = 6.γ6 (s, 4H), γ.8β (s, 18H), β.84 (s, 4H). 13C NMR (75 MHz, CDCl3) δ = 15γ.17 
(4 C), 137.46 (2 C), 136.34 (2 C), 105.60 (4 C), 61.00 (2 C), 56.19 (4 C), 38.57 (2 C). 
Analytical data match to the reported data.156 
 
4,4'-(Ethane-1,2-diyl)bis(N,N-dimethylaniline) (168h). 
 
Compound 168h was prepared from 166h (320.9 mg, 0.99 mmol, 1 equiv.), 4-
dimethylaminophenylacetic acic (533.1 mg, 2.97 mmol, 3 equiv.) and K2CO3 (230 mg, 
1.66 mmol, 1.6 equiv.) following general protocol G. Yield: 44.5 mg (0.166 mmol, 17%), 
brown solid. Rf (hexanes/EtOAc, 1/1) = 0.89. 1H NMR (300 MHz, cdcl3) δ = 7.10 (d, J = 8.8 
Hz, 4H), 6.72 (d, J = 6.2 Hz, 4H), 2.92 (d, J = 5.0 Hz, 12H), 2.80 (s, 4H). 13C NMR (75 MHz, 
cdcl3) δ = 149.08 (β C), 1β9.44 (β C), 1β9.04 (4 C), 11γ.11 (4 C), 41.0γ (4 C), γ7.γ7 (β C). 
Analytical data match to the reported data.157 
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1,1,2,2-tetraphenylethane (168i). 
 
Compound 168i was prepared from 166i (356.5 mg, 1.68 mmol, 1 equiv.), diphenylacetic acic 
(636.1 mg, 2.97 mmol, 3 equiv.) and K2CO3 (240 mg, 1.74 mmol, 1.5 equiv.) following 
general protocol G. Yield: 242.9 mg (0.726 mmol, 43%), pale yellow solid. 
Rf (hexanes/EtOAc, 4/1) = 0.87. 1H NMR (300 MHz, CDCl3) δ = 7.19 – 7.08 (m, 6H), 7.04 – 
6.98 (m, 4H), 4.78 (s, 2H). 13C NMR (75 MHz, CDCl3) δ = 14γ.50 (4 C), 1β8.55 (8 C), 
128.19 (8 C), 125.89 (4 C), 56.36 (2 C). 
Analytical data match to the reported data.158 
 
UV light-mediated benzylation of N-methoxyphthalimide 
2-Methoxyisoindoline-1,3-dione (261). 
 
Methyl iodide (1.05 ml, 16.8 mmol, 1.1 equiv.) was added dropwise to a solution of N-
hydroxyphthalimide (2.5 g, 15.33 mmol, 1 equiv.) and K2CO3 (2.54 g, 18.4 mmol, 1.2 equiv.) 
in DMF (50 ml). The reaction mixture was stirred for overnight. Water (60 ml) was added and 
the orange solution was extracted with dichloromethane (2x 100 ml). The combined organic 
phases were washed with water (2x 100 ml), dried with Na2SO4 and removed under reduced 
pressure. Purification by column chromatography (hexanes/EtOAc = 1/1, Rf = 0.58) gave the 
product 261 (2.0 g, 11.3 mmol, 83%) as pale yellow crystals. 1H NMR (300 MHz, CDCl3) δ = 
7.86 – 7.77 (m, 2H), 7.77 – 7.69 (m, 2H), 4.04 (s, 3H). 13C NMR (75 MHz, CDCl3) δ = 
163.33 (2 C), 134.61 (2 C), 128.97 (2 C), 123.62 (2 C), 65.92. 
Analytical data match to the reported data.159 
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3-Benzyl-3-hydroxy-2-methoxyisoindolin-1-one (181).160 
 
Photodecarboxylative benzylation under batch conditions 
N-Methoxyphthalimide (261, 170 mg, 0.96 mmol, 1 equiv.) was dissolved in acetone (30 ml). 
A solution of phenylacetic acid (400 mg, 2.94 mmol, 3 equiv.) in a pH 7 buffer (Fixanal®, 
30 ml) was added, and the mixture was irradiated in a Pyrex Schlenk tube for 26 h, while 
purging with a slow stream of nitrogen. Acetone was removed under reduced pressure and the 
remaining solution was extracted with dichloromethane (2 x 30 ml), dried over Na2SO4, 
filtered, and the solvent was evapurated. Purification by column chromatography 
(hexanes/EtOAc = 1/1, Rf = 0.27) and crystallization (DCM/n-hexane) gave a colorless solid 
(188.1 mg, 70 mmol, 73%). M.p. = 133-134 °C. IR (neat): 3228, 3030, 2930, 1688, 1498, 
1485, 1456, 1435, 1368, 1339, 1297, 1223, 1194, 1126, 1077, 1036, 999, 951, 902, 775, 
697 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.51 (dd, J = 11.8, 4.3 Hz, 2H), 7.40 – 7.34 (m, 
1H), 7.31 (d, J = 7.4 Hz, 1H), 7.10 – 7.04 (m, 3H), 6.93 (dd, J = 7.2, 2.3 Hz, 2H), 4.14 (s, 
3H), 3.47 (d, J = 13.5 Hz, 1H), 3.40 (d, J = 13.5 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ = 
163.62, 143.09, 133.92, 132.55, 130.40 (2 C), 129.78, 128.70, 127.94 (2 C), 127.01, 123.31, 
122.48, 91.70, 77.37, 77.05, 76.74, 66.09, 42.02. HRMS: (ES-MS) m/z calculated for 
C16H16NO3 [M+H]: 270.1125, found 270.1125. 
 
Photodecarboxylative benzylation under continuous-flow condition160 
A solution of N-methoxyphthalimide (261, 1-10 mmol) was dissolved in acetone (50 ml) and 
a solution of potassium phenylacetate (3-30 mmol) in water (50 ml) was added. The mixture 
was degassed and pumped through the UV-150 easy-Photochem reactor (Vapourtec Ltd, 
UK)161 at various flow rates while irradiated with a lamp power of 82 W. After complete 
collection of the product the reactor coil was flushed with additional acetone/water (~ 20 ml). 
Acetone was removed under reduced pressure and the remaining solution was extracted with 
dichloromethane (2 x 50 ml). The combined organic layer was washed eith saturated NaHCO3 
(1 x 50 ml) and brine (1 x 50 ml), dried over Na2SO4, filtered, and the solvent was evapurated. 
Conversion rates were subsequently determined via 1H NMR analysis. 
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4.5 Decarboxylative hydroxylation reactions 
(4-Methoxyphenyl)methanol (186b). 
 
General protocol H 
General procedure for the photochemical decarboxylaitive hydroxylation: A Schlenk tube 
with a magnetic stir bar was charged with N-acyloxyphthalimide 163 (416 mg, 1.34 mmol, 
1 equiv.) and the photocatalyst [Ir(ppy)2(dtb-bpy)]PF6 (11.2 mg, 1.2 µmol, 1 mol%) in 10 ml 
acetonitrile/water (2/1, v/v) mixture (0.1 M concentration). The solution was degassed using 
three freeze-pump-thaw cycles and closed with a Teflon-sealed inlet for a glass rod, through 
which irradiation with a 455 nm high power LED took place. The photochemical reaction was 
stirred at room temperature and monitored by TLC analysis. After completion the solvent was 
removed under reduced pressure. The residue was purified by flash silica gel column 
chromatography. Yield: 170.3 mg (1.23 mmol, 92%) white solid. 
Rf (hexanes/EtOAc = 1/2) = 0.86. 1H NMR (300 MHz, CDCl3) δ = 7.γ1 – 7.25 (m, 2H), 6.92 
– 6.84 (m, 2H), 4.60 (s, 2H), 3.80 (s, 3H), 2.03 (s, 1H). 
Analytical data match to the reported data.162 
 
(4-Chlorophenyl)methanol (186c). 
 
Compound 186c was prepared from 166j (408 mg, 1.29 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(10.9 mg, 11.9 µmol, 1 mol%) following general protocol H. Yield: 131.2 mg (0.92 mmol, 
71%) white solid. Rf (hexanes/EtOAc = 1/2) = 0.85.1H NMR (300 MHz, CDCl3) δ = 7.γ6 – 
7.30 (m, 4H), 4.68 (s, 2H), 1.25 (s, 1H). 
Analytical data match to the reported data.162 
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Diphenylmethanol (186d). 
 
Compound 186d was prepared from 166i (72.2 mg, 0.202 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(2.1 mg, 2.3 µmol, 1.1 mol%) following general protocol H. Yield: 27.1 mg (0.147 mmol, 
73%) white solid. Rf (hexanes/EtOAc = 1/1) = 0.70. 1H NMR (300 MHz, CDCl3) δ = 7.4γ – 
7.26 (m, 10H), 5.84 (s, 1H), 2.24 (s, 1H). 13C NMR (75 MHz, CDCl3) δ = 14γ.81 (β C), 
128.54 (4 C), 127.62 (2 C), 126.58 (4 C), 76.28. HRMS: (APCI-MS) m/z calculated for 
C13H11 [MH+-H2O]: 167.0855, found 167.0863. 
Analytical data match to the reported data.163 
 
(Ethoxymethylene)dibenzene (195). 
 
Compound 195 was prepared from 166i (70 mg, 0.196 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 
(3.1 mg, 3.4 µmol, 1.5 mol%) following general protocol H with a solvent mixture of 
MeCN/EtOH (1/1, conc.: 0.1 M). Yield: 28.4 mg (0.134 mmol, 68%) white solid. 1H NMR 
(400 MHz, CDCl3) δ = 7.40 – 7.28 (m, 8H), 7.23 (ddd, J = 6.2, 3.9, 1.6 Hz, 2H), 5.36 (s, 1H), 
3.53 (q, J = 7.0 Hz, 2H), 1.27 (t, J = 7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ = 14β.55 (β 
C), 128.38 (4 C), 127.36 (2 C), 126.96 (4 C), 83.50, 64.56, 15.37. 
Analytical data match to the reported data.164 
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4.6 Photoreactions of the decarboxylative α-amination 
General protocol I 
General procedure for visible light-promoted decarboxylative α-amination: 
A Schlenk tube with a magnetic stir bar was charged with N-acyloxyphthalimide (1 mmol, 
1 equiv.), 2-phenyl-1,2,3,4-tetrahydroisoquinoline (1 mmol, 1 equiv.) and the photocatalyst 
[Ir(ppy)2(dtb-bpy)]PF6 (10 µmol, 1 mol%) in 10 ml acetonitrile/water (40/1, v/v) mixture 
(0.1 M concentration). The solution was degassed using three freeze-pump-thaw cycles and 
closed with a Teflon-sealed inlet for a glass rod, through which irradiation with a 455 nm high 
power LED took place. The photochemical reaction was stirred at room temperature and 
monitored by TLC analysis. After completion the solvent was removed under reduced 
pressure. The residue was purified by flash silica gel column chromatography. 
 
1-Benzyl-2-phenyl-1,2,3,4-tetrahydroisoquinoline (224). 
 
Compound 224 was prepared from 171 (281.6 mg, 1.0 mmol, 1 equiv.), 2-phenyl-1,2,3,4-
tetrahydroisoquinoline (208, 209.6 mg, 1.0 mmol, 1 equiv.) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.1 mg, 1.0 µmol, 1 mol%) following general protocol I. Yield: 236.6 mg (0.79 mmol, 79%) 
brown oil. Rf (hexanes/EtOAc = 2/1) = 0.87. 1H NMR (300 MHz, CDCl3) δ = 7.β4 (dd, J = 
7.0, 1.4 Hz, 5H), 7.17 (dd, J = 6.3, 1.1 Hz, 2H), 7.07 – 7.02 (m, 3H), 6.87 (d, J = 8.1 Hz, 2H), 
6.75 (t, J = 7.3 Hz, 2H), 4.97 – 4.88 (m, 1H), 3.68 (ddd, J = 12.5, 7.6, 5.0 Hz, 1H), 3.60 – 
3.52 (m, 1H), 3.28 (dd, J = 13.3, 5.8 Hz, 1H), 3.06 – 2.95 (m, 2H), 2.82 – 2.72 (m, 1H). 13C 
NMR (75 MHz, CDCl3) δ = 149.γ5, 1γ8.89, 1γ7.65, 1γ5.1β, 1β9.8γ (β C), 1β9.β7 (β C), 
128.28, 128.19 (2 C), 127.69, 126.64, 126.30, 125.55, 117.21, 113.64 (2 C), 61.54, 42.45, 
42.14, 27.51. HRMS: (ES-MS) m/z calculated for C22H22N [M+H]: 300.1747, found 300. 
1749. 
Analytical data match to the reported data.165 
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1-(4-Methoxybenzyl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (229). 
 
Compound 229 was prepared from 163 (170.5 mg, 0.548 mmol, 1.1 equiv.), 2-phenyl-1,2,3,4-
tetrahydroisoquinoline (208, 103.7 mg, 0.496 mmol, 1 equiv.) and [Ir(ppy)2(dtb-bpy)]PF6 
(3.4 mg, 3.7 µmol, 0.74 mol%) following general protocol I. Yield: 108.6 mg (0.329 mmol, 
66%) yellow oil. Rf (hexanes/EtOAc = 3/1) = 0.74. 1H NMR (400 MHz, CDCl3) δ = 7.γγ (dd, 
J = 8.8, 7.3 Hz, 2H), 7.24 – 7.18 (m, 2H), 7.13 (td, J = 7.5, 1.8 Hz, 1H), 7.00 (d, J = 8.6 Hz, 
2H), 6.94 (d, J = 8.2 Hz, 2H), 6.83 (dd, J = 14.0, 7.9 Hz, 4H), 4.99 – 4.91 (m, 1H), 3.84 (s, 
3H), 3.70 (ddd, J = 12.4, 7.5, 5.0 Hz, 1H), 3.64 – 3.55 (m, 1H), 3.27 (dd, J = 13.5, 5.6 Hz, 
1H), 3.09 – 3.01 (m, 2H), 2.84 – 2.75 (m, 1H).  
Analytical data match to the reported data.165 
 
1-Allyl-2-phenyl-1,2,3,4-tetrahydroisoquinoline (231). 
 
Compound 231 was prepared from 230 (230 mg, 0.995 mmol, 1 equiv.), 2-phenyl-1,2,3,4-
tetrahydroisoquinoline (208, 208.2 mg, 0.994 mmol, 1 equiv.) and [Ir(ppy)2(dtb-bpy)]PF6 
(9.3 mg, 1.0 µmol, 1 mol%) following general protocol I. Yield: 128.4 mg (0.515 mmol, 
52%) yellow oil. Rf (hexanes/EtOAc = 5/1) = 0.83. 1H NMR (400 MHz, CDCl3) δ = 7.γ6 – 
7.27 (m, 2H), 7.25 – 7.13 (m, 4H), 6.96 (d, J = 8.2 Hz, 2H), 6.81 (t, J = 7.2 Hz, 1H), 5.93 
(ddt, J = 17.2, 10.2, 7.2 Hz, 1H), 5.18 – 5.08 (m, 2H), 4.82 (t, J = 6.8 Hz, 1H), 3.76 – 3.60 (m, 
2H), 3.09 (ddd, J = 15.7, 7.9, 5.7 Hz, 1H), 2.94 (dt, J = 15.9, 5.4 Hz, 1H), 2.81 (dt, J = 13.8, 
6.8 Hz, 1H), 2.56 (dt, J = 14.3, 7.2 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ = 149.4γ, 1γ8.16, 
135.69, 135.00, 129.28 (2 C), 128.53, 127.38, 126.58, 125.75, 117.24, 117.05, 113.88 (2 C), 
59.40, 41.93, 40.95, 27.42. HRMS: (ES-MS) m/z calculated for C18H20N [M+H]: 250.1590, 
found 250.1593. 
Analytical data match to the reported data.165 
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N-((2-Phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)benzamide (241). 
 
Compound 241 was prepared from 240 (33.6 mg, 0.104 mmol, 1 equiv.), 2-phenyl-1,2,3,4-
tetrahydroisoquinoline (208, 21.7 mg, 0.104 mmol, 1 equiv.) and [Ir(ppy)2(dtb-bpy)]PF6 
(1.0 mg, 1.1 µmol, 1.1 mol%) following general protocol I. Yield: 16.4 mg (48 µmol, 46%) 
yellow solid. Rf (hexanes/EtOAc = 3/1) = 0.29. 1H NMR (400 MHz, CDCl3) δ = 7.66 (d, J = 
7.7 Hz, 2H), 7.47 (t, J = 7.2 Hz, 1H), 7.39 (t, J = 7.5 Hz, 2H), 7.28 – 7.20 (m, 5H), 7.18 – 
7.13 (m, 1H), 7.06 (d, J = 8.2 Hz, 2H), 6.79 (t, J = 7.2 Hz, 1H), 6.49 (s, 1H), 5.02 (dd, J = 8.6, 
6.0 Hz, 1H), 3.96 – 3.84 (m, 1H), 3.76 (ddd, J = 13.6, 9.0, 4.4 Hz, 1H), 3.69 – 3.60 (m, 2H), 
3.12 – 2.99 (m, 1H), 2.81 (dt, J = 16.0, 4.5 Hz, 1H). LRMS: (ES-MS) m/z calculated for 
C23H23N2O [M+H]: 343.4300, found 343.1811. 
 
tert-Butyl (2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methylcarbamate (243). 
 
Compound 243 was prepared from 242 (33.1 mg, 0.103 mmol, 1 equiv.), 2-phenyl-1,2,3,4-
tetrahydroisoquinoline (208, 21.4 mg, 102 mmol, 1. equiv.) and [Ir(ppy)2(dtb-bpy)]PF6 
(0.9 mg, 1.0 µmol, 1 mol%) following general protocol I. Yield: 6.8 mg (20.1 µmol, 18%) 
yellow oil. Rf (hexanes/EtOAc = 3/1) = 0.63. 1H NMR (400 MHz, CDCl3) δ 7.ββ – 7.02 (m, 
6H), 6.93 (d, J = 8.0 Hz, 2H), 6.73 (t, J = 7.2 Hz, 1H), 4.83 (s, 1H), 3.68 – 3.43 (m, 3H), 3.38 
(s, 1H), 3.04 – 2.93 (m, 1H), 2.69 (d, J = 15.9 Hz, 1H), 1.41 (s, 9H). HRMS: (ES-MS) m/z 
calculated for C21H27N2O2 [M+H]: 339.2067, found 339.2073. 
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2,3,4,4a,5,6-hexahydro-1H-pyrido[1,2-a]quinoline (250) and 1-(2-ethylphenyl)piperidine 
(251). 
 
Compounds 250 and 251 were prepared from N-acyloxyphthalimide 249 (155.6 mg, 
0.411 mmol) and [Ir(ppy)2(dtb-bpy)]PF6 (4.0 mg, 4.3 µmol, 1 mol%) following general 
protocol F. Purification by column chromatography (hexanes/EtOAc = 2/1), Rf = 0.94) gave 
an inseparable mixture of 250 and 251. Yield: 29.3 mg (~19%).  
Compound 250: HRMS: (ES-MS) m/z calculated for C13H18N [M+H]: 188.1434, found 
188.1438. Compound 251: HRMS: (ES-MS) m/z calculated for C13H20N [M+H]: 190.1590, 
found 190.1592. 
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5 N-deprotection and synthesis of capsazepinoid 
precursor derivatives 
Methyl 4-methoxyphenethylcarbamate (87). 
 
Compound 85a (214.6 mg, 0.809 mmol) was dissolved in TFA (3 ml) and stirred at room 
temperature for 15 h. The solvent was removed under reduced pressure and a brown oil was 
isolated. Yield: 163.9 mg (0.783 mmol, 97%). 1H NMR (300 MHz, CDCl3) δ = 7.10 (d, J = 
8.6 Hz, 2H), 6.88 – 6.82 (m, 2H), 3.80 (s, 3H), 3.71 (s, 3H), 3.40 (s, 2H), 2.79 – 2.68 (m, 2H) 
1.36 (s, 1H). 13C NMR (75 MHz, CDCl3) δ = 159.60, 158.γ0, 1β9.7γ (β C), 1β6.9β, 114.1β (β 
C), 55.32, 55.12, 35.03, 29.66. HRMS: (APCI-MS) m/z calculated for C11H16NO3 [M+H]: 
210.1125, found 210.1131. 
Analytical data match to the reported data.166 
 
2-(4-Methoxyphenyl)ethanamine hydrochlorid (88). 
 
Compound 87 (150 mg, 0.717 mmol) was dissolved in a mixture of THF, MeOH and 2 M 
LiOH (1:1:1, 3 ml) and heated at 120 °C for 10 min in a microwave oven. The reaction 
mixture was treated with ethylacetate (10 ml) and 1 M NaOH solution and the phases were 
separated. The organic phase was extracted with 1 M HCl solution (2 x 10 ml) and the 
aqueous phase was removed under reduced pressure. 2-(4-Methoxyphenyl)ethanamine 
hydrochlorid (88) was received as a white solid. Yield: 118.9 mg (0.634 mmol, 88%). 1H 
NMR (400 MHz, D2τ) δ = 7.γ0 (d, J = 8.6 Hz, 2H), 7.03 (d, J = 8.7 Hz, 2H), 3.85 (s, 3H), 
3.26 (t, J = 7.3 Hz, 2H), 2.96 (t, J = 7.3 Hz, 2H), 1.37 (s, 1H). 13C NMR (101 MHz, D2τ) = δ 
157.99, 130.14, 129.15 (2 C), 114.51 (2 C), 55.40, 40.70, 31.86. 
Analytical data match to the reported data.167 
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7-Methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (106). 
 
Benzoazepinone 105c (93 mg, 0.376 mmol) was dissolved in 4 ml trifluoroacetic acid and 
heated under reflux conditions for 13 h. TFA was removed under reduced pressure and brown 
oil was purified by flash chromatography (hexanes/EtOAc = 2:1 to EtOAc) on deactivated 
silica (pretreated with 10% Et3N in hexanes) to give 61.8 mg (0.323 mmol, 86%) of 
compound 106 as pale beige solid. IR (neat):3340, 3250, 3056, 2956, 2866, 1689, 1644, 1607, 
1498, 1461, 1402, 1361, 1312, 1262, 1208, 1152, 1036, 973, 831, 798, 719 cm-1. 1H NMR 
(300 MHz, CDCl3) δ = 7.67 (d, J = 8.5 Hz, 1H), 6.83 (dd, J = 8.5, 2.6 Hz, 1H), 6.70 (d, J = 
2.5 Hz, 1H), 3.83 (s, 3H), 3.11 (q, J = 6.5 Hz, 2H), 2.82 (t, J = 7.1 Hz, 2H), 2.00 (p, J = 6.8 
Hz, 2H). 13C NMR (75 MHz, CDCl3) δ = 174.16, 161.89, 140.74, 1γ0.96, 1β7.β0, 114.30, 
111.80, 55.33, 39.79, 30.74, 30.47. HRMS: (ES-MS) m/z calculated for C11H14NO2 [M+H]: 
192.1019, found 192.1017. 
Analytical data match to the reported data.168 
 
Methyl 4-chlorophenethylcarbamate (262). 
 
Compound 85c (87.0 mg, 0.809 mmol) was dissolved in TFA (5 ml) and stirred at room 
temperature for 15 h. The solvent was removed under reduced pressure and a yellow oil was 
isolated. Yield: 60.2 mg (0.282 mmol, 87%). 1H NMR (400 MHz, CDCl3) δ = 7.γ1 – 7.22 (m, 
2H), 7.11 (d, J = 8.3 Hz, 2H), 4.73 (s, 1H), 3.65 (s, 3H), 3.40 (d, J = 6.3 Hz, 2H), 2.77 (t, J = 
6.9 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ = 157.07, 1γ7.β1, 1γβ.γ7, 1γ0.14 (β C), 1β8.75 
(2 C), 52.18, 46.04, 42.11, 35.54, 8.53. HRMS: (APCI-MS) m/z calculated for C10H12ClNO2 
[M+H]: 214.0629, found 214.0632. 
Analytical data match to the reported data.169 
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2-(4-Chlorophenyl)ethanamine hydrochloride (111). 
 
Compound 262 (49 mg, 0.229 mmol) was dissolved in a mixture of THF, MeOH and 2 M 
LiOH (1:1:1, 3 ml) and heated at 120 °C for 10 min in a microwave oven. The reaction 
mixture was treated with ethylacetate (10 ml) and 1 M KOH solution (10 ml) and the phases 
were separated. The organic phase was extracted with 1 M HCl solution (2 x 10 ml) and the 
aqueous phase was removed under reduced pressure. 2-(4-chlorophenyl)ethanamine (111) 
was received as a white solid. Yield: 39 mg (0.203 mmol, 89%). 1H NMR (300 MHz, D2O) δ 
= 7.28 – 7.20 (m, 2H), 7.16 – 7.09 (m, 2H), 3.10 (t, J = 7.3 Hz, 2H), 2.82 (t, J = 7.3 Hz, 2H). 
13C NMR (75 MHz, D2τ) δ = 1γ5.19, 1γβ.46, 1γ0.4β (β C), 1β8.90 (β C), 40.40, γβ.1γ. 
HRMS: (ES-MS) m/z calculated for C8H11ClN [M+H]: 156.0575, found 156.0573. 
Analytical data match to the reported data.170 
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E Appendix 
1 NMR spectra 
1H-NMR (upper image) followed by 13C-NMR (lower image) spectra of new N-acyl-
oxyphthalimides and new compounds arose from photoreactions are depicted.  
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1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-4-methoxybenzamido)propanoate (74/77a). 
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1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3-methoxybenzamido)propanoate (77b). 
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1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-2-methoxybenzamido)propanoate (77c). 
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1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-4-chlorobenzamido)propanoate (77d). 
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1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3-chlorobenzamido)propanoate (77e). 
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1,3-dioxoisoindolin-2-yl 3-(4-bromo-N-tert-butylbenzamido)propanoate (77f). 
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1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-4-methylbenzamido)propanoate (77g). 
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1,3-dioxoisoindolin-2-yl 3-(N-tert-butylbenzamido)propanoate (77h). 
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1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3-chloro-4-methoxybenzamido)propanoate (77i). 
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1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-2,6-dimethoxybenzamido)propanoate (77j). 
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1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-4-methoxybenzamido)-2-methylpropanoate 
(77k). 
 
 
E  Appendix 1  NMR spectra 
 
223 
 
1,3-Dioxoisoindolin-2-yl 3-(N-tert-butylisonicotinamido)propanoate (77l). 
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1,3-dioxoisoindolin-2-yl 3-(N-tert-butyl-3,4-dimethoxybenzamido)propanoate (77m).  
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1,3-Dioxoisoindolin-2-yl 3-(N-tert-butyl-3,4,5-trimethoxybenzamido)propanoate (77n). 
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1,3-Dioxoisoindolin-2-yl 3-(4-methoxybenzamido)propanoate (81). 
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1,3-Dioxoisoindolin-2-yl 3-(4-methoxy-N-methylbenzamido)propanoate (83). 
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1,3-Dioxoisoindolin-2-yl 2-(N-tert-butyl-4-methoxybenzamido)acetate (97). 
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1,3-dioxoisoindolin-2-yl 4-(N-tert-butylbenzamido)butanoate (102a). 
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1,3-dioxoisoindolin-2-yl 4-(N-tert-butylisonicotinamido)butanoate (102b). 
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1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-4-methoxybenzamido)butanoate (102c). 
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1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-3-chloro-4-methoxybenzamido)butanoate (102d) 
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1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-3,4-dimethoxybenzamido)butanoate (102e). 
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1,3-Dioxoisoindolin-2-yl 4-(N-tert-butyl-2,4,6-trimethylbenzamido)butanoate (102f). 
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1,3-Dioxoisoindolin-2-yl 4-(N-tert-butyl-2,6-dimethoxybenzamido)butanoate (102g). 
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1,3-dioxoisoindolin-2-yl 4-(N-tert-butyl-3,4,5-trimethoxybenzamido)butanoate (102h). 
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1,3-Dioxoisoindolin-2-yl 3-(tert-butoxycarbonyl(4-methoxybenzyl)amino)propanoate 
(118). 
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(S)-4-(1,3-Dioxoisoindolin-2-yl) 1-methyl 2-(tert-butoxycarbonyl(4-methoxybenzyl)-
amino)succinate (125). 
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1,3-Dioxoisoindolin-2-yl 2-benzamidoacetate (240). 
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1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl bis(4-(N-tert-
butyl-4-methoxybenzamido)butanoate) (109). 
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1,3,6,8-Tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl bis(3-(N-tert-
butyl-3,4,5-trimethoxybenzamido)propanoate) (110). 
 
 
E  Appendix 1  NMR spectra 
 
242 
 
1,3-Dioxoisoindolin-2-yl 5-(4-methoxyphenyl)-4-methylpentanoate (127). 
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1,3-Dioxoisoindolin-2-yl 5-oxo-5-phenylpentanoate (133). 
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1,3-Dioxoisoindolin-2-yl 2-m-tolylacetate (166c). 
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1,3-Dioxoisoindolin-2-yl 2-(3,4,5-trimethoxyphenyl)acetate (166g). 
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1,3-Dioxoisoindolin-2-yl 2-(4-(dimethylamino)phenyl)acetate (166h). 
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1,3-Dioxoisoindolin-2-yl but-3-enoate (230). 
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1,3-dioxoisoindolin-2-yl 3-(2-(piperidin-1-yl)phenyl)propanoate (249). 
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Methyl tert-butyl(4-methoxyphenethyl)carbamate (85a). 
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Isopropyl tert-butyl(4-methoxyphenethyl)carbamate (85b). 
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tert-butyl tert-butyl(4-methoxyphenethyl)carbamate (85c). 
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Methyl tert-butyl(2-methoxyphenethyl)carbamate (85d). 
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Methyl tert-butyl(4-chlorophenethyl)carbamate (85e). 
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Ethyl tert-butyl(4-chlorophenethyl)carbamate (85f). 
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Isopropyl tert-butyl(4-chlorophenethyl)carbamate (85g). 
 
 
E  Appendix 1  NMR spectra 
 
256 
 
tert-butyl tert-butyl(4-chlorophenethyl)carbamate (85h). 
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Benzyl tert-butyl(4-chlorophenethyl)carbamate (85i). 
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N-tert-Butyl-N-(3-(isopropylamino)-3-oxopropyl)-4-methoxybenzamide (86a). 
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N-tert-Butyl-N-(3-(dimethylamino)-3-oxopropyl)-4-methoxybenzamide (86b). 
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N-(3-(Benzylamino)-3-oxopropyl)-N-tert-butyl-4-methoxybenzamide (86c). 
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2-tert-butyl-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105a).  
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6-tert-butyl-6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one (105b).  
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2-tert-butyl-7-methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105c).  
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2-tert-butyl-8-chloro-7-methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105d´). 
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2-tert-butyl-6-chloro-7-methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105d´´). 
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2-tert-butyl-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105e´). 
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2-tert-butyl-6,7-dimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105e´´). 
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N-tert-Butyl-2,4,6-trimethyl-N-propylbenzamide (105f). 
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N-tert-butyl-2,6-dimethoxy-N-propylbenzamide (105g). 
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2-tert-butyl-6,7,8-trimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one (105h).  
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N-tert-butyl-3,4,5-trimethoxy-N-propylbenzamide (260). 
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3-Benzyl-3-hydroxy-2-methoxyisoindolin-1-one (181). 
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2 X-ray crystallographic data 
2-tert-Butyl-6,7,8-trimethoxy-3,4-dihydroisoquinolin-1(2H)-one (80). 
 
 
 
 
 
 
Compound  M096  
    
CCDC  n/a 
Formula  C16H23NO4  
Dcalc./ g cm-3  1.260  
/mm-1  0.735  
Formula Weight  293.35  
Colour  colourless  
Shape  block  
Max Size/mm  0.17  
Mid Size/mm  0.13  
Min Size/mm  0.07  
T/K  162.46(10)  
Crystal System  orthorhombic  
Flack Parameter  0.1(4)  
Hooft Parameter  0.36(18)  
Space Group  Pca21  
a/Å  13.7745(2)  
b/Å  9.69517(16)  
c/Å  23.1634(4)  
/°  90  
/°  90  
/°  90  
V/Å3  3093.38(9)  
Z  8  
Z'  2  
min/°  3.817  
max/°  73.533  
Measured Refl.  17335  
Independent Refl.  5726  
Reflections Used  5000  
Rint  0.0379  
Parameters  474  
Restraints  1  
Largest Peak  0.259  
Deepest Hole  -0.335  
GooF  1.056  
wR2 (all data)  0.1642  
wR2  0.1529  
R1 (all data)  0.0581  
R1  0.0516  
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Table 1: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters (Å2×103) 
for M096. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
Atom x y z Ueq 
C1 -95(4) 22(3) -924(2) 19.4(10) 
C2 329(4) 98(3) -337(3) 21.3(9) 
C5 1593(4) 1(3) -1253(3) 23.1(12) 
C6 167(4) -10(3) -1984(3) 20.8(10) 
C7 -460(3) -1298(5) -2100(2) 30.1(10) 
C8 -422(3) 1316(5) -2084(2) 32.3(10) 
C9 1005(4) -21(3) -2426(2) 25.7(12) 
C12 1009(4) -154(4) 800(3) 27.9(11) 
C3 1236(3) -435(4) -223(2) 16.9(8) 
C4 1852(3) -867(5) -735(2) 21.4(10) 
C10 -209(3) 645(5) 140(2) 18.6(8) 
C11 120(3) 489(5) 700(2) 18.8(8) 
C13 1588(3) -619(6) 338(2) 18.9(9) 
C14 -1002(4) 2603(5) -239(3) 29.7(10) 
C15 -304(4) 2325(5) 1292(3) 33.0(8) 
C16 2178(4) -1048(6) 1476(3) 33.0(8) 
O2 -1066(2) 1339(4) 82(2) 21.9(8) 
O3 -413(3) 899(3) 1164.6(19) 23.9(6) 
O4 1277(3) -348(4) 1365(2) 26.5(7) 
C3A 1212(14) 390(20) -219(11) 16.9(8) 
C4A 1877(13) 900(20) -754(11) 21.4(10) 
C10A -205(13) -640(20) 139(11) 18.6(8) 
C11A 86(13) -574(18) 696(8) 18.8(8) 
C13A 1594(13) 570(20) 339(11) 18.9(9) 
C16A 2192(18) 1080(20) 1460(12) 33.0(8) 
C14A -986(15) -2620(20) -229(11) 27(4) 
C15A -286(16) -2290(20) 1311(10) 33.0(8) 
O2A -1057(12) -1354(16) 79(9) 28(4) 
O3A -395(11) -869(14) 1161(9) 23.9(6) 
O4A 1286(13) 321(19) 1355(9) 26.5(7) 
C17 2577(4) 4972(3) 1939(2) 19.7(10) 
C18 2155(4) 4896(3) 1340(3) 22.2(10) 
C21 901(4) 4983(3) 2260(3) 23.1(11) 
C22 2334(4) 5024(3) 2998(3) 22.8(11) 
C23 1513(4) 5014(3) 3431(3) 30.1(14) 
C24 2944(3) 3728(5) 3097(2) 32.3(10) 
C25 2930(4) 6322(5) 3096(2) 33.3(10) 
C28 1469(4) 5143(4) 205(3) 27.2(11) 
N1 546(3) -38(2) -1379(2) 19.1(9) 
N2 1951(3) 5023(2) 2386(2) 22.4(10) 
O1 -976(3) -8(2) -994.3(19) 26.8(9) 
O5 3479(3) 5016(2) 2001.9(18) 24.2(9) 
C30 3510(4) 2403(5) 1259(3) 31.8(12) 
C31 2809(5) 2645(5) -271(3) 45.4(13) 
O6 3566(2) 3655(4) 925.1(19) 20.9(8) 
C19 1243(3) 5435(5) 1235(3) 18.6(9) 
C20 661(3) 5858(5) 1741(2) 22.3(9) 
C26 2698(3) 4342(5) 871(2) 17.6(8) 
C27 2354(3) 4554(4) 308(2) 18.2(8) 
C29 907(3) 5633(6) 674(3) 21.4(9) 
C32 321(3) 6029(6) -471(3) 26.2(9) 
O7 2907(3) 4082(3) -157.7(19) 22.6(6) 
O8 1221(3) 5358(4) -359(2) 27.4(7) 
O7A 2910(11) 5931(15) -156(9) 27.4(7) 
O8A 1230(12) 4663(18) -365(9) 27.4(7) 
C27A 2317(12) 5350(20) 311(9) 18.2(8) 
C19A 1215(13) 4530(20) 1233(10) 18.6(9) 
C20A 689(16) 4140(20) 1730(11) 27(4) 
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Atom x y z Ueq 
C26A 2677(12) 5640(20) 875(11) 17.6(8) 
C29A 915(19) 4340(20) 672(13) 35(5) 
C32A 343(13) 4000(20) -491(11) 26.2(9) 
O6A 3585(10) 6353(15) 921(8) 21(3) 
C30A 3537(16) 7590(20) 1265(13) 31.8(12) 
C31A 2920(20) 7400(20) -221(11) 45.4(13) 
Table 2: Anisotropic Displacement Parameters (×104) M096. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
Atom U11 U22 U33 U23 U13 U12 
C1 18(2) 22(2) 18(3) -2.1(10) 3.8(19) 1.5(9) 
C2 17.5(19) 29.4(19) 17(2) -0.2(14) 2.6(17) -2.0(11) 
C5 19(3) 31(3) 18(3) 0.8(11) -0.5(19) -0.8(10) 
C6 25(3) 17(2) 20(3) 0.4(9) -1(2) -1(1) 
C7 37(2) 26.3(19) 27(2) -6.0(19) -3.8(19) -11.8(18) 
C8 36(2) 28(2) 33(2) 6(2) -4(2) 8.8(19) 
C9 28(2) 33(3) 16(3) 1.3(11) 7(2) -0.7(11) 
C12 25(2) 45(2) 14(2) 0.3(19) -1.2(17) -4.9(14) 
C3 19(2) 15(2) 17(2) 0.3(15) 1.8(15) -2.3(13) 
C4 12.4(18) 32(2) 20(2) -0.1(14) 2.1(17) 0.8(13) 
C10 17.6(19) 16.7(17) 21(2) 0.1(11) 0.4(15) -2.4(11) 
C11 18(2) 22(2) 17(2) 0.4(13) 3.8(15) -1.7(12) 
C13 13.3(19) 23(2) 20(2) 1.3(13) -1.2(16) -1.0(12) 
C14 33(2) 21.2(19) 35(3) 1.8(16) -4(2) 5.6(14) 
C15 41.5(18) 30.4(16) 27.1(18) -0.7(11) 1.0(14) -2.8(11) 
C16 41.5(18) 30.4(16) 27.1(18) -0.7(11) 1.0(14) -2.8(11) 
O2 17.0(15) 23.9(16) 25(2) 0.1(16) -0.1(14) 1.8(13) 
O3 26.0(14) 25.9(13) 19.7(15) -3.1(10) 7.4(11) -1.4(10) 
O4 27.0(15) 37.2(17) 15.4(17) 1.5(17) -4.6(12) 0.6(16) 
C3A 19(2) 15(2) 17(2) 0.3(15) 1.8(15) -2.3(13) 
C4A 12.4(18) 32(2) 20(2) -0.1(14) 2.1(17) 0.8(13) 
C10A 17.6(19) 16.7(17) 21(2) 0.1(11) 0.4(15) -2.4(11) 
C11A 18(2) 22(2) 17(2) 0.4(13) 3.8(15) -1.7(12) 
C13A 13.3(19) 23(2) 20(2) 1.3(13) -1.2(16) -1.0(12) 
C16A 41.5(18) 30.4(16) 27.1(18) -0.7(11) 1.0(14) -2.8(11) 
C14A 31(9) 30(8) 21(9) -7(6) -5(7) -2(6) 
C15A 41.5(18) 30.4(16) 27.1(18) -0.7(11) 1.0(14) -2.8(11) 
O2A 35(8) 26(7) 23(9) 11(7) -3(6) 9(6) 
O3A 26.0(14) 25.9(13) 19.7(15) -3.1(10) 7.4(11) -1.4(10) 
O4A 27.0(15) 37.2(17) 15.4(17) 1.5(17) -4.6(12) 0.6(16) 
C17 19(2) 20(2) 20(3) -0.6(10) -5(2) 0.0(9) 
C18 16.9(19) 31(2) 19(2) 0.6(15) 0.0(18) -2.9(11) 
C21 17(3) 34(3) 18(3) 1.5(11) 2.7(18) -1.1(10) 
C22 25(3) 30(2) 13(3) -0.5(10) -5(2) 1.7(10) 
C23 37(3) 34(3) 19(3) -1.3(11) -5(2) 2.4(12) 
C24 36(2) 36(2) 25(2) 5(2) -0.6(19) 7.5(19) 
C25 38(2) 37(2) 24(2) -7(2) -2.4(19) -6(2) 
C28 20(2) 43(2) 19(3) 3.4(18) 0.8(17) -1.6(14) 
N1 16(2) 25.8(19) 16(2) -1.2(9) 1.9(16) 1.0(8) 
N2 20(2) 30(2) 17(2) -1.0(9) -3.3(17) -0.7(9) 
O1 18.0(19) 38(2) 24(2) -1.6(8) -1.1(15) 0.0(8) 
O5 14.5(18) 35(2) 23(2) -1.9(8) -0.4(15) -1.1(7) 
C30 31(2) 21(2) 44(3) 2.7(16) -2(2) 4.3(14) 
C31 78(4) 26(2) 33(3) -13.5(17) 16(2) -7.6(19) 
O6 17.0(16) 22.6(16) 22.9(19) 2.1(16) 5.3(14) 6.0(13) 
C19 14.2(19) 22(2) 19(2) -0.4(15) 0.7(15) -4.1(13) 
C20 16.2(17) 28(2) 23(2) -1.8(15) 2.3(17) 0.8(14) 
C26 14.5(19) 18.7(17) 19(2) 0.2(12) 0.4(14) -2.3(10) 
C27 21(2) 16(2) 18(2) 0.5(15) 4.1(15) -4.3(13) 
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Atom U11 U22 U33 U23 U13 U12 
C29 16(2) 25(2) 23(2) 4.8(15) 0.0(15) -1.4(14) 
C32 16.3(16) 38(2) 25(2) 8.3(15) -8.4(15) -3.0(14) 
O7 25.3(13) 24.0(13) 18.4(14) -5.1(10) 4.6(11) -2.1(10) 
O8 27.4(16) 35.8(17) 19.1(18) 3.2(16) -1.3(12) 1.6(15) 
O7A 27.4(16) 35.8(17) 19.1(18) 3.2(16) -1.3(12) 1.6(15) 
O8A 27.4(16) 35.8(17) 19.1(18) 3.2(16) -1.3(12) 1.6(15) 
C27A 21(2) 16(2) 18(2) 0.5(15) 4.1(15) -4.3(13) 
C19A 14.2(19) 22(2) 19(2) -0.4(15) 0.7(15) -4.1(13) 
C20A 30(9) 28(8) 22(9) 0(6) -4(7) 7(6) 
C26A 14.5(19) 18.7(17) 19(2) 0.2(12) 0.4(14) -2.3(10) 
C29A 58(13) 15(7) 31(11) -6(6) 5(9) 7(7) 
C32A 16.3(16) 38(2) 25(2) 8.3(15) -8.4(15) -3.0(14) 
O6A 18(6) 26(6) 19(7) -6(6) 10(5) -13(5) 
C30A 31(2) 21(2) 44(3) 2.7(16) -2(2) 4.3(14) 
C31A 78(4) 26(2) 33(3) -13.5(17) 16(2) -7.6(19) 
Table 3: Bond Lengths in Å for M096.
Atom Atom Length/Å 
C1 C2 1.482(8) 
C1 N1 1.376(7) 
C1 O1 1.224(8) 
C2 C3 1.377(7) 
C2 C10 1.432(7) 
C2 C3A 1.28(2) 
C2 C10A 1.51(2) 
C5 C4 1.507(8) 
C5 C4A 1.50(2) 
C5 N1 1.472(6) 
C6 C7 1.541(5) 
C6 C8 1.537(6) 
C6 C9 1.543(7) 
C6 N1 1.495(7) 
C12 C11 1.393(7) 
C12 C13 1.409(8) 
C12 O4 1.372(8) 
C12 C11A 1.356(18) 
C12 C13A 1.51(2) 
C12 O4A 1.42(2) 
C3 C4 1.518(7) 
C3 C13 1.398(7) 
C10 C11 1.383(7) 
C10 O2 1.365(6) 
C11 O3 1.362(6) 
C14 O2 1.436(6) 
C15 O3 1.422(6) 
C16 O4 1.438(7) 
C3A C4A 1.62(3) 
C3A C13A 1.40(3) 
C10A C11A 1.35(3) 
C10A O2A 1.37(2) 
C11A O3A 1.30(3) 
C16A O4A 1.47(3) 
C14A O2A 1.42(3) 
C15A O3A 1.43(3) 
C17 C18 1.506(8) 
C17 N2 1.348(7) 
C17 O5 1.251(8) 
C18 C19 1.382(7) 
C18 C26 1.423(7) 
Atom Atom Length/Å 
C18 C19A 1.367(18) 
C18 C26A 1.48(2) 
C21 N2 1.476(6) 
C21 C20 1.508(8) 
C21 C20A 1.51(2) 
C22 C23 1.512(8) 
C22 C24 1.529(6) 
C22 C25 1.520(6) 
C22 N2 1.513(7) 
C28 C27 1.368(7) 
C28 C29 1.416(8) 
C28 O8 1.367(8) 
C28 O8A 1.44(2) 
C28 C27A 1.210(18) 
C28 C29A 1.54(3) 
C30 O6 1.441(7) 
C31 O7 1.424(6) 
O6 C26 1.375(6) 
C19 C20 1.477(8) 
C19 C29 1.395(7) 
C26 C27 1.402(7) 
C27 O7 1.398(6) 
C32 O8 1.425(6) 
O7A C27A 1.47(2) 
O7A C31A 1.43(2) 
O8A C32A 1.41(2) 
C27A C26A 1.43(3) 
C19A C20A 1.41(3) 
C19A C29A 1.38(3) 
C26A O6A 1.43(2) 
O6A C30A 1.44(3) 
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Table 4: Bond Angles in ° for M096
Atom Atom Atom Angle/° 
N1 C1 C2 116.9(5) 
O1 C1 C2 120.9(5) 
O1 C1 N1 122.2(6) 
C1 C2 C10A 117.1(9) 
C3 C2 C1 120.9(5) 
C3 C2 C10 117.4(5) 
C10 C2 C1 121.5(5) 
C3A C2 C1 125.6(12) 
C3A C2 C10A 114.4(15) 
N1 C5 C4 112.1(4) 
N1 C5 C4A 115.1(8) 
C7 C6 C9 107.3(4) 
C8 C6 C7 110.8(5) 
C8 C6 C9 107.5(4) 
N1 C6 C7 110.1(4) 
N1 C6 C8 109.9(4) 
N1 C6 C9 111.1(4) 
C11 C12 C13 120.9(6) 
O4 C12 C11 117.2(5) 
O4 C12 C13 121.9(5) 
C11A C12 C13A 120.9(13) 
C11A C12 O4A 120.7(12) 
O4A C12 C13A 110.3(11) 
C2 C3 C4 117.5(5) 
C2 C3 C13 122.7(5) 
C13 C3 C4 119.8(4) 
C5 C4 C3 109.5(4) 
C11 C10 C2 120.9(4) 
O2 C10 C2 123.6(5) 
O2 C10 C11 115.4(5) 
C10 C11 C12 119.5(5) 
O3 C11 C12 118.2(5) 
O3 C11 C10 122.2(4) 
C3 C13 C12 118.0(4) 
C10 O2 C14 114.7(4) 
C11 O3 C15 113.1(4) 
C12 O4 C16 118.0(5) 
C2 C3A C4A 116.3(18) 
C2 C3A C13A 125.5(18) 
C13A C3A C4A 117.1(16) 
C5 C4A C3A 105.4(14) 
C11A C10A C2 122.0(15) 
C11A C10A O2A 112.1(18) 
O2A C10A C2 125.7(17) 
C10A C11A C12 117.5(15) 
O3A C11A C12 113.5(16) 
O3A C11A C10A 129.0(17) 
C3A C13A C12 113.2(15) 
C10A O2A C14A 115.3(17) 
C11A O3A C15A 111.1(16) 
C12 O4A C16A 122.8(17) 
N2 C17 C18 117.6(5) 
O5 C17 C18 119.5(5) 
O5 C17 N2 122.9(5) 
C19 C18 C17 119.5(5) 
C19 C18 C26 119.1(5) 
C26 C18 C17 121.2(5) 
C19A C18 C17 123.0(11) 
C19A C18 C26A 117.2(14) 
Atom Atom Atom Angle/° 
C26A C18 C17 117.2(9) 
N2 C21 C20 110.9(4) 
N2 C21 C20A 111.4(9) 
C23 C22 C24 107.8(4) 
C23 C22 C25 108.1(4) 
C23 C22 N2 111.2(4) 
C25 C22 C24 111.2(5) 
N2 C22 C24 109.4(4) 
N2 C22 C25 109.1(4) 
C27 C28 C29 119.5(6) 
O8 C28 C27 117.0(5) 
O8 C28 C29 123.1(5) 
O8A C28 C29A 111.7(12) 
C27A C28 O8A 117.6(13) 
C27A C28 C29A 114.9(15) 
C1 N1 C5 118.3(5) 
C1 N1 C6 119.5(4) 
C5 N1 C6 121.9(4) 
C17 N2 C21 118.3(5) 
C17 N2 C22 119.8(4) 
C21 N2 C22 121.7(4) 
C26 O6 C30 114.2(4) 
C18 C19 C20 117.4(5) 
C18 C19 C29 121.1(5) 
C29 C19 C20 121.4(4) 
C19 C20 C21 110.9(4) 
O6 C26 C18 124.8(5) 
O6 C26 C27 116.7(5) 
C27 C26 C18 118.5(4) 
C28 C27 C26 121.7(5) 
C28 C27 O7 119.1(5) 
O7 C27 C26 119.1(4) 
C19 C29 C28 119.2(5) 
C27 O7 C31 114.3(4) 
C28 O8 C32 117.4(4) 
C31A O7A C27A 117.6(17) 
C32A O8A C28 122.4(16) 
C28 C27A O7A 116.9(16) 
C28 C27A C26A 123.8(16) 
C26A C27A O7A 114.0(15) 
C18 C19A C20A 114.1(18) 
C18 C19A C29A 119.3(19) 
C29A C19A C20A 125.6(19) 
C19A C20A C21 114.9(17) 
C27A C26A C18 113.6(14) 
C27A C26A O6A 117.9(17) 
O6A C26A C18 127.1(17) 
C19A C29A C28 117(2) 
C26A O6A C30A 113.7(15) 
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Table 5: Torsion Angles in ° for M096.
Atom Atom Atom Atom Angle/° 
C1 C2 C3 C4 10.5(6) 
C1 C2 C3 C13 -167.8(4) 
C1 C2 C10 C11 168.4(4) 
C1 C2 C10 O2 -11.3(7) 
C1 C2 C3A C4A 8(2) 
C1 C2 C3A C13A 174.8(16) 
C1 C2 C10A C11A -176.0(15) 
C1 C2 C10A O2A -1(2) 
C2 C1 N1 C5 -1.0(4) 
C2 C1 N1 C6 -175.5(2) 
C2 C3 C4 C5 29.1(6) 
C2 C3 C13 C12 -4.2(7) 
C2 C10 C11 C12 3.0(7) 
C2 C10 C11 O3 -174.5(4) 
C2 C10 O2 C14 -62.8(6) 
C2 C3A C4A C5 -40(2) 
C2 C3A C13A C12 23(3) 
C2 C10A C11A C12 -18(3) 
C2 C10A C11A O3A 162.6(17) 
C2 C10A O2A C14A 71(2) 
C7 C6 N1 C1 -63.8(4) 
C7 C6 N1 C5 122.0(4) 
C8 C6 N1 C1 58.6(4) 
C8 C6 N1 C5 -115.6(4) 
C9 C6 N1 C1 177.5(2) 
C9 C6 N1 C5 3.2(3) 
C12 C11 O3 C15 98.7(5) 
C12 C11A O3A C15A -90.3(18) 
C3 C2 C10 C11 -7.8(7) 
C3 C2 C10 O2 172.5(4) 
C4 C5 N1 C1 41.4(5) 
C4 C5 N1 C6 -144.3(4) 
C4 C3 C13 C12 177.5(5) 
C10 C2 C3 C4 -173.3(4) 
C10 C2 C3 C13 8.5(6) 
C10 C11 O3 C15 -83.7(6) 
C11 C12 C13 C3 -1.0(7) 
C11 C12 O4 C16 178.1(4) 
C11 C10 O2 C14 117.5(5) 
C13 C12 C11 C10 1.4(7) 
C13 C12 C11 O3 179.1(4) 
C13 C12 O4 C16 0.1(7) 
C13 C3 C4 C5 -152.6(4) 
O2 C10 C11 C12 -177.3(4) 
O2 C10 C11 O3 5.1(7) 
O4 C12 C11 C10 -176.6(4) 
O4 C12 C11 O3 1.0(7) 
O4 C12 C13 C3 177.0(4) 
C3A C2 C10A C11A 22(2) 
C3A C2 C10A O2A -163.5(18) 
C4A C5 N1 C1 -35.6(11) 
C4A C5 N1 C6 138.8(11) 
C4A C3A C13A C12 -169.9(15) 
C10A C2 C3A C4A 167.9(16) 
C10A C2 C3A C13A -25(3) 
C10A C11A O3A C15A 89(3) 
C11A C12 C13A C3A -17(2) 
C11A C12 O4A C16A -165.5(17) 
C11A C10A O2A C14A -114(2) 
Atom Atom Atom Atom Angle/° 
C13A C12 C11A C10A 16(2) 
C13A C12 C11A O3A -164.5(15) 
C13A C12 O4A C16A -16(2) 
C13A C3A C4A C5 151.6(18) 
O2A C10A C11A C12 166.6(14) 
O2A C10A C11A O3A -13(3) 
O4A C12 C11A C10A 161.9(16) 
O4A C12 C11A O3A -19(2) 
O4A C12 C13A C3A -166.1(16) 
C17 C18 C19 C20 -9.7(6) 
C17 C18 C19 C29 167.2(4) 
C17 C18 C26 O6 10.1(7) 
C17 C18 C26 C27 -167.1(4) 
C17 C18 C19A C20A -4(2) 
C17 C18 C19A C29A -173.2(15) 
C17 C18 C26A C27A 171.2(12) 
C17 C18 C26A O6A 5(2) 
C18 C17 N2 C21 0.8(4) 
C18 C17 N2 C22 176.8(2) 
C18 C19 C20 C21 -30.4(6) 
C18 C19 C29 C28 6.5(8) 
C18 C26 C27 C28 -7.0(7) 
C18 C26 C27 O7 176.5(4) 
C18 C19A C20A C21 39(2) 
C18 C19A C29A C28 -26(3) 
C18 C26A O6A C30A -69(2) 
C23 C22 N2 C17 -177.2(2) 
C23 C22 N2 C21 -1.4(3) 
C24 C22 N2 C17 -58.2(4) 
C24 C22 N2 C21 117.7(4) 
C25 C22 N2 C17 63.7(4) 
C25 C22 N2 C21 -120.5(4) 
C28 C27 O7 C31 -96.6(5) 
C28 C27A C26A C18 35(3) 
C28 C27A C26A O6A -157.6(16) 
N1 C1 C2 C3 -26.6(5) 
N1 C1 C2 C10 157.3(4) 
N1 C1 C2 C3A 15.2(12) 
N1 C1 C2 C10A -144.6(9) 
N1 C5 C4 C3 -54.2(5) 
N1 C5 C4A C3A 53.3(16) 
N2 C17 C18 C19 26.6(5) 
N2 C17 C18 C26 -156.6(4) 
N2 C17 C18 C19A -17.3(11) 
N2 C17 C18 C26A 144.0(9) 
N2 C21 C20 C19 55.4(5) 
N2 C21 C20A C19A -53.5(19) 
O1 C1 C2 C3 152.3(4) 
O1 C1 C2 C10 -23.8(5) 
O1 C1 C2 C3A -165.9(12) 
O1 C1 C2 C10A 34.3(10) 
O1 C1 N1 C5 -179.8(3) 
O1 C1 N1 C6 5.7(4) 
O5 C17 C18 C19 -151.8(4) 
O5 C17 C18 C26 25.0(5) 
O5 C17 C18 C19A 164.3(11) 
O5 C17 C18 C26A -34.4(10) 
O5 C17 N2 C21 179.1(3) 
O5 C17 N2 C22 -4.9(4) 
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Atom Atom Atom Atom Angle/° 
C30 O6 C26 C18 61.8(6) 
C30 O6 C26 C27 -121.0(5) 
O6 C26 C27 C28 175.6(4) 
O6 C26 C27 O7 -0.9(6) 
C19 C18 C26 O6 -173.2(4) 
C19 C18 C26 C27 9.7(6) 
C20 C21 N2 C17 -41.0(5) 
C20 C21 N2 C22 143.2(4) 
C20 C19 C29 C28 -176.7(5) 
C26 C18 C19 C20 173.4(4) 
C26 C18 C19 C29 -9.6(7) 
C26 C27 O7 C31 80.0(6) 
C27 C28 C29 C19 -3.6(7) 
C27 C28 O8 C32 -177.2(4) 
C29 C28 C27 C26 4.0(7) 
C29 C28 C27 O7 -179.5(4) 
C29 C28 O8 C32 -4.2(7) 
C29 C19 C20 C21 152.7(5) 
O8 C28 C27 C26 177.2(4) 
O8 C28 C27 O7 -6.3(6) 
O8 C28 C29 C19 -176.4(4) 
O7A C27A C26A C18 -171.9(14) 
O7A C27A C26A O6A -4(3) 
O8A C28 C27A O7A 37(2) 
O8A C28 C27A C26A -170.9(17) 
O8A C28 C29A C19A 168.2(17) 
C27A C28 O8A C32A 160.6(17) 
C27A C28 C29A C19A 31(2) 
C27A C26A O6A C30A 125(2) 
C19A C18 C26A C27A -26(2) 
C19A C18 C26A O6A 167.4(17) 
C20A C21 N2 C17 31.9(10) 
C20A C21 N2 C22 -144.0(10) 
C20A C19A C29A C28 165.5(18) 
C26A C18 C19A C20A -165.0(17) 
C26A C18 C19A C29A 26(2) 
C29A C28 O8A C32A 25(2) 
C29A C28 C27A O7A 171.1(15) 
C29A C28 C27A C26A -36(2) 
C29A C19A C20A C21 -153(2) 
C31A O7A C27A C28 86(2) 
C31A O7A C27A C26A -69(2) 
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3-Benzyl-3-hydroxy-2-methoxyisoindolin-1-one (181). 
 
 
 
Crystal data 
Chemical formula C16H15NO3 
Mr 269.29 
Crystal system, space 
group 
Orthorhombic, P212121 
Temperature (K) 100 
a, b, c (Å) 9.0510 (18), 10.638 (2), 14.281 (3) 
V (Å3) 1375.0 (5) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 0.09 
Crystal size (mm) 0.12 × 0.08 × 0.05 
Data collection 
Diffractometer ? 
Absorption correction Multi-scan 
Tmin, Tmax 0.989, 0.995 
No. of measured, 
independent and 
observed [I > βı(I)] 
reflections 
13342, 2344, 2334  
Rint 0.111 
(sin θ/λ)max (Å−1) 0.594 
Refinement 
R[F2 > βı(F2)], wR(F2), 
S 
0.047, 0.123, 1.13 
No. of reflections 2344 
No. of parameters 186 
H-atom treatment H atoms treated by a mixture of independent and constrained 
refinement 
Δρmax, Δρmin (e Å−γ) 0.24, −0.β6 
Absolute structure Flack x determined using 987 quotients [(I+)-(I-)]/[(I+)+(I-)] 
(Parsons, Flack and Wagner, Acta Cryst. B69 (2013) 249-259). 
Absolute structure 
parameter 
0.0 (5) 
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Crystal data 
C16H15NO3 F(000) = 568 
Mr = 269.29 Dx = 1.301 Mg m−γ 
Orthorhombic, P212121 Mo Kα radiation, λ = 0.7107γ Å 
a = 9.0510 (18) Å µ = 0.09 mm−1 
b = 10.638 (2) Å T = 100 K 
c = 14.281 (3) Å Prism, colorless 
V = 1375.0 (5) Å3 0.12 × 0.08 × 0.05 mm 
Z = 4 
 
Data collection 
Absorption correction: multi-scan Rint = 0.111 
Tmin = 0.989, Tmax = 0.995 θmax = β5.0°, θmin = 2.7° 
13342 measured reflections h = −10→10 
2344 independent reflections k = −1β→1β 
2334 reflections with I > βı(I) l = −16→16 
Refinement 
Refinement on F2 Hydrogen site location: mixed 
Least-squares matrix: full 
H atoms treated by a mixture of 
independent and constrained 
refinement 
R[F2 > βı(F2)] = 0.047 
w = 1/[ı2(Fo2) + (0.0747P)2 + 
0.2092P]  
where P = (Fo2 + 2Fc2)/3 
wR(F2) = 0.123 (Δ/ı)max = 0.001 
S = 1.13 Δρmax = 0.24 e Å−γ 
2344 reflections Δρmin = −0.β6 e Å−γ 
186 parameters 
Absolute structure: Flack x 
determined using 987 quotients 
[(I+)-(I-)]/[(I+)+(I-)] (Parsons, Flack 
and Wagner, Acta Cryst. B69 (2013) 
249-259). 
0 restraints Absolute structure parameter: 0.0 (5) 
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are 
estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually 
in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between 
e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An 
approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. 
planes. 
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Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å2)  
 
x y z Uiso*/Ueq 
O1 0.43782 (17) 0.57477 (15) 0.25714 (12) 0.0173 (4) 
N1 0.5911 (2) 0.58154 (17) 0.26503 (14) 0.0132 (4) 
C9 0.3933 (3) 0.6076 (3) 0.16350 (17) 0.0232 (6) 
H1A 0.4278 0.6927 0.1488 0.035* 
H1B 0.2853 0.6047 0.1589 0.035* 
H1C 0.4364 0.5478 0.1190 0.035* 
O2 0.65760 (18) 0.79842 (16) 0.27454 (12) 0.0180 (4) 
C1 0.6585 (2) 0.6828 (2) 0.32124 (16) 0.0133 (5) 
O3 0.63180 (17) 0.37395 (15) 0.22574 (12) 0.0200 (4) 
C2 0.8153 (2) 0.6336 (2) 0.32560 (15) 0.0133 (5) 
C7 0.8227 (2) 0.5124 (2) 0.29043 (15) 0.0137 (5) 
C8 0.6738 (2) 0.4753 (2) 0.25705 (15) 0.0148 (5) 
C6 0.9542 (3) 0.4464 (2) 0.28695 (16) 0.0170 (5) 
H6 0.9575 0.3624 0.2644 0.020* 
C5 1.0812 (2) 0.5069 (2) 0.31742 (17) 0.0193 (5) 
H5 1.1734 0.4644 0.3149 0.023* 
C4 1.0747 (3) 0.6294 (2) 0.35172 (17) 0.0194 (5) 
H4 1.1630 0.6696 0.3716 0.023* 
C3 0.9412 (3) 0.6941 (2) 0.35737 (16) 0.0158 (5) 
H3 0.9366 0.7769 0.3822 0.019* 
C10 0.5835 (3) 0.6925 (2) 0.41836 (17) 0.0175 (5) 
H10A 0.6398 0.7527 0.4574 0.021* 
H10B 0.4826 0.7267 0.4102 0.021* 
C11 0.5736 (3) 0.5685 (2) 0.46938 (16) 0.0169 (5) 
C12 0.4445 (3) 0.4975 (3) 0.46567 (16) 0.0211 (5) 
H12 0.3608 0.5298 0.4336 0.025* 
C13 0.4360 (3) 0.3809 (3) 0.50777 (18) 0.0279 (6) 
H13 0.3468 0.3340 0.5047 0.034* 
C14 0.5577 (3) 0.3321 (3) 0.55453 (18) 0.0292 (7) 
H14 0.5525 0.2515 0.5829 0.035* 
C15 0.6867 (3) 0.4019 (3) 0.55950 (17) 0.0266 (6) 
H15 0.7703 0.3690 0.5915 0.032* 
C16 0.6943 (3) 0.5196 (2) 0.51793 (16) 0.0206 (5) 
H16 0.7826 0.5674 0.5226 0.025* 
H1 0.570 (4) 0.824 (3) 0.278 (3) 0.035 (9)* 
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Atomic displacement parameters (Å2)  
 
U
11
 U
22
 U
33
 U
12
 U
13
 U
23
 
O1 0.0071 (7) 0.0215 (9) 0.0231 (9) −0.00β0 (6) −0.00γ0 (6) 0.0021 (7) 
N1 0.0069 (9) 0.0131 (10) 0.0197 (9) −0.0010 (7) −0.00β8 (7) −0.0007 (8) 
C9 0.0183 (11) 0.0290 (13) 0.0224 (12) 0.0000 (10) −0.0059 (10) 0.0040 (11) 
O2 0.0142 (8) 0.0116 (8) 0.0283 (9) 0.0011 (6) −0.000γ (7) 0.0063 (7) 
C1 0.0121 (11) 0.0100 (10) 0.0179 (11) −0.001β (8) −0.00β1 (9) 0.0003 (8) 
O3 0.0163 (8) 0.0138 (9) 0.0299 (9) −0.00γ0 (6) −0.0001 (7) −0.0061 (7) 
C2 0.0133 (11) 0.0124 (11) 0.0143 (10) 0.0007 (9) 0.0014 (8) 0.0017 (8) 
C7 0.0138 (10) 0.0124 (10) 0.0149 (10) −0.0014 (9) 0.0008 (8) 0.0014 (8) 
C8 0.0138 (10) 0.0146 (12) 0.0158 (10) −0.0018 (8) 0.0010 (9) 0.0011 (9) 
C6 0.0174 (11) 0.0147 (10) 0.0189 (11) 0.0017 (9) −0.0005 (9) −0.0001 (9) 
C5 0.0136 (10) 0.0208 (11) 0.0235 (12) 0.0038 (9) 0.0007 (9) 0.0034 (10) 
C4 0.0147 (11) 0.0227 (12) 0.0209 (11) −0.00γ7 (9) −0.00β7 (9) 0.0019 (10) 
C3 0.0156 (11) 0.0132 (11) 0.0185 (11) −0.0009 (9) −0.0018 (9) −0.000γ (9) 
C10 0.0167 (11) 0.0142 (11) 0.0216 (12) 0.0032 (9) 0.0014 (9) −0.00γ5 (9) 
C11 0.0190 (12) 0.0170 (12) 0.0147 (10) 0.0013 (9) 0.0032 (9) −0.00β0 (9) 
C12 0.0165 (11) 0.0282 (12) 0.0187 (11) 0.0007 (10) 0.0027 (9) 0.0012 (10) 
C13 0.0303 (14) 0.0291 (14) 0.0244 (12) −0.0097 (11) 0.0072 (11) −0.0001 (1β) 
C14 0.0449 (17) 0.0234 (14) 0.0191 (11) 0.0003 (12) 0.0058 (11) 0.0039 (10) 
C15 0.0352 (15) 0.0281 (14) 0.0166 (11) 0.0094 (11) −0.00β8 (11) 0.0023 (10) 
C16 0.0205 (11) 0.0250 (12) 0.0162 (11) 0.0005 (10) −0.0018 (9) −0.00β0 (9) 
Geometric parameters (Å, º)  
O1—N1 1.394 (2) C5—C4 1.393 (4) 
O1—C9 1.440 (3) C4—H4 0.9500 
N1—C1 1.475 (3) C4—C3 1.394 (3) 
N1—C8 1.360 (3) C3—H3 0.9500 
C9—H1A 0.9800 C10—H10A 0.9900 
C9—H1B 0.9800 C10—H10B 0.9900 
C9—H1C 0.9800 C10—C11 1.510 (3) 
O2—C1 1.399 (3) C11—C12 1.393 (4) 
O2—H1 0.84 (4) C11—C16 1.394 (3) 
C1—C2 1.514 (3) C12—H12 0.9500 
C1—C10 1.547 (3) C12—C13 1.380 (4) 
O3—C8 1.228 (3) C13—H13 0.9500 
C2—C7 1.385 (3) C13—C14 1.388 (4) 
C2—C3 1.385 (3) C14—H14 0.9500 
C7—C8 1.483 (3) C14—C15 1.386 (4) 
C7—C6 1.383 (3) C15—H15 0.9500 
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C6—H6 0.9500 C15—C16 1.388 (4) 
C6—C5 1.387 (3) C16—H16 0.9500 
C5—H5 0.9500 
  
N1—O1—C9 109.96 (17) C4—C5—H5 119.7 
O1—N1—C1 119.56 (17) C5—C4—H4 119.4 
C8—N1—O1 119.88 (18) C5—C4—C3 121.3 (2) 
C8—N1—C1 115.12 (18) C3—C4—H4 119.4 
O1—C9—H1A 109.5 C2—C3—C4 117.7 (2) 
O1—C9—H1B 109.5 C2—C3—H3 121.2 
O1—C9—H1C 109.5 C4—C3—H3 121.2 
H1A—C9—H1B 109.5 C1—C10—H10A 108.8 
H1A—C9—H1C 109.5 C1—C10—H10B 108.8 
H1B—C9—H1C 109.5 H10A—C10—H10B 107.7 
C1—O2—H1 105 (2) C11—C10—C1 113.58 (18) 
N1—C1—C2 99.07 (17) C11—C10—H10A 108.8 
N1—C1—C10 110.81 (18) C11—C10—H10B 108.8 
O2—C1—N1 112.34 (18) C12—C11—C10 120.4 (2) 
O2—C1—C2 109.20 (17) C12—C11—C16 118.3 (2) 
O2—C1—C10 111.46 (18) C16—C11—C10 121.3 (2) 
C2—C1—C10 113.40 (17) C11—C12—H12 119.4 
C7—C2—C1 110.60 (18) C13—C12—C11 121.2 (2) 
C7—C2—C3 120.8 (2) C13—C12—H12 119.4 
C3—C2—C1 128.6 (2) C12—C13—H13 120.0 
C2—C7—C8 108.69 (18) C12—C13—C14 120.1 (3) 
C2—C7—C6 121.8 (2) C14—C13—H13 120.0 
C6—C7—C8 129.5 (2) C13—C14—H14 120.2 
N1—C8—C7 104.62 (18) C15—C14—C13 119.6 (2) 
O3—C8—N1 126.1 (2) C15—C14—H14 120.2 
O3—C8—C7 129.2 (2) C14—C15—H15 119.9 
C7—C6—H6 121.1 C14—C15—C16 120.2 (2) 
C7—C6—C5 117.8 (2) C16—C15—H15 119.9 
C5—C6—H6 121.1 C11—C16—H16 119.6 
C6—C5—H5 119.7 C15—C16—C11 120.7 (2) 
C6—C5—C4 120.6 (2) C15—C16—H16 119.6 
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3 List of abbreviations 
Å angstrom 
abs absolute 
Ac acetyl 
alk alkyl 
Ar aryl 
ATRA atom transfer radical addition 
BDMAP 1,6-bis(dimethylamino)-
pyrene 
Boc tert-butyloxycarbonyl 
Bn benzyl 
BNAH 1-benzyl-1,4-
dihydronicotinamide 
bpy 2,2´-bipyridine, 2,2´bipyridyl 
13C-NMR carbon NMR 
°C degrees Celsius 
CAN ceric ammonium nitrate 
Cbz carboxybenzyl 
CFL compact fluorescent lamp 
CI chemical ionization 
cm centimeter 
cm-1 wavenumber(s) 
conc. concentrated 
CT charge transfer 
d day(s); doublet (spectral) 
DABCO 1,4-diazabicyclo[2.2.2]octane 
dap dianisol phenanthrolin 
DCM dichloromethane 
DCC N-N´-
dicyclohexylcarbodiimide 
dF(CF3)ppy 2-(2,4-difluorophenyl)-5-
trifluoromethylpyridine 
DIPEA N,N-diisopropylethylamine 
DME dimethyl ether 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
dtb-bpy 4-4´-di-tert-butyl-2,2´-
bipyridine 
E1/2 standard reduction potential 
EA electron acceptor 
ED electron donor 
EDA electron donor acceptor 
e. g. for example 
equiv. equivalents 
ET energy transfer 
Et ethyl 
et al. and others (co-authors) 
EtOAc ethyl acetate 
ESI electrospray ionization 
eV electron volt 
EWD electron withdrawing 
fac facial 
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g gram(s) 
GC gas chromatography 
1H-NMR proton NMR 
h hour 
hal halogen 
hν light 
hp high pressure 
HRMS high resolution mass 
spectrometry 
Hz Hertz 
IET intramolecular electron 
transfer  
IR infrared spectroscopy 
iPr iso-propyl 
iPrOH iso-propyl alcohol 
J coupling constant (in NMR 
analysis) 
k kilo 
l liter 
LED light emitting diode 
λmax max. UV-vis wavelength 
m meter; milli; multiplet 
(spectral) 
M molar (moles per liter) 
µ micro 
max maximum 
Me methyl 
MeCN acetonitrile 
min minute(s) 
ml milliliter 
mol mole(s) 
mp melting point 
MS mass spectrometry 
NEt3 triethylamine 
NMR nuclear magnetic resonance 
Nu nucleophile 
OQ oxidative quencher 
PC photocatalyst 
PET photoinduced electron 
transfer 
Ph phenyl 
Phth phthaloyl 
ppm parts per million 
ppy 2-phenylpyridine 
q quartet (spectral) 
R arbitrary residue 
redox reduction-oxidation 
Ref reference 
Rf retention factor 
RQ reductive quencher 
room temp. room temperature 
rt Raumtemperatur 
s second(s) 
sat. saturated 
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SCE saturated calomel electrode 
t triplet (spectral) 
tBu tert-butyl 
temp. temperature 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMS trimethylsilyl 
UV ultra violet 
UV-Vis ultraviolet-visible absorption 
spectroscopy 
vis. visible 
vs versus 
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